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Abstract 
 
Gangliosides are a family of sialic acid-containing glycosphingolipids that are 
enriched in the nervous system. They are located in the outer leaflet of the 
plasma membrane within lipid rafts and are thought to be involved in numerous 
cellular events, including proliferation, differentiation, migration and neurite 
outgrowth.  Gangliosides have also been shown to have neuroprotective actions 
and have been considered as candidates for the treatment of several 
neurodegenerative disorders.     
In this thesis, the role of gangliosides in glial proliferation, migration and 
differentiation as well as the regeneration of the olfactory system and 
myelination were studied using mice lacking enzymes involved in ganglioside 
biosynthesis.  Regeneration of the olfactory system in ganglioside knockout mice 
was similar to that of wild-type mice.  However, proliferation of olfactory 
ensheathing cells grown on collagen and the migration of Schwann cells grown 
on laminin or collagen was increased in Sia T -/- mice, which lack b-series 
gangliosides but have increased levels of a-series gangliosides.  These findings 
suggest that complex gangliosides modulate glial cell function to some extent. 
However, since the effects observed were subtle, it is possible that simpler 
gangliosides are able to compensate for the lack of complex gangliosides. 
Axonal density and myelination were unaffected in ganglioside knockout mice. 
However, the localisation of sodium channels at the node of Ranvier and 
potassium channels at juxtaparanode was retarded in GalNAc T -/- mice lacking 
all complex gangliosides, suggesting that complex gangliosides modulate the 
formation of nodes of Ranvier.  In addition, GalNAc T -/- mice had significantly 
lower numbers of NG2 positive early oligodendrocyte progenitors compared to 
wild-type and Sia T -/- mice, suggesting that complex gangliosides may affect 
early progenitor differentiation, proliferation or survival. 
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CHAPTER 1 
Introduction 
  2 
1.1 Gangliosides 
Gangliosides are a class of cell surface glycosphingolipids that are particularly 
enriched in neuronal and glial membranes.  As a result, they are thought to play 
an important role in the function of the nervous system.  Since their discovery in 
the 1940s by Ernst Klenk (Klenk, 1942), gangliosides have been associated with a 
number of biological processes.  However, very little is known about their role in 
glial cell biology. 
1.1.1 Nomenclature, structure and biosynthesis 
Glycosphingolipids are defined by their core oligosaccharide sequence and are 
divided into ganglio-, hemato-, lacto- and globo-series (Miljan and Bremer, 
2002).  Gangliosides are a family of anionic glycosphingolipids that carry one or 
more sialic (neuraminic) acid residues.  The sialic acid is usually N-acetyl-
neuraminic acid, but can also be N-glycosyl-neuraminic acid (Tettamanti and 
Riboni, 1994).  Gangliosides are ubiquitously expressed in embryonic and adult 
tissues of vertebrates but are highly enriched in the nervous system (Ledeen et 
al., 1976).  The majority of complex gangliosides are found in the outer leaflet 
of plasma membranes in structures termed “lipid rafts” (Pande, 2000), such that 
the polar sugar moiety protrudes into the extracellular space.  However, simple 
gangliosides are ubiquitously distributed to mitochondria, endoplasmic reticulum 
(ER), Golgi, lysosomes and the plasma membrane (Caputto et al., 1976, Maccioni 
et al., 1977, Miller-Podraza and Fishman, 1982, Riboni et al., 1994, Trinchera et 
al., 1990).  Gangliosides can be shed from the membrane (Chang et al., 1997) 
and are also found in non-cell-associated forms in plasma and cerebrospinal fluid 
(Bergelson, 1995).   
The nomenclature commonly used for naming gangliosides was proposed by 
Svennerholm (1994).  Briefly, gangliosides are designated G for ganglioside, 
followed by a letter M (mono-), D (di-) or T (tri-sialo), indicating the number of 
sialic acid residues, followed by an arabic numeral to indicate their 
chromatographic mobility (Svennerholm, 1994).  Gangliosides are composed of a 
hydrophobic ceramide core, immersed in the lipid membrane, linked to an 
oligosaccharide, bearing one or more sialic acid residues, which extends into the 
extracellular space (Stults et al., 1989) (Figure 1.1).  Gangliosides have a 
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common minimum-energy conformational structure in which the axis of the 
oligosaccharide chain is perpendicular to the axis of ceramide (Hakomori, 1986, 
Stromberg et al., 1991) (Figure 1.2). 
Gangliosides are synthesised by the stepwise addition of monosaccharides to 
lactosylceramide by glycotransferases in the Golgi apparatus and are then 
transported to the outer leaflet of the plasma membrane (Huwiler et al., 2000).  
The various expression patterns of gangliosides are determined by the 
combination of activated glycotransferase genes (Lloyd and Furukawa, 1998).  
The first ganglioside in the biosynthetic pathway is GM3.  GM3 is then modified 
by either β1,4-N-acetyl-galactosaminyl transferase (GalNAc T) to produce GM2 
and other a-series gangliosides or by α-2,8-sialyltransferase (Sia T) to produce 
GD3 and other b- and c-series gangliosides (Figure 1.3).  These different series 
are characterised by the number of sialic acid residues attached to the 3-
position of the inner galactose moiety: 0-series (zero), a-series (one), b-series 
(two) and c-series (three sialic acid residues) (Kolter et al., 2002).   
The sialic acids on gangliosides can be modified to give a range of different 
structures.  The most common modification in mammals is the addition of O-
acetyl esters to the hydroxyl group at the C9 position. 
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Figure 1.1. Ganglioside structure 
Structure of ganglioside GM3 (NeuAcα3Galβ4Glcβ1Cer) showing the lipid ceramide core 
embedded in the plasma membrane and the carbohydrate group (glucose and galactose) 
extending into extracellular space.  A single sialic (neuraminic) acid group is attached to the 
carbohydrate group. 
 
 
 
Figure 1.2. Ganglioside conformation. 
Minimum-energy model of gangliosides showing that the axis of carbohydrate moiety is 
perpendicular to the axis of ceramide.  Adapted from (Hakomori, 2002).   
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Figure 1.3.  Ganglioside biosynthesis pathway showing the effect of knocking out Sia T and 
GalNAc T genes.   
Most gangliosides are derived from glucosyl-ceramide.  Addition of galactose to glucosyl-
ceramide forms lactosyl-ceramide (LacCer).  A 'second sugar substitution' of LacCer, at its' 
galactose in 3-position by a mono-, bis- or tris-sialic acid residue distinguishes the a-, b- and c-
series gangliosides, respectively.  Further extension of this ceramide disaccharide by a third 
monosaccharide leads to the formation of different carbohydrate series.   
Disruption of Sia T results in the absence of all b- and c-series gangliosides (dashed box      ).   
Disruption of GalNAc T results in the absence of all complex gangliosides (solid box         ).  
Consequently, double knockout mice will lack all the complex gangliosides within both boxes and 
express only GM3 and GM4 gangliosides.  
CER – ceramide; LacCer – lactosylceramide  
  –  glucose;       – galactose;      – N-acetyl neuraminic acid (sialic acid);  
GalNAc T - β1,4-N-acetylgalactosaminyl transferase (GM2/GD2 synthase) 
Sia T - α2,8-sialyltransferase (GD3 synthase)  
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1.1.2 Lipid rafts 
Gangliosides are not evenly distributed throughout the plasma membrane.  
Rather, they segregate into unique structures in the exoplasmic leaflet of the 
lipid bilayer.  In the literature these structures are referred to by various terms 
such as “glycosphingolipid enriched microdomains”, “detergent resistant 
membranes” and “detergent-insoluble glycolipid-rich domain”.  For simplicity, I 
shall be referring to them as “lipid rafts” throughout this thesis.  Lipid rafts are 
plasma membrane microdomains characterised by a unique lipid environment, 
enriched in glycosphingolipids and cholesterol, leading to their insolubility in 
non-ionic detergents.  However, some lipid rafts, particularly those enriched in 
proteolipid/tetraspanin, are independent of cholesterol, are soluble in Triton-X 
and are termed “glycosynapse” (Hakomori, 2002). 
Within lipid rafts, the saturated hydrocarbon chains of glycosphingolipids allow 
for cholesterol to be tightly intercalated, whereas the plasma membrane 
surrounding lipid rafts is more fluid, consisting mostly of phospholipids with 
unsaturated fatty acyl chains, and cholesterol.  As a result, lipid rafts form rigid 
platforms that move around in the lipid bilayer (Schroeder et al., 1994, Brown 
and London, 1998, , 1997).   
Presently, it is unclear as to how the inner leaflet is coupled to the lipid rafts in 
the outer leaflet.  However, it is possible that long chain fatty acids of 
sphingolipids in the outer leaflet couple the exoplasmic and cytoplasmic leaflets 
by interdigitation and that transmembrane proteins stabilise this coupling 
(Simons and Toomre, 2000).  It is thought that the inner leaflet is rich in 
phospholipids with saturated fatty acids and cholesterol (Fridriksson et al., 
1999). 
Lipid rafts are thought of as platforms coordinating the induction of signalling 
pathways since they contain many molecules involved in signal transduction, 
including numerous growth factor receptors (Harder and Simons, 1997, Iwabuchi 
et al., 1998a).  They are important as a site for the interaction between 
glycolipids and signalling molecules.  Lipid rafts can include or exclude proteins 
to variable extents and many proteins and receptors are constitutively or 
inducibly localised within them.  Proteins and receptors appear as if they are in 
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dynamic equilibrium, constantly moving in and out of lipid rafts.  When separate 
rafts cluster, receptors and other signalling molecules are exposed to new 
membrane environments enriched with specific enzymes such as kinases, 
phosphatases and possibly palmitoylases and depalmitoylases.  The 
phosphorylation state of the receptors can thus be altered, consequently 
modulating the downstream signalling pathway. 
Proteins with raft affinity include growth factor receptors associated with 
intrinsic tyrosine kinases, glycosylphosphatidylinositol (GPI)-anchored proteins 
(Brown and London, 1998, Hooper, 1999), doubly acylated proteins, such as Src-
family kinases or the α-subunits of heterotrimeric G proteins (Resh, 1999), 
cholesterol-linked and palmitoylated proteins such as Hedgehog (Rietveld et al., 
1999), and transmembrane proteins, especially palmitoylated ones (Brown and 
London, 1998).  Mutational analysis has shown that amino acids in the 
transmembrane domains near the exoplasmic leaflet are critical for inclusion 
into lipid rafts (Scheiffele et al., 1997).  Acyl lipid modifications, such as 
palmitoylation and myristoylation, can increase a protein’s affinity for rafts, but 
are not sufficient for raft association (Melkonian et al., 1999, Simons and 
Toomre, 2000).  Cross linking or oligomerisation of proteins also increases their 
affinity for rafts (Harder et al., 1998).  In addition, rafts contain a class of 
tetraspanin proteins termed proteolipids (PLs) (Kawakami et al., 2002), which 
were originally described as PL-A, B and C (Folch and Lees, 1951). 
Lipid rafts are heterogeneous and contain different ganglioside compositions.  
For instance, some are GM3-enriched (Iwabuchi et al., 1998b) while others are 
enriched in GM1 (Schnitzer et al., 1995).  The lipid raft hypothesis argues that 
the heterogeneity of lipid rafts provides important locations for cell signalling 
processes, having distinct concentrations of specific signalling molecules (Simons 
and Ikonen, 1997, Brown and London, 1998, Simons and Toomre, 2000, Munro, 
2003).   
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1.1.3 Function of gangliosides 
Initially, gangliosides were thought to be inactive components of the plasma 
membrane.  However, ganglioside storage diseases, such as Sandhoff’s disease 
(Sandhoff et al., 1968, Okada et al., 1972), where gangliosides accumulate due 
to impaired degradation pathways, result in neuronal apoptosis (Huang et al., 
1997), progressive loss of motor behaviours and a shortened life span (Sango et 
al., 1995). 
Since gangliosides are present in relatively high concentrations in neural cell 
membranes (about 5-10% of total membrane lipid), they are thought to play 
important roles in the function of the nervous system.  Numerous studies have 
been carried out to investigate the function of gangliosides in the nervous 
system and as a result many diverse functions have been suggested.  
Gangliosides have been proposed to act as modulators of transmembrane 
signalling and as a result regulate cell proliferation and induce differentiation 
(Hakomori, 1990).  They have also been implicated in the regulation of 
apoptosis, migration, neurite outgrowth, cell-cell recognition as well as acting as 
endogenous ligands for myelin associated glycoprotein (MAG).  Gangliosides are 
also thought to play a role in neuronal regeneration and in the maintenance of 
myelin.  Some of the proposed functions of gangliosides are discussed in more 
detail below. 
1.1.3.1 Proliferation 
Gangliosides were the first described tumour-associated antigens and changes in 
cellular ganglioside composition were associated with altered growth properties 
(Hakomori, 2000).  Following nerve injury, Schwann cells are stimulated to 
proliferate resulting in regeneration.  Myelin basic protein (MBP) and two 
peptides derived from MBP induce Schwann cell proliferation via GM1 and 
fibroblast growth factor receptor (FGFR) binding (Tzeng et al., 1999).  
Furthermore, cholera toxin (CTx), which is known to bind to GM1 ganglioside, is 
a potent mitogen of Schwann cell proliferation (Moss and Vaughan, 1979).  Also, 
gangliosides GM1, GD1a, GD1b and GT1b stimulate astrocyte proliferation in 
culture in the absence of serum (Katoh-Semba et al., 1986). 
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It has also been shown that Sia T gene expression in pheochromocytoma cell line 
(PC12), which results in the expression of complex b-series gangliosides, causes 
enhanced proliferation (Fukumoto et al., 2000).  Moreover, embryonic 
fibroblasts generated from sialyltransferase-I (GM3 synthase) knockout mice, 
lacking all gangliosides, showed increased proliferation (Hashiramoto et al., 
2006). 
1.1.3.2 Differentiation 
Many reports have demonstrated that gangliosides play a role in neuronal 
differentiation.  Exogenously added gangliosides induce neuritogenesis, a typical 
differentiation phenotype of neuronal cells (Schengrund, 1990, Hakomori, 1990).  
For instance, exogenous administration of gangliosides to neuro-2A 
neuroblastoma cells stimulates neurite sprouting and enhances axonal elongation 
(Roisen et al., 1981).  Also, Sia T gene expression in neuro-2A cells, resulting in 
conversion of simple gangliosides into complex b-series gangliosides, stimulates 
neurite sprouting and cholinergic differentiation (Kojima et al., 1994).  This 
conversion of simple gangliosides to more complex gangliosides may be required 
to induce the neuro-2A differentiation (Liu et al., 1997). 
Gangliosides also play a role in glial differentiation.  Rat astrocytes treated with 
CTx, which binds to GM1, rapidly convert from a flat polygonal morphology to a 
stellate morphology (Facci et al., 1988).  Ganglioside GM3 enhances the 
formation of processes by mature oligodendrocytes in culture (Yim et al., 1991).  
In addition, optimal concentrations of GM3 change the morphology of 
oligodendrocytes from having a complex network of long processes with a few 
fine branches to networks of very thick processes near the cell bodies with many 
more fine processes (Yim et al., 1994).  Furthermore, GM3 induces a 
redistribution of O4 and O1 antigens from cell bodies to a network of thick 
processes surrounding the cells (Yim et al., 1994).  GM3 increases synthesis of 
sulphatide, galactocerebroside (GalC) and MAG, which are present in initial 
stages of myelination but has no effect on the synthesis of MBP, which is a major 
component of compact myelin suggesting that GM3 affects a relatively early 
stage in the preparation of oligodendrocytes to myelinate (Yim et al., 1994).   
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1.1.3.3 Apoptosis 
Changes in ganglioside concentration, localisation, and composition can lead to 
the activation of an ER stress response and mitochondrial apoptotic signalling 
that trigger cell death under physiological or pathological conditions (d'Azzo et 
al., 2006). 
GD3 is a minor ganglioside in normal adult brains (Ellison and de Vellis, 1995, 
Goldman and Reynolds, 1996, Molander et al., 2000), but is expressed in 
activated microglia (Andersson et al., 1998, Wolswijk, 1995) and in reactive 
astrocytes (Kawai et al., 1994).  Upon exposure to inflammatory stimuli, 
microglia secrete GD3, which triggers apoptosis in oligodendrocytes (Simon et 
al., 2002).  It has been shown that GD3 induces opening of the mitochondrial 
permeability transition pore complex, with the consequent release of 
apoptogenic factors (Malisan and Testi, 2002).   
GD3-mediated apoptosis is cell type specific.  Although it has been shown to 
cause apoptosis in many different cell types, such as oligodendrocytes, many cell 
types, such as astrocytes, are resistant to GD3-mediated apoptosis (Simon et al., 
2002).   
1.1.3.4 Cell adhesion and migration  
Cell adhesion to extracellular matrix molecules is a crucial step in cell 
migration.  Cell adhesion and migration can either be enhanced or suppressed by 
gangliosides, depending on the ganglioside species and/or cell type specificity.  
For instance, GM3 has been shown to increase migration in several cell types, 
such as in corneal epithelium (Yang et al., 1996), while decreasing migration in 
others.  GM3 and GM2 enhance migration of melanoma cells through artificial 
basement membrane, while GT1b, GD1b, GT1a and GM1 have no effect, 
suggesting a possible role for tumour gangliosides during invasion of metastatic 
tumour cells through basement membrane of the surrounding tissues in vivo 
(Saha et al., 2005).  In contrast, suppression of Sia T expression, which results in 
a marked decrease in the concentration of GD3 and a concomitant increase in 
GM3, greatly reduces tumour cell migration (Zeng et al., 2000).  In addition, 
GM3 and GT1b inhibit carcinoma cell migration (Wang et al., 2005) , while 
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membrane GM3 enrichment of retinal Mϋller glia significantly inhibits fibroblast 
growth factor (FGF)-induced proliferation and migration, while having much less 
effect on analogous epidermal growth factor (EGF)-mediated functions (Meuillet 
et al., 1996).  
The simple ganglioside GD3 is considered a marker for cell division and migration 
during embryonic development (Hilbig et al., 1983).  Adhesion of glioma cells to 
fibronectin, laminin, vitronectin and collagen I is enhanced by exogenous 
addition of GD3, GM1, GD1a, GD1b or GT1b and, in vitro, gangliosides generally 
promote glioma cell and foetal brain cell migration while inhibiting their 
proliferation (Merzak et al., 1995a, Merzak et al., 1995b).  A2B5 which binds to 
gangliosides GT3, O-acetyl GT3 (Dubois et al., 1990, Fenderson et al., 1987) and 
GQ1c (Kasai and Yu, 1983) inhibits the adhesion of glioma cells to fibronectin, 
laminin, vitronectin and collagen I (Merzak et al., 1995b) and inhibits glioma cell 
invasion in vitro (Merzak et al., 1994).  Moreover, inhibition of ganglioside 
biosynthesis by an inhibitor of glucosyl-ceramide synthase reduces laminin-
mediated attachment and migration in carcinoma cells, but has no effect on 
fibronectin-mediated attachment and migration (Inokuchi et al., 1990).  In 
contrast, GM3 and GD3 purified from human melanoma tumours impair the 
migration of Langerhans cells, the first immune barrier against the tumour cells.  
Also, GD3 and GD2 inhibit melanoma and neuroblastoma cell attachment to 
collagen, vitronectin, laminin, fibronectin (Cheresh et al., 1986).  
A lung cancer cell line transfected with GalNAc T and thus expressing more 
complex gangliosides showed decreased adhesion to fibronectin as well as 
reduced migration (Chen et al., 2003).  In accordance, GT1b inhibits 
keratinocyte adhesion and migration on a fibronectin matrix, but does not affect 
the adhesion or migration of keratinocytes on other matrices such as laminin or 
collagen IV (Paller et al., 1995).  GD3 also inhibits keratinocyte adhesion to 
fibronectin (Wang et al., 2001a), while endogenous accumulation of GM3 inhibits 
their adhesion to fibronectin as well as collagen I, IV and VII (Wang et al., 2003).  
Contrastingly, FGF combined with complex gangliosides GM1, GD1b or GT1b 
synergistically accelerates endothelial migration (De Cristan et al., 1990).   
Granule neurons maintained under thyroid hormone deficient conditions fail to 
migrate and have reduced levels of GM1 (Chakraborty et al., 1992).  In addition, 
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anti-GM1 antibody inhibits granule neuron migration which suggests that reduced 
levels of GM1 may be partially responsible for the failure of granule neurons to 
migrate during development in hypothyroidism (Chakraborty et al., 1992).  
During T lymphocyte migration GM3- and GM1-enriched lipid rafts redistribute to 
the leading edge and uropod, respectively, suggesting that these are involved in 
the redistribution of molecules needed for T cell migration (Gomez-Mouton et 
al., 2001). 
In peroxisome biogenesis disorders, characterised by disturbances in the 
differentiation of neural cells, such as migration arrest, increased a-series 
gangliosides GM2, GM1 and GD1a, are observed in fibroblasts of patients, but are 
absent in normal fibroblasts (Tatsumi et al., 2001).  Moreover, GD1a, which is 
highly expressed in poorly metastatic FBJ-S1 cells, has been shown to inhibit the 
serum-induced migration capability of highly metastatic FBJ-LL cells and to 
reduce their adhesion to vitronectin (Hyuga et al., 1997, Hyuga et al., 1999).  
However, membrane GD1a enrichment of endothelial cells enhances vascular 
endothelial growth factor (VEGF)-induced proliferation and migration (Lang et 
al., 2001) and lowers the threshold for VEGF signalling (Liu et al., 2006).   
9-O-acetyl GD3 is localised to the membrane of neurons and glial cells and is 
expressed in regions of cell migration and neurite outgrowth in the developing 
and adult rat nervous system (Mendez-Otero and Santiago, 2003).  In addition, 
olfactory ensheathing glia express 9-O-acetyl GD3 and their migration is largely 
impaired by immunoblockage (Calvacante and Santos-Silva, 2003).  Furthermore, 
an in vivo study demonstrated that immunoblockage of 9-O-acetyl GD3 can 
prevent cerebellar granule neuron migration (Santiago et al., 2004).   
1.1.3.5 Neurite outgrowth 
Gangliosides have also been implicated in the regulation of neurite outgrowth.  
For instance, MAG binds to GD1a and GT1b to inhibit neurite outgrowth 
(McKerracher et al., 1994, Mukhopadhyay et al., 1994).  In addition, elongation 
of neurites extended by neurons of embryonic rat dorsal root ganglia explants 
grown on laminin is halted in the presence of Jones monoclonal antibody which 
binds to 9-O-acetyl GD3 (Mendez-Otero and Friedman, 1996).  Moreover, sialic 
acid residues on astrocytes regulate neuritogenesis by controlling the assembly 
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of laminin matrices (Freire et al., 2004).  Freire et al (2004) showed that 
embryonic astrocytes supported neuritogenesis with higher efficiency than 
astrocytes isolated from newborn animals and that this difference in the 
neuritogenic potential correlated with the organization of the laminin matrices 
deposited by astrocytes.  Films of either a mixture of gangliosides or pure 
ganglioside GT1b induced formation of matrices of morphological and functional 
features similar to the matrices deposited by embryonic astrocytes, whereas 
films of phosphatidylcholine or ganglioside GM1 led to the formation of bulky 
laminin aggregates that lacked a defined structure similar to matrices deposited 
by new-born astrocytes (Freire et al., 2004). 
1.1.3.6 Myelin stability 
MAG is a sialic acid binding lectin that is found selectively on the myelin 
membranes of Schwann cells and oligodendrocytes directly apposed to the 
surface of the axon.  MAG is a minor constituent of myelin and is thought to 
mediate axonal-glial interactions (Trapp et al, 1989; Trapp, 1990; Fruttiger et 
al, 1995; Yin et al, 1998).  MAG appears to act both as a ligand for an axonal 
receptor that is needed for the maintenance of myelinated axons (Schachner and 
Bartsch, 2000) and as a receptor for an axonal signal that promotes the 
differentiation, maintenance and survival of oligodendrocytes (Quarles, 2007).  
MAG also functions as an inhibitor of nerve regeneration acting through a 
receptor complex involving the Nogo receptor and/or gangliosides containing 
2,3-linked sialic acid (Mukhopadhyay et al., 1994, McKerracher et al., 1994).   
In order to elicit these physiological effects, MAG is thought to bind to specific 
targets on the axon of the nerve cell.  Studies have demonstrated that 
gangliosides on the axon surface act as functional MAG ligands (Vyas and 
Schnaar, 2001, Vyas et al., 2002).  MAG binds to the terminal sequence found on 
the major nerve gangliosides GD1a and GT1b (Collins et al., 1997).  Binding of 
MAG to GD1a and GT1b induces the association of low affinity neurotrophin 
receptor p75 (p75NTR) to lipid rafts and induces signal transduction (Fujitani et 
al., 2005).  Antibody cross-linking of cell surface GT1b, but not GD1a, mimics 
the effect of MAG, in that neurite outgrowth is inhibited through activation of 
Rho kinase, which suggests that interaction with GT1b on the neuronal cell 
surface is a potential mechanism for inhibition of neurite outgrowth by MAG 
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(Vinson et al., 2001).  Accordingly, MAG does not inhibit neurite outgrowth of 
postnatal cerebellar neurons from mice lacking complex gangliosides such as 
GD1a and GT1b (Fujitani et al., 2005).   
Because of their role as MAG ligands, gangliosides are thought to be important in 
myelin stability.  Indeed, it was found that in mice lacking complex gangliosides, 
myelin sheaths were not tightly wrapped around the axon and were separated 
from the axolemma by wide spaces (Ma et al., 2003).  Vacuolated nerve fibres, 
axonal atrophy, redundant myelin sheaths as well as a decrease in the number of 
myelinated fibres were also observed (Ma et al., 2003).  In addition, mice 
lacking complex gangliosides display progressive and selective loss of MAG from 
the brain (Sun et al., 2004).  Moreover, mice lacking complex gangliosides, mice 
lacking MAG and mice lacking both MAG and complex gangliosides (double-null 
mice) exhibit similar neuropathological and behavioural deficits, which supports 
the hypothesis that MAG binding to gangliosides contributes to long-term axon-
myelin stability (Pan et al., 2005).  All three exhibited quantitatively and 
qualitatively similar central and peripheral axon degeneration and nearly 
identical decreases in axon diameter and neurofilament spacing and displayed 
similar motor behavioural deficits, with double-null mice only modestly more 
impaired (Pan et al., 2005). 
1.1.3.7 Regeneration 
Gangliosides play a role in neurite outgrowth during regeneration as well as 
during development.  Gangliosides also have a neurotrophic role (Schengrund, 
1990) and have been administered to experimental animals after generating 
artificial neurological damage or disorders by mechanical or chemical 
manipulation (Karpiak, 1984, Karpiak and Mahadik, 1984), by the injection of 
toxic reagents (Schneider et al., 1992) or by ischemic treatment (Karpiak et al., 
1986).  These studies showed that exogenously added gangliosides enhance 
nerve regeneration.   
Gangliosides have been shown to prevent glutamate and kainate neurotoxicity in 
primary neuronal cultures of neonatal rat cerebellum and cortex (Favaron et al., 
1988).  In addition, ganglioside GT1b prevents neuronal death and promotes 
regeneration of a lesioned rat hypoglossal nerve (Itoh et al., 2001).  GD1b, 
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GD1a, GQ1b, and GM1 also had the ability to promote regeneration but were not 
as effective (Itoh et al., 2001).  Furthermore, 9-O-acetyl GD3 expression was 
upregulated during the regeneration of crushed sciatic nerves, suggesting that 9-
O-acetyl GD3 may also play a role in neurite outgrowth during regeneration 
(Mendez-Otero and Santiago, 2003).  Moreover, passive transfer of anti-GD1a 
antibody severely inhibits axon regeneration after peripheral injury in mice 
(Lehmann et al., 2007). 
1.1.3.8 Signalling  
Many functional effects of gangliosides are based on their interaction with 
specific target molecules within lipid rafts.  Examples of such interactions 
include:  
(i) Interaction with and activation of signal transducers including Src family 
kinases and small G-proteins to initiate signal transduction (Sorice et al., 1997, 
Yamamura et al., 1997, Iwabuchi et al., 1998a, Iwabuchi et al., 1998b); 
(ii) Modulation of growth factor receptors with intrinsic tyrosine kinases in order 
to modulate cell growth (Bremer et al., 1986, Nojiri et al., 1991, Yates et al., 
1993, Mutoh et al., 1995, Yates and Rampersaud, 1998) 
(iii) Interaction with integrin receptors to modulate cell adhesion and motility 
(Cheresh et al., 1987, Zheng et al., 1993); 
(iv) Formation of complexes with tetraspanins to affect complex formation with 
integrin or with growth factor receptor (Ono et al., 2001, Kawakami et al., 
2002, Toledo et al., 2005); 
(v) Carbohydrate-to-carbohydrate interaction with other glycosphingolipids to 
mediate cell to cell adhesion; 
(vi) Acting as receptors for microbial toxins, thus mediating the interaction of 
microbes with host cells during infection. 
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1.1.3.9 Regulation of growth factor receptors 
Growth factors are proteins which act as signalling molecules between cells.  
They exert their effects by binding to specific receptors on the surface of their 
target cells.  Growth factors play essential roles in the regulation of a variety of 
cellular processes such as proliferation and differentiation.  Numerous studies 
report the effects of gangliosides on growth factor receptors.  Indeed most, if 
not all, growth factor receptors have been described as regulated by 
gangliosides.  As mentioned previously, gangliosides are found within lipid rafts, 
hence why they are thought to play a role in signal transduction.  The discovery 
that growth factor receptor activity can be modulated by gangliosides suggested 
a mechanism by which they could cause changes in growth and differentiation.  
The following is a description of the effects of gangliosides on neurotrophin 
receptor, tropomyosin-related kinase A (TrkA), epidermal growth factor receptor 
(EGFR), FGFR and platelet-derived growth factor receptor (PDGFR) (Summarised 
in Figure 1.4).  
1.1.3.9.1 Nerve growth factor receptor, TrkA 
Nerve growth factor (NGF) is a member of the neurotrophin family of growth 
factors that includes brain derived neurotrophic factor (BDNF), neurotrophin-3 
(NT-3), and NT-4.  All neurotrophins bind to p75NTR, whereas NGF, BDNF and NT-
3 also bind to the high affinity receptors TrkA, TrkB and TrkC, respectively.   
A number of studies have been performed to investigate the effects of 
gangliosides on the function of nerve growth factor receptors.  The rat PC12 cell 
line has been extensively utilised as a differentiation model of neuronal cells, 
since they show neurite extension following NGF stimulation (Greene and 
Tischler, 1976).  TrkA is a high affinity NGF receptor containing tyrosine kinase 
activity, which together with p75NTR mediates the effects of NGF.  Binding of 
neurotrophins to TrkA induces activation of the receptor tyrosine kinase, 
dimerisation and autophosphorylation, and initiates a complex cascade of signal 
transduction events.  Extracellular signal-regulated kinase (Erk) subfamily of 
structurally related serine–threonine kinases, known as mitogen-activated 
protein kinases (MAPKs), which convert extracellular stimuli to intracellular 
signals that control gene expression (Schaeffer and Weber, 1999), is activated in 
response to TrkA stimulation via the small G proteins, Ras and Rap1 (Grewal et 
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al., 1999).  The Erk1 and Erk2 isoforms are thought to mediate some of the 
survival and differentiative effects of neurotrophins in specific subsets of both 
peripheral and central neurons (Klesse and Parada, 1999). 
Exogenous GM1 tightly binds to TrkA on the surface of PC12 cells and enhances 
TrkA phosphorylation as well as neurite formation when added with a low 
concentration of NGF (Mutoh et al., 1995).  Also, GM1 enhances NGF-generated 
TrkA phosphorylation and dimerization (Rabin and Mocchetti, 1995, Farooqui et 
al., 1997).  In addition, GM1 could rescue PC12 cells from apoptotic death 
induced by serum deprivation (Ferrari et al., 1995).  Furthermore, GM1 alone 
was able to induce the phosphorylation and activation of TrkA and Erks in glioma 
cells expressing TrkA (Rabin and Mocchetti, 1995).  
Duchemin et al (2002) demonstrated that GM1 induces tyrosine phosphorylation 
of TrkA, TrkB and TrkC high-affinity receptors for neurotrophins, and initiates 
signal transduction resulting in activation of the MEK1/2/Erk1/2 pathway in rat 
brain slices.  However, high concentrations of GM1 (>500 µM) attenuate this 
response.  Other major gangliosides present in brain GD1a, GD1b, GT1b as well 
as GM2 and GM3 display a similar action when added to brain slices.  They also 
showed that GM1 induces tyrosine phosphorylation of TrkA and Erk1/2 in vivo 
following intracerebroventricular administration (Duchemin et al, 2002).  In 
addition, GM1 potentiates the neurotrophic effect of NGF on central cholinergic 
neurons in vivo (Cuello et al., 1989, Fong et al., 1995, Hadjiconstantinou and 
Neff, 1998). 
All of the studies mentioned above show that GM1 induces the phosphorylation 
of Trks and acts as a neurotrophin mimetic.  However, a study using PC12 cells 
transfected with GM1/GD1b/GA1 synthase cDNA (GM1 overexpressing cells) 
showed marked alterations in their response to the induced differentiation by 
NGF and in the activation of signalling molecules (Nishio et al., 2004).  These 
GM1 overexpressing cells did not form neurites after stimulation with NGF.  
Binding of [125I] NGF was not altered in these cells.  However, 
autophosphorylation of TrkA, dimer formation of TrkA and phosphorylation of 
Erk1/2 following NGF treatment were markedly suppressed in these cells.  This 
study also revealed dramatic changes in the intracellular localization of TrkA, 
p75NTR, and Ras in GM1 overexpressing cells.  Most of TrkA, p75NTR, and Ras 
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moved from the raft to the non-raft, whereas GM1 remained in the raft fraction.  
This means that TrkA is not easily activated outwith lipid rafts in GM1 
overexpressing cells, suggesting that appropriate physicochemical circumstances 
of rafts are required for the early step of its activation.  Nishio et al (2004) also 
showed that in vitro, low concentrations of GM1 enhanced TrkA kinase activity, 
whereas high concentrations of GM1 (>500 µM) suppressed the kinase in a dose-
dependent manner.   
The difference observed in the effects of exogenous GM1 and cDNA-derived GM1 
may be due to several factors:  
i) GM1 mediates its effects through interaction with TrkA inside the membrane 
itself within lipid rafts and although some exogenous GM1 is incorporated into 
the membrane, it may also directly interact with the extracellular portion of 
TrkA on the cell surface, producing a different effect. 
ii) The expression levels of GM1 or the difference in the duration of the exposure 
of cells to GM1 may vary, resulting in the different effects on TrkA. 
1.1.3.9.2 Epidermal growth factor receptor (EGFR) 
EGFR activity is modulated by gangliosides GM1, GM2, GM3, GM4, GD3, GD1a and 
GT1b (Bremer et al., 1986, Weis and Davis, 1990, Miljan et al., 2002, Slomiany 
et al., 1992, Li et al., 2001).  GD1a, added to certain fibroblasts, followed by 
prolonged starvation, causes receptor kinase activation rather than down-
regulation in response to EGF; this effect was claimed to be triggered by initial 
activation of cSrc followed by cascades of signalling (Li et al., 2000, Li et al., 
2001). 
Exogenous addition of GM3 to the culture media of human epidermal carcinoma 
KB and A431 cells inhibited cell growth.  It also inhibited EGF-stimulated EGFR 
tyrosine phosphorylation in membrane preparations from KB and A431 in vitro 
(Bremer et al., 1986).  This inhibition of the EGFR by GM3 appears to be a very 
early event after ligand binding since tyrosine autophosphorylation of the EGF 
receptor was inhibited but ligand binding was not (Bremer et al., 1986).  Since 
dimerisation is required for the intermolecular autophosphorylation and 
activation of the EGFR it is possible that GM3 may inhibit EGFR dimerisation.  
Miljan et al (2002) showed that GM3 acts as a physiological competitor for EGFR 
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dimerisation through direct binding to the extracellular domain of the EGFR thus 
inhibiting EGFR autophosphorylation.  Hanai et al (1988) demonstrated that two 
clones of A431 cells containing different concentrations of GM3 produced 
different responses to EGF; the clone with the greater GM3 concentration 
showed a reduced response to EGF (Hanai et al., 1988).  Chinese hamster ovary 
cells, transfected with EGFR and with a reversible defect in ganglioside 
biosynthesis, showed an inverse correlation between ganglioside content and 
EGFR kinase activity (Weis and Davis, 1990).  Depletion of endogenous 
gangliosides in cells transfected to overexpress ganglioside catabolic enzymes 
resulted in enhanced EGFR kinase activity (Meuillet et al., 1999, Zurita et al., 
2001).  D,L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) is 
an inhibitor of uridine diphosphate (UDP)-glucose-ceramide glucosyltransferase, 
which catalyses the transfer of glucose to ceramide in the initial phases of 
ganglioside synthesis, and is used to deplete total gangliosides from the cell 
membrane.  The addition of PDMP depletes gangliosides, thus reversing the 
inhibitory effect of exogenous GM3 on EGFR activity (Meuillet et al., 2000).   
However, GM3 does not completely attenuate ligand-stimulated signalling for 
EGFR.  Instead it alters the time course of gene expression of EGF-stimulated 
immediate early genes c–fos and c-jun, shifting the peak expression from 1 h to 
20 min (Rebbaa et al., 1996).  In PC12 cells EGF stimulates proliferation through 
a more transient signal, whereas NGF stimulates neural differentiation through a 
more prolonged signal, therefore a change in the time course of the signal could 
lead to a change in the final outcome.   
Wang and co-workers (2001b) demonstrated that GM3 binds only to glycosylated 
EGFR in order to inhibit EGFR activation, suggesting that there is a 
carbohydrate-carbohydrate interaction between GM3 and EGFR within lipid 
rafts.  
1.1.3.9.3 Platelet-derived growth factor receptor (PDGFR) 
Platelet derived growth factor (PDGF) exists as 3 isoforms (PDGF-A, -B and –C) 
and active PDGF is a homo- or heterodimer that acts on one of two receptors, 
PDGFα-R and PDGFβ-R.   
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Bremer et al (1984) showed that GM1 and GM3 inhibit the PDGF receptor-
associated tyrosine kinase, while Van Brocklyn et al (1993) showed that GM1, 
GM2, GD1a, GD1b, GD3 and GT1b but not GM3 inhibit PDGFR dimerisation and 
PDGF-dependent cell growth.  It is possible that gangliosides inhibit receptor 
dimerisation by destabilising the dimer through direct binding to the PDGFR, as 
is the case for GM1 (Mitsuda et al., 2002).  Under normal conditions the PDGFR is 
aggregated in lipid rafts.  Mitsuda et al (2002) showed that GM1 regulates the 
duration of PDGFR-generated signal by altering the intracellular localisation of 
the PDGFR in Swiss3T3 cells.  In cells containing high concentrations of GM1, the 
PDGF receptor was dispersed from lipid rafts and had a shorter PDGF-induced 
MAPK signal (Mitsuda et al., 2002).  Although gangliosides do not completely 
attenuate ligand-stimulated signalling for PDGFR in some cases the change in the 
signal duration can produce a different outcome.  In the neuronal cell line SH-
SY5Y, PDGF causes proliferation, but in the presence of GM1, PDGF causes 
neurite outgrowth (Lee et al., 1994). 
1.1.3.9.4 Fibroblast growth factor receptor (FGFR) 
Fibroblast growth factors, or FGFs, are a family of growth factors crucial for 
development and any irregularities in their function leads to a range of 
developmental defects (Amaya et al., 1991, Borland et al., 2001, Coumoul and 
Deng, 2003).  They are involved in many cellular processes including 
proliferation, migration, differentiation and survival of neurons and glial cells 
(Thisse and Thisse, 2005).  FGF molecules signal through a family of 
transmembrane receptor tyrosine kinases consisting of 4 members: FGFR1, 
FGFR2, FGFR3, and FGFR4 (Ornitz et al., 1996).  Among the 23 FGF family 
members, at least 10 different FGFs are expressed in the brain during 
development in a spatially and temporally regulated manner (Reuss and von 
Bohlen und Halbach, 2003).  The most studied FGF family member is FGF-2 (basic 
FGF), which activates all known FGFRs. 
Interaction of FGFs with cell-surface associated heparan sulphate proteoglycans 
is required for FGF binding to its receptor (Rapraeger et al., 1991, Yayon et al., 
1991), and cells that cannot synthesise heparan sulphate proteoglycans typically 
do not respond to FGF.  The signalling complex at the cell surface is believed to 
be a ternary complex formed between two identical FGF ligands, two identical 
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FGFR subunits and either one or two heparan sulphate chains (Kan et al., 1993, 
Pellegrini et al., 2000, Schlessinger et al., 2000). 
Ganglioside modulation of FGF signalling is distinct from that of their modulation 
of other growth factor signalling in that only FGF interacts directly with a 
ganglioside (Rusnati et al., 1999).  FGFR activity is inhibited by both GM3 
(Bremer and Hakomori, 1982) and GM1 (Rusnati et al., 1999), yet the mode of 
GM3 inhibition differs from that of GM1, because GM1 binds directly to FGF and 
GM3 does not.  Although this data suggests a mechanism in which GM1 blocks 
FGF binding to the FGFR, inhibiting its activity, another study showed that GM1 
could stimulate FGFR activity.  
Exogenously added GM1 restored the ability of heparan sulphate-deficient cells 
to respond to FGF2 (Rusnati et al., 2002), suggesting that GM1 can present FGF 
to its receptor in a way analogous to that of heparan sulphate proteoglycans.  
The reason for the difference in the effects of GM1 could be that excess GM1 
inhibits FGFR activity through competition with the physiological ligand, whereas 
physiological levels of GM1 can aid in the activation of FGFR. 
 
GM1 (low concentration) Increased NGF-generated TrkA phosphorylation  
    Increased NGF-dependent neurite formation 
    
GM1 (high concentration) Inhibition of TrkA phosphorylation  
    No neurite formation in response to NGF 
 
 
GD1a     Increased EGF-generated EGFR-phosphorylation 
 
GM3     Inhibition of EGF-generated EGFR-phosphorylation 
    Inhibition of EGF-dependent proliferation  
 
    
GM1 
GM2 
GM3 
GD1a    Inhibition of PDGF-generated PDGFR-phosphorylation 
GD1b    Inhibition of PDGF-dependent proliferation 
GD3 
GT1b 
 
 
 
GM3    Inhibition of FGF-dependent proliferation      
 
GM1 (free)     Inhibition of FGF-dependent proliferation (by binding FGF2) 
 
GM1 (membrane)     Activation of FGFR (by acting as a co-receptor for FGF2 
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Figure 1.4. Regulation of growth factor receptors by gangliosides 
A summary of the regulation of TrkA, EGFR, PDGFR and FGFR by various gangliosides (listed on 
the left). 
1.1.3.10 Interaction with integrins 
Integrins are the major cell surface receptors for extracellular matrix (ECM) 
ligands, and are widely expressed in many cell types.  They comprise a 
heterodimer of two receptor subunits, termed α and β, which together form a 
ligand binding site and have short cytoplasmic domains that assemble a complex 
of kinases, adaptor proteins, and other signalling molecules following ligand 
binding.  This initiates downstream signalling pathways which have been shown 
to regulate all fundamental aspects of cell behaviour.  Eighteen different α and 
eight β subunits generate a significant diversity in ligand binding and signalling 
properties, thus enabling different ECM environments to regulate distinct 
aspects of cell behaviour (Hynes, 2002). 
Glial cells express a distinct repertoire of integrins.  Astrocytes express the 
collagen/laminin receptor α1β1, the fibronectin receptor α5β1, the laminin 
receptors α6β1 and α6β4 and the vitronectin/fibronectin receptors αvβ3, αvβ5, 
and αvβ8 (Malek-Hedayat and Rome, 1994, Tawil et al., 1993, Tawil et al., 1994, 
Wagner et al., 1997, Milner et al., 1999).  Oligodendrocytes also express a 
number of integrins which are described in section 1.2.2.3.2.  
It has been shown that gangliosides interact with integrin receptors to modulate 
cell adhesion and motility.  Although integrin mediated adhesion to ECM is based 
on the binding of α and β receptor subunits to defined peptide sequences of 
fibronectin, strength of binding is modulated by several factors including 
association of integrin receptors with adjacent surface membrane gangliosides 
(Zheng et al., 1993, Cheresh et al., 1987).  It has been suggested that GD2 plays 
an essential role in vitronectin receptor function in human melanoma cells 
(Cheresh et al., 1987).  GT1b and GD3 inhibit keratinocyte adhesion to 
fibronectin and migration by blocking the interaction of fibronectin with α5β1 
integrin via a carbohydrate-carbohydrate interaction with α5β1 integrin (Wang 
et al., 2001a).  GM3 also inhibits keratinocyte adhesion and migration on 
fibronectin but is unable to directly bind to α5β1 (Wang et al., 2003).  Instead, 
GM3 blocks the interaction of α5β1 integrin with matrix metalloproteinase-9 
(Wang et al., 2003), which facilitates migration by proteolytic degradation of 
matrices such as fibronectin, laminin, and collagen IV (Amano et al., 2001, 
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Bannikov et al., 2002, Thant et al., 2000).  Furthermore, expression of GT1b or 
GM3 in carcinoma cells inhibits urokinase-type plasminogen activator (uPA)-
dependent cell migration by preventing the association of uPA receptor with 
α5β1 integrin or uPA receptor/α5β1 with EGFR, respectively (Wang et al., 2005).  
It has also been shown that optimal concentrations of GM3 enhance α5β1 
integrin-dependent adhesion of a carcinoma cell line to fibronectin, whereas 
GM3 concentrations above the optimal range decrease adhesion (Zheng et al., 
1993).  
Integrin receptors are often found associated with tetraspanins and integrin-
tetraspanin complexes are found within lipid rafts (Kazui et al., 2000, Mannion 
et al., 1996, Ono et al., 2001, Kawakami et al., 2002).  Gangliosides form 
complexes with tetraspanins to affect complex formation with integrins (Ono et 
al., 2001, Kawakami et al., 2002, Toledo et al., 2005).  It has been shown that 
GM3 inhibits tetraspanin CD9-facilitated cell motility in various cell lines (Ono et 
al., 2001).  In addition, GM3 promotes the interaction of CD9 with α3 integrin in 
lipid rafts, leading to inhibition of laminin-5-dependent cell motility (Kawakami 
et al., 2002).  It has also been shown that GM2 suppresses cell adhesion via 
fibronectin-integrin interaction since cells expressing GM2 attached more slowly 
to fibronectin and exhibited reduced phosphorylation of focal adhesion kinase 
(FAK) downstream of integrins (Chen et al., 2003).  Furthermore, GM3 and 
tetraspanins CD9 and CD81 affect the functional interaction between integrins 
and FGFR within lipid rafts and consequently affect FGF-independent 
proliferation of fibroblasts (Toledo et al., 2005). 
1.1.4 Ganglioside knockout mice 
To assess the function of gangliosides, the following knockout mice have been 
generated (Figure 1.3):  
1.1.4.1 α-2,8-sialyltransferase knockout  
α-2,8-sialyltransferase knockout (Sia T -/-) mice were created by knocking out 
Sia T, the enzyme which converts the first ganglioside, GM3, to GD3 and is thus 
responsible for generating all b- and c-series gangliosides (Kawai et al., 2001, 
Okada et al., 2002).  These mice lack all b- and c-series gangliosides and have 
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slightly increased levels of a-series gangliosides (Okada et al., 2002).  Despite 
the deletion of b- and c-series, the Sia T -/- mice had an intact gross morphology 
(Kawai et al., 2001, Okada et al., 2002) and there was no observable 
demyelination (Kawai et al., 2001).  Furthermore, the mice had normal motor 
functions, learning and memory (Okada et al., 2002).  Sia T -/- mice were also 
fertile, had normal growth and had no behavioural abnormalities (Kawai et al., 
2001).  These results suggest that the remaining a-series gangliosides 
compensate for the lack of b- and c-series gangliosides.  However, the knockout 
mice exhibited reduced regeneration of axotomised hypoglossal nerves 
compared with wild-type (Okada et al., 2002), which supports previous work 
showing that b-series gangliosides may be important in the repair of the nervous 
system. Despite earlier evidence implicating GD3 in apoptosis, Sia T -/- mice did 
not display an apoptosis related phenotype (Okada et al., 2002).   
1.1.4.2 N-acetylgalactosaminyl transferase knockout  
GalNAc T knockout (GalNAc T -/-) mice were created by knocking out GalNAc T, 
the enzyme which catalyses the conversion of GM3 to GM2, GD3 to GD2, and GT3 
to GT2, hence preventing the synthesis of all complex a-, b- and c-series 
gangliosides, respectively (Takamiya et al., 1996).  In contrast to wild-type 
mice, sciatic nerves and brains of GalNAc T -/- mice lacked the four major 
nervous system gangliosides, GM1, GD1a, GD1b and GT1b (Sun et al., 2004, 
Susuki et al., 2007a, Takamiya et al., 1996).  Instead, GalNAc T -/- mice have 
increased levels of simple gangliosides GM3, O-acetyl GD3 and GD3 (Susuki et 
al., 2007a).  Histological analysis of the brain tissue at 10 weeks old showed that 
the GalNAc T -/- mice had a normal morphology and no difference in the myelin 
structure or synapse formation.  The mice also had normal memory and motor 
functions and were normal in gross behaviour.  There was a decreased 
conduction velocity from the tibial nerve to the somatosensory cortex, but not 
to the lumbar spine, suggesting a role for gangliosides in neural function 
(Takamiya et al., 1996).  These results were surprising because gangliosides 
were expected to play important roles in the development of the nervous 
system.   
However, an independent strain of GalNAc T -/- mice generated by Sheikh et al 
(1999b) displayed axonal degeneration in both optic and sciatic nerves.  
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Furthermore, there was a decrease in myelination in the central nervous system 
(CNS), as demonstrated by a 2-fold increase in the number of unmyelinated 
fibres as well as an increase in the mean diameter of unmyelinated fibres.  It 
was also observed that there was ongoing demyelination and remyelination in 
the peripheral nervous system (PNS).  There was also evidence of doubly 
myelinated axons and redundant myelin loops indicating dysregulation in CNS 
myelination (Sheikh et al., 1999b).  Unusual myelin anomalies are also seen in 
MAG knockout mice (Bartsch, 1996).  GalNAc T -/- mice also display 
dysregulation of MAG expression in that MAG levels decrease to about 30% of 
normal levels as the mice age (Sun et al., 2004).  This further supports the 
evidence that gangliosides may be endogenous MAG ligands. 
Another study showed that adult mice expressing only GM3 and GD3 developed 
significant and progressive behavioural neuropathies, including deficits in 
reflexes, strength, coordination and balance (Chiavegatto et al., 2000).  In 
addition, there was significant incidence of tremor and catalepsy in twelve 
month old GalNAc T -/- mice (Chiavegatto et al., 2000).   
1.1.4.3 Double knockout mice 
By crossbreeding the Sia T -/- mice and GalNAc T -/- mice, double knockout 
mice (DKO) have been generated that express only the GM3 simple ganglioside 
(Inoue et al., 2002, Kawai et al., 2001).  DKO mice contained similar amounts of 
total brain ganglioside but reduced levels of lipid-linked sialic acid compared 
with wild-type and single knockout mice.  In contrast to the single knockout 
mice, double mutant mice had an extremely high mortality rate: 92% had died 
during the observation period of 36 weeks (Kawai et al., 2001).  Kawai et al 
(2001) also found that DKO mice were susceptible to audiogenic seizures, which 
in most cases resulted in death.   
However, the cause of premature death of the DKO mice is now not thought to 
be due to the audiogenic seizures since another study showed that 12- and 18-
week old mice did not have seizures when treated with various audiogenic 
stimuli (Inoue et al., 2002). 
DKO mice generated by Inoue and colleagues (2002) developed a characteristic 
skin lesion that appeared mostly on the face of the mutant mice 25 weeks after 
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birth or later.  The lesions are thought to be triggered by the reduced sensitivity 
of the sensory nerve due to nerve degeneration, leading to over-scratching 
(Inoue et al., 2002).  Inoue et al (2002) showed that degeneration of peripheral 
nerves in DKO mice was more prominent than in the single mutants.  
1.2 Glial cells 
Glial cells exist alongside neurons in the nervous system where they perform 
many different structural and supporting functions.  Glial cells can be divided 
into two subtypes: microglia and macroglia.  The macroglia comprise many 
subtypes including astrocytes, oligodendrocytes and Schwann cells.  The nervous 
system consists of a central and a peripheral component.  The CNS contains the 
brain and the spinal cord, whereas the PNS contains all the nerves which connect 
the rest of the body to the spinal cord and the brain.  The PNS and CNS contain 
different glial populations.  The CNS contains oligodendrocytes, astrocytes and 
microglia, whereas the main PNS glia are the Schwann cells.  Oligodendrocytes 
are glia responsible for myelination of neuronal axons in the CNS while Schwann 
cells are responsible for myelination in the PNS.  Astrocytes are not involved in 
producing myelin; however they perform many other important functions which 
will be discussed later.  The olfactory system, which spans both the CNS and the 
PNS, contains a further glial population, called olfactory ensheathing cells 
(OECs).   
1.2.1 Astrocytes 
Differences in the cellular composition between the PNS and the CNS involve 
many cells, the most significant being the astrocytes.  Astrocytes comprise 25% 
of the total CNS cells, making them the most abundant cell type within the CNS 
(Eng et al., 1992).  Anatomical studies show that they are generally stellate in 
shape with long, branching processes which interact with neuronal, glial, and 
endothelial cells.  Differentiated astrocytes can be identified both in vitro and 
in vivo by the expression of glial fibrillary acidic protein (GFAP) (Bignami et al., 
1972), the major constituent of glial intermediate filaments (Schachner et al., 
1977, Eng, 1985). 
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Classically, astrocytes in vivo have been classified into two types which are 
distinct in morphology and distribution.  Protoplasmic astrocytes, which have 
short, thick, highly branched processes, are mostly found in the grey matter.  
Fibrous astrocytes, which have long, thin, less branched processes, are found in 
the white matter (Wilkin et al., 1990, Somjen, 1988).  Astrocytes are very 
heterogeneous and exhibit regional variations (Shinoda et al., 1989, Wilkin et 
al., 1990).   
1.2.1.1 Type-1 and type-2 astrocytes 
Studies in cultures of white matter have characterised two types of astrocytes 
(type-1 and -2), which develop from two distinct precursor cells (Raff et al., 
1984a).  In cultures of grey matter only type-1 astrocytes are seen (Raff et al., 
1983a).  Type-1 astrocytes of the optic nerve are thought to develop from optic 
stalk cells (Small et al., 1987) beginning several days before birth (Miller et al., 
1985), whereas type-2 astrocytes are thought to develop postnatally (Miller et 
al., 1985) from oligodendrocyte precursor cells, which can differentiate into 
type-2 astrocytes in culture media containing 10% serum (Levi et al., 1986, Raff 
et al., 1983b).   
Both type-1 and -2 astrocytes express GFAP but differ in morphology, growth 
characteristics and ganglioside expression (Raff et al., 1983a, Raff, 1989).  Type-
1 astrocytes are morphologically similar to fibroblasts in that they are flat and 
sheet-like and proliferate in culture (Raff et al., 1983a).  In contrast, type-2 
astrocytes divide infrequently, appear similar to neurons or oligodendrocytes, 
and bear numerous processes (Raff et al., 1983a).  Type-1 astrocytes are 
positive for rat neural antigen 2, whereas type-2 astrocytes do not express this 
antigen (Bartlett et al., 1981).   
It is unclear how the in vitro classification corresponds with the in vivo 
classification.  The morphologies and regional origins of type-1 and type-2 
astrocytes suggest that these two cell types may correspond to protoplasmic and 
fibrous astrocytes in vivo, respectively.  Tetanus toxin-binding, A2B5 and GFAP 
positive cells (type-2 astrocytes) were found in cell suspensions prepared from 
freshly dissected white matter tracts but not from freshly dissected grey matter 
of developing rats (Raff et al., 1983a).  However, the optic nerve is composed 
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entirely of white matter and is generally thought to contain astrocytes that are 
almost exclusively of the fibrous type (Vaughn and Peters, 1967).  Yet cultures of 
developing optic nerve contained many type-1 astrocytes.  So the argument that 
type-1 astrocytes correspond to protoplasmic astrocytes of the grey matter is an 
oversimplification.  Miller and colleagues (1985) showed that type-1 astrocytes 
(GFAP+/A2B5-) first appear in the optic nerve at embryonic day 16 (E16), 
oligodendrocytes (GFAP-/GalC+) at birth (E21) and type-2 astrocytes 
(GFAP+/A2B5+) at postnatal day 7.  They also showed that type-2 astrocytes did 
not develop from type-1 astrocytes in vivo, suggesting that the two types of 
astrocytes develop from two serologically distinct precursor cells (Miller et al., 
1985).  However, Skoff et al, (1990, 1991) showed that only one wave of 
astrocyte development exists and did not observe the second wave of astrocyte 
development following the development of oligodendrocytes (Skoff, 1990, Skoff 
and Knapp, 1991).  They conclude that separate lineages exist for astrocytes and 
oligodendrocytes during postnatal development and suggest that there is no 
compelling in vivo evidence for a bipotential progenitor cell that generates both 
oligodendrocytes and astrocytes (Skoff, 1990, Skoff and Knapp, 1991).  
Furthermore, labelled oligodendrocyte precursor cells transplanted into neonatal 
rat brains develop into oligodendrocytes but not type-2 astrocytes (Espinosa de 
los Monteros et al., 1993).  Therefore, another possibility is that type-1 
astrocytes represent those in the brain, whereas type-2 astrocytes may be an 
artefact of culture. 
1.2.1.2 Ganglioside expression of astrocytes 
As mentioned above, cultured type-1 and type-2 astrocytes differ in their 
ganglioside content.  Type-2 astrocytes are positive for A2B5, which labels 
gangliosides GT3, O-acetyl GT3 (Farrer and Quarles, 1999) and GQ1c, and 
tetanus toxin which binds to gangliosides GD1b and GT1 (Van Heyningen, 1963), 
whereas type-1 astrocytes are negative for both (Raff et al., 1983a, Murakami et 
al., 1999).  GM3 is the major ganglioside expressed in cultured type-1 
astrocytes, whereas in type-2 astrocytes it is GM3 and GD3 (Murakami et al., 
1999).  Numerous studies have found GM3 to be the predominant ganglioside in 
cultured rodent astrocytes (Asou and Brunngraber, 1983, Asou et al., 1989b, 
Asou et al., 1989a, Sbaschnig-Agler et al., 1988), whereas in human tissue little 
or no GM3 is found on astrocytes (Satoh et al., 1996, Marconi et al., 2005).  
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Surprisingly many studies have shown that astrocytes do not contain the major 
brain ganglioside GM1 on their cell surface both in rodents (Asou and 
Brunngraber, 1983, Yamamoto et al., 2007, Asou et al., 1989a, Asou et al., 
1989b, Sbaschnig-Agler et al., 1988) and in human foetal astrocytes (Satoh et 
al., 1996).  In contrast, a study of adult human brain tissue found GM1 and GD1b 
to be expressed on all astrocytes (Marconi et al., 2005) and a study in mouse 
foetal astrocytes found GM1 expression to be regulated by the cell cycle, with 
maximal expression during G0/G1 phase (Majoul et al., 2002).  In addition, GM1 
is found on the nuclear envelope of astrocytes and is thought to be involved in 
the regulation of nuclear calcium (Xie et al., 2004, Ledeen and Wu, 2006).  
Marconi et al (2005) found that GD3 is expressed on less than 20% of astrocytes 
in adult human tissue.  In contrast, Kawai et al (1999b, , 1999a) found that 
normal astrocytes in adult human tissue do not express GD3, instead they find 
that GD3 is expressed in the cytoplasm of reactive and neoplastic astrocytes.  It 
was found that in young and adult mouse brain, both normal and reactive 
astrocytes express GD3 (Cammer and Zhang, 1996).  GD3 is also expressed in 
cultured rat astrocytes (Kawashima et al., 1996) and in small population of 
cultured human foetal astrocytes (Satoh and Kim, 1995, Satoh et al., 1996).   
Other gangliosides expressed on astrocytes include GM2, GD2 and GM4 in foetal 
human brains (Satoh et al., 1996), and GM4 in chicken cerebellum (Ozawa et al., 
1993). 
1.2.1.3 Function of astrocytes 
Astrocytes are the housekeeping cells of the CNS, maintaining and supporting its 
normal functions.  As such, they are involved in maintaining pH homeostasis and 
local ion concentrations such as potassium (K+) and calcium (Ca2+), as well as 
regulating the extracellular volume within the CNS (Sykova et al., 1992).  The 
regulation of brain energy metabolism is under the control of an intimate 
dialogue between astrocytes and neurons (Escartin et al., 2006).  Astrocytes 
provide neurons with glucose and metabolic substrates, while removing neuronal 
waste such as metabolic byproducts. 
The glia limitans, which is the outermost layer of nervous tissue of the CNS, 
directly under the pia mater, arises from astrocytes (Yonezawa et al., 2003). 
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Ends of astrocyte processes, known as perivascular end feet, contact the 
basement membrane under the pia mater, where they seal off the CNS through 
tight association of these processes, forming the glia limitans (Peters et al., 
1991). 
In addition, densely packed astrocyte processes surround endothelial cells of CNS 
capillaries and venules that form the blood brain barrier (BBB) (Janzer, 1993, 
Goldstein, 1988).  This barrier protects the brain by preventing the entry of 
numerous large molecules, such as proteins and toxic substances from the blood.  
BBB function is induced , maintained, regulated and repaired by astrocytes 
(Janzer, 1993). 
Following injury to the CNS, astrocytes become reactive, undergoing 
morphological changes and expressing distinct markers from resting astrocytes 
(Ridet et al., 1997).  They respond to injury by becoming hypertrophic, 
migrating and proliferating around the affected region to form a glial scar, thus 
sealing off the damaged area (Eng and Ghirnikar, 1994).  Although the astrocytes 
act to preserve the integrity of the host tissue, the glial scar appears to limit the 
regenerative capacity of the CNS (Fawcett, 1997), inhibiting regeneration of 
severed axons (Davies et al., 1997). 
1.2.1.4 Perinodal astrocytes 
It is well established that perinodal astrocyte processes are closely associated 
with nodes of Ranvier in the CNS (Waxman, 1986, Black and Waxman, 1988), 
suggesting that, in addition to the axon and oligodendrocyte, astrocytes 
participate in the formation of mature CNS nodes.  Electron microscopic studies 
of the feline spinal cord demonstrated that processes extend from astrocyte cell 
bodies to approach the node of Ranvier where they come into close association 
with the bare nodal segment of the axon (Hildebrand, 1971a, 1971b).  This 
association has subsequently been confirmed in rabbit corpus callosum (Waxman 
and Swadlow, 1976), rat optic nerve (Hildebrand and Waxman, 1984, Waxman 
and Black, 1984, ffrench-Constant et al., 1986) and guinea pig (Raine, 1984), rat 
(Sims et al., 1985) and lower vertebrate (Bodega et al., 1987) spinal cord.  Some 
of these studies showed that perinodal astrocyte processes travel many 
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micrometers to contact the nodal axon membrane (Hildebrand, 1971b, Waxman 
and Black, 1984, Waxman and Sims, 1984, Raine, 1984). 
It could be argued that the presence of astrocyte processes at nodes is due to 
the abundance of astrocytes within the CNS, with astrocyte processes merely 
occupying the space between adjacent oligodendrocytes within the perinodal 
region.  However, the relationship between astrocyte processes and the sodium 
channel-rich axon membrane at the node seems to be highly specific.  Sims et al 
(1985) reduced the population of astrocytes and oligodendrocytes in the dorsal 
funiculus of the spinal cord by irradiation, resulting in the minimisation of 
random glial-axonal interactions and myelination of only a limited number of 
axons.  Despite the low numbers of astrocytes, the nodes of Ranvier that were 
formed within the irradiated cord were invariably associated with astrocyte 
processes, and in some instances the astrocyte process bypassed unmyelinated 
axons as it extended to become associated with a node (Sims et al., 1985). 
The interaction between perinodal astrocyte processes and nodal membrane is 
likely to be mediated by cell adhesion molecules since J1, a glycoprotein 
involved in neuron-astrocyte adhesion (Kruse et al., 1985), is concentrated at 
the interface between the axon and perinodal astrocyte processes at nodes of 
Ranvier (ffrench-Constant et al., 1986).  
Several suggestions have been put forward with regard to the role of perinodal 
astrocytes, including the formation of nodal gap substance and regulation of the 
extracellular ionic environment (Hildebrand, 1971a, 1971b).  Charged molecules, 
such as potassium K+, are released into the extracellular space during neuron 
firing and need to be removed in order to maintain the electrical homeostasis.  
Astrocytes can buffer the excess K+ released by neurons (Sykova et al., 1992).  
Astrocytes form gap junctions amongst themselves (Gutnick et al., 1981, Massa 
and Mugnaini, 1982), which allow them to distribute charged molecules among 
the resulting syncytia. 
Cultured astrocytes have been shown to express functional ion channels, 
including voltage-sensitive sodium channels (Nav) (Barres et al., 1988, Bevan et 
al., 1985, Nowak et al., 1987).  Moreover, immuno-ultrastructural studies have 
demonstrated that white matter astrocytes express Nav on the plasmalemma of 
the perinodal process as well as the cytoplasm (Black et al., 1989a, Black et al., 
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1989b).  Whereas neurons express Nav most intensely in the axon membrane, 
astrocyte Nav are heterogeneously distributed within the cytoplasm and are also 
associated with some regions of astrocyte plasmalemma (Black et al., 1989a, 
Black et al., 1989b).  In addition, perinodal astrocyte processes display more 
intense Na+ channel immunoreactivity than astrocyte processes at the glia 
limitans and surrounding blood vessels (Black et al., 1989b).  Therefore, it is 
possible that perinodal astrocytes complement neuronal perikaryal Nav
 synthesis 
and axonal transport by functioning as extra-neuronal sites for the synthesis of 
Nav, which are subsequently transferred to the axon membrane at nodes of 
Ranvier (Bevan et al., 1985). 
1.2.1.5 Calcium waves and the tripartite synapse 
Astrocytes exhibit a form of communication based on the propagation of 
transient rises in cytosolic free Ca2+, termed “calcium waves” (Cornell-Bell et 
al., 1990, Charles et al., 1991, Cornell-Bell and Finkbeiner, 1991, Duffy and 
MacVicar, 1995, Finkbeiner, 1992).  These calcium waves can be initiated by 
neuronal synaptic activity (Dani et al., 1992, Porter and McCarthy, 1996, Kang et 
al., 1998).  Calcium waves are thought to be mediated via the diffusion of 
inositol triphosphate through gap junctions (Finkbeiner, 1992) as well as through 
the extracellular release of adenosine triphospate (ATP), and consequent 
activation of purinergic receptors on other cells (Arcuino et al., 2002, Cotrina et 
al., 1998, Hassinger et al., 1996, Newman, 2001).  These astrocytic Ca2+ 
variations can cause the release of the excitatory neurotransmitter glutamate, 
which then signals to adjacent neurons (Hassinger et al., 1995, Parpura et al., 
1994, Pasti et al., 1997) and modulates synaptic transmission (Araque et al., 
1998a, Araque et al., 1998b, Kang et al., 1998, Parpura and Haydon, 2000).  
Astrocytes also modulate synaptic transmission by removing neurotransmitters, 
such as glutamate, gamma amino butyric acid (GABA) and acetylcholine, from 
the synaptic cleft (Schousboe et al., 1992, Bergles et al., 1999, Smit et al., 
2001).  
The discovery of the existence of bidirectional communication between glial 
cells and neurons gave rise to a new concept, the tripartite synapse, in which 
the synapse is formed by three mutually interacting elements: the presynaptic 
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terminal, the postsynaptic membrane and the surrounding astrocytes (Araque et 
al., 1999, Carmignoto, 2000). 
1.2.1.6 Astrocytes and myelination 
Growth factors influence oligodendrocyte differentiation and myelination as 
described in section 1.2.2.3.1 and astrocytes are known to secrete many of 
these factors including FGF2 (Araujo and Cotman, 1992), PDGF (Richardson et 
al., 1988), ciliary neurotrophic factor (CNTF) (Stockli et al., 1989), NGF 
(Furukawa et al., 1986, Houlgatte et al., 1989) and NT-3 (Rudge et al., 1992), 
suggesting that astrocytes could be indirectly involved in myelination. 
Recent evidence suggest that astrocytes promote myelination by mature 
oligodendrocytes in an activity-dependent manner (Ishibashi et al., 2006).  
Ishibashi et al (2006) stimulated dorsal root ganglion (DRG) neurons, co-cultured 
with mature oligodendrocytes and astrocytes, with a pattern of electrical 
activity know to stimulate ATP release from axons and found that myelination 
increased 3-fold on axons firing action potentials compared with unstimulted 
controls, or axons stimulated in the presence of tetrodotoxin (TTX), which 
blocks sodium-dependent action potentials.  Treatment of these co-cultures with 
a non-hydrolysable form of ATP, 2MeSATP, also resulted in significantly more 
myelinated axons per field of view.  A search of the literature for factors that 
might affect myelination after OPCs have differentiated to a promyelinating 
phenotype led them to cytokine leukaemia inhibitory factor (LIF).  To test the 
hypothesis that ATP might promote myelination through an LIF-dependent 
mechanism, Ishibashi et al added antibodies against LIF to co-cultures treated 
with 2MeSATP and found that the increase in myelin induced by 2MeSATP was 
blocked by the presence of antibody blocking LIF activity.  Addition of antibody 
against LIF alone had no effect on myelination indicating that the effects of 
endogenous LIF on myelination require activation of P2 receptors.  They then 
measured the concentration of LIF in these cultures to determine if LIF was 
released when axons were stimulated to fire action potentials and found that 
the concentration of LIF was significantly increased following stimulation.  Since 
astrocytes are a probable source of LIF, Ishibashi et al tested this and showed 
that electrical activity in axons increased the level of mRNA for LIF in 
astrocytes.  In addition, this increase in LIF mRNA due to electrical stimulation 
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was inhibited in the presence of apyrase, an enzyme that rapidly degrades 
extracellular ATP, supporting the hypothesis that the increase in LIF mRNA in 
astrocytes growing on electrically active DRG axons is dependent upon release of 
ATP from axons.  In summary, Ishibashi et al showed that electrical activity in 
premyelinated axons increases myelination after oligodendrocyte precursors 
mature to a promyelinating stage by the activity dependent release of ATP from 
axons, which acts in a paracrine manner on astrocytes to release LIF and 
stimulate myelination at this later stage of development. 
1.2.2 Oligodendrocytes 
Oligodendrocytes are the myelinating cells of the CNS (Bunge, 1968).  They 
extend multiple processes that wrap concentrically around the axons to form the 
insulating myelin sheath.  Electron microscopy shows that they have a 
characteristic electron-dense cytoplasm containing few if any intermediate 
filaments but large numbers of microtubules (Raff et al., 1983b).  They have a 
small cell body and a large number of branching processes, which enable them 
to ensheath and myelinate fifteen axons on average, as well as surround 
neuronal cell bodies in the grey matter.   
1.2.2.1 Development of oligodendrocytes 
Like most other CNS neural cells, oligodendrocytes derive from cells of the 
neural tube (Warf et al., 1991).  It is thought that they arise from ventral 
subsets of multi-potential neuroepithelial precursors cells in the ventricular zone 
of the brain and spinal cord (Pringle and Richardson, 1993, Woodruff et al., 
2001); although there is evidence that a subset of oligodendrocytes arise from 
radial glia in the dorsal spinal cord (Fogarty et al., 2005).  In the 
oligodendrocyte lineage there is a progression of cells from immature to mature 
states and each stage is demarcated by distinct morphological, biochemical, and 
behavioural characteristics (Figure 1.5) (Hardy and Reynolds, 1991, Pfeiffer et 
al., 1993).   
The earliest cells in the oligodendrocyte lineage are early oligodendrocyte 
progenitor cells (OPCs), which label with the antibody A2B5 (Raff et al., 1984b).  
Early OPCs are bipolar or unipolar with a large cell body (Raff et al., 1984b).    
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They are first detected at E12 to 14 in the rat and can be identified by 
expression of the PDGFα-R (Pringle et al., 1992), as well as mRNA for myelin 
genes 2’,3’-cyclic-nucleotide 3’-phosphodiesterase (CNP) (Yu et al., 1994) and 
DM20, an isoform of proteolipid protein (PLP) (Timsit et al., 1995).  Early OPCs 
also express the sulphated proteoglycan, NG2 (Nishiyama et al., 1996) and the 
embryonic form of polysialic acid containing neural cell adhesion molecule (E-
NCAM or PSA-NCAM), thought to be involved in their migration (Zhang et al., 
2004).  OPCs are thought to arise from NG2-positive pre-OPCs (Baracskay et al., 
2007).  Although early OPCs constitutively differentiate into oligodendrocytes, 
under the influence of different signals they can give rise to type-2 astrocytes 
(Raff et al., 1983b), type-1 astrocytes and neurons (Kondo and Raff, 2000), 
suggesting that they have stem like properties.  Early OPCs divide and migrate, 
populating most of the CNS during early development.  At birth, early OPCs are 
evenly distributed throughout the CNS and begin to proliferate and differentiate 
(Nishiyama et al., 1996). 
These early OPCs differentiate into late OPCs (also known as pro-
oligodendrocytes), which are committed to the oligodendrocyte linage and are 
post migratory but still proliferative (Warrington et al., 1993).  Late progenitors 
are multipolar and begin to express antigens that are recognised by the antibody 
O4 (Bansal et al., 1992, Sommer and Schachner, 1981).  Antigens which are 
recognised by the O4 antibody include seminolipid (Bansal et al., 1989), 
prooligodendrocyte antigen (Bansal et al., 1992) and galactosulphatide that 
subsequently becomes a structural component of myelin (Sommer and 
Schachner, 1981).  In the presence of correct differentiation factors, late OPCs 
differentiate into pre-myelinating oligodendrocytes (also known as immature 
oligodendrocytes) (Trapp et al., 1997).  However, some late OPCs remain 
undifferentiated and persist in the adult CNS (Wolswijk and Noble, 1989, Shi et 
al., 1998, Dawson et al., 2003).  Adult OPCs differ from neonatal OPCs in that 
their motility, proliferation and time course of differentiation are all 
significantly slower (Dawson et al., 2000, Dawson et al., 2003, Wolswijk and 
Noble, 1989). 
Pre-myelinating oligodendrocytes develop a few days before myelination starts 
(Trapp et al., 1997).  Structurally, the morphology of pre-myelinating 
oligodendrocytes is more complex in that they extend multiple processes.  They 
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lose the expression of A2B5, NG2 and PDGFαR, but continue to express antigens 
labelled with the O4 antibody (Raff et al., 1984b).  Pre-myelinating 
oligodendrocytes express GalC, the major glycolipid in myelin (Raff et al., 
1978b, Ranscht et al., 1982), as well as low levels of myelin-related proteins 
such as MAG, MBP, DM20 and CNP (Reynolds et al., 1989).  
In the absence of axons to ensheath, pre-myelinating oligodendrocytes form 
broad membranous sheets that have been suggested to represent early stages of 
myelin formation (Reynolds et al., 1989).  In vivo, pre-myelinating 
oligodendrocytes have a limited lifespan of 2 to 3 days before they differentiate 
into myelinating oligodendrocytes (also known as mature oligodendrocytes) or 
undergo apoptosis.  Contact between pre-myelinating oligodendrocytes and 
axons induces the expression of myelin proteins such as PLP and myelin 
oligodendrocyte glycoprotein (MOG) and the wrapping of oligodendrocyte 
processes around the axon to form the myelin sheath (Pfeiffer et al, 1993).  
Differentiation of a pre-myelinating oligodendrocyte to a myelinating 
oligodendrocyte is characterised by maturation from a nonpolarised to a 
polarised cell: as myelination begins, the myelin proteins are targeted to 
specific membrane domains (Trapp et al., 1997).  Pre-myelinating 
oligodendrocytes that fail to contact an axon undergo programmed cell death 
(Barres et al., 1992, Trapp et al., 1997). 
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Figure 1.5. Summary of oligodendrogenesis in vivo.   
Oligodendrocyte progenitor cells (OPCs) originate in the subventricular zone (SVZ), migrate and 
populate the CNS as early OPCs.  Early OPCs give rise to late OPCs which, in turn, give rise to 
premyelinating oligodendrocytes.  Upon contact with axons, premyelinating oligodendrocytes 
differentiate into myelinating oligodendrocytes.  Those that fail to contact an axon die by 
apoptosis.  Some of the phenotypic markers for each stage are listed.  Adapted from (Trapp et 
al., 1997).  A2B5 recognises gangliosides GT3 and O-acetyl GT3; NG2 recognises a sulphated 
proteoglycan; PDGFαR is platelet derived growth factor receptor alpha; O4 recognises 
seminolipid, sulfatide and prooligodendrocyte antigen; CD9 is a tetraspanin proteolipid; DM20 is 
an isoform of proteolipid protein; CNP is 2’,3’-cyclic-nucleotide 3’-phosphodiesterase; MAG is 
myelin associated glycoprotein; MBP is myelin basic protein; PLP is proteolipid protein. 
 
1.2.2.2 Ganglioside expression of oligodendrocytes   
Oligodendrocytes express different gangliosides during different stages of 
development (Figure 1.6).  It has been shown in vitro that an OPC cell line CG-4 
expresses different gangliosides during distinct differentiation stages (Schnaar et 
al., 1996).  OPCs in culture express ganglioside GT3 and O-acetyl GT3, antigens 
that react with A2B5 antibody (Farrer and Quarles, 1999).  Both of these 
gangliosides are down-regulated as OPCs differentiate into oligodendrocytes; 
however, they continue to be expressed when they differentiate into type 2 
astrocytes (Farrer and Quarles, 1999).  Moreover, OPCs also express 9-O-acetyl 
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GD3, which is also expressed in type 2 astrocytes but down-regulated in 
oligodendrocytes (Farrer and Quarles, 1999).   
 
Figure 1.6. Ganglioside expression of oligodendrocytes. 
Gangliosides expressed during distinct stages of oligodendrocyte differentiation are listed below 
the representative drawings of each stage.  Early OPCs express gangliosides simple gangliosides 
GM3, GT3, O-acetyl GT3, GD3 and O-acetyl GD3.  Late OPCs continue to express GD3 and have 
increased levels of GM3, but do not express GT3, O-acetyl GT3 and O-acetyl GD3.  Myelinating 
oligodendrocytes continue to express GM3 and GD3, have increased expression of GM4 and GM1 
and express GM2, GD1a, GT1a, GD2, GD 1b, GT1b and GQ1b.  The above is a summary of data 
found in several journals looking at ganglioside expression of oligodendrocytes and myelin (Farrer 
and Quarles, 1999, Yim et al., 1994, Yim et al., 1995, Yu and Yen, 1975, Cochran et al., 1982). 
 
 
 
1.2.2.3 Factors affecting oligodendrocytes 
Myelination of the CNS requires a precise regulation of proliferation, migration, 
survival, and differentiation of the oligodendrocyte lineage cells.  Accordingly, 
the behaviour of OPCs and oligodendrocytes is tightly regulated by growth 
factors and extracellular matrix molecules (Barres and Raff, 1994, Kiernan et 
al., 1996, Orentas and Miller, 1998).   
1.2.2.3.1 Growth factors 
OPCs in culture proliferate in response to a number of different growth factors 
such as PDGF, FGFs, insulin-like growth factors (IGFs) and neuregulin (NRG) 
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(McMorris and Dubois-Dalcq, 1988, Richardson et al., 1988, Bogler et al., 1990, 
Canoll et al., 1996).  The onset of differentiation in OPCs and oligodendrocytes 
is thought to be controlled by a combination of cell intrinsic factors and extrinsic 
environmental signals.  Differentiation is the default pathway for OPCs in the 
absence of mitogens.  As a result, the availability of growth factors such as 
PDGF, IGF-1 and FGF-2 is likely to play a role in the onset of differentiation 
(Barres and Raff, 1994, Goddard et al., 1999).   
Astrocytes and neuronal cell bodies provide mitogenic, migratory, and survival 
signals to the OPCs (Noble et al., 1988, Barres et al., 1992, Fruttiger et al., 
2000) by releasing PDGF (Richardson et al., 1988, Yeh et al., 1991), which is 
recognised by the PDGF α receptor (PDGFαR) expressed on the surface of OPCs 
(Pringle et al., 1992).  PDGF stimulates migration of OPCs by enhancing motility 
(Noble et al., 1988) and by acting as a chemotactic agent (Armstrong et al., 
1990).  PDGF is also a potent survival factor for OPCs (Barres et al., 1992), and 
the limited supply of PDGF in the normal CNS may act to keep OPC proliferation 
under tight control and allow cell cycle exit and differentiation (van Heyningen 
et al., 2001).  As OPCs differentiate into pre-myelinating oligodendrocytes, they 
downregulate PDGFαR (Hall et al., 1996) and become unresponsive to PDGF 
(Hart et al., 1989, Gard and Pfeiffer, 1993). 
FGF2 stimulates OPC proliferation and migration in vitro and inhibits terminal 
differentiation (Bogler et al., 1990, Milner et al., 1997a, Osterhout et al., 1997).  
FGF2 also upregulates PDGFαR and co-operates with PDGF to induce 
proliferation and inhibit differentiation of OPCs (Bogler et al., 1990, McKinnon 
et al., 1990).  In contrast to OPCs, where it causes proliferation and migration, 
in mature oligodendrocytes FGF2 causes Mbp gene downregulation, loss of 
myelin compaction as well as demyelination of axons (Fressinaud et al., 1995, 
Grinspan et al., 1996b, Bansal and Pfeiffer, 1997, Butt and Dinsdale, 2005a, 
2005b).  In addition, FGF2 knockout mice showed increased OPC differentiation 
and oligodendrocyte repopulation of experimentally demyelinated white matter 
compared with wild-type mice (Armstrong et al., 2002).  Consequently, FGF2 has 
been proposed to play a role in the pathogenesis of demyelination and the 
failure of remyelination in experimental models of multiple sclerosis (MS). 
  40 
Neuregulins are a large family of proteins related to EGF that contain an EGF-
like domain critical to their activity (Buonanno and Fischbach, 2001) and 
activate the ErbB family of tyrosine kinase receptors, which includes ErbB1 (the 
EGF receptor), ErbB2, ErbB3 and ErbB4.  Neurons, astrocytes and 
oligodendrocytes all secrete neuregulins (Meyer and Birchmeier, 1994, Raabe et 
al., 1997, Francis et al., 1999) and cells of the oligodendrocyte lineage express 
ErbB2, ErbB3, and ErbB4 (Canoll et al., 1996).  Neuregulins appear to be 
necessary for the formation of oligodendrocytes (Vartanian et al., 1999) and are 
a potent survival factor for cells of the oligodendrocyte lineage (Canoll et al., 
1996, Fernandez et al., 2000, Flores et al., 2000).  A soluble isoform of 
neuregulin-1, glial growth factor 2 (GGF-2), is mitogenic for both O4+ late OPCs 
and GalC+ pre-myelinating oligodendrocytes in vitro, promotes survival of late 
OPCs (Canoll et al., 1996), and strongly inhibits oligodendrocyte maturation into 
MBP+ myelinating oligodendrocytes (Canoll et al., 1999, Canoll et al., 1996).  On 
the other hand, neuregulin/ErbB2 is required for the terminal differentiation of 
oligodendrocytes and for development of myelin (Park et al., 2001, Kim et al., 
2003), suggesting that, like other growth factors, neuregulins play different roles 
during different stages of oligodendrocyte differentiation.  
Oligodendrocytes also express neurotrophin receptors TrkA and TrkC.  NT-3 is 
involved in oligodendrocyte development and promotes the survival and 
proliferation of OPCs (Barres et al., 1994, Barres et al., 1993b, Cohen et al., 
1996, Kumar et al., 1998) 
Both OPCs and oligodendrocytes express insulin and IGF receptors (Baron-Van 
Evercooren et al., 1991).  Astrocytes secrete IGF-1 (Chernausek, 1993), whereas 
neurons have been shown to secrete IGF-1 (Schechter et al., 1995) and insulin 
(Schechter et al., 1994).  Insulin, IGF-1 and IGF-2 promote survival of OPCs 
(Barres et al., 1992, Barres et al., 1993b, Cui et al., 2005).  IGF-1 also promotes 
the proliferation of OPCs (McMorris and Dubois-Dalcq, 1988), is a mitogenic co-
factor for FGF-2 and NT-3 (Barres et al., 1993b, Barres and Raff, 1994), and 
promotes the differentiation of oligodendrocytes into mature GalC+ cells 
(McMorris and Dubois-Dalcq, 1988, McMorris et al., 1986, Goddard et al., 1999).  
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1.2.2.3.2 Extracellular matrix molecules and integrins 
ECM molecules bind to integrin receptors which form a transmembrane linkage 
between the ECM and the cytoskeleton and signal to the inside of the cell 
(Hynes, 1992, Diamond and Springer, 1994).  Interaction between growth factor 
and integrin signalling pathways provides a mechanism for integration of short-
range ECM signalling and long-range growth factor signalling in OPCs. 
Oligodendrocytes express 5 integrins: the laminin receptor α6β1, as well as 
αvß1, αvß3, αvß5 and αvß8, all of which bind vitronectin (Milner and ffrench-
Constant, 1994, Milner et al., 1997b), fibronectin, and a number of other 
extracellular and cell surface ligands containing the Arg-Gly-Asp (RGD) 
recognition sequence.  Integrins α6β1 and αvß8 are expressed throughout 
oligodendrocyte development, whereas αvβ1, αvβ3 and αvβ5 are expressed 
sequentially during development (Milner and ffrench-Constant, 1994, Milner et 
al., 1997b) and are thought to be involved in oligodendrocyte migration, 
proliferation  and differentiation, respectively (Blaschuk et al., 2000).  The 
differential expression and activation of integrins has been proposed to regulate 
growth factor signalling and influence multiple aspects of oligodendrocyte 
development and myelination (Baron et al., 2005).  
In vitro studies have demonstrated a role for αvβ1 integrin in PDGF mediated 
migration of OPCs (Milner et al., 1996).  The mitogenic effects of PDGF are 
mediated through the PDGFαR and the activation of αvβ3 integrin (Baron et al., 
2002).  While physiological concentrations of PDGF (1 ng/ml) are not sufficient 
to directly promote OPC proliferation, they do so indirectly via activation of 
integrin αvβ3 that leads to increased affinity for PDGF (Baron et al., 2002). 
As OPCs differentiate into oligodendrocytes, the major role of the PDGFαR is to 
provide a survival signal for newly formed oligodendrocytes (Barres et al., 1992, 
Calver et al., 1998).  The PDGF generated survival signal is amplified by α6β1 
integrin signalling via Fyn tyrosine kinase and the phosphatidylinositol 3´-kinase 
(PI3K) pathway in response to laminins expressed on the target axons, thereby 
providing a mechanism for the target dependence of oligodendrocyte survival 
(Colognato et al., 2002, Colognato et al., 2004).   
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It has been shown that oligodendrocyte membranes contain lipid rafts (Taylor et 
al., 2002) and that PDGFαR and α6β1 integrin are localised in lipid rafts of newly 
differentiated oligodendrocytes (Baron et al., 2003).  Laminin-2 induces the co-
localization of integrin α6β1 and the PDGFαR within the same raft domain and 
enhances PI3K signalling in response to PDGF (Baron et al., 2003).  This 
localisation is important for normal survival signalling, because depletion of lipid 
rafts increases oligodendrocyte apoptosis and inhibits PI3K signalling, whereas 
integrin activation increases raft localization and rescues the effects of both raft 
depletion and PDGF removal on survival and PI3K signalling (Decker and ffrench-
Constant, 2004).  In contrast, integrin αvβ3, which is associated with PDGFαR in 
OPCs and is part of the signalling pathway by which PDGF stimulates 
proliferation, is not present in lipid rafts of differentiated oligodendrocytes 
(Baron et al., 2002).  Thus the integrin associated with the PDGFαR determines 
the response to PDGF.  Lipid rafts provide a favourable environment for growth 
factor-mediated integrin activation and the localisation of different integrins in 
lipid rafts at different stages of differentiation allows for switching of growth 
factor responses.  
A similar change in response occurs with NRG signalling following axonal contact.  
NRG binding to ErbB receptors on OPCs stimulates survival and proliferation via a 
PI3K dependent pathway, whereas following axonal contact α6β1-laminin 
interactions trigger a switch to a MAPK signalling pathway that enhances survival 
and differentiation of more mature oligodendrocytes (Colognato et al., 2002, 
Colognato et al., 2004).  β1 integrins are also implicated in myelin membrane 
formation following axonal contact (Relvas et al., 2001, Colognato et al., 2004, 
Olsen and ffrench-Constant, 2005).  Thus association of growth factors with 
integrins provides a mechanism for contact dependent regulation of 
oligodendrocyte development. 
1.2.2.3.3 Axon-oligodendrocyte interactions 
In vitro, OPCs have the intrinsic potential to differentiate into oligodendrocytes 
even in the absence of axons, demonstrated by their ability to form myelin 
membrane-like sheets and the expression of myelin structural proteins (Reynolds 
et al., 1989).  In contrast, myelination in vivo requires a high level of specificity 
and requires axonal signals (Barres and Raff, 1999).  The establishment of axon-
glial contact during development is critical for the onset of myelination, with 
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the axon providing important signalling cues to the oligodendrocytes (Barres and 
Raff, 1999).  In turn, the myelinating oligodendrocytes regulate axonal diameter 
and induce increased phosphorylation of neurofilaments (Sanchez et al., 1996, 
Yin et al., 1998).  Axon derived survival signals regulate oligodendrocyte cell 
number and ensure that the oligodendrocyte population is precisely matched to 
the surface area of axons to be myelinated.  This is achieved both by increasing 
the proliferation of OPCs (Wood and Bunge, 1986, Gard and Pfeiffer, 1990, Hardy 
and Reynolds, 1993, Barres and Raff, 1993) and by increasing oligodendrocyte 
survival (Barres et al., 1993a, Frost et al., 1999, Fernandez et al., 2000).   
Axons and oligodendrocytes are mutually dependent, both during development 
and in the adult, and the integrity of the axon-glial unit requires continual 
bidirectional signalling between the oligodendrocyte and the axon.  The precise 
nature of the signals involved in axonal-oligodendrocyte interaction is not fully 
understood and may involve both soluble factors released from the axon and/or 
contact-dependent signalling following attachment of the oligodendrocyte to the 
axonal surface.   
1.2.3 Microglia 
Microglia are the immune cells of the CNS, and can act as phagocytes, cleaning 
up CNS debris.  They are ontogenetically related to mononuclear phagocytes 
(Kreutzberg, 1996).  Resting microglia are small cells with short, branched 
processes that comprise approximately 5% of the CNS glia.  Microglia become 
activated upon injury and mainly function as phagocytes, although they also play 
other roles involved in tissue repair and neural regeneration.   
1.2.4 Schwann cells 
Schwann cells are the main peripheral nerve glial cells.  Mature Schwann cells 
are traditionally classified according to their morphological relationship with 
axons into two different phenotypes: myelinating and non-myelinating Schwann 
cells.  Like their CNS equivalents, the oligodendrocytes, myelinating Schwann 
cells insulate large diameter axons by producing myelin sheaths.  However, 
whereas one oligodendrocyte can envelop approximately fifteen axonal 
internodes, the Schwann cell only envelops one axonal internode belonging to 
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the neuron to which it is associated.  Schwann cell myelin differs to 
oligodendrocyte myelin in that it contains different proteins.  The major 
peripheral myelin protein is P0, whereas the central myelin contains PLP.  Non-
myelinating Schwann cells typically ensheath bundles of axons which are less 
than 1 µm in diameter without forming a myelin sheath (Jessen and Mirsky, 
1991).  Myelinating and non-myelinating Schwann cells can be distinguished by 
their antigenic phenotype.  Both myelinating and non-myelinating Schwann cells 
express O4 (Mirsky et al., 1990).  Myelinating Schwann cells also express high 
levels of glycolipid GalC as well as myelin-related proteins including P0, 
peripheral myelin protein 22kDa, MAG and MBP.  Non-myelinating Schwann cells 
express GFAP, growth associated protein 43kDa (GAP 43), p75NTR as well as 
adhesion molecules L1, neural cell adhesion molecule (N-CAM), and Ca2+ 
dependent cell adhesion molecule (N-cadherin) (Mirsky et al., 1986, Jessen et 
al., 1990, Curtis et al., 1992). 
1.2.4.1 Development of Schwann cells 
The majority of Schwann cells originate directly from the neural crest (Jessen 
and Mirsky, 1992, Le Douarin et al., 1991), along with other glial cells of the 
PNS, peripheral neurons and melanocytes.  Some Schwann cells are derived from 
boundary cap cells (Maro et al., 2004), which in turn derive from the neural 
crest (Niederlander and Lumsden, 1996).   
The generation of Schwann cells from the neural crest involves two intermediate 
cell types: Schwann cell precursors and immature Schwann cells (Mirsky and 
Jessen, 1999).  Schwann cell precursors, which do not express S100 and lack a 
basal lamina, are detected in rat peripheral nerves at embryonic days (E) 14 and 
15.  These are dependent upon axonal signals for survival (Jessen et al., 1994).  
Immature Schwann cells which form from the precursor cells can be observed 
from E17 until the time of birth (Jessen et al., 1994, Dong et al., 1995, Dong et 
al., 1999).  Immature Schwann cells envelop unmyelinated axons and form a 
basal lamina.  Schwann cells require axonal contact to drive their differentiation 
from immature Schwann cells to myelinating or non-myelinating mature Schwann 
cells (Mirsky and Jessen, 1999).   
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Myelinating Schwann cells begin to form from the time of birth, whereas the 
non-myelinating Schwann cells appear later.  Schwann cells are able to 
interchange between myelinating and non-myelinating phenotypes.  In addition, 
mature Schwann cells are able to return to a cell type similar to the immature 
phenotype (Mirsky and Jessen, 1996) and to redifferentiate to the mature 
phenotype following re-establishment of appropriate axonal contact. 
Schwann cell development is, in part, regulated by neuregulins.  Neuregulins 
influence survival and proliferation of Schwann cells (Grinspan et al., 1996a, 
Trachtenberg and Thompson, 1996).  Inactivation of the neuregulin receptor 
ErbB3 (Garratt et al., 2000) or the reduction of neuregulin-1 (Michailov et al., 
2004) results in reduced myelin sheath thickness which suggests that neuregulins 
also play a role in myelination of peripheral nerves. 
1.2.4.2 Function of Schwann cells 
Schwann cells provide an interface between the axon and the surrounding tissue.  
As mentioned above, Schwann cells produce the myelin sheath which allows 
saltatory conduction of nerve impulses.  Schwann cells also play important roles 
in the development of the nerves (Mirsky et al., 2002) and are thought to be 
responsible for the regenerative properties of the PNS.  Schwann cells also 
provide the cellular scaffolds for regeneration in the nerve tracts and sprouting 
axons at neuromuscular junctions (Son et al., 1996).   
Following injury to the peripheral nerve, nerve fibres distal to the lesion 
undergo a calcium-mediated process called Wallerian degeneration (Waller, 
1850).  The axon and the surrounding myelin fragment as the nerve degenerates 
in an anterograde fashion, leaving behind Schwann cells inside the basal lamina 
that surrounded the original nerve.  Schwann cells are able to survive without 
axonal contact because they are maintained by an autocrine mechanism 
involving IGF-2, PDGF-BB and NT-3 (Meier et al., 1999). 
The degeneration is followed by removal and recycling of axonal and myelin 
derived material to prepare the environment for subsequent axonal growth by 
the regenerating nerve.  An initial role of Schwann cells is to help remove the 
degenerated axonal and myelin debris and then pass it on to macrophages.  Once 
the axon and the myelin degenerate, the remaining denervated Schwann cells 
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are stimulated to proliferate within the basal lamina, forming columns of 
Schwann cells known as endoneurial tubes or bands of Büngner (Torigoe et al., 
1996, Burnett and Zager, 2004).  These act as conduits for the regenerating 
axons.  The basal lamina is comprised of collagen, fibronectin and laminin 
produced by Schwann cells (Baron-Van Evercooren et al., 1986).  Both 
fibronectin and laminin are potent substrates for neurite outgrowth (Cohen et 
al., 1987, Humphries et al., 1988).  The axonal and myelin debris (Salzer and 
Bunge, 1980, Salzer et al., 1980a, Salzer et al., 1980b) as well as invading 
macrophages which have phagocytosed myelin (Baichwal et al., 1988) stimulate 
proliferation of denervated Schwann cells within the bands of Büngner.   
The presence of Schwann cells is the critical factor in peripheral nerve 
regeneration.  This has been demonstrated in experiments where the nerve is 
frozen, killing the Schwann cells while leaving the basal lamina intact.  When 
this nerve is grafted onto a proximal stump in a host animal, regeneration 
through the graft is only possible when it is accompanied by Schwann cells.  If 
the invasion of live Schwann cells into the nerve graft is prevented by cytotoxic 
agents, axons fail to regenerate (Hall, 1986). 
Denervated Schwann cells have a similar phenotype to that of non-myelinating 
Schwann cells (Guenard et al., 1996), but express higher levels of GAP 43 and 
lower levels of glycolipids GalC and sulphatide (Mirsky and Jessen, 1996).  They 
express large numbers of growth factors and cytokines including neurotrophins 
such as NT-4/5, neuregulins (Raabe et al., 1996), NGF, BDNF (Yamamoto et al., 
1993); transforming growth factor β1 (TGFβ1); and glial derived neurotrophic 
factor (GDNF) which have been shown to attract and nourish axons in the distal 
nerve stump (Fu and Gordon, 1997).  They also express a number of cell 
adhesion molecules that are believed to promote axonal regeneration and 
sprouting including N-CAM, L1 (Martini et al., 1994), integrins and N-cadherin 
(Bixby et al., 1988). 
1.2.4.3 Ganglioside expression of Schwann cells 
Numerous studies examining the Schwann cell expression of gangliosides have 
been performed, however, they have yielded conflicting results.  The major 
ganglioside expressed by neonatal Schwann cells appears to be GM3 (Farrer and 
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Quarles, 1996).  Levison and McCarthy (Levison and McCarthy, 1989) found that 
in culture, GD3 was expressed by peripheral neurons and fibroblasts but not 
Schwann cells and that the intensity of GD3 labelling on neuronal processes was 
diminished at sites contacted by Schwann cells (Levison and McCarthy, 1989).  In 
contrast, GD3 was found to expressed on the surface of Schwann cells and at 
nodes of Ranvier in peripheral nerves (Usuki et al., 2006).  Two studies have 
found that Schwann cells derived from neonatal rat sciatic nerve label with CTx 
suggesting they express GM1 (Brockes et al., 1979, Raff et al., 1979), whereas 
another similar study showed that neonatal rat Schwann cell cultures do not 
express GM1 (Okada et al., 1982).  The finding that CTx is mitogenic for 
neonatal rat Schwann cells suggests that rat Schwann cells express GM1 (Raff et 
al., 1978a).  In addition, MBP induces Schwann cell proliferation via an 
interaction with GM1 (Tzeng et al., 1995, Tzeng et al., 1999).  Furthermore, a 
study of mature, myelinating Schwann cells found that low amounts of GM1 are 
found on the Schwann cell internodal surfaces but that GM1 is primarily localised 
on specialised Schwann cell structures in the nodal region in rat peripheral 
nerves (Ganser et al., 1983).  Another study using GM1 immunofluorescence of 
adult rat spinal roots by Molander et al (1997) confirmed that GM1 is confined to 
Schmidt-Lanterman’s incisures, myelin sheath paranodal end segments and to 
some extent the abaxonal Schwann cell cytoplasm.  Also, some studies have 
found that Schwann cells express GD1a (Santafe et al., 2005) whereas others 
have found that it is expressed by axons but not Schwann cells (Ho et al., 1999). 
1.2.4.4 Integrin expression by Schwann cells 
In peripheral nerves Schwann cells interact with axons and extracellular matrix 
in order to ensheath and myelinate axons during development and regeneration.  
These interactions are likely to be mediated by adhesion molecules, including 
integrins, which mediate cell-cell and cell-extracellular matrix interactions.  
Studies have shown that Schwann cells express the following integrin receptors: 
α1β1, α2β1, α5β1, α6β1, α7β1, α6β4, αvβ3 and αvβ8 (Milner et al., 1997a). 
Collagen/laminin receptor α1β1 is expressed in large amounts in 
undifferentiated Schwann cells in contact with axons (Fernandez-Valle et al., 
1994) and only at very low levels on myelinating Schwann cells (Stewart et al., 
1997).  Fibronectin receptor α5β1 is expressed on Schwann cells during 
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peripheral nerve development and during regeneration (Lefcort et al., 1992).  
The laminin receptor α6β1 is expressed on migrating Schwann cells before birth 
(Dubovy et al., 2001, Previtali et al., 2003b).  Undifferentiated Schwann cells in 
contact with axons express large amounts of α6β1 (Fernandez-Valle et al., 
1994), although it is constitutively expressed by Schwann cells even in the 
absence of axonal contact (Einheber et al., 1993).  The laminin-2 receptor, 
α7β1, which is expressed on Schwann cells postnatally, is the last laminin 
receptor expressed by differentiating Schwann cells (Chernousov et al., 2007, 
Previtali et al., 2003a). 
α6β4 is expressed at the abaxonal surface of myelinating Schwann cells, 
opposite the Schwann cell basal lamina (Feltri et al., 1994, Niessen et al., 1994).  
α6β4 expression is axonally regulated and is irrespective of myelin formation, 
although it dramatically increases at the onset of myelination  (Einheber et al., 
1993, Niessen et al., 1994).  αvβ8 is expressed by Schwann cells, and is a 
receptor for fibrin, which derives from fibrinogen infiltrating into peripheral 
nerve following injury (Chernousov and Carey, 2003). 
1.3 Myelin 
Schwann cell and oligodendrocyte processes wrap around axons to form an 
electrically insulating membrane known as myelin, which reduces current flow 
across the axonal membrane and increases resistance.  The myelin sheath is 
interrupted at regular intervals by gaps, called nodes of Ranvier, where axonal 
electrical excitation is confined (Sherman and Brophy, 2005).  Because the 
cytoplasm of the axon is electrically conductive, and because the myelin inhibits 
charge leakage through the membrane, depolarisation at one node of Ranvier is 
sufficient to elevate the voltage at a neighboring node to the threshold for 
initiation of a nerve impulse.  As a result, nerve impulses, known as action 
potentials, travel along the axon by jumping from node to node, which greatly 
increases the rate and efficiency of nerve impulse propagation.  This mode of 
action potential propagation is termed saltatory conduction.  
The myelin sheath and the underlying axon are organised into discrete molecular 
structural and functional domains, which include the node of Ranvier, paranodal 
and juxtaparanodal regions and the internode (Salzer, 2003) (Figure 1.7).  Each 
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domain contains unique complexes of molecules, both on the axonal surface and 
within the myelin sheath (Menon et al., 2003).  Axon-glial interactions are 
critical for the formation of these domains which allow saltatory conduction to 
take place.   
 
Figure 1.7. Schematic depiction of the node of Ranvier, paranode, juxtaparanode, and 
internode. 
The left hand side panel depicts CNS myelin whereas the right hand side panel depicts PNS 
myelin.  Axonal membrane in each domain is characterised by their expression of a different set 
of molecules in both the PNS and the CNS.  Voltage-gated sodium channels are concentrated at 
nodes of Ranvier, while shaker-type voltage-gated potassium channels are concentrated at 
juxtaparanodes. The axonal cell adhesion molecules, contactin and caspr, and the glial cell 
adhesion molecule, neurofascin 155, are essential components of paranodal junctions.  Adapted 
from (Arroyo and Scherer, 2000).  In the PNS, components of the paranode and juxtaparanode 
extend into the internode as a thin spiral apposed to the inner mesaxon (red and green lines). 
 
1.3.1 Node of Ranvier 
The nodes of Ranvier contain clusters of voltage dependent Na+ channels (Nav) in 
the axonal membrane that are essential for the generation of action potentials 
(Rasband et al., 1999a, Rasband and Trimmer, 2001).  During development the 
main subtype of Nav at node of Ranvier is Nav1.2, which is replaced by Nav1.6 in 
the adult CNS (Kaplan et al., 2001).  Nav are molecular complexes that consist of 
a pore-forming α subunit and ancillary β subunits.  Nav interact with other 
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molecules at the node to form macromolecular complexes.  They form a 
complex with the cell adhesion molecules neuron-glia related CAM (Nr-CAM) and 
neurofascin 186 (NF186) and this complex is stabilised by association with the 
cytoskeletal adapter protein ankyrin G and the actin binding protein spectrin βIV 
located in the axoplasm (Kordeli et al., 1995, Davis et al., 1996, Berghs et al., 
2000).  Perinodal astrocyte processes and the ECM molecules tenascin-R, 
tenascin-C and phosphacan are also present within the perinodal space and may 
further stabilise nodal molecular complexes.  Nav are initially continuously 
distributed along axons, but eventually become clustered within nodes of 
Ranvier.  Contact with Schwann cells induces clustering of sodium channels along 
the axons of peripheral neurons in vitro and in vivo (Joe and Angelides, 1992, 
Dugandzija-Novakovic et al., 1995, Vabnick et al., 1996).  Similarly 
oligodendrocytes are crucial in inducing clustering of sodium channels in central 
neurons in vitro and in vivo (Kaplan et al., 1997).  Accordingly, rats lacking 
oligodendrocytes form very few Na+ channel clusters (Kaplan et al., 1997).  
Induction of Nav clustering is independent of paranodal oligodendrocyte contact 
(Kaplan et al., 1997, Jenkins and Bennett, 2002, Ishibashi et al., 2003, Dupree 
et al., 2005) and seems to be triggered by a protein released by 
oligodendrocytes (Kaplan et al., 1997).   
Nav accumulate at the ends of the developing myelin sheath and as two adjacent 
internodal regions elongate, Nav clusters fuse, forming the node of Ranvier.  
Potassium channels (Kv) are then excluded from the nodal region by the 
developing paranodal region and localise beneath the myelin sheath (Vabnick 
and Shrager, 1998).  Based on the sequential appearance of antigens in 
developing nerves, NF186 and ankyrin G appear to be instrumental in the 
formation of the node and the recruitment of Na+ channels to the node (Davis et 
al., 1996, Lambert et al., 1997, Jenkins and Bennett, 2002, Koticha et al., 
2006).  Indeed, nodes of Ranvier fail to form correctly in NF186 deficient mice 
(Sherman et al., 2005) 
1.3.2 Paranode 
Paranodes are the predominant interaction sites between myelinating glia and 
the axon.  At paranodes, the lateral edge of the myelin sheath spirals around the 
axon forming a septate-like axoglial junction that provides a barrier to ion flow 
  51 
within the axon.  These septate-like paranodal junctions are important for the 
establishment of saltatory conduction because they separate Na+ channels at the 
node from K+ channels at the juxtaparanode (Rios et al., 2003).  The disruption 
of paranodal junctions results in mislocalisation of both Na+ and K+ channels, 
suggesting that they function as a diffusion barrier restricting the lateral 
mobility of membrane proteins (Bhat et al., 2001, Boyle et al., 2001, Rios et al., 
2003, Sherman et al., 2005).  Autotypic junctions also form between the 
paranodal loops themselves including tight junctions and gap junctions (Spiegel 
and Peles, 2002).  
Glial and axonal membranes have distinct molecular specialisations at the 
paranodes.  The 155 kDa isoform of neurofascin (NF155), a member of the L1 
family of cell adhesion molecules, is expressed exclusively by oligodendrocytes. 
It is localised at the paranodes of myelinated nerves where the oligodendrocyte 
processes attach to the axon (Tait et al., 2000).  The axonal proteins contactin 
and contactin associated protein (Caspr) form a cis complex in the axolemma at 
the paranode (Einheber et al., 1997, Rios et al., 2000).  The caspr/contactin 
complex binds to NF155, forming a critical component of the axo-glial paranodal 
junction (Charles et al., 2002).  In the PNS, the paranodes are enriched in 
gangliosides GD1b and GQ1b (Chiba et al., 1993, Kusunoki et al., 1993). 
The proper assembly of the paranodes depends on many factors including 
protein–protein interactions and protein–lipid interactions.  Caspr fails to localise 
to paranodes in shiverer mice lacking the myelin protein MBP as well as in mice 
lacking glycolipids GalC and sulphatide, which are involved in the formation of 
lipid rafts (Dupree et al., 1998, Dupree et al., 1999, Rasband et al., 1999a).  
Paranodal junctions are also severely disrupted in both Caspr and contactin 
deficient mice (Bhat et al., 2001, Boyle et al., 2001).  Furthermore, paranodes 
are completely absent in mice lacking NF155, suggesting that NF155 is critical 
for the formation of paranodes (Sherman et al., 2005). 
1.3.3 Juxtaparanode 
The juxtaparanodal region is located adjacent to the innermost paranodal loop 
and forms the most lateral edge of the internodal compact myelin.  Delayed 
rectifier Shaker type potassium channels Kv1.1 , Kv 1.2 and Kvβ2.1 are highly 
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enriched in the juxtaparanodal region and are thought to promote membrane 
repolarisation and maintenance of internodal resting potential (Rasband et al., 
1999b, Rasband and Trimmer, 2001).  In the axolemma of the juxtaparanode Kv 
co-localise with the adhesion molecules caspr-2, structurally similar to Caspr 
found at the paranodes, and transient axonal protein (TAG-1) (Poliak et al., 
2003, Traka et al., 2003). Caspr 2 and TAG-1 form a complex in the axonal 
membrane, which interacts with TAG-1 present on the glial membrane.  This 
complex is essential for the accumulation of Kv at the juxtaparanode (Poliak et 
al., 2001, Poliak et al., 2003, Traka et al., 2003). 
1.3.4 Internode 
The internodal region consists of compact myelin surrounding the axon and no 
specific molecular complexes have been described in this region.  In the PNS 
components of the paranode and juxtaparanode, including Caspr-2, Kv, NF155 
and TAG-1 extend into the internode as a thin spiral apposed to the inner 
mesaxon but this is not thought to occur in the CNS (Arroyo et al., 2001, Traka 
et al., 2003). 
1.3.5 Role of lipid rafts in myelination 
Lipid rafts have been implicated in protein sorting and as sites for signalling in 
the plasma membrane.  It has been hypothesised that oligodendrocytes may 
adopt a mechanism of co-clustering proteins destined for myelination with lipid 
rafts during sorting and transport from the trans-Golgi network (Kim et al., 
1995).  A study looking at the association of known myelin proteins with lipid 
rafts found that approximately 40% of non-compact myelin proteins CNP and 
MOG were selectively associated with lipid rafts, suggesting that they may have 
both non-active, and functionally active lipid raft-associated forms in the 
membrane (Kim and Pfeiffer, 1999). 
As mentioned above, NF155 is required for the establishment of the paranodal 
axo-glial junctions.  NF155 is recruited to lipid rafts during oligodendrocyte 
development (Maier et al., 2005).  It is not located in lipid rafts in cultured 
premyelinating oligodendrocytes but becomes raft associated during its 
progressive localisation to paranodes (Schafer et al., 2004).  Conditions 
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resembling the perturbation of the blood brain barrier, such as alteration of the 
extracellular matrix, interfere with NF155 raft association.  In oligodendrocytes 
cultivated on poly-L-lysine, NF155 is recruited to lipid rafts during development 
and becomes enriched in secondary and tertiary processes, whereas in those 
grown on fibronectin the localisation and raft association of NF155 is perturbed 
and inhibits the molecular differentiation of oligodendrocytes.  It has been 
demonstrated that efficient raft-association of NF155 is essential for the 
assembly of the paranodal junction and that reduced association of NF155 to 
lipid rafts is accompanied by the disassembly of the paranodal junction and thus 
contributes to the demyelination process in MS (Maier et al., 2007).  In MS 
lesions, the association of NF155 with lipid rafts was reduced, indicating that 
membrane association of NF155 was generally affected (Maier et al., 2007).   
GalC and its sulphated derivative, sulphatide, are major myelin galactolipids and 
are essential components of lipid rafts.  It has been shown that these myelin 
galactolipids are important for paranode stability (Dupree et al., 1998, Dupree 
et al., 1999, Honke et al., 2002, Ishibashi et al., 2002, Marcus et al., 2002) and 
may contribute to maintenance of axo-glial contacts by promoting the 
stabilisation of NF155 in lipid rafts (Schafer et al., 2004).  In accordance with 
this, mutant animals lacking PLP, GalC or sulphatide have disrupted paranodal 
junctions and have significantly reduced levels of raft-associated NF155 (Schafer 
et al., 2004).  
1.3.6 Role of gangliosides in myelination 
Gangliosides are abundant on glial and neuronal cell membranes but their 
precise functions in the nervous system remain largely undefined.  GalNAc T -/- 
mice that lack all complex gangliosides have a reduced conduction velocity 
(Takamiya et al., 1996), which is indicative of myelination defects since it is 
myelin which facilitates saltatory conduction and greatly increases conduction 
velocity.  A subsequent study in 4 to 10 week old GalNAc T -/- mice found 
morphological changes in the nerve fibre tracts of the spinal cord (Ma et al., 
2003).  Specifically, the number of degenerated axons and unmyelinated fibres 
were markedly increased (Ma et al., 2003).  Ma et al (2003) also observed 
loosened myelin sheaths and myelin sheaths separated from axons by wide 
spaces.  In addition, 12 to 16-week old GalNAc T -/- mice have decreased 
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myelination and axonal degeneration in optic and sciatic nerves (Sheikh et al., 
1999b).  Furthermore, 8 to 12-month old GalNAc T -/- mice develop motor 
dysfunction (Chiavegatto et al., 2000).  These findings indicate that complex 
gangliosides are important for the maintenance of myelin and the integrity of 
nerve fibres. 
Gangliosides have been shown to be important in the maintenance of paranodal 
junctions and ion channel clusters.  It has been shown that antibodies to GM1 
ganglioside label paranodal regions (Susuki et al., 2007a).  Autoantibodies to 
gangliosides GM1 and GD1a are thought to disrupt nodes of Ranvier in peripheral 
motor nerves and cause an axonal subtype of Guillain-Barré syndrome, termed 
acute motor axonal neuropathy (AMAN) (Hughes and Cornblath, 2005), an 
autoimmune neuropathy characterised by acute limb weakness.  In addition, 
nodes of Ranvier are abnormally lengthened in ventral roots from early AMAN 
cases (Griffin et al., 1996).  Also, in a Guillain-Barré disease model, anti-GM1 
antibodies bind to the nodal region, causing abnormally lengthened node of 
Ranvier (Susuki et al., 2007b).  This leads to the disruption of paranodal axoglial 
junctions, resulting in the disruption or disappearance of nodal Na+ channel 
clusters (Susuki et al., 2007b).   
GalNAc T -/- mice lacking all complex gangliosides, including GM1 and GD1a, 
also have altered paranodal junctions, broadened Na+ channel clusters, and 
mislocalisation of juxtaparanodal K+ channels at the paranodes (Susuki et al., 
2007a).  In these mice, immunostaining of Caspr and NF155 was reduced and 
some paranodal loops failed to attach to the axolemma in both peripheral and 
central nervous nerves (Susuki et al., 2007a).  Moreover, abnormal 
immunostaining at paranodes became more prominent with age (Susuki et al., 
2007a).  These defects were more prevalent in ventral than dorsal roots, and 
less frequent in Sia T -/- mice lacking b-series gangliosides but with excess a-
series gangliosides such as GM1 and GD1a (Susuki et al., 2007a).  Susuki et al 
(2007) also found slower nerve conduction and reduced nodal Nav current in 
GalNAc T -/- peripheral motor nerves.  In addition, the amounts of Caspr and 
NF155 in lipid rafts were reduced in GalNAc T -/- brains (Susuki et al., 2007a).  
Earlier, Shafer et al (2004) showed that NF155 inclusion into lipid rafts occurs 
during paranode formation.  These findings suggest that gangliosides are lipid 
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raft components that play important roles in stabilising neuron-glia interactions 
at paranodal junctions. 
1.4 The olfactory system  
The olfactory system is the sensory system is involved in the perception of 
odours.  In mammals, odorants are inhaled through the nose where they interact 
with an odorant receptor located in the cilia of the olfactory receptor neurons 
(ORNs) (Farbman, 1990).  ORNs transduce molecular features of the odorants 
into electrical signals which then travel along the olfactory nerve into the 
olfactory bulb. 
1.4.1 PNS-CNS transitional zone 
The PNS is able to support axonal outgrowth throughout life.  In contrast, most 
CNS tissues can only support axonal outgrowth during development.  This is 
exemplified by the dorsal root crush model.  The dorsal root entry zone (DREZ) is 
a transitional zone between the CNS and the PNS and has been widely used to 
study the regenerative capacity of the nervous system.  It is the region at which 
the dorsal roots enter the spinal cord and exemplifies the difference in the 
regenerative capacities of the two divisions of the nervous system.  Cell bodies 
of the primary neurons lie in the dorsal root ganglia and they have a single axon 
which projects one branch peripherally and one branch centrally, to form the 
dorsal roots (Ramer et al., 2001).  Following a crush lesion of a dorsal root, the 
damaged axons are able to regrow through the Schwann cell environment of the 
PNS but they come to an abrupt halt when they reach the boundary between the 
PNS and the CNS, the DREZ (Carlstedt et al., 1989).   
The olfactory system is also a transitional zone between the PNS and the CNS 
(Doucette, 1991).  Olfactory receptor neurons are one of the only populations of 
neurons to undergo neurogenesis throughout the lifetime of an organism, both as 
a result of natural turnover and in response to injury (Graziadei and Graziadei, 
1979, Farbman, 1990).  Unlike at the DREZ, new ORNs are generated from basal 
cells in the PNS environment of the olfactory epithelium (OE) and are able to re-
enter the olfactory bulb and reform synapses with second order neurons in the 
CNS (Schwob, 2002).   
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1.4.2 Anatomy of the olfactory system 
The two major components of the primary olfactory system are the olfactory 
mucosa which is located in the nasal cavity in the PNS and the olfactory bulb 
which is located in the CNS (Figure 1.8).  The olfactory mucosa is composed of 
the OE and the lamina propria (LP).  The nasal cavity also contains the 
respiratory epithelium.  In addition, the trigeminal, vagus and glossopharyngeal 
nerves all have chemoreceptive free endings in the mucosal lining of the 
respiratory tract.  
Olfactory epithelium is a pseudostratified columnar epithelium which lies in the 
posteriodorsal region of the nasal cavity.  In humans it occupies an area of 1 
cm2, however in macrosmatic animals where the sense of smell is of paramount 
importance such as rodents, this area is increased by the presence of elaborate 
turbinates that extend from the lateral wall of the nasal cavity.  The olfactory 
epithelium develops from the olfactory placode, a localised epithelial thickening 
that develops at E10 in rats, at the rostrolateral region of the embryonic head 
(Brunjes and Frazier, 1986, De Carlos et al., 1995).  The olfactory epithelium is 
composed of three main cell types: the sustentacular cells, ORNs and basal cells 
(Figure 1.9).  
The lamina propria is a layer of loose connective tissue which lies beneath the 
epithelium.  It contains Bowman’s glands and OECs which ensheath ORNs as they 
travel from the olfactory epithelium to the olfactory bulb (Au and Roskams, 
2003).  The connective tissue is made up of various cell types including: 
fibroblasts, macrophages, pericytes, endothelial cells, smooth muscle cells from 
the lining of the blood vessels and Schwann cells that ensheath nerves that 
innervate the blood vessels (Barnett and Chang, 2004). 
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Figure 1.8. Cells of the olfactory epithelium 
The olfactory epithelium contains the following cell types: sustentacular cell, immature 
olfactory receptor neurons, mature olfactory receptor neurons, globose basal cells and 
horizontal basal cells.  Olfactory ensheathing cells are located in the lamina propria. 
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Figure 1.9. Anatomy of the olfactory system. 
The olfactory system contains both PNS and CNS components.  The olfactory mucosa, which 
contains the olfactory epithelium and the lamina propria, is located within the PNS, whereas the 
olfactory bulb is in the CNS.  Cells of the olfactory epithelium are described in figure 1.8.  
Lamina propria consists of loose connective tissue and olfactory ensheathing cells, which 
ensheath bundles of olfactory receptor neurons as they travel from the olfactory epithelium to 
the olfactory bulb.  The connective tissue within lamina propria contains many cell types such as 
fibroblasts, macrophages, pericytes, endothelial cells, smooth muscle cells from the lining of the 
blood vessels and Schwann cells that ensheath nerves that innervate the blood vessels.  Figure 
taken from (Barnett and Chang, 2004). 
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1.4.2.1 Sustentacular cells 
Sustentacular cells are supporting columnar epithelial cells that are similar to 
Müller cells in the retina (Pixley, 1992) and compose 15 to 25% of the total cell 
population of the olfactory epithelium (Weiler and Farbman, 1998).  They 
possess numerous microvilli and much ER (Farbman and Buchholz, 1992).  
Sustentacular cells are thought to be involved in detoxification, due to the 
presence of a prominent cytochrome P-450 system, as well as in processing of 
odorants (Schwob and Mozell, 1999, Carr et al., 1990), regulating the ionic 
composition of the mucus (Getchell et al., 1984) and providing a structural, 
supportive matrix (Getchell et al., 1984). 
1.4.2.2 Olfactory receptor neurons 
ORNs are bipolar neurons which project an apical dendrite to the surface of the 
epithelium, where it expands into a ciliated dendritic knob and a basal axon 
through the epithelium and underlying basal lamina.  ORN axons are small in 
diameter, approximatey 0.2 µm and therefore unmyelinated.  Upon exiting the 
base of the epithelium ORN axons form fascicles, which comprise the olfactory 
nerve, the first cranial nerve.  The olfactory nerve projects through foramina in 
the cribiform plate of the ethmoid bone to enter the CNS at the olfactory bulbs.  
Mature ORNs are characterised by the expression of 19 kDa cytoplasmic protein, 
the olfactory marker protein (OMP) (Margolis, 1982).  OMP is also expressed in 
other small groups of neurons throughout the CNS (Baker et al., 1989).  The 
function of OMP has not been fully elucidated, although it is known to cause an 
increase in the proliferation of both neural progenitors and sustentacular cells 
(Farbman et al., 1998).  OMP-null mice have an ultrastructurally normal 
epithelium and bulb, however, they have an impaired physiological response to 
odour stimuli (Buiakova et al., 1996).  Mature ORNs have both an axon and a 
dendrite, whereas immature ORNs lack a dendrite and are characterised by the 
expression of GAP 43 (Verhaagen et al., 1989, Meiri et al., 1991). 
1.4.2.3 Basal cells 
There are two classes of basal cell within the olfactory epithelium, globose and 
horizontal basal cells.  Globose basal cells (GBCs) are the most mitotically active 
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cells within the epithelium.  They label with antibodies to the putative 
glycolipids GBC-1, 2 and 3 (Goldstein and Schwob, 1996).  They are located 
beneath the immature ORNs in the epithelium and above the horizontal basal 
cells (HBCs).  
The HBCs are located at the base of the epithelium, immediately above the 
basement membrane, are flattened in shape and are characterised by the 
expression of cytokeratins 5 and 14 (Holbrook et al., 1995).  It has been 
proposed that they function as intermediate signalling cells, transmitting 
information regarding the status of the ORN population to the GBCs causing 
them to respond accordingly (Holbrook et al., 1995).  
As mentioned previously, ORNs undergo constant replacement from progenitors 
residing in the olfactory epithelium, the identity of which has been the subject 
of some contention, both the HBCs and GBCs having been contenders.  It now 
appears, however, that GBCs are the neuronal progenitors since they have a 
faster turnover rate than HBCs (Holbrook et al., 1995, Huard and Schwob, 1995).  
Lineage studies using replication-incompetent retroviral vectors encoding 
heritable markers also suggest that GBCs are neuronal precursors (Caggiano et 
al., 1994, Schwob et al., 1994a).  Not only are they neuronal precursors, but 
they have also been demonstrated in certain circumstances to generate 
sustentacular cells, cells of the Bowman’s glands and ducts as well as HBCs 
(Huard et al., 1998). 
Neurogenesis in the olfactory epithelium is under the regulation of a negative 
feedback, mature ORNs feeding-back to inhibit the further differentiation of 
basal cells.  In vivo studies have shown the rate of proliferation of GBCs 
increases if the death of the ORNs is induced, whereas it decreases if ORNs are 
protected from damage (Farbman, 1990).  In vitro data also supports this theory, 
proliferative colonies of olfactory progenitors being inhibited when grown in the 
presence of differentiated ORNs (Mumm et al., 1996).  This feedback is 
regulated by the bone morphogenetic proteins (BMPs), which are members of 
the TGFβ superfamily that play important roles in neurogenesis.  In cell culture, 
BMP-2, 4 and 7 decreased the number of proliferating olfactory progenitors and 
inhibited the differentiation of ORNs, due to the proteolysis of Mash 1 (Shou et 
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al., 1999) and all three are expressed in the olfactory system in vivo (Shou et 
al., 2000). 
There are two different classes of GBCs.  One population expresses the 
transcription factor Mash 1 and functions as transient amplifying cells (Gordon et 
al., 1995) whereas the other expresses the transcription factor neurogenin 1 and 
functions as immediate neuronal precursors (Gordon et al., 1995, Cau et al., 
1997).  This has been confirmed using transgenic animals.  In Mash 1 null mutant 
mice, olfactory progenitors are not produced, while in neurogenin 1 null mutant 
mice, progenitors are produced but differentiation is blocked (Cau et al., 2002). 
1.4.2.4 Bowman’s glands 
Bowman’s glands produce a layer of mucus that constantly washes over the 
surface of the epithelium, removing odorant molecules (Schwob and Mozell, 
1999).  The ducts of Bowman’s glands extend from the lamina propria, through 
the epithelium to the luminal surface.   
1.4.2.5 Olfactory ensheathing cells 
OECs are a unique class of macroglial cell which straddle the divide between the 
glia of the CNS and the PNS.  They ensheath the thin non-myelinated axons of 
the ORNs from their peripheral origin in the olfactory mucosa across the 
cribiform plate and into the olfactory nerve layer of the ipsilateral olfactory 
bulb within the CNS.  The cytoplasmic processes of OECs enfold bundles of 
unmyelinated ORN axons, with OEC perikarya aligning along the length of the 
fascicles (Ramon-Cueto and Avila, 1998).   
OECs share similarities with both astrocytes and Schwann cells and although in 
the past they have been considered to be variants of both types of glia 
(Doucette, 1984, Chuah and Au, 1991), they are now regarded as a unique glial 
cell.  OECs have a different developmental origin to neural crest derived PNS 
glia and neuroectoderm derived CNS glia, originating instead from the olfactory 
placode.   
OEC that share many properties with the well characterised rat OECs have been 
identified in the human olfactory system (Barnett et al., 2000).  Human OECs 
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were shown to have a similar flattened morphology and demonstrated 
immunoreactivity for p75NTR, although no E-NCAM positive cells were observed.  
They were also capable of remyelinating experimentally created demyelinated 
lesions (Barnett et al., 2000). 
1.4.2.5.1 Properties in vivo 
OEC characteristics include fusiform morphology, indented nuclei, electron 
dense cytoplasm, and scattered intermediate filaments (Doucette, 1984).  
Morphologically, OECs in vivo appear most similar to non-myelinating Schwann 
cells since they both ensheath small diameter axons (<1 µm) without forming 
myelin sheaths.  OECs are often compared to non-myelinating Schwann cells 
because they have many things in common.  For instance, OECs express laminin 
(Liesi, 1985), L1 (Miragall et al., 1988), vimentin (Ramon-Cueto and Nieto-
Sampedro, 1992) and p75NTR (Barnett et al., 1993), as do non-myelinating 
Schwann cells (Bunge et al., 1986, Jessen and Mirsky, 1991, Ramon-Cueto and 
Nieto-Sampedro, 1992).   
However, OECs differ from Schwann cells in many ways.  Although both cell 
types express GFAP, OECs express the central type whereas Schwann cells 
express peripheral GFAP (Barber and Dahl, 1987, Jessen et al., 1990).  Unlike 
both myelinating Schwann cells and non-myelinating Schwann cells (Jessen and 
Mirsky, 1991), OECs do not express GalC (Barnett et al., 1993).  Also, unlike 
Schwann cells, OECs do not have a basal lamina apart from where they form part 
of the glia limitans at the surface of the olfactory bulb and form end-feet on 
blood vessels (Doucette, 1984).  They also differ from non-myelinating Schwann 
cells in the number of axons they ensheath.  Non-myelinating Schwann cells 
ensheath approximately 20 axons entrenched in separate furrows, whereas 
individual OECs embrace bundles of up to 200 axons separated by a few 
cytoplasmic processes (Franklin and Barnett, 1997).  
1.4.2.5.2 Properties in vitro 
OECs are a heterogeneous population in vitro with respect to morphology and 
express different markers depending on the conditions in which they are grown, 
time in culture and the age of the tissue donor.  In culture, OECs also have an 
antigenic phenotype most akin to non-myelinating Schwann cells (Barnett et al., 
1993).   
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When OECs are maintained in serum-free conditioned medium from confluent 
type-1 astrocytes, known as astrocyte conditioned medium (ACM) (Noble and 
Murray, 1984), two phenotypes are observed with either Schwann cell-like or 
astrocyte-like properties (Pixley, 1992, Franceschini and Barnett, 1996).  
Astrocyte-like OECs have a flattened morphology and express E-NCAM, fibrous 
GFAP and weak levels or no p75NTR.  The Schwann cell-like OECs have a spindle-
like morphology, lack E-NCAM, and express diffuse GFAP and high levels of 
p75NTR (Franceschini and Barnett, 1996, Yan and Johnson, 1988).  Intermediate 
phenotypes are observed, even in an established clonal cell line, supporting the 
opinion that they are derived from a common precursor (Franceschini and 
Barnett, 1996).  Manipulation of culture conditions can vary these expression 
patterns, although S100 (glial low molecular weight Ca2+ binding protein) 
appears to be expressed by all OECs in vitro and in vivo (Ramon-Cueto and Avila, 
1998).    
A combination of the growth factors forskolin, heregulin β1 and FGF2, known as 
olfactory mitogen medium (OMM), in addition to ACM, which contains type III 
neuregulin-1 (Pollock et al., 1999), was found to be the most mitogenic 
condition for OECs (Alexander et al., 2002, Yan et al., 2001).  Subsequent tissue 
culture work has also revealed that the addition of medium containing 10% 
foetal bovine serum (FBS) to this mixture, in a 1:1 ratio, augments the mitogenic 
effect.  Other factors found to be mitogenic for OECs are NGF and hepatocyte 
growth factor (Chuah and Teague, 1999).   
1.4.2.5.3 OECs and regeneration 
The unique restorative capacity of the olfactory system may be due to the 
supportive glial cell environment provided by the presence of the OECs since 
OECs express a number of growth promoting molecules (Schwob, 2002).  
Vimentin is the main constituent of OEC intermediate filaments (Franceschini 
and Barnett, 1996).  This protein is normally expressed by astrocytes during 
development (Bignami et al., 1982) but this expression is shifted to GFAP as 
astrocytes become non-permissive to axonal growth (Carlstedt et al., 1987, 
Ramon-Cueto and Avila, 1998).  Vimentin being a major constituent of adult 
OECs suggests that OECs maintain an immature growth-permissive phenotype.  
OECs also express nestin (Doucette, 1993).  Nestin is an intermediate filament 
protein that is used as a marker for precursor cells in the CNS and the presence 
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of nestin within OECs is perhaps a reflection of the cellular plastic potential of 
these cells.   
Williams et al (2004) showed that following damage to the olfactory epithelium, 
OECs appear to maintain their architecture and act as a conduit for regenerating 
olfactory nerve axons.  The plasma membranes of OECs contain a number of 
adhesion molecules such as L1 (Miragall et al., 1988), E-NCAM (Franceschini and 
Barnett, 1996), fibronectin, laminin and type IV collagen (Doucette, 1996, Kafitz 
and Greer, 1997).  These adhesion molecules could guide regenerating axons.  In 
addition, OECs also produce and secrete growth factors such as PDGF, NGF, FGF 
and BDNF (Woodhall et al., 2001).  Barnett and colleagues (1993) detected 
neonatal OEC expression of p75NTR while others report CNTF and CNTF receptor-
α expression (Wewetzer et al., 2001).  Expression of such factors may contribute 
to the persisting regenerative properties of the olfactory system.  
Furthermore, a number of experiments have demonstrated that the OEC is 
responsible for the olfactory system’s ability to regenerate.  Following 
transection of a segment of adult rat spinal cord, a guidance channel containing 
Schwann cells was placed between the spinal cord stumps with OECs injected 
into either end of this channel.  This resulted in OEC migration into the channel 
and the passage of regenerating axons through the channel (Ramon-Cueto et al., 
1998) with recovery of forepaw function (Imaizumi et al., 1998).  In the absence 
of OEC injection few axons were capable of exiting the channel. 
The cells of the primary olfactory system express a large number of growth 
factors, which may contribute to the regenerative properties of the region.  The 
following growth factors have been shown to be expressed in the olfactory 
epithelium: NGF (Williams and Rush, 1988, Aiba et al., 1993), BDNF (Buckland 
and Cunningham, 1999), FGF2 (Goldstein et al., 1997), IGFI and II (Ayer-le Lievre 
et al., 1991, Federico et al., 1999), GDNF (Buckland and Cunningham, 1999), 
TGFα (Farbman and Buchholz, 1996) and type I NRG heregulin (Salehi-Ashtiani 
and Farbman, 1996).  Cells of the olfactory epithelium also express the following 
growth factor receptors: TrkA, TrkB and TrkC (Roskams et al., 1996), FGFR 
(Mackay-Sima and Chuahb, 2000), EGFR (Farbman, 1994, Holbrook et al., 1995) 
as well as neuregulin receptors ErbB2, ErbB3 and ErbB4 (Salehi-Ashtiani and 
Farbman, 1996, Perroteau et al., 1998, Lindholm et al., 2002). There is some 
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disagreement within the literature regarding the presence of p75NTR in the 
epithelium, some investigators reporting it to be expressed in basal cells 
(Roskams et al., 1996) whilst others describe a lack of expression (Gong et al., 
1994).    
In vitro data indicates that the survival and differentiation of ORNs are likely to 
be under the control of many different, interacting growth factors.  It has been 
suggested that NGF acts indirectly via OECs to act as a survival factor for ORNs, 
although this effect was only sustained for 10 days (Mahanthappa and 
Schwarting, 1993), and NT3 prevented apoptosis of mature ORNs (Holcomb et 
al., 1995).  PDGF-AB has also been shown to promote the survival of ORNs 
(Newman et al., 2000).  It has also been shown that NGF, BDNF and NT-3 act 
together to induce c-fos expression and increase the number of differentiating 
ORNs (Roskams et al., 1996). 
FGF2 is mitogenic for GBCs (DeHamer et al., 1994), while TGFα and EGF  
stimulate the proliferation of HBCs (Getchell et al., 2000, Farbman, 1994) and 
sustentacular cells (Farbman and Buchholz, 1996).  IGF1 also stimulates the 
proliferation of neuronal precursors (Pixley et al., 1998), although they do not 
express the receptors (Pixley et al., 1998). 
As mentioned earlier, in most areas of the brain 9-O-acetyl GD3 staining of 
pathways of axon outgrowth disappears as soon as the axons reach their target 
axons.  However, in the primary olfactory system the expression of 9-O-acetyl 
GD3 begins at E13, when the olfactory epithelium and the migratory mass are 
intensely stained and at E19, the immunoreactivity disappears from the olfactory 
epithelium but remains in a few fascicles and some glomeruli of the olfactory 
bulb in the newborn and the adult (Mendez-Otero and Ramon-Cueto, 1994).  This 
suggests the expression of 9-O-acetyl GD3 by ORN axons and/or migrating cells 
may facilitate axonal outgrowth during development and may be involved in the 
formation of new glomeruli in the mature olfactory bulb (Mendez-Otero and 
Ramon-Cueto, 1994).   
1.4.2.6 The olfactory bulb 
The olfactory bulbs are located ventral to the orbital surfaces of the frontal 
lobes and are highly distinctive due to their laminated structure.  They derive 
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from the neural tube (Hinds, 1968).  The outer layer of the bulb, termed the 
olfactory nerve layer, is comprised solely of axons of the ORNs and their 
associated glial cells.  The glomerular layer is immediately adjacent to the outer 
nerve layer and consists of round structures termed glomeruli, where the axons 
of the ORNs synapse onto dendrites of interneurons and projection neurons 
(Meisami and Sendera, 1993).  Glomeruli are dense collections of interweaving 
processes that are demarcated by the cell bodies of interneurons and glia. 
There are believed to be at least 3 morphologically distinct types of 
periglomerular interneurons.  Two types, the periglomerular cells, and the 
external or superficial tufted cells, send dendrites into the glomeruli, forming 
dendrodendritic synapses with both the ORNs and projection neurons.  The third 
type, the short axon cells, have processes that do not enter the glomeruli 
(Kosaka et al., 1998).  At ORN terminals both GABA acting on presynaptic GABAB 
receptors (Bonino et al., 1999) and dopamine acting on presynaptic D2 receptors 
(Hsia et al., 1999) act as inhibitory neurotransmitters.  Glutamate acting via 
NMDA (N-methyl-D-aspartate) and AMPA (α-amino-3-hydroxy-5-methyl-4-
soxazolepropionic acid)/kainite receptors acts as an excitatory 
neurotransmitter. 
There are two types of output neuron in the olfactory bulb, the mitral and 
tufted cells (Kishi et al., 1982, Macrides and Schneider, 1982).  The cell bodies 
of the tufted neurons are located in the wide external plexiform layer along with 
those of the periglomerular interneurons, whereas the cell bodies of the mitral 
neurons form the adjacent narrow mitral cell layer.  Mitral cells are large 
neurons, approximately 20-30µm in diameter and are normally arranged in single 
layer.  Next to the mitral cell layer is the internal plexiform layer, which is also 
very narrow and contains many processes.  The granule cell layer contains the 
cell bodies of the most numerous interneurons in the bulb, the granule cells, 
which are approximately 5-10µm in diameter.  Granule cells lack axons, sending 
their dendrites into the external plexiform layer where they form dendro-
dendritic synapses with mitral and tufted cells.  It is through these connections 
that lateral inhibition of the output neurons occurs, an important mechanism in 
odour discrimination (Isaacson and Strowbridge, 1998).  
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Both of the populations of interneurons in the bulb, the periglomerular and 
granule cells also undergo neurogenesis throughout life, are replaced from 
progenitors in the subependymal layer (Altman, 1969, Lois et al., 1996).  These 
originate in the subventricular zone of the lateral ventricles (Lois et al., 1996) 
and migrate to the olfactory bulb via the rostral migratory stream. 
Axons of the mitral and the tufted cells form the olfactory tract which projects 
to the cortex and the contralateral olfactory bulb.  In turn, the olfactory bulbs 
receive afferent connections from many different areas of the brain (Parent, 
1996). 
1.4.3 Models of degeneration and regeneration 
The unique regenerative property of the primary olfactory system can be 
exploited experimentally to study regeneration.  Several techniques have been 
employed to induce the degeneration and subsequent regeneration of the 
olfactory system, some of which are outlined below. 
1.4.3.1 Physical lesioning 
Transection of the olfactory nerve within the PNS portion of the olfactory system 
has been widely used to induce retrograde degeneration and apoptosis of ORNs 
(Graziadei and Monti Graziadei, 1980, Doucette et al., 1983).  The degeneration 
of ORNs following transection is rapid, starting 15 to 24 hours following 
transection and is complete after 10 days (Graziadei and Monti Graziadei, 1980).  
The axons of regenerated ORNs reach the glomeruli after 25 to 30 days 
(Graziadei and Monti Graziadei, 1980, Doucette et al., 1983) and the olfactory 
epithelium reacquires a population of mature ORNs similar to controls after 60 
to 90 days (Graziadei et al., 1980).  This technique mimics inherent 
degeneration of ORNs that happens throughout life in that it does not damage 
any cell types within the epithelium other than mature ORNs.  However, this 
method damages the tissue surrounding the axons, producing scar tissue, which 
does not occur during normal turnover.  Also, when the axons are cut within the 
olfactory nerve layer, which is in the CNS, the axons are unable to grow through 
the resulting scar (Doucette et al., 1983). 
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1.4.3.2 Chemical lesioning  
A number of different chemicals have been directly administered into the 
olfactory epithelium to induce degeneration including triton X-100 (Verhaagen et 
al., 1990, Turner and Perez-Polo, 1993), colchicine (Rochel and Margolis, 1980, 
Suzuki, 1998), methyl bromide (Schwob et al., 1995, Schwob et al., 1999) and 
zinc sulphate (ZnSO4) (Matulionis, 1975, Williams et al., 2004).  The advantage 
of chemical lesioning is that, apart from the epithelium, it does not affect any 
other tissue in the olfactory system.  Application of colchicine causes the 
disaggregation of microtubules and thus results in the degeneration of ORNs and 
GBCs, while HBCs and sustentacular cells remain unaffected (Suzuki, 1998).  
Triton X-100 treatment causes the least damage to the olfactory epithelium 
resulting in faster regeneration (Rochel and Margolis, 1980).  Chemical lesioning 
using methyl bromide and ZnSO4 causes the degeneration of all cell types within 
the epithelium except the basal cells which remain attached to the underlying 
basal lamina.   
Although ZnSO4 has been used extensively to cause the degeneration of the 
ORNs, it is reported to produce varying degrees of damage.  In some studies it 
was only 25% effective, while in others it caused “irreversible damage” (Rochel 
and Margolis, 1980).  However, Williams et al (2004) showed that following 
ZnSO4 treatment, degeneration in the epithelium is reproducible and rapid, with 
regeneration following after 4 days, and being morphologically complete by 5 
weeks.  
Inhalation of methyl bromide over 6 hours causes the destruction of ORNs and 
sustentacular cells in 90% of epithelium (Schwob et al., 1995).  There is an 
increase in the number of proliferating cells 24 to 48 hours following methyl 
bromide treatment, which returns to normal levels between 4 to 6 weeks.  
Immature ORNs start to appear 3 days later, while the mature ORNs and 
sustentacular cells first appear 1 to 2 weeks after treatment.  ORNs begin to 
extend axons after 1 week and these reach the glomeruli after 2 weeks (Schwob 
et al., 1999).  The olfactory system returns to normal 2 months after methyl 
bromide treatment (Schwob et al., 1995, Schwob et al., 1999). 
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1.4.3.3 Removal of the target 
The surgical removal of olfactory bulbs is known as bulbectomy.  Removal of the 
synaptic targets of ORNs by bulbectomy results in apoptosis of ORNs which peaks 
after two days (Holcomb et al., 1995, Calof et al., 1996).  Five to six days after 
target deprivation, the width of the olfactory epithelium is reduced to a 
minimum (Holcomb et al., 1995).  There is also an increase in the proliferation 
of ORNs progenitors in the epithelium (Schwartz Levey et al., 1991, Nan et al., 
2001).  However, the lifespan of the newly generated ORNs is reduced to 
approximately 10 days (Carr and Farbman, 1993), and the majority of ORNs 
within the regenerating epithelium remain in an immature state, unable to 
extend dendrites (Verhaagen et al., 1990).  This suggests that ORNs are 
dependent on factors from the olfactory bulbs for their survival and maturation 
(Schwob et al., 1992).  In adults, the cavity previously occupied by the bulb 
becomes filled with scar tissue, preventing the newly regenerated axons from 
making contact with the brain (Butler et al., 1984, Hendricks et al., 1994).  In 
neonates, younger than postnatal day 13, there is the forward displacement of 
the frontal lobes into the vacant space left by the bulbs, which is innervated by 
the regenerating axons to form glomeruli-like structures (Butler et al., 1984, 
Evers et al., 1996). 
1.5 Aims of the thesis  
Many functions have been attributed to gangliosides such as, migration and 
axonal outgrowth, proliferation, differentiation and repair.  I was interested in 
these functions in relation to ascertaining the role gangliosides play in glial cells.  
Specifically, this thesis will address the role of complex gangliosides in the 
biology of OECs and Schwann cells in order to gain a better understanding of 
these two glial cells.  I will initially compare the ganglioside expression of OECs 
and Schwann cells followed by a comparison of proliferation and migration of 
OECs and Schwann cells obtained from wild-type and ganglioside knockout mice. 
Previous studies have shown that exogenously added gangliosides enhance 
peripheral nerve regeneration.  In addition, Sia T -/- mice have reduced 
regeneration of axotomised hypoglossal nerves compared with wild-type.  There 
have also been numerous studies suggesting that gangliosides play a role in 
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migration and neurite extension.  It was, therefore, interesting to compare 
regeneration in ganglioside knockout and wild-type mice.  The olfactory system 
was chosen for the regeneration experiments because it is a constantly 
regenerative tissue and it contains both PNS and CNS components.  Unlike most 
CNS tissue, the olfactory system regenerates throughout life – after damage the 
olfactory receptor neuron axons can, with the help of the OECs, grow back into 
the CNS and form synapses.  This makes the olfactory system an ideal system to 
study regeneration.  I shall first examine the ganglioside expression of the 
olfactory system using immunocytochemistry.  In order to study the 
degeneration and regeneration of the olfactory system, I shall use an established 
method whereby the olfactory receptor neurons are destroyed using ZnSO4.  I 
shall look at several markers to track and compare the degeneration and 
regeneration of the olfactory system in wild-type and ganglioside knockout mice. 
During the development of the CNS, oligodendrocyte precursor cells progress 
through migratory and proliferative stages before differentiating into myelin-
forming oligodendrocytes.  Gangliosides are differentially expressed throughout 
oligodendrocyte differentiation suggesting they may play a role in 
oligodendrocyte differentiation.  I will initially study differentiation in 
oligodendrocytes isolated from wild-type and Sia T -/- optic nerves.  In order to 
study the role of gangliosides in myelination, I shall compare oligodendrocyte 
differentiation, myelination and axonal density in dissociated spinal cord 
cultures, which contain a mixture of cells including oligodendrocytes, axons and 
astrocytes, isolated from wild-type, Sia T -/- and GalNAc T -/- mice. 
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2 CHAPTER 2 
Methods 
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2.1 Ganglioside knockout mice 
Three types of ganglioside knockout mice were used in this project:  α-2,8-
sialyltransferase knockout (Sia T -/-), N-acetylgalactosaminyl transferase 
knockout (GalNAc T -/-) and double knockout (DKO) mice lacking both Sia T and 
GalNAc T genes (Figure 1.3).  Ganglioside knockout mice were obtained from 
Koichi Furukawa and were generated as described below. 
2.1.1 Generation of α-2,8-sialyltransferase knockout mice 
Carried out by (Okada et al., 2002) 
α-2,8-sialyltransferase (Sia T) gene knockout mice were generated as described 
in Okada et al, 2002.  Briefly, the chromosomal Sia T gene was cloned from the 
λgt11 phage genomic library using a radiolabeled fragment of α-2,8-
sialyltransferase cDNA, clone pD3T-31, as a probe.  The α-2,8-sialyltransferase 
gene was mapped as described in Furukawa et al, 1996, using restriction enzyme 
digestion, Southern blotting using Sia T cDNA probes and sequencing of exon 
regions.  In situ hybridisation was performed to distinguish the Sia T gene from 
pseudo-genes.  The identity of the gene was confirmed based on the 
correspondence of the gene assignment between humans and mice.  The 
targeting plasmid was constructed containing a neomycin-resistant gene inserted 
between the BalI and AccI sites in exon 1 of the gene, and a 9.5-kb gene 
fragment was used as a targeting vector as shown in (Figure 2.1.A).  The 
diphtheria toxin A gene was attached to eliminate nonhomologous recombinants 
as described previously (Aizawa et al, 1990).  Homologous recombination was 
confirmed by Southern blotting using a probe, generating 4.5- and 2.8-kb 
fragments by BamHI and 4.6- and 3.1-kb fragments by HindIII digestion in the 
wild-type and the recombinant allele, respectively, as shown in (Figure 2.1.B).” 
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Figure 2.1. Generation of Sia T -/- mice (Modified from Okada et al, 2002).  
(A) The strategy of the mouse Sia T gene knockout with a targeting vector.  “Wild type” 
represents the normal genomic structure of mouse Sia T gene.  Exon 1 is shown as a box on the 
line with the filled box representing coding regions.  The middle line is the “Targeting vector” 
into which  the neomycin-resistant gene was inserted between the EcoRI and BamHI sites in exon 
1 of the gene (the text states the neor is inserted between the BalI and AccI sites in exon 1 of the 
gene but the figure shows it is inserted between E and B).  The diphtheria toxin A fragment 
(DTA) gene was ligated on the 3’ terminus across the vector backbone for negative selection.  
The lower line labelled “Homologous recombinants” shows the structure of the Sia T gene after a 
correct targeting event.  The bold line labelled “probe” represents the HindIII fragment used as 
a probe to identify gene targeting events.  Predicted sizes (kb) of BamHI and HindIII-digested 
fragments hybridising to this probe are shown.   
(B) Example of Southern blot analysis of F2 mice showing the homologous recombination as 
presented in A.  Using BamHI and HindIII-digested DNA, the wild-type allele gave a 4.5 and 4.6-
kb band and the recombinant allele gave a 2.8 and 3.1-kb band, respectively.  +/+ indicates 
wild-type lanes, +/- indicates heterozygous lanes, -/- indicates homozygous mutant lanes.   
Abbreviations: TM, transmembrane; Neo, Neomycin resistant gene; DTA, diphtheria toxin A 
fragment gene; B, BamHI; H, HindIII; E, EcoRI 
 
 
B 
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2.1.2 Generation of N-acetylgalactosaminyl transferase 
knockout mice 
Carried out by (Takamiya et al., 1996). 
N-acetylgalactosaminyl transferase (GalNAc T) gene knockout mice were 
generated as described in Takamiya et al, 1996.  Briefly, the BALB/c mouse 
genomic library was screened with a 2.1-kb XbaI fragment of mouse cDNA (clone 
pTm3-5, (Takamiya et al., 1995)) to isolate the chromosomal GalNAc T gene.  
The neomycin-resistant gene with phospoglycerate kinase-1 gene promoter and 
without poly(A)+ addition signal was inserted into the HindIII site in exon 4 as 
shown in (Figure 2.2.A).  The targeting vector (24nM) was linearised with NotI 
and was mixed with embryonic stem (ES) cell suspension (1 x 107), then 
electroporated at 0.25 kV, 960 µF, using a Bio-Rad Genepulser.  G418 was added 
to the medium 48 hours after electroporation at the concentration of 150 µg/ml. 
The G418-resistant clones were isolated after 7 to 8 days and subjected to 
screening for homologous recombination by PCR.  The sense primer was 5'-
TCGTGCTTTACGGTATCGCCGCTCCCGATT-3' in 3' terminus of the neomycin-
resistant gene, and the antisense primer was 5'-GGGTGTGGCGGCATACATCT-3' in 
the intron of the GalNAc T gene.  The following PCR protocol was used: one 
cycle of 95°C (2 min), 55°C (1 min), 74°C (5 min), thereafter 35 cycles of 94°C 
(1 min), 60°C (30 sec), 74°C (1.5 min).  Homologous recombinant clones gave a 
1.1-kb fragment.  Two chimeric males derived from ES cell lines D-120 and G-
193, respectively, transmitted the GalNAc T mutation to progeny.  Mice 
heterozygous for the disrupted GalNAc T gene were mated, and homozygous 
mutant progeny were identified by PCR and Southern blot analysis of DNA 
isolated from mouse tails. 
2.1.3 Generation of double knockout mice   
Sia T and GalNAc T knockouts were mated to produce double knockout (DKO) 
mice lacking both Sia T and GalNac T.  Because GalNac T -/- males are sterile, 
Sia T -/- females were mated with GalNAc T heterozygous males.  This produced 
litters containing Sia T -/-, heterozygous and DKO mice.  Therefore, the 
genotypes of the offspring were screened for the two genes using DNA extraction 
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and PCR and mice which lacked both Sia T and GalNac T (ie DKO mice) were 
used in the experiments. 
 
 
 
 
Figure 2.2. Generation of GalNAc T -/- mice (Modified from Takamiya et al, 1996.)  
(A) Strategy for disruption of the mouse GalNAc T gene.  “Wild type” represents the normal 
genomic structure of mouse GalNAc T gene.  Exons 1 to 10 are shown as a box on the line with 
filled boxes representing coding regions.  The translation initiation site is indicated as ATG.  The 
middle line is the “Targeting vector” which was linearized at unique NotI site.  In this vector, 
neomycin-resistant gene (PGK neo) was inserted into the HindIII site in exon 4.  The DTA gene 
with MC1 promoter was ligated on the 3’ terminus across the vector backbone for negative 
selection.  The lower line labelled “Recombinant” shows the structure of the GalNAc T gene 
after a correct targeting event.  PCR was used in the identification of homologous recombinants.  
The bold line labelled “A” represents the 800-bp HindIII fragment used as a probe to identify 
gene targeting events.  Predicted sizes (kb) of BglII and BamHI-digested fragments hybridising to 
this probe are shown.  Abbreviations for restriction enzyme sites: X, XhoI; B, Bam HI; H, HindIII; 
Bg, BglII.  
(B) Example of Southern blot analysis of F2 mice.  The genomic DNA extracted from the tail was 
digested with BglII or BamHI, and hybridised with the shown probe under high stringency.  Using 
BglII or BamHI digested DNA, the wild-type allele gave a 4.0-kb, 5.6kb band and the recombinant 
allele gave a 5.3-kb and 5.0-kb band, respectively.  +/+ indicates wild-type lanes, +/- indicates 
heterozygous lanes, -/- indicates homozygous mutant lanes 
 
Bgl II                     Bam HI 
+/+  +/-  +/-  -/-   +/+ +/-  +/-   -/- 
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2.2 Genotyping of heterozygous and GalNAc T -/- mice 
GalNAc T -/- were bred by mating GalNAc T -/- females with GalNAc T 
heterozygous males.  Adult mice were genotyped by extracting DNA from the 
tails of the mice followed by PCR, whereas the embryos and the neonates were 
genotyped by labelling with CTx.   
2.2.1 Tail tip DNA extraction 
DNA was extracted using a PureGene Mouse Tail Kit (Gentra Systems) containing 
a cell lysis solution, a protein precipitation solution and a DNA hydration 
solution.  Five 1 mm tail tip segments were cut on clean Parafilm using a 
disposable scalpel and were added to an autoclaved 1.5 ml eppendorf containing 
300 µl of cell lysis solution.  Proteinase K (1.5 µl of 20 mg/ml stock) was added 
to the eppendorf and the contents were mixed and incubated for 2 hours at 
55ºC.  The sample was cooled to room temperature, 100 µl of protein 
precipitation solution was added and the tube contents were mixed by inverting 
the eppendorfs 10 times.  The sample was centrifuged at 12 500 rpm for 3 
minutes.  The supernatant was added to an autoclaved 1.5 ml eppendorf 
containing 300 µl of 100% isopropanol (2-propanol) and the tube was inverted 
until the DNA became visible.  The samples were centrifuged at 12 500 rpm for 3 
minutes, the supernatant was poured off and 300 µl of 70% ethanol was added to 
the DNA pellet.  The sample was centrifuged at 12 500 rpm for 3 minutes and 
the ethanol removed.  The tubes were inverted and placed on absorbent paper 
to dry out for 1 hour.  The sample was rehydrated by adding 50 µl DNA hydration 
solution to the dried pellet and was left to go into solution.  
2.2.2 GM2 primer PCR 
The master mix was made up as described in the appendix.  4 µl of extracted 
DNA was mixed with 21 µl master mix in a 0.5 ml PCR tube.  The following PCR 
protocol was used:  one cycle of 95ºC (3 min), 60ºC (1 min), 72ºC (2 min), then 
35 cycles of 94ºC (1 min), 57ºC (30 sec), 72ºC (1 min) and a final step of 72 ºC 
(10 min).  As a positive control a sample was made up containing 4 µl 
heterozygous DNA (made up as described in section 2.2.1) and 21 µl master mix.  
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A negative control sample was made up containing 4 µl distilled water and 21 µl 
master mix. 
2% agarose gel was made up as described in the appendix and was poured into 
the tank and left to set.  A 100 bp DNA ladder was placed in the first well of the 
gel.  The loading buffer was made up as described in the appendix and 1.5 µl 
was added to the 25 µl PCR mixture.  8 µl of sample containing the loading gel 
was placed into a well of the agarose gel.  The gel was run for approximately 30 
minutes and was taken out and photographed using a Syngene Bioimaging 
System. 
2.2.3 Labelling with cholera toxin 
To determine the genotype of neonatal mice or embryos from which the cells 
were derived, the cells from each mouse or embryo were cultured separately 
and were stained with CTx.  2.5 µg/ml of FITC labelled cholera toxin was added 
to the live cells in PBS for 30 minutes at room temperature.  The cells were then 
fixed with 4% paraformaldehyde for 10 minutes, and then mounted in 
Vectashield containing 4’-6-diamidino-2-phenylindole (DAPI), which forms 
fluorescent complexes with double-stranded DNA, and hence labels nuclei.  
GalNAc T -/- tails and cells were negative for CTx whereas the heterozygous tails 
and cells were positive.   
2.3  Tissue culture 
2.3.1 General tissue culture 
Primary cell cultures of Schwann cells, olfactory ensheathing cells and 
oligodendrocyte precursor cells and dissociated spinal cord cultures were 
cultured as described below.  All cell cultures were grown in 12.5 cm3 (T12.5) 
and 25 cm3 (T25) culture flasks, and 24-well culture plates.  All dishes and 
coverslips were coated in poly-L-lysine solution (PLL, 13.3 µg/ml in distilled 
water; Sigma).  PLL was added to the dishes in a volume sufficient to cover the 
bottom for at least 30 minutes at 37ºC, washed in distilled water (dH2O) and left 
to air-dry in a tissue culture hood before use. 
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All cells were maintained in a humidified incubator at 37°C with 7% carbon 
dioxide in the appropriate medium depending on the cell type.  Cells grown in 
T12.5 flasks, T25 flasks or in 24-well plates were fed with 3 ml, 4 ml and 0.5 ml 
of media respectively, and were fed three times a week, by removing half of the 
media, and replacing with fresh media.  All fresh media and tissue culture 
reagents were filtered through a 0.22 µm filter. 
Cell cultures were passaged as follows: first, cells were washed in pre-warmed 
(37ºC) phosphate-buffered saline (PBS), and then 1.5 ml of pre-warmed PBS 
containing 0.1% trypsin was added for 2 minutes at 37ºC, with frequent agitation 
to assist cell detachment.  The PBS-trypsin containing the cell suspension was 
then transferred to a 15 ml falcon tube, and trypsin activity inhibited by 
addition of 10 ml of 1%FBS (foetal bovine serum (FBS) in Dulbecco’s Modified 
Eagle Medium (DMEM)).  The suspension was centrifuged at 1200 rpm for 6 
minutes.  The resulting pellet was resuspended in fresh media and re-plated 
onto dishes as required.   
In some instances, the number of cells was counted before plating down.  This 
was done by placing 10 µl of the resuspended pellet in a haemocytometer and 
counting the number of cells within the 4x4 grid under a light microscope, and 
multiplying this by 104 to give the total number of cells/ml. 
2.3.2 Olfactory ensheathing cell culture  
Olfactory ensheathing cells (OECs) were obtained from olfactory bulbs of 7 day 
old mice of mixed sex.  Instruments were sterilised using 100% ethanol.  Mice 
were decapitated and olfactory bulbs dissected as follows; the skin on the head 
was sterilised with 100% ethanol and removed to expose the skull.  The skull was 
cut on either side of the head to a point between the eyes and above the nose 
and was peeled back to exposed the brain.  The olfactory bulbs (OB) were 
removed by cutting the olfactory tracts connecting them to the forebrain.  OBs 
were placed in 4 ml Leibovitz medium containing 50 µg/ml gentamicin (L-15).  
OBs were finely chopped using a sterile scalpel in order to increase the reactive 
surface for enzymatic digestion.  The tissue was then digested in 0.5 ml of 1.33% 
collagenase in L-15 for 30 min at 37°C.  0.5 ml of SD (soybean trypsin inhibitor-
0.52mg/ml; bovine pancreas DNAse-0.04mg/ml; bovine serum albumin-3.0 
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mg/ml) was added to inhibit the enzymatic activity and a single cell suspension 
was made by passing five times through a 5ml pipette and once through 21G and 
23G needles.  The dissociated cells were transferred into a 15 ml falcon tube, 
washed in 10 ml of 1%FBS, centrifuged for 6 min at 12000 rpm, resuspended in 
olfactory mitogen medium (containing FGF2, forskolin, heregulin and astrocyte 
conditioned media) with 10%FBS (OMM+5%FBS) and plated in PLL-coated T25 
tissue culture flasks at a density of 6 to 8 OBs per flask.  Fresh OMM+5%FBS was 
replaced every 3 to 4 days.   
Approximately a week later, the cells were purified using Fluorescent Activated 
Cell Sorting (FACS) and the p75NTR antibody (Abcam).  Mixed olfactory bulb cells 
were trypsinised, resuspended in 10%FBS containing p75NTR antibody (1:800) and 
incubated on ice for 3 hours.  Cells were washed twice in 10 ml of 1% FBS and 
then resuspended in 10%FBS containing goat anti rabbit IgG-FITC (1:100) and 
incubated for 45 min on ice.  The cells were again washed twice in 10ml of 
1%FBS, then resuspended in 4 ml of 1%FBS.  The resuspended cells were poured 
through a 70 µm cell strainer to ensure that clumps of cells did not cause 
blockages in the FACS machine, and transferred to a polystyrene round bottom 
5ml tube.  Cell sorting was carried out by Tom Gilbey.  A ‘FACSVantage SE’ 
sorter was used to purify the cells by exciting the fluorophores with a 488 nm 
argon laser at 100-150 mW.  The sort windows were set in order to firstly 
separate live cells from dead cells and debris by size (forward scattering of light) 
and granularity (side scatter).  The gated cells were plotted on a SSC-FL1 dot 
plot and the p75NTR positive, FITC cells were sorted.  Purified cells were 
collected in a second polystyrene round bottom 5 ml tube, containing 4 ml of 
1%FBS and then centrifuged for 6 min at 1200 rpm.  The resulting pellet was 
resuspended in 100 µl of OMM+5%FBS and plated as a strip in the centre of a PLL-
coated T12.5 tissue culture flask.  After 30 min 4 ml of OMM+5%FBS was added 
and the cells were maintained in OMM+5%FBS medium.   
A small aliquot of each sort was plated onto PLL-coated coverslips to assess the 
purity of cells.  This was carried out by immunolabelling for p75NTR and cultures 
which were over 95% pure were used in subsequent experiments. 
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2.3.3 Schwann cell culture 
Schwann cells were obtained from sciatic nerves of 7 day old mice of mixed sex, 
killed by decapitation.  The skin on the back of the hind legs was sterilised and 
removed to reveal the muscles.  The muscles were separated to reveal the 
sciatic nerves, which were dissected and cells dissociated as described for OECs.  
The cells were then resuspended in 10%FBS containing heregulin and forskolin 
(10%HF) and plated in T25 tissue culture flasks at a density of 12 to 16 sciatic 
nerves per flask.  Fresh 10%HF was replaced every 3 to 4 days.  Around one week 
after culture, Schwann cells were separated from contaminating fibroblasts by 
selective trypsination whereby the Schwann cells were selectively removed from 
the flask using a low concentration of trypsin (0.02%), leaving the contaminating 
fibroblasts behind.  The trypsinised cells were added to a 15 ml falcon, washed 
in 10 ml of 1%FBS, centrifuged at 1200rpm for 6 min and the resulting pellet 
reconstituted in 10%HF and plated in T12.5 tissue culture flasks.   
Schwann cell purity was assessed by plating an aliquot of cells onto coverslips 
and immunolabelling with anti- p75NTR and cultures over 90% pure were used in 
subsequent experiments.   
2.3.4 Oligodendrocyte precursor cell culture 
Oligodendrocyte precursor cells (OPCs) were obtained from optic nerves of 7 day 
old mice of mixed sex.  The optic nerves were dissected and pooled in L-15, cut 
into small pieces using a scalpel and digested in 1.33% collagenase in Leibovitz 
medium for 15 min at 37°C.  75 µl of 2.5% trypsin was then added and the 
mixture was incubated for a further 15min.  The reaction was terminated by 
adding SD.  The tissue was triturated 5 times through an 18G needle and then a 
21G needle in order to generate a single cell suspension.  The cells were washed 
in 10 ml 1%FBS and centrifuged for 6 min at 12000 rpm, resuspended in DMEM-BS 
containing 20 ng/ml PDGF and FGF and plated in PLL-coated 13mm coverslips in 
a 24-well tissue culture plate.            
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2.3.5 Dissociated spinal cord culture 
An in vitro myelinating culture system was generated from dissociated spinal 
cords from E13.5 mouse embryos.  A pregnant female mouse at E13.5 was killed 
by overdose of CO2, followed by cervical dislocation.  The hair covering the 
abdomen was sterilised using 100% ethanol.  The skin and the tissue in the 
middle of the abdomen were cut and the uterus was removed and placed in L-
15.  The foetuses were extruded, decapitated about 3mm rostral to the cervical 
flexure and the umbilical cord cut.  The skin and the tissue on the back of the 
foetus covering the spinal cord were removed gently using sterile forceps and 
the spinal cords were cut just above the hind legs and removed.  The meninges 
were stripped, dorsal root ganglia removed and the spinal cords placed in 1 ml 
HBSS without calcium and magnesium.   
The cords were chopped lightly with a sterile scalpel then collected in 1 ml HBSS 
without calcium and magnesium.  1 ml of 0.25% trypsin and 100 µl of 1% 
collagenase were added and the mixture incubated for 15 min at 37ºC. 2ml SD 
was added to stop the reaction.  The tissue was allowed to sink to the bottom 
and excess liquid was removed leaving behind approximately 1 ml.  The tissue 
fragments were broken down by gentle trituration through a glass Pasteur 
pipette.  The tissue was transferred into a 15 ml falcon tube, 5 ml plating 
medium added and centrifuged for 5 min at 800 rpm. The supernatant was 
removed and the cells reconstituted in plating medium to achieve a live cell 
count of 1,500,000/ml (approximately 5ml for 5 cords).   
The cells were counted and 100 µl of the cell suspension, containing 150,000 
cells, was plated onto PLL-coated coverslips in a 30 mm diameter petri dish, 
containing three 13 mm coverslips.  The cells were left to attach for 
approximately 2 h at 37ºC.  200 µl of plating media see appendix for 
composition) and 500µl of either differentiation or neurobasal/B27 media (see 
appendix for composition) was added and the cells subsequently maintained in 
either differentiation or neurobasal/B27 media.  In cultures where 
differentiation media was used insulin was withdrawn from this media after 12 
DIV. 
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2.4 Assays 
2.4.1 Proliferation 
5-bromo-2’-deoxyuridine (BrdU) uptake was used as an indicator of cell 
proliferation in order to assess the proliferation rates of wild-type and 
ganglioside knockout OECs and Schwann cells on different substrates.  OECs and 
Schwann cells were cultured and purified 5 to 7 days later as described above.  
Two to five days after purification, cells were plated onto coverslips coated with 
10 µg/ml PLL, laminin or collagen in PBS (all from Sigma).   
400 µl of PLL, laminin or collagen was added to the coverslips for 4 hours at 
37ºC.  The coverslips were washed three times in PBS and were not allowed to 
dry out before the addition of cells. 
OECs and Schwann cells were plated onto coated coverslips at a density of 
10,000 cells per well, and left to adhere overnight.  Media was changed the 
following day to DMEM-BS or the optimal medium for each cell type and two days 
after plating 20 µM of BrdU, which is incorporated by cells synthesising DNA 
(Gratzner, 1982), was added.  Cells were immunolabelled for anti-BrdU 16 h 
after BrdU addition as described in section 1.3.2.  
Proliferation was measured as the percentage of DAPI nuclei which have taken 
up BrdU.  Fifteen images at x10 magnification were taken of each coverslip and 
using a macro devised by John Annan (described in the Appendix 1.7 Macro: 
“percentage of BrdU positive nuclei”) in a programme called Image J, the 
number of DAPI positive and BrdU positive nuclei were counted and the 
percentage of BrdU uptake was calculated for each image.  The macro counts 
the number of blue (DAPI) nuclei, the number of green (BrdU) nuclei and the 
number of nuclei which are positive for both.  Experiments were carried out in 
duplicate and were performed at least three times (n=3).   
2.4.2 Time-lapse migration 
To compare migration speeds of wild-type and ganglioside knockout OECs and 
Schwann cells on different substrates, cells were imaged using time-lapse 
microscopy and their migration speeds assessed.  Wells of a 24-well plate were 
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coated with PLL, laminin or collagen (as outlined above).  OECs and Schwann 
cells were cultured and purified 5 to 7 days later as described above.  Two to 
five days after purification, cells were plated onto coated wells at a density of 
5,000 cells per well in their optimal medium, and left to adhere overnight.  
Media was changed the following day to DMEM-BS or the optimal medium for 
each cell type and a day later time-lapse imaging of the cells was performed.   
Time-lapse imaging of cells was performed using an Axiovert S100 microscope or 
an Axioplan 200 microscope connected to a computer, using a programme called 
AndorIQ.  The 24-well plate was placed under the microscope within a box 
heated to 37ºC and was connected to a supply of CO2.  Three fields of view were 
chosen per well at x10 magnification.  Images were taken at 3 min intervals, for 
a period of 5 hours.  The position of the cell body was measured for each time 
point using a programme called Tracker, and an average speed of migration for 
each cell was calculated.  15 cells were tracked from each field of view.  
Experiments were carried out in duplicate and were performed at least three 
times (n=3).   
2.4.3 Wound assays 
To assess migration, a wound assay was performed where 30,000 wild-type or 
ganglioside knockout OECs or Schwann cells were plated onto PLL, laminin or 
collagen coated wells.  Media was changed the following day to DMEM-BS or the 
optimal medium for each cell type and the cells were maintained in these media 
until they reached confluence.  Once the cells reached confluence, a single 
scratch wound was made in the middle of the well using a micropipette tip. 
The 24-well plate was then placed under the microscope within a box heated to 
37ºC and was connected to a supply of CO2.  Time-lapse imaging of cells was 
performed using an Axiovert S100 microscope or an Axioplan 200 microscope 
connected to a computer, using a programme called AndorIQ.  Three fields of 
view were chosen by the user per wound at x10 magnification.  Images were 
taken at 30 min intervals, for a period of 24 hours.  The width of the wound was 
measured using ImageJ: the distance between the opposing edges of the wound 
was measured at five points within each field of view and the time taken for the 
wound to close was noted.  In the instances where the wound had not closed by 
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24 hours, the width of the wound was measured at 24 hours and the distance 
travelled per hour was calculated (Figure 2.3).  Experiments were carried out in 
duplicate and were performed at least three times (n=3). 
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Figure 2.3. Image of a wound assay showing how the width of the wound was measured. 
The width between two cell fronts was measured at five points along the length of the wound, at 
0 and 24 hours and was divided by 24 to obtain the migration speed which was expressed as the 
distance travelled (in micrometers) per hour. 
 
 
2.4.4 Axonal density and PLP labelling 
Axonal density and the extent of PLP labelling in dissociated spinal cord cultures 
derived from wild-type or ganglioside knockout mice was compared after 21 and 
28 days in vitro (DIV).  Axons were labelled using the antibody SMI 31, which 
detects a phosphorylated epitope in phosphorylated neurofilament H and, to a 
lesser extent, neurofilament M, and immunocytochemically reacts with thick and 
thin axons.  Myelin was labelled with the AA3 antibody, which recognizes 
proteolipid protein (PLP), one of the major structural proteins in CNS myelin, 
and its functionally distinct DM20 isoform.  Nine images were taken of each 
coverslip at x10 magnification.  These images were analysed using image J to 
calculate the area (in pixels) of axonal staining and the background.  Using this 
information it was possible to calculate the percentage area occupied by axons 
for each image.  Using Adobe Photoshop Elements, the PLP labelling was traced 
and using a macro devised by John Annan (described in the Appendix 1.8 Macro: 
“quantitation of PLP labelling”) in ImageJ, the area (in pixels) occupied by 
myelin in each image was measured.  Using the area of axons and the area of 
PLP labelling, the percentage area of axons labelled with PLP was calculated for 
each image.  Three separate experiments were carried out in triplicate and the 
mean was calculated for each experiment (n=3). 
0h 24h
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2.5 Nasal irrigation 
Wild-type, Sia T -/-, GalNAc T -/- and DKO adult mice were lightly anaesthetized 
by inhalation with halothane.  20µl of autoclaved 10% zinc sulphate made up in 
distilled water was administered into the left nostril using a DNA pipette tip.  
Control animals were administered 20 µl of distilled water, also into the left 
nostril.  The right hand side nostril in both experimental and control animals was 
not irrigated 
At least five experimental animals and two control animals of each genotype 
were sacrificed by transcardial perfusion at each of the following time points: 1, 
4 and 7 days and 3 and 9 weeks.  Animals were firstly anaesthetized by 
inhalation with 3% halothane, 200 cc/min oxygen and 500 cc/min N2O.  Animals 
were perfused through the left ventricle with 20 ml heparinised saline (1000 
units/ml), followed by fixation with 20ml 4% paraformaldehyde in PBS.  All 
animal studies were performed under a Home Office licensing protocol. 
Olfactory bulb and the olfactory mucosa were dissected out together and placed 
in 4% paraformaldehyde.   
2.6 Tissue processing 
2.6.1 Snap frozen sections 
Tissue for ganglioside immunocytochemistry was embedded in OCT immediately 
after dissection, frozen on dry ice and stored at -20ºC.  10 µm thick sections 
were cut onto Vectabond coated slides and stored at -20ºC.   
2.6.2 Frozen sections 
Tissue for cryosectioning was fixed in 4% paraformaldehyde in PBS for 4 hours at 
4ºC before cryoprotecting overnight in 30% sucrose in PBS, at 4ºC.  Tissue was 
then embedded in OCT, frozen on dry ice and stored at -20ºC.  15 µm thick 
sections were cut onto Vectabond coated slides and stored at -20ºC.   
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2.6.3 Paraffin sections 
Tissue for paraffin embedding was fixed overnight in 4% paraformaldehyde in 
PBS at 4ºC and processed for embedding using an automated processor (carried 
out by Tom Gilby and Margaret O’Prey).  It was passed through increasing 
concentrations of alcohol and into melted paraffin wax before being embedded 
in paraffin wax.  Surface decalcification was achieved by placing tissue blocks 
for 30 minutes at room temperature in a suspension of 200 g of sodium chloride 
in 50ml distilled water and 2 ml concentrated hydrochloric acid.  Tissue blocks 
were rinsed in distilled water and 10 µm longitudinal sections were cut with a 
microtome onto Vectabond coated slides and stored at room temperature (some 
of the tissue was cut by Colin Nixon and Tom Gilby). 
2.7 Immunocytochemistry/immunohistochemistry 
For details of antibodies see table 1.1 and 1.2 (primary and secondary antibody 
lists). 
2.7.1 General immunocytochemistry 
Cells for immunolabelling were plated onto PLL-coated coverslips contained 
within 24-well plates or 35 mm diameter petri dishes as described above.  In 
order to immunolabel the cells, the coverslips were taken out and any remaining 
media was blotted on tissue paper.  Between all steps the coverslips were 
washed in PBS and any remaining media blotted onto tissue paper.  Primary and 
secondary antibodies were made up in PBS at the concentrations indicated in 
Tables 1.1 and 1.2.  50 µl of primary antibody was added for 45 min at room 
temperature.  The primary antibody was washed off and 50 µL of secondary 
antibody was added for 30 min.  Cells were washed and fixed by adding 100 µl 
ice cold methanol per coverslip for 15 min at -20°C.  In the case of intracellular 
antigens the fixation step is performed before incubating with primary antibody.  
After a final wash the coverslips were mounted using Vectashield containing 
DAPI.  
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Table 1.1 Primary antibody list 
 
ANTIBODY CLASS DILUTION SOURCE 
β tubulin isotype III; TUJ1 IgG2a 1:500 Covance  
A2B5 hybridoma IgM 1:1 Gift from Mark Noble 
AA3 Anti-rat 1:10 Hybridoma;Yamamura, 1991 
BrdU IgG1 1:20 DakoCytomation 
CGM-3 IgM 20 µg/ml Prof. Hugh Willison 
caspr Anti-rabbit 1:1000 Dr Ori Peles 
contactin Anti-human  neat Dr Ori Peles 
EG-2 IgG3 50 µg/ml Prof. Hugh Willison 
EG-3 IgG1 50 µg/ml Prof. Hugh Willison 
Gap43 IgG2a 1 in 5000 SigmaAldrich 
GFAP Anti-rabbit 1:100 DakoCytomation 
Kv1.2 Anti-rabbit 1:100 Alomone Laboratories 
MBP Anti-rat 1:200 Serotec 
MOG-1 IgG3 90 µg/ml Prof. Hugh Willison 
MOG-30 IgG3 160 µg/ml Prof. Hugh Willison 
MOG-35 IgG2b 20 µg/ml Prof. Hugh Willison 
Nav (pan) IgG1 1:100 SigmaAldrich 
NG2 Anti-rabbit 1:200 Chemicon 
Nestin    IgG1 1:200  Chemicon 
Neurofascin 155 Anti-rabbit 1:200 Dr Ori Peles 
O4 hybridoma IgM 1:1 Sommer & Schachner, 1981 
OMP Anti-goat 1:500 Wako 
p75NTR Anti-rabbit  1:800 Abcam 
PCNA IgG2a 1:20,000 Santa Cruz 
R24 IgG3 1:100 Prof. Hugh Willison 
SMI 31 IgG1 1:1500 Sternberger monoclonals 
Synaptophysin IgG1 1:400 Sigma 
Thy 1.2 IgM 1:10 Serotec 
 
 
Table 1.2 Secondary antibody list 
 
ANTIBODY CONJUGATE DILUTION SOURCE 
Goat anti mouse IgG1 FITC; TRITC 1:100 Southern Biotech 
Goat anti mouse IgG1 Alexa Fluor: 488, 555, 647 1:600 Molecular Probes 
Goat anti mouse IgG2a FITC; TRITC 1:100 Southern Biotech 
Goat anti mouse IgG2b FITC; TRITC 1:100 Southern Biotech 
Goat anti mouse IgG3 FITC; TRITC 1:100 Southern Biotech 
Goat anti mouse IgM FITC; TRITC 1:100 Southern Biotech 
Goat anti rabbit IgG   FITC; TRITC 1:100 Southern Biotech 
Goat anti rabbit IgG Alexa Fluor: 488, 555 1:600 Molecular Probes 
Goat anti rat IgG FITC; TRITC 1:100 Southern Biotech 
Goat anti rat IgG Alexa Fluor: 488, 555, 647 1:600 Molecular Probes 
Donkey anti goat IgG FITC 1:100 Southern Biotech 
Goat anti human IgG, 
Fcγ 
Cy3 1:500 Jackson Labs 
Rabbit anti mouse IgG Biotinylated 1:300 DakoCytomation 
Goat anti rabbit IgG Biotinylated 1:300 DakoCytomation 
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2.7.2 Bromodeoxyuridine immunocytochemistry  
The cells were fixed with ice-cold methanol for 10 min at -20ºC, washed in PBS 
and further fixed with 0.2% paraformaldehyde for 1 min at room temperature. 
They were washed in PBS, and 0.07 M sodium hydroxide was added for 10 min at 
room temperature.  The cells were washed in PBS, and anti-BrdU (1:20) was 
added for 45 min at room temperature.  The primary antibody was washed off 
using PBS and goat anti mouse IgG1-FITC (1:100) was added for 30 min at room 
temperature.  The coverslips were mounted with Vectashield containing DAPI. 
2.7.3 SMI 31 and AA3 immunocytochemistry  
Cells were fixed in 4% paraformaldehyde for 15 minutes, washed in PBS, 
permeabilised with 0.5% triton X-100 in PBS for 15 minutes and blocked using a 
blocking buffer (0.2% pig skin gelatine and 0.1% triton X-100 in PBS) for 20 
minutes at room temperature.  Primary antibodies AA3 (1:10) and SMI 31 
(1:1,500), diluted in blocking buffer, were added overnight at 4ºC, washed in 
PBS and the secondary antibodies goat anti rat-FITC (1:100) and goat anti mouse 
IgG1-TRITC (1:100) diluted in blocking buffer were added for 30 minutes at room 
temperature.  The coverslips were mounted with Vectashield containing DAPI. 
2.7.4 O4, NG2 and MBP immunocytochemistry 
Spinal cord cultures were rinsed briefly in DMEM and the primary antibodies O4 
(1:1) and NG2 (1:200), diluted in DMEM, were applied for 45 minutes at room 
temperature.  The coverslips were washed in DMEM and the secondary 
antibodies goat anti mouse IgM-TRITC (1:100) and goat anti rabbit-AF488 (1:600), 
diluted in DMEM, were added for 30 minutes.  The coverslips were washed in 
DMEM and fixed in 4% paraformaldehyde for 15 minutes, washed in PBS, 
permeabilised with 0.5% triton X-100 in PBS for 15 minutes and blocked using a 
blocking buffer (0.2% pig skin gelatine and 0.1% triton X-100 in PBS) for 20 
minutes at room temperature.  MBP (1:100) diluted in blocking buffer was added 
for 45 minutes at room temperature, washed in PBS and the secondary antibody 
goat anti rat-AF647 (1:600) diluted in blocking buffer was added for 30 minutes 
at room temperature.  The coverslips were mounted with Vectashield containing 
DAPI. 
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2.7.5 Neurofascin immunocytochemistry  
Cells were fixed with 4% paraformaldehyde for 10 minutes, washed in PBS, fixed 
in Bouins fixative for 1 minute and washed in PBS.  Cells were blocked using a 
blocking solution (0.2% triton X-100, 10% normal goat serum and 1% glycine in 
PBS) for 40 minutes at room temperature.  The cells were washed in PBS and the 
primary antibodies neurofascin 155 (1:200), SMI 31 (1:1,500) and AA3 (1:10) 
diluted in blocking solution were added overnight at 4ºC, washed in PBS and the 
secondary antibodies goat anti rabbit-alexa488 (1:600), goat anti mouse IgG1-
alexa647 (1:600) and goat anti rat-alexa555 (1:600) diluted in blocking solution 
were added for 30 minutes at room temperature. The coverslips were mounted 
with Vectashield containing DAPI. 
2.7.6 Caspr immunocytochemistry 
Cells were fixed with 4% paraformaldehyde for 10 minutes, washed in PBS, fixed 
in methanol for 10 minutes at -20°C and washed in PBS.  Cells were blocked 
using a blocking solution (0.1% triton X-100, 10% normal goat serum and 1% 
glycine in PBS) for 40 minutes at room temperature.  The cells were washed in 
PBS and the primary antibodies caspr (1:1000), SMI 31 (1:1,500) and AA3 (1:10) 
diluted in blocking solution were added overnight at 4ºC, washed in PBS and the 
secondary antibodies goat anti rabbit-alexa488 (1:600), goat anti mouse IgG1-
alexa647 (1:600) and goat anti rat-alexa555 (1:600) diluted in blocking solution 
were added for 30 minutes at room temperature. The coverslips were mounted 
with Vectashield containing DAPI. 
2.7.7 Sodium and potassium channel immunocytochemistry 
Cells were fixed with 100% methanol for 6 minutes at -20ºC, were permeabilised 
using 5% NGS & 1% Triton X for 1 hour at room temperature, and were blocked 
using 5% NGS for 1 hour at room temperature.  Sodium channel antibody 
(Nav,1:100) and potassium channel antibody (Kv, 1:100) in 5% NGS were added 
overnight at 4ºC, excess was washed off using PBS and the secondary antibodies 
goat anti mouse IgG1- alexafluor 488 (1:600) for Nav and anti rabbit- 
alexafluor555 (1:600) for Kv in 5% NGS were added for 1h at room temperature. 
The coverslips were mounted with Vectashield containing DAPI. 
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2.8 Immunohistochemistry 
2.8.1 General immunohistochemistry of frozen tissue 
The tissue was circled with a hydrophobic pen and incubated for 1 hour at room 
temperature in blocking solution containing 2% bovine serum albumin (BSA) and 
10% normal animal sera (corresponding to the animal in which the secondary 
antibody to be used was raised in) in PBS.  The sections were incubated in 
primary antibody in blocking solution overnight at 4ºC.  The excess antibody was 
removed by washing in PBS twice for 5 minutes with agitation.  Sections were 
incubated in the relevant fluorescent secondary antibody in blocking solution for 
an hour at room temperature and excess antibody removed by washing in PBS 
twice for 5 minutes on a rocker.  Sections were mounted in Vectashield 
containing DAPI. 
2.8.2 General immunohistochemistry on paraffin sections 
Paraffin embedded sections were cleared in histoclear for 15 minutes and 
rehydrated through a graded series of ethanol solutions (100% and 70%) and 
water.   
2.8.2.1 Immunofluorescence 
Following clearing and rehydration, the tissue was circled with a hydrophobic 
pen and incubated for 1 hour at room temperature in blocking solution 
containing 2% BSA and 10% normal animal sera (corresponding to the animal in 
which the secondary antibody to be used was raised in) in PBS.  The sections 
were incubated in primary antibody in blocking solution overnight at 4ºC.  The 
excess antibody was removed by washing in PBS twice for 5 minutes with 
agitation.  Sections were incubated in the relevant fluorescent secondary 
antibody in blocking solution for an hour at room temperature and excess 
antibody removed by washing in PBS twice for 5 minutes on a rocker.  Sections 
were mounted in Vectashield containing DAPI. 
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2.8.2.2 Immunohistochemistry 
Following clearing and rehydration, endogenous peroxidases were inhibited by 
incubating sections in 3% hydrogen peroxide in methanol for 30 minutes at room 
temperature.  Sections were then washed for 5 minutes in running water and for 
5 minutes in PBS with agitation.  The tissue was circled with a hydrophobic pen 
and incubated for 1 hour at room temperature in blocking solution containing 2% 
BSA and 10% normal animal sera (corresponding to the animal in which the 
secondary antibody to be used was raised in) in PBS.  The sections were 
incubated in primary antibody in blocking solution overnight at 4ºC.  The excess 
antibody was removed by washing in PBS twice for 5 minutes with agitation.  
Sections were incubated in the relevant biotinylated secondary antibody in 
blocking solution for an hour at room temperature and excess antibody removed 
by washing in PBS twice for 5 minutes on a rocker.  Avidin (1:400) in PBS  was 
added for 45 minutes at room temperature.  Sections were washed twice for 5 
minutes in PBS with agitation and a solution of diaminobenzidine (DAB) was 
added to the sections for 5 minutes.  DAB was washed off in running water and 
the sections dehydrated, cleared and mounted in Histomount.  Negative control 
sections were performed in parallel where the primary antibody was omitted to 
ensure that staining observed was not due to non-specific binding of the 
secondary antibody to the tissue. 
2.8.3 PCNA and GFAP immunohistochemistry 
Following clearing and rehydration, endogenous peroxidases were inhibited by 
incubating sections in 3% hydrogen peroxide in methanol for 30 minutes at room 
temperature. Sections were then washed for 5 minutes in running water and for 
5 minutes in PBS with agitation.  The tissue was circled with a hydrophobic pen 
and incubated for 1 hour at room temperature in blocking solution containing 2% 
BSA and 10% normal goat serum in PBS.  The sections were incubated in GFAP 
antibody (1:400) in blocking solution overnight at 4ºC.  The excess antibody was 
removed by washing in PBS twice for 5 minutes with agitation.  The biotinylated 
goat anti-rabbit secondary antibody (1:300) in blocking solution was added for 1 
hour at room temperature.  Excess antibody was removed by washing in PBS 
twice for 5 minutes on a rocker.  Avidin was added for 45 minutes at room 
temperature at a concentration of 1 in 400 in PBS.  Sections were washed twice 
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for 5 minutes in PBS with agitation and a solution of DAB was added to the 
sections for 5 minutes.  DAB was washed off in running water and PBS.  The 
sections were placed in citric acid buffer and were microwaved on high for 10 
minutes, then left to cool down for an hour.  The tissue was incubated for 1 hour 
at room temperature in blocking solution containing 2% BSA and 10% normal 
rabbit serum in PBS.  The sections were incubated in the proliferating cell 
nuclear antigen (PCNA) antibody at a concentration of 1 in 10,000 in blocking 
solution overnight at 4ºC.  Sections were then washed twice for 5 minutes in PBS 
with agitation and the biotinylated rabbit anti-mouse secondary antibody (1:300) 
in blocking solution was added for 1 hour at room temperature.  Excess antibody 
was removed by washing in PBS twice for 5 minutes on a rocker.  Avidin was 
added for 45 minutes at room temperature at a concentration of 1 in 400 in PBS.  
Sections were washed twice for 5 minutes in PBS with agitation and a solution of 
Vector SG was added to the sections for 5 minutes.  Vector SG was washed off in 
PBS for 5 minutes and water for 20 minutes. The sections were dehydrated, 
cleared and mounted in Histomount. 
2.9 Histological staining 
2.9.1 Haematoxylin and eosin    
Sections were stained with routine histological stains haematoxylin and eosin 
(H&E) to study the general features of the tissue.  Paraffin embedded sections 
were cleared in Histoclear for 15 minutes and rehydrated through a graded 
series of ethanol solutions (100% and 70%) and water.  Sections were placed in 
haematoxylin for 1 minute, washed in water, and blued in Scott’s Tap Water 
Substitute.  Excess haematoxylin was removed by immersion in acid alcohol (1% 
concentrated HCl in 70% ethanol).  The sections were washed and placed in 
eosin for 10 seconds, rinsed in water, dehydrated through a series of alcohols 
and cleared in Histoclear. 
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2.10 Quantification of regeneration 
2.10.1 Olfactory epithelium width assessment 
Sections 10, 20 and 30 from each animal were stained with H & E and sections of 
the olfactory epithelium were photographed using a light microscope at x20 
magnification.  Measurements of the control and experimental olfactory 
epithelial width were taken at right angles from the basement membrane to the 
luminal surface of the epithelium using Image J.  A measurement was taken at 
20 µm intervals along the length of the epithelium as shown in Figure 2.4.  Width 
results from mice of the same age, genotype and time point of perfusion were 
averaged out and analysed using ANOVA analysis of variance in Minitab.  Eileen 
Brown did some of the OE width measurements. 
 
Figure 2.4. OE width measurements. 
Image of olfactory epithelium showing how the olfactory epithelium width was measured at 
intervals of 20 µm along the length of the epithelium. 
 
 
2.10.2 Quantification of immunohistochemistry 
Relative optical density for synaptophysin and SMI 31 (phosphorylated 
neurofilament) immunohistochemistry was measured using ImageJ.  Images for 
each antibody were taken at 40x magnification at the same microscope light 
intensity.  For SMI 31, 3 sections were used for each time point and Mean Gray 
Value (MGV) measurements were taken at 25 random areas along the olfactory 
nerve.  For anti-synaptophysin, 3 sections were used for each time point and 3 
MGV measurements were taken from each of 10 randomly selected glomeruli.  
Background levels were determined by taking MGV measurements from 
36µ
m 
70µm 
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unlabelled areas. The mean background MGV was subtracted from the mean MGV 
of the positive areas to give the relative optical density value. 
2.10.3 Quantification of cell number 
To quantify the number of proliferating cells within the olfactory epithelium, 
cells expressing PCNA within the olfactory epithelium were counted.  3 sections 
were used for each time point and counts were made from 10 random areas 
along the length of the epithelium.  The number of cells was divided by the 
length of the olfactory epithelium to give the number of cells per mm of 
olfactory epithelium. 
2.11 Microscopy 
Confocal microscopy was carried out using an Olympus Fluoview FV1000 confocal 
microscope at 10 and 40 x magnifications.  Images of nodal regions were taken 
using an Olympus Fluoview FV1000 confocal microscope at 60x magnification 
with a zoom of 3 or using a Leica TCS SP2 confocal at 63x magnification.  Other 
microscopy was carried out using Zeiss Axioskop and Zeiss Axioplan microscopes 
at x40 magnification. 
2.12 Statistical analysis 
To compare values between groups, data were analysed by one-way analysis of 
variance (ANOVA) using MINITAB, to determine if at least two of the populations 
had significantly different means.  Experimental means were compared to 
controls using Dunnett’s two-tailed t-test, to allow for multiple comparisons.  
All values were expressed as the mean +/- standard error of the mean (SEM).  p-
values were displayed using three levels of statistical significance (p < 0.001, p < 
0.01 and p < 0.05).  Values below 0.05 were considered significant, and were 
indicated in figures by the presence of an asterisk. 
All experiments were performed in triplicate and repeated three times, unless 
otherwise stated, and the mean from each individual experiment was used to 
calculate the final mean value. 
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3 CHAPTER 3 
Comparison of the proliferative and migratory 
properties of wild-type and ganglioside-knockout 
Schwann cells and OECs. 
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3.1 Introduction 
It is a well established fact that the CNS is unable to regenerate following injury.  
This is due to a number of factors such as the presence of inhibitory myelin 
components, the presence of inhibitory guidance molecules and the formation of 
a glial scar.  CNS glia play a major role in the normally abortive regeneration of 
CNS axons, due most likely both to the presence of inhibitory molecules as well 
as the lack of sufficient growth promoting molecules (Reier and Houle, 1988, 
Hoke and Silver, 1994, Gebicke-Haerter et al., 1996, Moore and Thanos, 1996, 
Frisen, 1997, Ridet et al., 1997). 
The olfactory system is exceptional in that it is one of the few CNS regions that 
can support neurogenesis throughout life (Farbman, 1990).  Olfactory receptor 
neurons detect odours and relay this information to the brain.  These neurons 
die as a result of injury or normal cell turnover and are replaced by new neurons 
generated from putative stem cells in the olfactory epithelium (Schwob, 2002).  
The regenerative property of the olfactory system is thought to be partially due 
to the permissive nature of the glial cells found only in the olfactory system, 
namely the olfactory ensheathing cells (OECs).  OECs provide ensheathment for 
small C fibres within both the CNS and PNS portions of the olfactory nerve 
(Doucette, 1984, Doucette, 1993, Raisman, 1985).  It is thought that OECs act as 
conduits, guiding the axons of newly generated ORNs through the PNS 
environment of the olfactory mucosa and into the CNS environment of the 
olfactory bulb (Williams et al., 2004).   
Several studies have described the ganglioside expression in the olfactory system 
(Chiba et al., 1997, Hofteig et al., 1981, Ohsawa, 1989, Ohsawa and Shumiya, 
1991, Suchy et al., 1988, Valdes-Gonzalez et al., 2001).  GM4, GM3, GM2, GM1, 
GD1a, GD3, GD1b, GT1b and GQ1b have been shown to be expressed in the fish 
and human olfactory nerve (Chiba et al., 1997, Hofteig et al., 1981).  In mouse 
olfactory bulbs, GM3 was characteristically more concentrated than in the other 
brain regions (Ohsawa and Shumiya, 1991).  Mouse olfactory bulbs also express 
GM1, GD1a, GT1b and GD1b (Ohsawa and Shumiya, 1991).   
Gangliosides have been shown to affect proliferation and migration in a number 
of different cell types.  Gangliosides can not only stimulate but also inhibit cell 
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growth and motility, and their effect depends both on the structure of their 
carbohydrate chains and the type of cell.  For instance, Sia T expression in PC12 
cells led to decreased expression of a-series ganglioside, GM1 and increased 
expression of b-series gangliosides, GD1b and GT1b, and resulted in increased 
cell growth (Fukumoto et al., 2000) and motility (Kamimura et al., 2005).  Swiss 
3T3 cells almost exclusively express the simplest ganglioside, GM3 (Kamimura et 
al., 2005).  Swiss 3T3 cells transfected with GalNAc T express the a-series 
ganglioside GM1, which results in decreased proliferation (Mitsuda et al., 2002).  
Sia T expression in Swiss 3T3 led to the expression of b-series ganglioside GD3 
and increased cell motility.  However, unlike in PC12 cells where increased b-
series gangliosides resulted in increased proliferation, increased b-series 
gangliosides in Swiss 3T3 cells had no effect on their growth (Kamimura et al., 
2005). 
Prior to studying the role of gangliosides in the olfactory system, the role of 
gangliosides in the biology of the olfactory system glia, the OECs, as well as the 
related cell type, Schwann cells, was studied.  Although OECs are a unique cell 
type, they share many cellular and molecular properties with peripheral 
myelinating cells, Schwann cells.  These include molecular markers, 
morphological phenotype in culture and responsiveness to growth-promoting 
molecules.   
Many strategies have been employed in order to promote CNS regeneration.  One 
of these is glial cell transplantation.  OECs and Schwann cells have both been 
proposed as candidates for transplant-mediated repair.  Although OECs and 
Schwann cells share many features in common, there are several differences 
which are important when considering their suitability as candidates for 
transplant mediated repair.  For instance, OECs are able to freely migrate and 
co-exist with astrocytes, whereas Schwann cells have a limited ability to migrate 
in the presence of astrocytes and induce a reactive phenotype in astrocytes.  A 
better understanding of the biology of OECs and Schwann cells may aid in their 
use for CNS repair.  With this in mind, the aim of the present study was to 
examine the biological properties of glial cells isolated from wild-type and 
ganglioside knockout mice. 
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Glial cells were grown from wild-type and ganglioside knockout mice.  Initially, 
the proliferation of mouse OECs and Schwann cells was compared using different 
culture conditions in order to determine their optimal growth conditions.  The 
ganglioside expression of these cells was assessed by immunocytochemistry and 
subsequent experiments were performed to determine what role, if any, 
gangliosides play in the modulation of OEC and Schwann cell migration and 
proliferation.   
3.2 Results  
3.2.1 Mitogenic activity of known glial growth factors  
Schwann cells and OECs were obtained from sciatic nerves and olfactory bulbs of 
7 day old mice, respectively. They were purified as described in the methods 
section in order to remove any contaminating cells and only cultures which were 
more than 95% pure were used in the experiments.   
The growth response of glial cells isolated from mice and rats was initially 
observed.  It was clear that rodent cells had different growth requirements in 
vitro since Schwann cells and OECs isolated from mice grew much slower than 
comparable rat cells.  For instance, olfactory bulbs purified from 4 rats, plated 
into a T25 flask would become confluent within a few days and if split between 
two T25 flasks would again grow and become confluent within a few days.  In 
contrast, olfactory bulbs purified from 6 mice, plated into a T25 flask would 
take a lot longer to become confluent and if split between two T25 flasks would 
not reach confluence again.  The mouse cells were maintained for up to 2 
months and although they proliferated initially, eventually they stopped 
proliferating.  In order to identify mitogenic factors that would enable the 
expansion of purified mouse Schwann cells and OECs in vitro for further studies, 
the effect of a range of growth factors, previously identified Schwann cell and 
OEC mitogens, was examined: BDNF, EGF, FGF, forskolin, heregulin, IGF-1, NT-3, 
PDGF and TGFβ  (Alexander et al., 2002, Dong et al., 1997, Levi et al., 1995, 
Ramon-Cueto and Avila, 1998, Yan et al., 2001, Zhang et al., 1995, Pollock et 
al., 1999).  Due to the small number of viable cells recovered following mouse 
OEC or Schwann cell purification only one concentration of each growth factor 
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was tested as shown in Figure 3.1.  The concentrations used were higher than 
those used previously in the literature (Pollock et al., 1999). 
To observe the effects of the individual growth factors, these were added to 
serum- and growth factor-free DMEM-BS medium.  The mitogenic activity of 
individual growth factors was compared to that of DMEM-BS, 10% FBS in DMEM-
BS, and well-established rat OEC and Schwann cell media, OMM+5%FBS 
(Alexander et al., 2002) and 10%HF, respectively (Figure 3.1).  Mitogenic activity 
was quantified using an assay of DNA synthesis based on immunocytochemical 
detection of nuclear BrdU incorporation of cells having entered the S phase 
during a set period of exposure to this agent (Gratzner, 1982).  Approximately 
10,000 purified OECs or Schwann cells were plated onto PLL-coated coverslips 
and were maintained overnight in OMM+5%FBS and 10%HF, respectively, then 
exposed to the appropriate medium. 
As shown in Figure 3.1 (B) BrdU uptake in mouse Schwann cells grown in serum-
free medium was not significantly increased compared to DMEM-BS in response 
to the following single mitogens: BDNF, EGF, NT-3 or TGFβ.  A selection of single 
mitogens significantly increased Schwann cell proliferation compared to serum-
free medium, DMEM-BS.  These include: PDGF (p < 0.01), IGF-1 (p < 0.05), 
heregulin (p < 0.001), forskolin (p < 0.05) and FGF (p < 0.001).  Schwann cells 
grown in 10%FBS or OMM+5%FBS also proliferated significantly better than in 
serum-free medium (p < 0.001).  None of the single mitogens increased Schwann 
cell proliferation above the level achieved by maintaining the cells in 10%HF.   
OECs do not proliferate in response to forskolin or NT-3 alone as shown in Figure 
3.1 (A).  Most other mitogens tested, including EGF (p < 0.01), FGF (p < 0.01), 
BDNF, heregulin, IGF-1, PDGF and TGFβ (p < 0.05), increased the proliferation of 
OECs to above base levels.  OECs grown in 10%FBS (p < 0.05) as well as 10%HF (p 
< 0.01) also showed significantly greater proliferation than those grown in 
serum-free media.  However, none of the other media tested increased OEC 
proliferation to above the level achieved by maintaining the cells in OMM+5%FBS.  
In subsequent experiments, OECs were grown in OMM+5%FBS (olfactory mitogen 
medium containing FGF2, forskolin, heregulin, and astrocytes conditioned 
medium and an equal volume of 10% foetal bovine serum), while Schwann cells 
were grown in 10%HF (10% FBS 20 ng/ml heregulin and 2 µM forskolin). 
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Purified mouse OECs and Schwann cells proliferated slowly in control medium 
DMEM-BS (Figure 3.1); the percentage of OECs incorporating BrdU over a 16 hour 
exposure was 20.98 ± 6 whereas the percentage of Schwann cells incorporating 
BrdU over a 16 hour period was 6.5 ± 1.94.  However, this difference was not 
statistically significant.  Mouse OECs had higher proliferation rates than Schwann 
cells under most of the growth factor conditions used: 10%FBS (p < 0.01), 10%HF 
(p < 0.05), BDNF (p < 0.001), EGF (p < 0.001), FGF (p < 0.001), forskolin (p < 
0.001), heregulin (p < 0.01), IGF-1 (p < 0.001), NT-3 (p < 0.001), PDGF (p < 
0.01), and TGFβ (p < 0.001). 
3.2.2 Mitogenic effect of increasing acidity  
As mentioned previously, it was observed that OECs and Schwann cells derived 
from mice did not grow as well as comparable cells derived from rats.  Several 
parameters can alter the growth of cells including available growth factors, cell 
density, osmolality and pH.   
To determine if any of these factors would improve growth and identify the 
optimal growth conditions for mouse Schwann cells and OECs the effect of 
increasing the acidity of tissue culture media on their proliferation was 
investigated.  Increasing the percentage of CO2 in the air lowers the pH of the 
culture media making it more acidic. Purified OECs and Schwann cells were 
grown in 5, 7 or 10% CO2 for 48 hours and the incorporation of BrdU, which is 
added to the culture media 16 hours before the end of the experiment, was 
compared.  Cell nuclei were visualised with DAPI and cells that had incorporated 
BrdU were recognised by an anti-BrdU antibody.  Proliferation rate was 
expressed as the proportion of total cells that were BrdU-positive. 
Increasing the concentration of CO2 the cells were maintained in, and thereby 
lowering the pH of the media, did not significantly affect the proliferation of 
either Schwann cells or OECs (Figure 3.2).  For this reason, the cells were 
subsequently maintained in incubators containing 7% CO2 in OMM+5%FBS (OEC) or 
10%HF (Schwann cells).  It can be seen in Figures 3.1 and 3.2 that OEC 
proliferation was generally higher than Schwann cell proliferation, suggesting 
that the two cell types require different growth conditions. 
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Figure 3.1. Schwann cell and OEC proliferation under different growth factor conditions. 
Schwann cells and OECs isolated from 7 day old mice were purified after approximately 7 DIV 
and plated onto glass coverslips (10,000 cells per coverslip) in 10%HF and OMM+5%FBS, 
respectively.  They were left to attach overnight, washed with DMEM-BS and treated with various 
growth factors in DMEM-BS for 48h.  Twenty micromolar of BrdU was added for the last 16h of 
the experiment.  Proliferating cells were visualised by indirect immunolabelling with an anti-
BrdU antibody, and nuclei were visualised with DAPI.  The mean OEC proliferation rates 
expressed as the percentage of BrdU positive nuclei are displayed in A.  The mean Schwann cell 
proliferation rates are displayed in B.  Each point represents the mean ± SEM (n=3); (*) p < 0.05.  
The table in C explains the abbreviations used in the graphs and shows the concentration of each 
growth factor used.   
Abbreviation Contents 
DMEM-BS See Appendix for contents 
10%FBS 10% foetal bovine serum and 100 mM glutamine in DMEM 
10%HF “10%FBS”; 2 µM forskolin; 20 ng/ml heregulin 
OMM+5%FBS 5% FBS; 500 ng/ml FGF2; 50 ng/ml heregulin; 0.5 nM 
forskolin; 20% ACM in DMEM-BS  
BDNF 20 ng/ml brain derived neurotrophic factor in DMEM-BS 
EGF 20 ng/ml epidermal growth factor in DMEM-BS 
FGF 50 ng/ml fibroblast growth factor in DMEM-BS 
Forskolin 20 µg/ml forskolin in DMEM-BS 
Heregulin 20 ng/ml heregulin in DMEM-BS 
IGF-1 20 ng/ml insulin-like growth factor-1 in DMEM-BS 
NT-3 20 ng/ml neurotrophin-3 in DMEM-BS 
PDGF 5 ng/ml platelet-derived growth factor in DMEM-BS 
TGFβ 20 ng/ml transforming growth factor β in DMEM-BS 
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Figure 3.2. Effect of increasing acidity on Schwann cell and OEC proliferation. 
Purified Schwann cells and OECs from 7 day old mice were plated on PLL-coated coverslips at a 
density of approximately 10,000 cells per coverslip. Schwann cells were maintained in 10%HF and 
OECs in OMM+5%FBS throughout the experiment.  The cells were allowed to attach overnight in 
incubators containing 7% CO2, then washed with DMEM-BS and fresh media added.  They were 
maintained in 5%, 7% or 10% CO2 for 48 hours.  Twenty micromolar of BrdU was added for the last 
16 h of the experiment and the percentage of cells expressing BrdU was assessed by indirect 
immunocytochemistry using an anti-BrdU antibody, to label proliferating nuclei and DAPI to 
visualise all nuclei.  Increasing the CO2 concentration and thereby increasing the acidity did not 
significantly alter the growth of either Schwann cells or OECs.  (A) displays the mean 
proliferation rates in OECs expressed as % of BrdU incorporation and (B) displays the data for 
Schwann cells.  Each point represents the mean ± SEM (n=3).   
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3.2.3 Ganglioside expression of Schwann cells and OECs 
To assess if ganglioside expression varied in OECs and Schwann cells, the 
ganglioside expression of OECs and Schwann cells isolated from 7 day old mice 
was examined by immunocytochemistry.  Antibodies used were a gift from Prof. 
Willison’s lab.  The antibodies used were EG2 which binds to gangliosides GT1a, 
GD1b, GT1b and GQ1b; EG3 which recognises GT1a and GQ1b; MOG1 which is 
specific for GD1b; MOG30 which is specific for GQ1b; MOG35 which specifically 
binds to GD1a; and R24 which binds to GD3, GT1a and GQ1b.  CTx, which binds 
to GM1, was also used.  The results are summarised in Table 3.1.   
OECs and Schwann cells have a similar ganglioside expression in that the major 
gangliosides expressed in vitro by both cell types are a-series complex 
gangliosides GM1 (Figure 3.3 and 3.4) and GD1a (Figure 3.5 and 3.6).  The 
majority of p75NTR-immunoreactive OECs and Schwann cells double-labelled with 
MOG35, which binds to GD1a or CTx which binds to GM1.  The intensity of CTx 
and MOG35 in both Schwann cells and OECs was heterogeneous.  The 
contaminating cells in OEC and Schwann cell cultures also expressed GM1 and 
GD1a (Figure 3.12 and 3.13).   
Binds to ganglioside: Marker 
a-series b-series 
OEC SC 
CTx GM1  80-100% positive  80-100% positive  
EG2 GT1a +++ GD1b ++ ; 
GT1b +++; 
GQ1b ++ 
negative <1% positive 
EG3 GT1a ++++ GQ1b +++ negative 0-5% positive 
MOG1  GD1b ++++ <1% positive <1% positive 
MOG30  GQ1b +++ negative <1% positive 
MOG35 GD1a ++++  80-100% positive  80-100% positive  
R24 GT1a ++ GQ1b ++ ; 
GD3 +++ 
<5% positive <5% positive 
 
Table 3.1. Table showing ganglioside expression of OEC and Schwann cells 
OECs and Schwann cells purified from 7 day old mice were maintained in known optimal 
conditions, namely OMM+5%FBS or 10%HF, respectively, and labelled with antibodies which bind 
to gangliosides and FITC-labelled CTx which binds to ganglioside GM1, after 7 to 14 days in vitro.  
In instances where the antibodies labelled less than 1% of the cells, the labelled cells 
morphologically resembled OECs or Schwann cells and were p75NTR-positive.  Anti-ganglioside 
reactivities: optical density >0.1 ≤0.5 (+); >0.5 ≤1.0 (++); >1.0 ≤1.5 (+++); >1.5 (++++). 
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Figure 3.3. Representative images of CTx labelling of OECs. 
Purified OECs from 7 day old wild-type (I-III), Sia T -/- (IV-VI) and GalNAc T -/- mice (VII-IX) were 
labelled with CTx (green) and p75NTR (red).  Nuclei were visualised with DAPI (blue).  I, IV and VII 
illustrate the p75NTR immunoreactivity; II, V and VIII illustrate the CTx immunoreactivity; III, VI 
and IX illustrate the merged images.  CTx binds to ganglioside GM1, whereas p75NTR identifies 
OECs.  The majority of wild-type and Sia T -/- OECs express GM1 as demonstrated by the double-
labelling of p75NTR with CTx.  The intensity of CTx labelling is heterogeneous: in some cells the 
immunoreactivity is strong (arrowhead) whereas in others it is weak (arrow) (V).  GalNAc T -/- 
mice lack all a-series gangliosides and therefore do not express GM1 as demonstrated by the lack 
of CTx labelling (VIII).  Scale bar = 50 µm. 
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Figure 3.4. Representative images of CTx labelling of Schwann cells. 
Purified Schwann cells from 7 day old wild-type (I-III), Sia T -/- (IV-VI) and GalNAc T -/- mice 
(VII-IX) were labelled with CTx (green) and p75NTR (red).  Nuclei were visualised with DAPI (blue).  
I, IV and VII show the p75NTR immunoreactivity; II, V and VIII show the CTx immunoreactivity; III, 
VI and IX show the merged images.  CTx binds to ganglioside GM1, whereas p75NTR identifies 
Schwann cells.  The majority of wild-type and Sia T -/- Schwann cells express GM1 as 
demonstrated by the double-labelling of p75NTR with CTx.  The intensity of CTx labelling is 
heterogeneous: in some cells the immunoreactivity is strong (arrowhead) whereas in others it is 
weak (arrow) (V).  Note that the brightness in image V was digitally increased to reveal the 
weaker staining.  GalNAc T -/- mice lack all a-series gangliosides and therefore do not express 
GM1 as demonstrated by the lack of CTx labelling (VIII).  I-III scale bar = 50 µm; IV-IX scale bar = 
20 µm. 
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Figure 3.5. Representative images of MOG35 labelling of OECs.   
Purified OECs from wild-type (I-III), Sia T -/- (IV-VI) and GalNAc T -/- mice (VII-IX) were labelled 
with MOG35 (green) and p75NTR (red).  Nuclei were visualised with DAPI (blue).  I, IV and VII show 
the p75NTR immunoreactivity; II, V and VIII show the MOG35 immunoreactivity; III, VI and IX show 
the merged images.  MOG35 binds to ganglioside GD1a, whereas p75NTR identifies OECs.  Majority 
of wild-type and Sia T -/- OECs express GD1a as demonstrated by the double-labelling of p75NTR 
with MOG35, however some OECs do not express MOG35 (arrow) (IV).  GalNAc T -/- mice lack all 
a-series gangliosides and therefore do not express GD1a as demonstrated by the lack of MOG35 
labelling (VIII).  Scale bar = 50 µm. 
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Figure 3.6. Representative images of MOG35 labelling of Schwann cells.   
Purified Schwann cells from wild-type (I-III), Sia T -/- (IV-VI) and GalNac T -/- mice (VII-IX) were 
labelled with MOG35 (green) and p75NTR (red).  Nuclei were labelled with DAPI (blue).  I, IV and 
VII show the p75NTR immunoreactivity; II, V and VIII show the MOG35 immunoreactivity; III, VI and 
IX show the merged images.  MOG35 binds to ganglioside GD1a, whereas p75NTR identifies 
Schwann cells.  Majority of wild-type and Sia T -/- OECs express GD1a as demonstrated by the 
double-labelling of p75NTR with MOG35.  Contaminating fibroblast also label with MOG35 (arrow) 
(II).  GalNAc T -/- mice lack all a-series gangliosides and therefore do not express GD1a as 
demonstrated by the lack of MOG35 labelling.  I-III scale bar = 50 µm; IV-IX scale bar = 20 µm. 
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A very small proportion of both Schwann cells and OECs (less than 1%) expressed 
ganglioside GD1b which is recognised by the antibody MOG1 (Figure 3.7).  This 
was not due to the contaminating cells since the positive cells co-labelled with 
p75NTR.  A small percentage of both OECs and Schwann cells (less than 5%) 
labelled with the marker R24 which binds to GD3 and several complex 
gangliosides.  A similar proportion of GalNAc T -/- cells, which lack all complex 
gangliosides, labelled with R24 (Figure 3.8).  The contaminating cells in OEC and 
Schwann cell cultures also labelled with MOG1 and R24 (Figure 3.12 and 3.13).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7.  Representative images of MOG1 labelling of OECs and Schwann cells. 
Purified wild-type OEC (I-III) and Schwann cells (IV-VI) were labelled MOG1 (green) and p75NTR 
(red).  Nuclei were visualised with DAPI (blue). I and IV show the p75NTR immunoreactivity; II and 
V show the MOG1 immunoreactivity; III and VI show the merged images. Less than 1% of wild-
type p75NTR immunoreactive Schwann cells and OECs double labelled with MOG1, which binds to 
ganglioside GD1b.  Scale bar = 20 µm. 
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Figure 3.8. Representative images of OEC and Schwann cell expression of R24. 
Purified wild-type and GalNAc T -/- OECs and Schwann cells were double labelled with p75NTR 
(red) and R24 (green).  I-III wild-type OEC; IV-VI wild-type Schwann cells; VII-IX GalNAc T -/- 
OEC; X-XII GalNAc T -/- Schwann cells.  R24 labels gangliosides GT1a, GQ1b and GD3.  Since 
GalNAc T -/- lack all complex gangliosides, the R24 labelling in GalNAc T -/- cells is due to R24 
binding to simple ganglioside GD3.  Nuclei were visualised with DAPI.  I-IX Scale bar = 50 µm; X-
XII scale bar = 20 µm. 
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There was a slight difference in the ganglioside expression between OECs and 
Schwann cells.  A very small proportion of Schwann cells were positive for 
MOG30, EG2 and EG3 (less than 1%), whereas OECs were negative for all three 
(Figures 3.9, 3.10 and 3.11, respectively).  The EG2, EG3 and MOG30 labelling in 
Schwann cell cultures was not due to the contaminating fibroblasts since the 
positive cells also labelled with p75NTR.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.9. Representative images of MOG30 labelling of OECs and Schwann cells. 
Purified OECs (I-III) and Schwann cells (IV-VI) from 7 day old wild-type mice were double labelled 
with p75NTR (red) and MOG30 (green).  Nuclei were visualised with DAPI (blue).  Merged images 
are shown in images III and VI.  All of the p75NTR positive OECs were negative for MOG30.  Less 
than 1% of Schwann cells were positive for MOG30, which binds to ganglioside GQ1b.  I-III scale 
bar = 50µm; IV-VI scale bar = 20 µm. 
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Figure 3.10. Representative images of EG2 labelling of OECs and Schwann cells. 
Purified wild-type OECs (I-III) and Schwann cells (IV-VI) were labelled with p75NTR (red) and EG2 
(green).  Nuclei were visualised with DAPI (blue). III and VI show the merged images. p75NTR 
labels OECs and Schwann cells; EG2 labels gangliosides GT1a, GD1b, GT1b and GQ1b.  All of the 
p75NTR OECs were negative for EG2, whereas less than 1% of p75NTR immunoreactive Schwann 
cells were also EG2 immunoreactive.  Scale bar = 50 µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.11.  Representative images of EG3 labelling of OECs and Schwann cells. 
Purified wild-type OECs (I-III) and Schwann cells (IV-VI) were labelled with p75NTR (red) and EG3 
(green).  Nuclei were visualised with DAPI (blue). III and VI show the merged images.  p75NTR 
labels OECs and Schwann cells; EG3 labels gangliosides GT1a and GQ1b.  All of the p75NTR OECs 
were negative for EG3, whereas less than 1% of p75NTR immunoreactive Schwann cells were also 
EG3 immunoreactive.  Scale bar = 50 µm. 
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Figure 3.12. Ganglioside expression of contaminating cells in OEC cultures.   
Mixed olfactory bulb cultures from wild-type mice were labelled with p75NTR (red, I-VI) and the 
following ganglioside markers (green): CTx (I), MOG35 (II), EG2 (III), EG3 (IV), MOG30 (V) and R24 
(VI).  OECs purified from 7-day old wild-type olfactory bulbs contain less than 5% of 
contaminating cells.  These contaminating cells differ in morphology from the OECs and are 
p75NTR negative.  These contaminating cells express gangliosides, SMA (red, VII) and Thy 1.2 
(green, VIII).  Note the difference in morphology between p75NTR positive OECs (arrow) and the 
p75NTR negative cell in II.  Nuclei were visualised with DAPI (blue).  Scale bar = 20 µm   
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Figure 3.13. Ganglioside expression of contaminating cells in Schwann cell cultures.   
Mixed sciatic nerve cultures from wild-type mice were labelled with p75NTR (red, I-VI) and the 
following ganglioside markers (green): CTx (I), MOG35 (II), MOG1 (III), MOG30 (IV), and R24 (V).  
Schwann cells purified from 7-day old wild-type sciatic nerves contain less than 5% of 
contaminating cells.  These contaminating cells differ in morphology from the Schwann cells and 
are p75NTR negative.  These contaminating cells express gangliosides, as well as, fibronectin (red, 
VI) and SMA (green, VII).  Nuclei were labelled with DAPI.  VIII shows the merged SMA and 
fibronectin image.  Scale bar = 20 µm. 
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3.2.4 Antigen profile and morphology of wild-type and 
ganglioside knockout cells 
Having shown that both OECs and Schwann cells express complex gangliosides, 
the aim was to investigate the role gangliosides play in the biology of OECs and 
Schwann cells.  Firstly, the morphology of wild-type and ganglioside knockout 
OECs and Schwann cells was compared on PLL, laminin and collagen (Figure 
3.14-3.17).   
Examination by phase contrast microscopy of the morphology of OECs and 
Schwann cells after re-plating on culture dishes coated with PLL, laminin or 
collagen showed that the appearance of cells varied depending on the type of 
growth surface and whether they were grown in the presence or absence of 
serum and growth factors.  However, the morphological characteristics of 
ganglioside knockout OECs and  Schwann cells grown on PLL or ECM components 
collagen IV and laminin were similar to wild-type cells.   
In serum and growth factor-free medium, DMEM-BS, both OECs and Schwann 
cells extended two or three long processes which were sometimes branched 
(Figures 3.14 and 3.16, respectively), while those grown in the presence of 
serum and growth factors had comparably shorter processes and appeared 
flatter (Figures 3.15 and 3.17, respectively).   
OECs and Schwann cells grown on laminin (Figures 3.14 to 3.17 II, V and VIII), 
both in the presence and absence of serum and growth factors, had much longer 
processes than those grown in PLL and collagen. 
Secondly, the antigen profile of OECs and Schwann cells obtained from wild-
type, Sia T -/- and GalNAc T -/- mice was examined (Figure 3.18 and 3.19).  It 
was found that ganglioside knockout cells had the same antigen profile as the 
wild-type cells with all genotypes expressing p75NTR, nestin and GFAP. 
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Figure 3.14. Morphology of wild-type and ganglioside knockout OECs grown in DMEM-BS.  
Wild-type (I-III), Sia T -/- (IV-VI) and GalNAc T -/- (VII-IX) OECs were trypsinised from parent 
cultures, and re-plated at low density on wells coated with PLL (I, IV & VII) , laminin (II, V & VIII) 
or collagen (III, VI & IX) as described in the Methods section.  Cells were left to attach overnight 
in OMM+5%FBS.  This was replaced by growth factor- and serum free medium, DMEM-BS, and 
phase contrast images were taken 48 hours later.  In each image, a cell was chosen as an 
example and arrows were used to show where its processes end.  These representative images 
show that there was no difference in the morphology of OECs derived from wild-type, Sia T -/- 
and GalNAc T -/- mice.  Scale bar = 100 µm. 
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Figure 3.15. Morphology of wild-type and ganglioside knockout OECs grown in OMM+5%FBS.  
Wild-type (I-III), Sia T -/- (IV-VI) and GalNAc T -/- (VII-IX) OECs were trypsinised from parent 
cultures, and re-plated at low density on wells coated with PLL (I, IV & VII) , laminin (II, V & VIII) 
or collagen (III, VI & IX) as described in the Methods section.  Cells were maintained in 
OMM+5%FBS.  Phase contrast images were taken 48 hours after plating.  In each image, a cell was 
chosen as an example and arrows were used to show where its processes end.  Scale bar = 100 
µm. 
 
I II III
IV V VI
VII VIII IX
wild-type
Sia T -/-
GalNAc T -/-
PLL laminin collagen
  118 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.16. Morphology of wild-type and ganglioside knockout Schwann cells grown in 
DMEM-BS.   
Wild-type (I-III), Sia T -/- (IV-VI) and GalNAc T -/- (VII-IX) Schwann cells were trypsinised from 
parent cultures, and re-plated low density on wells coated with PLL (I, IV & VII) , laminin (II, V & 
VIII) or collagen (III, VI & IX) as described in the Methods section.  Cells were left to attach 
overnight in 10%HF.  This was replaced by growth factor- and serum free medium, DMEM-BS, and 
phase contrast images were taken 48 hours later.  In each image, a cell was chosen as an 
example and arrows were used to show where its processes end.  The round cells in III are cells 
which had detached from the substrate.  Scale bar = 100 µm. 
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Figure 3.17. Morphology of wild-type and ganglioside knockout Schwann cells grown in 
10%HF.  Wild-type (I-III), Sia T -/- (IV-VI) and GalNAc T -/- (VII-IX) Schwann cells were 
trypsinised from parent cultures, and re-plated at low density on wells coated with PLL (I, IV & 
VII) , laminin (II, V & VIII) or collagen (III, VI & IX) as described in the Methods section.  Cells 
were maintained in 10%HF.  Phase contrast images were taken 48 hours after plating.  In each 
image, a cell was chosen as an example and arrows were used to show where its processes end.  
Scale bar = 100 µm. 
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Figure 3.18.  Antigen profile for wild-type, Sia T -/- and GalNAc T -/- OECs. 
Purified OECs from 7-day old wild-type, Sia T -/- and GalNAc T -/- mice were labelled with 
typical OEC markers p75NTR, nestin and GFAP.  The antigen profile was similar in all three 
genotypes.  Nuclei are labelled with DAPI (blue).  Scale bar = 20 µm.   
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Figure 3.19. Antigen profile for wild-type, Sia T -/- and GalNAc T -/- Schwann cells. 
Purified Schwann cells from 7 day old wild-type, Sia T -/- and GalNAc T -/- mice were labelled 
with typical Schwann cell markers p75NTR, nestin and GFAP.  The antigen profile was similar in all 
three genotypes.  Nuclei are labelled with DAPI (blue).  Scale bar = 20 µm.   
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3.2.5 Proliferation of wild-type and ganglioside knockout cells 
As it has been shown that gangliosides can interact with growth factor receptors 
and integrins to modulate cell function (Cheresh et al., 1987, Zheng et al., 
1993), the growth and motility of OECs and Schwann cells was investigated on 
different substrates in the presence or absence of growth factors.  The 
proliferation of wild-type, Sia T -/- and GalNAc T -/- OECs and Schwann cells 
was therefore compared on PLL, laminin and collagen in media with or without 
growth factors.  OECs and Schwann cells were isolated from the olfactory bulbs 
and sciatic nerves of 7 day old mice, respectively.  The cells were purified as 
described in the methods section and after approximately 7 DIV, the purified 
cells were trypsinised and re-plated onto PLL, collagen or laminin coated 
coverslips at a density of around 10,000 cells per coverslip.  The cells were 
maintained in their respective optimal growth media (OECs in OMM+5%FBS and 
Schwann cells in 10%HF) overnight to allow them to attach.  The following day, 
the cells were washed in DMEM-BS and the cells were subsequently maintained in 
either serum- and growth factor-free medium (DMEM-BS), or in media containing 
growth factors (OMM+5%FBS for OECs and 10%HF for Schwann cells).  BrdU was 
added for the last 16 hours of the experiment.  Finally, the cells were fixed and 
stained with an anti-BrdU antibody to label the proliferating cells, and DAPI to 
label the nuclei.  Proliferation rates are presented as the percentage of cells 
which have taken up BrdU over the 16 hour period.  Each experiment was 
performed in duplicate and a minimum of 1000 cells was counted per coverslip. 
It was found that the proliferation of OECs derived from ganglioside knockout 
mice did not differ from wild-type OEC proliferation in serum- and growth 
factor-free medium.  Furthermore, in serum- and growth factor-free medium, 
wild-type and ganglioside knockout OECs proliferated at a similar rate on all 
three substrates.   
OECs from all three genotypes had significantly higher proliferation rates when 
grown in OMM+5%FBS regardless of substrate (p < 0.05).  In addition, Sia T -/- 
OECs proliferated significantly better on laminin compared with PLL when grown 
in the presence of growth factors (p < 0.05).  Ganglioside knockout OECs grown 
on PLL and laminin had similar proliferation rates to wild-type OECs.  However, 
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Sia T -/- OECs had a higher proliferation (p < 0.05) compared with wild-type and 
GalNAc T -/- OECs when grown on collagen in OMM+5%FBS (Figure 3.20).  
As with the OECs, Schwann cells proliferated better on all substrates in media 
containing growth factors compared with DMEM-BS (p < 0.05).  In contrast to 
OECs, Sia T -/- Schwann cells did not proliferate better on laminin when grown 
in media containing growth factors: Schwann cell proliferation was similar on all 
three substrates.  Also in contrast to OECs, ganglioside knockout Schwann cells 
had similar proliferation rates to wild-type Schwann cells on all three substrates 
in both serum- and growth factor-free medium (DMEM-BS) and in medium 
containing growth factors (10%HF) (Figure 3.21).  
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Figure 3.20. Proliferation of OECs derived from wild-type and ganglioside knockout mice.  
A comparison was made of the proliferation of OECs purified from 7 day old wild-type, Sia T -/- 
and GalNAc T -/- mice grown in serum- and growth factor-free medium, DMEM-BS (A) or 
OMM+5%FBS (B) on PLL, laminin and collagen.  OECs cultured from wild-type and ganglioside 
knockout mice have similar proliferation rates on all three substrates when grown in DMEM-BS.  
OECs proliferation was significantly higher in medium containing growth factors.  OECs derived 
from ganglioside knockout mice grown on PLL and laminin in OMM+5%FBS had similar 
proliferation rates to OECs derived from wild-type mice.  Sia T -/- OECs grown in OMM+5%FBS on 
collagen had increased proliferation compared with WT cells (p < 0.05).  Each point represents 
the mean ± SEM (n=3). Sia T -/- OECs proliferate better on laminin compared with PLL (p < 0.01, 
pink *).  Sia T -/- OEC grown on collagen have a higher proliferation rate that wild-type and 
GalNAc T -/- OECs (p < 0.05, blue *).  
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Figure 3.21.  Proliferation of wild-type and ganglioside knockout Schwann cells. 
A comparison was made of the proliferation of Schwann cells purified from 7 day old wild-type, 
Sia T -/- and GalNAc T -/- mice grown in serum- and growth factor-free medium, DMEM-BS (A) or 
10%HF (B) on PLL, laminin and collagen.  The proliferation of Schwann cells was significantly 
higher in medium containing growth factors.  Schwann cells obtained from ganglioside knockout 
mice had similar proliferation rates in both DMEM-BS and 10%HF on all three substrates.  Each 
point represents the mean ± SEM (n=3).   
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3.2.6 Motility of wild-type and ganglioside knockout cells 
In order to test whether gangliosides play a role in OEC and Schwann cell 
motility, the motility of wild-type and ganglioside knockout cells was measured 
using time-lapse microscopy.  OECs and Schwann cells were isolated from the 
olfactory bulbs and sciatic nerves of 7 day old mice, respectively.  The cells 
were purified as described in the methods section and after approximately 7 
DIV, the purified cells were plated onto PLL, collagen or laminin coated wells at 
a density of around 5,000 cells per well for the migration experiments and 
30,000 cells per well for the wound assay experiments.  The cells were 
maintained in their respective optimal growth media (OECs in OMM+5%FBS and 
Schwann cells in 10%HF) overnight to allow them to attach.  The following day 
the cells were washed in DMEM-BS and were subsequently maintained in either 
serum- and growth factor-free medium (DMEM-BS), or in media containing 
growth factors (OMM+5%FBS for OECs and 10%HF for Schwann cells). 
No difference was observed in the motility of cells between wild-type and 
ganglioside knockout OECs (Figure 3.22) and Schwann cells (Figure 3.23) using an 
assay where the migration of individual cells plated at low density was 
measured.  The greatest migration velocities were achieved on laminin in all 
genotypes tested in medium with or without growth factors (p < 0.05).  Whereas 
the proliferation of OECs and Schwann cells increased in the presence of growth 
factors, the motility of both cell types was unaffected by the presence of growth 
factors (Figure 3.22 and 3.23).   
Using a wound assay it was observed that the migration of wild-type OECs and 
Schwann cells was again similar in medium with or without growth factors 
(Figure 3.24 and 3.25).  Because it was difficult to obtain a confluent layer of 
cells for the wound assay in the medium lacking growth factors, it was decided 
to study the migration of ganglioside knockout cells using wound assays only in 
the presence of growth factors.  When the cells were plated at high density and 
a wound was made, Sia T -/- Schwann cells grown on laminin and collagen 
exhibited a significantly higher wound healing migration compared with wild-
type cells (p < 0.05). 
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Figure 3.22. Motility of wild-type and ganglioside knockout OECs. 
The motility of OECs isolated from wild-type and ganglioside knockout mice was compared in 
medium containing no growth factors, DMEM-BS (A) and in optimal growth media, OMM+5%FBS (B) 
on PLL, laminin and collagen.  Wild-type and ganglioside knockout OECs have similar migration 
profiles, with all cells migrating faster on laminin.  The presence of growth factors in the culture 
medium did not affect the motility of OECs.  Each point represents the mean ± SEM (n=3).   
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Figure 3.23. Motility of wild-type and ganglioside knockout Schwann cells. 
The motility of Schwann cells from wild-type and ganglioside knockout mice was compared in 
medium containing no growth factors, DMEM-BS (A) and in optimal growth media, 10%HF (B) on 
PLL, laminin and collagen.  Wild-type and ganglioside knockout Schwann cells have similar 
migration profiles, with all cells migrating faster on laminin.  Schwann cell motility was similar in 
the presence and absence of growth factors.  Each point represents the mean ± SEM (n=3).   
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Figure 3.24. Motility of wild-type OECs and Schwann cells in a wound assay. 
The motility of OECs (A) and Schwann cells (B) isolated from wild-type mice was compared in 
medium containing no growth factors (DMEM-BS) and in optimal growth media (OMM+5%FBS for 
OECs and 10%HF for Schwann cells) on PLL, laminin and collagen.  A scratch was made using a 
pipette tip on a layer of confluent cells thus creating a gap between two confluent cell layers.  
The cells were washed with PBS to remove any cell debris and the two cell fronts growing 
towards each other were filmed using time-lapse microscopy over a period of 24 hours. The 
distance travelled between the two cell fronts was measured over time.  The motility of OECs 
and Schwann cells was similar in medium with and without growth factors.  Each point 
represents the mean ± SEM (n=3). 
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Figure 3.25. Representative images of wild-type OEC and Schwann cell motility in a wound 
assay. 
The motility of OECs (A) and Schwann cells (B) from wild-type mice was compared in medium 
containing no growth factors, DMEM-BS, and in optimal growth media (OMM+5%FBS for OEC; 
10%HF for Schwann cells) on PLL (I-IV), laminin (V-VIII) and collagen (IX-XI).  A scratch was made 
using a pipette tip on a layer of confluent cells thus creating a gap between two confluent cell 
layers.  The cells were washed with PBS to remove any cell debris and the two cell fronts 
growing towards each other were filmed using time-lapse microscopy over a period of 24 hours. 
The distance travelled between the two cell fronts was measured over time.  Scale bar = 100 
µm. 
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Figure 3.26. Motility of wild-type and Sia T -/- OECs and Schwann cells in a wound assay. 
Confluent OECs (A) and Schwann cells (B) from wild-type and Sia T -/- mice, grown on PLL, 
laminin or collagen were used in the wound assays to compare their migration rates.  A scratch 
was made using a pipette tip on a layer of confluent cells thus creating a gap between two 
confluent cell layers.  The cells were washed with PBS to remove any cell debris and the two cell 
fronts growing towards each other were filmed using time-lapse microscopy over a period of 24 
hours. The rate of change of distance between the two cell fronts was measured over time.  Sia 
T -/- Schwann cells had significantly higher motility compared with wild-type cells on laminin (p 
< 0.05) and collagen (p < 0.05).  Each point represents the mean ± SEM (n=3).   
 
A
B
*
*
0
10
20
30
40
50
60
70
PLL Laminin Collagen PLL Laminin Collagen
wild-type Sia T -/-
Olfactory ensheathing cells
m
ig
ra
ti
o
n
 v
e
lo
c
it
y
 µ
m
/
h
0
5
10
15
20
25
30
35
40
PLL Laminin Collagen PLL Laminin Collagen
wild-type Sia T -/-
Schwann cells
m
ig
ra
ti
o
n
 v
e
lo
c
it
y
 µ
m
/
h
m
ig
ra
ti
o
n
 v
e
lo
c
it
y
 µ
m
/
h
m
ig
ra
ti
o
n
 v
e
lo
c
it
y
 µ
m
/
h
  132 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.27. Representative images of wild-type and Sia T -/- OEC and Schwann cell motility 
in a wound assay. 
The motillity of OECs (A) and Schwann cells (B) from wild-type and Sia T -/- mice was compared 
in optimal growth media (OMM+5%FBS for OEC; 10%HF for Schwann cells) on PLL (I-IV), laminin 
(V-VIII) and collagen (IX-XI) using a wound assay described in the Methods section.  Scale bar = 
100 µm. 
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3.3 Discussion 
3.3.1 Proliferaton of mouse OECs and Schwann cells 
This study showed that mouse OECs and Schwann cells had a similar basal rate of 
division, but that there was a notable difference in their mitogenic response to 
the addition of growth factors.  Namely, OECs proliferated significantly better 
than Schwann cells in response to serum, 10%HF and individual growth factors.  
Among the growth factors tested, OECs had higher proliferation rates than 
Schwann cells in response to BDNF, EGF, FGF, forskolin, heregulin, IGF-1, NT-3, 
PDGF, and TGFβ.  The difference in the response to growth factors between 
OECs and Schwann cells gives further weight to the argument that they are two 
distinct cell types.  
It has been shown that in rat Schwann cell cultures, FGF and PDGF are mitogenic 
only in the presence of agents which elevate intracellular levels of cAMP, as well 
as, either serum (Davis and Stroobant, 1990), IGF1, IGF2 (Stewart et al., 1996) 
or high concentrations of insulin (Stewart et al., 1991).  However, in this study it 
was found that some single growth factors, including FGF and PDGF, were 
mitogenic for mouse Schwann cells.  Despite this, mouse Schwann cells and OECs 
failed to proliferate as well as rat cells when a combination of growth factors 
was used.  Rat OECs and Schwann cells maintained under the conditions used in 
the present study continued to proliferate and increase in cell number while 
mouse OECs and Schwann cells maintained under identical conditions only 
proliferated initially.  This suggests that mouse cells differ in their mitogenic 
requirements from rat cells.   
Previous studies have reported an inherent species difference in growth 
requirements between mouse and rat cells.  For instance, Svendsen et al (1997) 
showed that mouse neural precursors can self renew and remain pluripotent for 
over 50 days, whereas rat neural precursor cells began to undergo apoptosis 
after 28 days in culture.  Ray and Gage (2006) also found major differences 
between rat and mouse progenitor proliferation in response to various 
substrates, growth factors and heparin.  In addition, the present study showed 
that spinal cord cultures obtained from embryonic mice could be maintained on 
PLL (see Chapter 5) whereas other studies have shown rat spinal cord cultures 
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maintained under the same conditions did not survive well on PLL (Sorensen et 
al., 2008). 
The reason why mouse OECs and Schwann cells did not continue to proliferate is 
not known, but presumably it is due to some imbalance of factors or deficiency 
in the culture environment.  Future experiments could test different 
combinations of growth factors, hormones and substrates to find their optimal 
growth conditions. 
3.3.2 Ganglioside expression of OECs and Schwann cells 
Several studies have examined the ganglioside content of Schwann cells both in 
vitro and in vivo.  In contrast, I have not found any reports in the literature 
describing the ganglioside expression of OECs.  Although many studies have 
examined Schwann cell ganglioside expression, the results were variable.  For 
instance, two studies found that Schwann cells derived from neonatal rat sciatic 
nerve label with CTx suggesting they express GM1 (Brockes et al., 1979, Raff et 
al., 1979), whereas another similar study showed that neonatal rat Schwann cell 
cultures do not express GM1 (Okada et al., 1982).  In agreement with the first 
two studies, the present study showed that CTx labelled the majority of 
neonatal mouse Schwann cells isolated from sciatic nerves.  This is supported by 
the findings that CTx is mitogenic for neonatal rat Schwann cells (Raff et al., 
1978a) and that MBP induces Schwann cell proliferation via an interaction with 
GM1 (Tzeng et al., 1995, Tzeng et al., 1999).  In addition, a study of mature, 
myelinating Schwann cells found that low amounts of GM1 are found on Schwann 
cell internodal surfaces but that GM1 is primarily localized on specialised 
Schwann cell structures in the nodal region in rat peripheral nerves (Ganser et 
al., 1983).  Another study using GM1 immunofluorescence of adult rat spinal 
roots by Molander et al (1997) confirmed that GM1 is confined to Schmidt-
Lanterman’s incisures, myelin sheath paranodal end segments and to some 
extent the abaxonal Schwann cell cytoplasm.   
Neuraminidase converts GD1a and GT1b (and other complex gangliosides) to 
GM1.  The study by Ganser et al (1983) also found that the amount of CTx 
binding to Schwann cells increases when the nerve fibres are treated with 
neuraminidase suggesting that the enzyme is converting polysialogangliosides to 
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GM1.  Since Schwann cells do not bind tetanus toxin (Fields et al., 1978, Brockes 
et al., 1979, Raff et al., 1979) which recognises gangliosides GD1b, GT1b, GQ1b 
(Holmgren et al., 1980) it is possible that this polysialoganglioside is GD1a.  This 
would be in agreement with the present study where it was found that the 
majority of Schwann cells expressed GD1a.  Also, in mouse muscle, an antibody 
which binds to GM2, GD1a and GM1b was found presynaptically in Schwann cells 
(Santafe et al., 2005) and since GM2 is rarely found in normal mouse Schwann 
cells (Watabe et al., 2001), the staining is likely due to either GD1a or GM1b.  
However, in humans anti-GD1a antibody is associated with axonal but not 
demyelinating forms of Guillain-Barré syndrome, which would suggest that 
human Schwann cells do not express GD1a (Ho et al., 1999).  These contrasting 
results might be due to species differences in ganglioside expression.   
Using Thin Layer Chromatography (TLC) it was found that the major ganglioside 
in normal peripheral nerves is GD1a, whose expression is reduced in trembler 
mutant mice (Harpin et al., 1982) which have a defect of PNS myelination 
related to impairment in Schwann cell differentiation (Aguayo et al., 1977) and 
increased Schwann cell proliferation (Perkins et al., 1981).  The same study also 
showed that the Trembler mutant peripheral nerves had increased levels of the 
simple ganglioside GM3 (Harpin et al., 1982).  Another study using TLC in 
Schwann cells isolated from neonatal rat dorsal root ganglia showed that the 
simple ganglioside GM3 is the major glycolipid in these cells (Farrer and Quarles, 
1996).  It remains possible that mouse Schwann cells also contain GM3 as their 
major ganglioside, however, this possibility was not investigated in the present 
study.  
Halstead et al (Halstead et al., 2005) showed that GD3 antibodies induced 
perisynaptic Schwann cell death, suggesting that mouse perisynaptic Schwann 
cells express GD3.  The present study found that less than 5% of neonatal mouse 
sciatic nerve Schwann cells labelled with R24, which mainly binds to GD3 as well 
as complex gangliosides GT1a and GQ1b.  GalNAc T -/- Schwann cells, which lack 
all complex gangliosides also labelled with R24 suggesting that the R24 staining 
in Schwann cells is due to the simple ganglioside GD3.  Therefore, it is possible 
that GD3 expression is particular to perisynaptic Schwann cells but not other 
Schwann cell types.   
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The present study has shown that Schwann cells and OECs have a similar 
ganglioside expression profile which is unsurprising since these two cell types 
have many markers in common.  However, a very small percentage of Schwann 
cells (less than 1%), but not OECs labelled with EG2, EG3 and MOG30.  EG2 binds 
to GT1a, GD1b, GT1b and GQ1b, EG3 binds to GT1a and GQ1b and MOG30 is 
specific for ganglioside GQ1b.  It is likely that the ganglioside expressed by a 
very small proportion of Schwann cells but not OECs is GQ1b, since all three 
markers, which bind to Schwann cells but not OECs, bind to this ganglioside.  
However, previous studies in cultured rat Schwann cells showed that tetanus 
toxin, which binds to GD1b, GT1b and GQ1b (Holmgren et al., 1980), does not 
bind to Schwann cells (Brockes et al., 1979, Fields et al., 1978, Raff et al., 
1979).  It is possible that these contrasting results are due to a species 
difference in ganglioside expression.     
As mentioned above, some of the anti-ganglioside antibodies used bound to less 
than 1% of the cells.  Since these cells also labelled with p75NTR it is likely that 
they are OECs or Schwann cells and not the contaminating cells present in the 
cultures.  The reason why such a small proportion of cells labelled with certain 
antibodies is unclear.  It is possible that OECs or Schwann cells express particular 
gangliosides during different phases of the cell cycle.  An example of this is seen 
in mouse foetal astrocytes where GM1 expression was found to be regulated by 
the cell cycle, with maximal expression during G0/G1 phase (Majoul et al., 
2002).  Alternatively, it is possible that the small proportion of cells that are 
labelling with particular anti-ganglioside antibodies are senescent or are 
undergoing apoptosis.  Future studies could test this possibility, by double-
labelling OECs and Schwann cells with anti-ganglioside antibodies and apoptotic 
markers, such as annexin V, Apolipoprotein C-1, BM-1/JIMRO, BV2 or senescence 
markers such as senescence-associated ß-galactosidase.  
To confirm the ganglioside expression of OECs and Schwann cells, gangliosides 
could be extracted from primary cultures and the ganglioside content examined 
by TLC and tandem mass spectrometry.  
Therefore, to summarise, the main gangliosides expressed in cultured wild-type 
mouse OECs and Schwann cells are GM1 and GD1a.  Sia T -/- mice lack all b-
series gangliosides and as a result have slightly increased levels of a-series 
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gangliosides (Okada et al., 2002).  It is therefore likely that Sia T -/- OECs and 
Schwann cells will have slightly higher levels of GM1 and GD1a.  In contrast, 
GalNAc T -/- mice lack all complex gangliosides (Takamiya et al., 1996) and 
accordingly, as shown in the present study, GalNAc T -/- OECs and Schwann cells 
do not express GM1 and GD1a.  Consequently, the lack or excess of GM1 and 
GD1a in ganglioside knockout OECs and Schwann cells would be expected to have 
an impact on the biology of these cells.  
3.3.3 Antigen profile and morphology of wild-type and 
ganglioside knockout OECs and Schwann cells 
Previous studies have demonstrated that the addition of gangliosides to glia and 
neuronal cell lines alters the morphology of these cells (Facci et al., 1987, Hefti 
et al., 1985, Morgan and Seifert, 1979, Rybak et al., 1983, Skaper et al., 1986, 
Sobue et al., 1988, Spero and Roisen, 1984).  Astrocytes cultured in serum 
normally assume a flat, epithelioid morphology.  The addition of a mixture of 
gangliosides containing GM1, GD1a, GD1b and GT1b or pure gangliosides GM1 and 
GD1a to cultures of dissociated rat septal cells caused the astrocytes within 
these cultures to change from a flat to a process bearing morphology as 
visualised by GFAP immunocytochemistry (Hefti et al., 1985).  Skaper et al 
(1986) showed that the addition of CTx, which binds GM1, to neonatal rat 
astrocytes, changed their morphology from a flat to a stellate shape but in 
contrast to the previous study, the addition of GM1 did not alter the morphology 
of astrocytes.  Moreover, the addition of GM1, GD1a, GD1b or GT1b to these 
cultures blocked or reversed the effect of CTx addition to astrocytes (Skaper et 
al., 1986).   
Sobue et al (1988) showed that the addition of GM1, GM3 or a ganglioside 
mixture containing GM1, GD1a, GD1b and GT1b caused Schwann cells to extend 
extremely long processes.  Contrary to this, in the present study, Sia T -/- 
Schwann cells and OECs, which have increased levels of GM1 and GD1a and 
GalNAc T -/- Schwann cells and OECs, which lack GM1 and GD1a, did not differ 
morphologically from wild-type cells.   
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It is possible that exogenously added gangliosides act differently from membrane 
associated gangliosides and therefore no change in morphology is seen when the 
amount of membrane bound gangliosides is altered in ganglioside knockout cells.  
This suggests that experiments consisting of the addition of gangliosides, while 
valuable, may not always adequately address the physiological role of 
gangliosides and that studies in knockout mice may be better at assessing the 
physiological role of gangliosides.  To test the possibility that exogenously added 
gangliosides act differently from membrane-associated gangliosides, future 
studies could examine the morphology of OECs and Schwann cells following the 
addition of GM1 and CTx to cultures to see if a change in morphology is 
observed. 
The present study found that the wild-type and ganglioside knockout cells had 
the same antigen profile.  However, the number of markers examined in the 
present study was limited.  Future studies could examine the antigen expression 
of wild-type and ganglioside knockout OECs and Schwann cells in more detail.  
For example, the expression of O4 which labels both OECs (Barnett et al., 1993) 
and non-myelinating Schwann cells (Mirsky et al., 1990) could be examined.  In 
addition, OECs express several adhesion molecules such as such as L1 (Miragall et 
al., 1988), E-NCAM (Franceschini and Barnett, 1996), fibronectin, laminin and 
type IV collagen (Doucette, 1996, Kafitz and Greer, 1997), whose expression 
could be examined.  Finally, the expression of GAP 43 and adhesion molecules 
L1, N-CAM, and N-cadherin (Mirsky et al., 1986, Jessen et al., 1990, Curtis et al., 
1992), which are normally found on non-myelinating Schwann cells could be 
compared between wild type and ganglioside knockout cells.   
3.3.4 Proliferation of wild-type and ganglioside knockout 
OECs and Schwann cells 
The present study found that the lack of complex gangliosides in GalNAc T -/- 
mice did not affect the proliferation of OECs or Schwann cells but that a lack of 
b-series gangliosides and a concurrent increase in a-series gangliosides in Sia T -
/- mice led to increased proliferation of OECs maintained on collagen in the 
presence of growth factors. 
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The fact that the proliferation of GalNAc T -/- OECs and Schwann cells did not 
differ from wild-type cells may be due to increased levels of the simple 
gangliosides, such as GM3 and GD3, compensating for the lack of complex 
gangliosides or it may be that complex gangliosides are not involved in 
modulating OEC proliferation.  Therefore it is likely that in Sia T -/- mice an 
excess of a-series gangliosides leads to increased OEC proliferation on collagen 
in the presence of growth factors.  These findings suggest that physiological 
levels of gangliosides do not modulate the proliferation of OECs and Schwann 
cells grown on PLL, laminin or collagen IV. To examine whether the increased 
proliferation in Sia T -/- OECs was due to increased levels of a-series 
gangliosides GM1 and GD1a, future studies should examine the proliferation of 
wild-type and GalNAc T -/- OECs on collagen following the exogenous addition of 
GM1 and/or GD1a. 
Numerous studies have demonstrated the effect of gangliosides on the 
proliferation of various cell types (Section 1.1.3.3 in the Introduction).  For 
instance, the addition of GM1, GM3 or a mixture of gangliosides containing GM1, 
GD1a, GD1b and GT1b reduced the baseline proliferation of cultured rat 
Schwann cells (Sobue et al., 1988).  In contrast, CTx acts as a mitogen for 
cultured Schwann cells by binding to GM1 (Raff et al., 1978a).  MBP and MBP 
peptides interact with GM1 and FGFR to induce Schwann cell and astrocyte 
proliferation (South et al., 2000, Tzeng et al., 1995, Tzeng et al., 1999). 
Since OECs and Schwann cells express gangliosides GD1a and GM1, which have 
been shown to modulate proliferation in Schwann cells and other cell types, it 
was interesting to examine the effect of increased and decreased levels of these 
gangliosides in Sia T -/- and GalNAc T -/- mice, respectively, on OEC and 
Schwann cell proliferation.  Yet, the present study found that the proliferation 
rate of Schwann cells was unaffected in ganglioside knockout mice.  Therefore, 
in contrast to a study which showed that the addition of GM1 or GD1a reduced 
proliferation of Schwann cells and reduced their response to growth factors 
(Sobue et al., 1988), excess endogenous GM1 and GD1a in Sia T -/- mice did not 
reduce the proliferation of Schwann cells.  Although some added gangliosides do 
incorporate into the membrane, this difference could be due to free gangliosides 
having a different mechanism of action than endogenous, membrane bound 
gangliosides.  Similarly, the lack of GM1 and GD1a in GalNAc T -/- mice did not 
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increase proliferation of Schwann cells, suggesting that the increase in simple 
gangliosides may be sufficient to compensate for the lack of these complex 
gangliosides.  It would, therefore, be interesting to examine if mouse Schwann 
cells do indeed express the simple ganglioside GM3 and to see if the GD3-
expressing Schwann cells are more mitotically active, since both of these simple 
gangliosides have been shown to modulate the proliferation of various cell types.  
However, it is also possible that studies where exogenous gangliosides are added 
can be misleading and are not useful for elucidating the physiological effects of 
gangliosides. 
It was surprising that ganglioside knockout OECs behaved differently from 
ganglioside knockout Schwann cells, since their ganglioside profile was so 
similar.  The present study showed that Sia T -/- OECs had increased 
proliferation rate compared with wild-type and GalNAc T -/- when cultured on 
collagen IV, but only when grown in the presence of growth factors.  It is 
possible that this difference is due to OECs and Schwann cells expressing other 
gangliosides which were not labelled for in the present study.  To examine this 
possibility, future studies should examine the ganglioside content of OECs and 
Schwann cells in more detail.  Alternatively, it may be that gangliosides play 
different roles in these two cell types as it has been observed before that the 
effect of gangliosides on proliferation can depend on the cell type (Kamimura et 
al., 2005).   
Another possibility is that the difference in the proliferation of Sia T -/- OECs 
and Schwann cells which has been observed is due to different growth factors 
present in the culture media.  Indeed, gangliosides have been shown to 
modulate most, if not all, growth factor receptors and to interact with integrins 
(Sections 1.1.3.1 and 1.1.3.2 in the Introduction).  Schwann cells were 
maintained in their optimal proliferation medium containing 10% serum, 
heregulin and forskolin, whereas OECs were maintained in their optimal growth 
medium, which contains 5% serum, heregulin, forskolin, FGF and ACM.  To test if 
the differences in the proliferation of Sia T -/- OECs and Schwann cells is 
different because they are grown in different media, the proliferation of OECs 
and Schwann cells grown on collagen in both OEC media and Schwann cell media 
should be compared.     
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It is possible that the increased proliferation in Sia T -/- OECs could be due to an 
interaction between the a-series gangliosides and FGF or some other growth 
factor present within ACM.  To test this, OECs and Schwann cells could be grown 
in medium containing only DMEM-BS and FGF2 or DMEM-BS and ACM.   
Because OECs and Schwann cells were grown in different media it is difficult to 
directly compare the effect of gangliosides on their proliferation.  This is not 
only due to the presence of different growth factors which gangliosides can 
interact with but also the fact that there may be gangliosides present in the 
serum or ACM.  Gangliosides can be shed from the membrane (Chang et al., 
1997) and are also found in non-cell-associated forms in plasma (Bergelson, 
1995). It is thus possible that the OEC media contains gangliosides from the 
serum and those shed from astrocytes in the ACM, whereas Schwann cell media, 
which contains more serum, may also contain serum gangliosides. To enable a 
direct comparison of the effects of gangliosides on the proliferation of OECs and 
Schwann cells, future studies should examine the proliferation of OECs and 
Schwann cells in media that does not contain serum or ACM, such as OMM, which 
contains DMEM-BS and a combination of the growth factors forskolin, heregulin 
β1 and FGF2. 
The fact that Sia T -/- OECs proliferate significantly better on extracellular 
matrix substrates, collagen IV and laminin, and not on non-specific substrate 
PLL, suggests that this effect may be due to an interaction between 
gangliosides, integrins and growth factors or growth factor receptors.  To be 
able to investigate this further, the integrin expression of OECs would first need 
to be characterised, and the proliferation of OECs grown on corresponding 
substrates assessed in the presence of individual growth factors.   
Studies have shown that Schwann cells express several laminin or collagen 
receptors, such as the integrins α1β1, α2β1, α6β1, α7β1 and α6β4 (Milner et al., 
1997a).  In the present study, it was shown that a lack of complex gangliosides 
has no effect on the proliferation of Schwann cells on PLL, laminin or collagen IV 
which may suggest that gangliosides do not interact with collagen or laminin 
receptors to modulate Schwann cell proliferation.  However, Schwann cells 
express other integrin receptors such as the fibronectin receptor (α5β1), the 
vitronectin receptor (αvβ3) and the fibrin receptor (αvβ8).  Therefore, future 
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studies could examine the proliferation of Schwann cells on substrates such as 
extracellular matrix, fibronectin or vitronectin.  
3.3.5  Motility of wild-type and ganglioside knockout OECs and 
Schwann cells 
Gangliosides are thought to modulate cell adhesion and motility by interacting 
with integrin receptors (Cheresh et al., 1987, Zheng et al., 1993) and many 
studies have demonstrated their involvement in the migration of several cell 
types (Section 1.1.3.6 in the Introduction).  It was therefore decided to study 
the motility of wild-type and ganglioside knockout OECs and Schwann cells using 
two assays.  Their migration was examined on the non-specific substrate PLL and 
on extracellular matrix substrates laminin and collagen IV which bind to integrins 
present on Schwann cells (Milner et al., 1997a).  No difference was observed in 
the motility of wild-type and ganglioside knockout OECs and Schwann cells 
plated at low density, which suggests that complex gangliosides are not required 
for cell movement per se.  However, in a wound assay, Sia T -/- Schwann cells 
had a significantly greater migration velocity compared to wild-type cells when 
grown on extracellular matrix substrates laminin and collagen IV but not on PLL. 
The contrasting results obtained by the two assays may be due to cell 
interactions since OECs and Schwann cells plated at low density will only 
interact with the substrate whereas those in the wound assay are in a confluent 
cell layer and will therefore be interacting not just with the substrate but also 
with each other.  In addition, a dense population of cells may secrete more 
growth factors, which could have an autocrine effect on their motility.   
The fact that an increase in Sia T -/- Schwann cell motility is observed on 
laminin and collagen IV but not PLL indicates the involvement of integrins.  
Future studies should, therefore, examine the signalling involved in the 
increased motility.  Future studies should also examine the motility of OECs and 
Schwann cell on other substrates such as fibronectin and vitronectin which bind 
to integrins expressed on Schwann cells.    
Sia T -/- Schwann cells lack all b-series gangliosides but have increased levels of 
a-series gangliosides.  Future studies should examine the motility of GalNAc T -/- 
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Schwann cells using the wound assay: since these cells lack all a-series 
gangliosides it might be predicted that their motility would be reduced.  
However, if no difference is observed in the motility of Schwann cells obtained 
from GalNAc T -/- mice, it will indicate that physiological levels of gangliosides 
do not modulate Schwann cell motility and that the effect seen in Sia T -/- are 
due to an excess of a-series gangliosides. 
The present study did not find a difference in the migration between wild-type 
and ganglioside knockout OECs, which is surprising since OECs and Schwann cells 
express similar gangliosides.  This may be due to a different ganglioside 
expressed on one cell but not the other that was not detected in the present 
study or it may be the case that the same gangliosides play different roles in the 
two cell types.  The different behaviour of ganglioside knockout OECs and 
Schwann cells in terms of migration and proliferation supports the argument that 
they are two different cell types.  However, as was the case for the proliferation 
experiments, to make a proper comparison, future studies could compare the 
motility of OECs and Schwann cells grown in the same medium. 
The findings of the present study suggest that gangliosides are not essential for 
OEC and Schwann cell motility.  However, future studies should examine the 
directed migration of these cells by examining their migration on different ECM 
substrates towards different chemoattractants. 
3.3.6 Conclusions 
In conclusion, in this chapter it has been demonstrated that a change in the 
amount/type of gangliosides does affect the proliferation and migration of OECs 
and Schwann cells to some degree.  No significant difference is seen with GalNAc 
T -/- cells which lack all complex gangliosides but rather with Sia T -/- cells 
which lack b-series gangliosides and instead have higher levels of a-series 
gangliosides.  Since the major gangliosides expressed by OECs and Schwann cells 
are a-series gangliosides GM1 and GD1a, it is possible that an increase in these 
gangliosides results in the increased proliferation and migration of Sia T -/- cells 
observed on certain substrates.  Further experiments involving the addition of 
GM1 and GD1a to wild-type and GalNAc T -/- cells or the addition of antibodies 
against GM1 and GD1a to Sia T -/- cells would be needed to clarify these 
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observations.  However, the findings of this study suggest that gangliosides are 
not likely to be involved in the proliferation and motility of OECs or Schwann 
cells.  
This conclusion may seem surprising because numerous studies have shown that 
gangliosides modulate proliferation and migration in so many cell types.  
However, this conclusion is supported by the fact that both Sia T -/- and GalNAc 
T -/- mice have no obvious developmental defects.  Since migration and 
proliferation are paramount during development, it is more likely that 
gangliosides do not play a big role in modulating these functions.  This suggests 
that studies where gangliosides or antibodies that bind to gangliosides are added 
to cells may not show the physiological role of gangliosides and that studies 
where gangliosides are removed are more likely to reveal the role of 
gangliosides.   
Initially, I had planned to also examine the role of gangliosides in the apoptosis 
of OECs and Schwann cells because gangliosides are thought to be involved in 
the apoptosis of several cell types (Section 1.1.3.3 in the Introduction).  
However, due to time constraints, this was not possible.  Finally, future studies 
should examine the proliferation and migration of OECs and Schwann cells in 
DKO mice which only express the simple ganglioside GM3, as this should clarify 
the role of complex gangliosides in the biology of these cells. 
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4 CHAPTER 4 
Degeneration and regeneration of the olfactory 
system in wild-type and ganglioside knockout mice 
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4.1 Introduction 
The peripheral nervous system (PNS) is able to support axonal outgrowth 
throughout life, whereas most central nervous system (CNS) tissues can only 
support axonal outgrowth during development.  Unlike most of the CNS, the 
primary olfactory system continually generates new neurons throughout life.  
This unique regenerative property of the primary olfactory system can be 
exploited experimentally to study CNS regeneration.  
Gangliosides seem to play a role in neurite outgrowth during regeneration as 
well as during development (Constantine-Paton et al., 1986, Mendez-Otero and 
Constantine-Paton, 1990, Mendez-Otero and Santiago, 2003, Mendez-Otero et 
al., 1988).  The Jones antibody binds to O-acetylated gangliosides GD3 and GQ1c 
(Bonafede et al., 1989).  Using Jones antibody immunolabelling, Mendez-Otero 
et al (Mendez-Otero and Ramon-Cueto, 1994) showed that its expression 
coincides with pathways of axon extension in the brain during development.  
This expression was downregulated in all areas of the brain after axons reached 
their destination except in the olfactory system where its expression continued 
into adulthood, suggesting that O-acetylated gangliosides may play a role in the 
regenerative capacity of the olfactory system.  However, a recent study in Sia T 
-/- mice showed that the inhibition of neuronal migration by Jones antibody is 
not due to its binding to O-acetylated gangliosides (Yang et al., 2007).  
Therefore, it is possible that the Jones antibody immunolabelling seen by 
Mendez-Otero et al (Mendez-Otero and Ramon-Cueto, 1994) in rats may, in fact, 
not be due to O-acetylated ganglioside expression.   
Many studies have shown that exogenously added gangliosides enhance 
peripheral nerve regeneration.  Furthermore, Sia T -/- mice exhibited reduced 
regeneration of axotomised hypoglossal nerves compared with wild type (Itoh et 
al., 2001).   
It was shown in the previous chapter that OECs in vitro express complex 
gangliosides GM1 and GD1a.  Williams et al (Williams et al., 2004) showed that 
OECs act as conduits for the regenerating axons.  Extracellular matrix molecules 
are also involved in axonal guidance.  Since gangliosides interact with integrins, 
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the receptors for extracellular matrix molecules, it is possible that the 
gangliosides expressed on OECs play a role in this guidance.  
In the present study the regeneration of the olfactory system, which contains 
both central and peripheral nervous system components, was examined 
following zinc sulphate (ZnSO4) treatment in wild-type and ganglioside knockout 
mice.  ZnSO4 destroys olfactory receptor neurons, which, with time, grow back 
from the putative stem cells in the olfactory epithelium (OE) and with the help 
of the OECs, their axons find their way back to the olfactory bulb and re-form 
synapses with second order neurons.  This allowed the examination of the effect 
of gangliosides on the proliferation of the putative stem cells, neurite outgrowth 
and synapse formation.  Because many of the defects observed in ganglioside 
knockout mice are amplified with age, two age groups were examined in the 
present study: young adult (6 weeks old) and adult (6 months old). 
4.2 Results 
4.2.1 Ganglioside expression of the olfactory system. 
The expression of major brain gangliosides GM1, GD1a, GD1b, GT1b and GQ1b in 
the olfactory system of 6-week old mice was examined by immunocytochemistry 
using the following antibodies: CTx, CGM-3, EG2, EG3, MOG1, MOG30 and 
MOG35.  Paraffin-embedded olfactory tissue was initially stained with 
histological stains haematoxylin and eosin (H & E) to observe its general 
morphology and to demonstrate the regions imaged in the subsequent figures, 
namely glomeruli, olfactory nerve and the olfactory mucosa (Figure 4.1). 
The majority of gangliosides tested for were expressed in the wild-type olfactory 
system with the exception of MOG35 as summarised in Table 4.1.  As a control, 
Sia T -/- and GalNAc T -/- tissue was also labelled to look at their expression of 
major brain gangliosides.  CTx, which binds to GM1, labelled all of the regions 
examined in wild-type and Sia T -/- mice: glomeruli, olfactory nerve, lamina 
propria (LP) and OE (Figure 4.2).  GalNAc T -/- olfactory system did not label 
with CTx since it lacks all a-series gangliosides (Figure 4.2).  CGM3 labelling was 
observed in all three genotypes, although the labelling was less prevalent in Sia 
T -/- and GalNAc T -/- mice (Figure 4.3).  CGM3 recognises sulphatide as well as 
  148 
gangliosides GD3, GT1a and GQ1b which could account for the immunolabelling 
observed in Sia T -/- and GalNAc T -/- mice.  Whereas CTx appeared to label all 
of the cells in the regions examined (Figure 4.2), CGM3 labelling was localised to 
particular cell types (Figure 4.3).  In addition, CGM3 labelled cells in the 
glomeruli, olfactory nerve and LP but not the OE (Figure 4.3).  EG2, EG3, MOG1 
and MOG30 labelled wild-type but not Sia T -/- or GalNAc T -/- tissue (Figure 4.4 
to 4.7).  EG2, which binds to GT1a, GD1b, GT1b and GQ1b, appeared to label 
majority of cells in wild-type glomeruli and the LP but did not label any cells in 
the OE (Figure 4.4).  EG3, which binds to gangliosides GT1a and GQ1b, appeared 
to label the majority of gangliosides in the glomeruli, and rarely labelled cells in 
the LP (Figure 4.5).  EG3 did not label the OE (Figure 4.5).  EG3 labelling in the 
olfactory system is likely to be due to GQ1b and not GT1a since Sia T -/- tissue, 
which has increased levels of a-series gangliosides such as GT1a, did not label 
with this antibody (Figure 4.5).  However, EG3 did label cells in the LP 
underlying respiratory epithelium.  This is confirmed by immunolabelling with 
MOG30, which specifically binds to GQ1b.  Like EG3, MOG30 labelled the 
majority of cells in the glomeruli, but did not label cells in the olfactory nerve 
or the olfactory mucosa (Figure 4.7).  MOG1, which specifically binds to GD1b, 
appeared to label the majority of cells in the glomeruli and the olfactory nerve 
and labelled some cells in the LP and OE (Figure 4.6).  In addition, MOG1 
labelled cells in the LP associated with the respiratory epithelium (Figure 4.6). 
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Figure 4.1. The olfactory system of the mouse. 
Parasagittal sections of decalcified, paraffin-embedded olfactory system tissue were stained 
with haematoxylin and eosin (H & E).  This enabled visualisation of the olfactory bulb in the CNS 
and olfactory mucosa in the PNS as well as the olfactory nerve connecting the two (I).  The parts 
of the olfactory system imaged in Figures 4.2 to 4.8 are shown in II to IV: glomeruli (II), olfactory 
nerve (III) and the olfactory mucosa (IV), which contains the olfactory epithelium and the lamina 
propria.   
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Table 4.1. Ganglioside expression in the olfactory system. 
Unfixed, frozen olfactory system sections from 6 week old wild-type, Sia T -/- and GalNAc T -/- mice were labelled with antibodies which bind to gangliosides and 
FITC-labelled cholera toxin which binds to ganglioside GM1.  Anti-ganglioside reactivities: optical density >0.1 ≤0.5 (+); >0.5 ≤1.0 (++); >1.0 ≤1.5 (+++); >1.5 (++++).  
Note, the intensity of CTx labelling was higher in Sia T -/- mice. 
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Figure 4.2. CTx labelling of the olfactory system. 
Olfactory system tissue from 6 week old wild-type (I, IV and V), Sia T -/- (II) and GalNAc T -/- 
(III) mice was labelled with CTx, which binds to a-series ganglioside GM1.  CTx labelled the 
majority of cells in the glomeruli, olfactory nerve and olfactory mucosa of wild-type and Sia T -
/- mice but not GalNAc T -/- tissue.  Refer to Figure 4.1 for orientation.  Scale bar = 100 µm. 
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Figure 4.3. CGM3 labelling of the olfactory system. 
Olfactory system tissue from 6 week old wild-type (I, IV to VI), Sia T -/- (II) and GalNAc T -/- (III) 
mice was labelled with CGM-3, which binds to a-series ganglioside GT1a, b-series gangliosides 
GD3 and GQ1b and sulphatide.  CGM3 labelled the majority of cells in the glomeruli of wild-type 
mice (I), few cells in the glomeruli of Sia T -/- (II) and GalNAc T -/- (III) mice and olfactory nerve 
(IV) and lamina propria (V and VI) of wild-type mice.  Refer to Figure 4.1 for orientation.  Scale 
bar = 50 µm. 
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Figure 4.4. EG2 labelling of the olfactory system 
Olfactory system tissue from 6 week old wild-type (I, IV and V), Sia T -/- (II) and GalNAc T -/- 
(III) mice was labelled with EG2, which binds to a-series ganglioside GT1a, and b-series 
gangliosides GD1b, GT1b and GQ1b.  EG2 labelled the majority of cells in the glomeruli (I) and 
lamina propria (IV and V) of wild-type mice, but did not label Sia T -/- (II) or GalNAc T -/- (III) 
tissue.  Refer to Figure 4.1 for orientation.  Scale bar = 50 µm. 
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Figure 4.5. EG3 labelling of the olfactory system. 
Olfactory system tissue from 6 week old wild-type (I, IV and V), Sia T -/- (II) and GalNAc T -/- 
(III) mice was labelled with EG3, which binds to a-series ganglioside GT1a, and b-series 
ganglioside GQ1b.  EG3 labelled the majority of cells in the glomeruli of wild-type mice (I), but 
did not label Sia T -/- (II) or GalNAc T -/- (III) tissue.  While EG3 rarely labelled cells in the 
lamina propria underlying the OE (IV), it labelled the majority of cells in the lamina propria 
associated with respiratory epithelium (V).  Refer to Figure 4.1 for orientation.  Scale bar = 50 
µm. 
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Figure 4.6. MOG1 labelling of the olfactory system. 
Olfactory system tissue from 6 week old wild-type (I, IV to VI), Sia T -/- (II) and GalNAc T -/- (III) 
mice was labelled with MOG1, which binds to b-series ganglioside GD1b.  GD1b was found in the 
glomeruli (I), olfactory nerve (IV), OE (V) and lamina propria associated with both OE (V) and 
respiratory epithelium (VI) of wild-type mice.  MOG1 did not label Sia T -/- (II) and GalNAc T -/- 
(III) tissue.  Refer to Figure 4.1 for orientation.  Scale bar = 50 µm.   
 
II IIIMOG1 MOG1 MOG1I
glomeruli
olfactory mucosa
wild-type Sia T -/- GalNAc T -/-
respiratory epithelium
IV MOG1V
MOG1VI
wild-type
wild-type
olfactory nerve
wild-type
MOG1
OE
LP
  156 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7. MOG30 labelling of the olfactory system. 
Olfactory system tissue from 6 week old wild-type (I, IV to VI), Sia T -/- (II) and GalNAc T -/- (III) 
mice was labelled with MOG30, which binds to b-series ganglioside GQ1b.  GQ1b was found in the 
glomeruli (I) of wild-type mice.  Olfactory nerve (IV), and olfactory mucosa of wild-type mice 
were negative for MOG30.  MOG30 did not label Sia T -/- (II) and GalNAc T -/- (III) tissue.  Refer 
to Figure 4.1 for orientation.  Scale bar = 50 µm.   
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Figure 4.8. MOG35 labelling of the olfactory system.  
Olfactory system tissue from 6 week old wild-type (I, IV & V), Sia T -/- (II) and GalNAc T -/- (III) 
mice was labelled with MOG35, which binds to a-series ganglioside GD1a.  However, all sections 
were negative for GD1a.  Refer to Figure 4.1 for orientation.  Scale bar = 50 µm.   
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4.2.2 Comparison of olfactory epithelial width 
To investigate whether the lack or the overexpression of gangliosides had an 
effect on the anatomy of the olfactory system, the olfactory widths of wild-type 
and ganglioside knockout mice were compared. The OE is a pseudo-stratified 
columnar (cuboidal) epithelium that has been well characterised.  It contains 
three main cell types: olfactory receptor neurons, sustentacular cells and basal 
cells, which can be distinguished by their morphology, position within the 
epithelium and the expression of a number of cellular markers.  The width of the 
OE is therefore a good indication of whether the cell composition is normal.  The 
epithelial widths of wild-type and ganglioside knockout mice were measured 
using ImageJ from frozen olfactory tissue sections labelled with H & E.  All 4 
genotypes (wild-type, Sia T -/-, GalNAc T -/- and DKO) were found to have a 
mean epithelial width of between 60 and 80 µm, suggesting no difference during 
development (Figure 4.9). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9. Comparison of epithelial width. 
Frozen sections of the olfactory system were cut and stained with H & E and the width of the epithelium was measured using ImageJ.  A: Representative images show 
the control olfactory epithelium from wild-type (I), Sia T -/- (II), GalNAc T -/- (III) and double knockout (IV) mice.  B: Bar chart of the control epithelial widths from 
wild-type, Sia T -/-, GalNAc T -/- and DKO mice.  OE = olfactory epithelim.  LP = lamina propria.  Scale bar = 50 µm.    
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4.2.3 Preliminary studies of nasal ZnSO4 irrigation 
Preliminary studies were performed to test the concentration of ZnSO4 to use in 
the subsequent intranasal deafferentation experiments.  A literature search 
revealed that various volumes and concentrations of ZnSO4 have been used to 
induce damage to the olfactory epithelium in mice including: 1 to 2 µl of 4% 
ZnSO4 into each nostril (Edwards et al., 1972), 100 µl of 5% ZnSO4 into one nostril 
(Margolis et al., 1974), three drops of 1% ZnSO4 into each nostril, three times at 
24-hour (Matulionis, 1975) or 30-minute (Matulionis, 1976) intervals, and 20 µl of 
10% ZnSO4 (Ducray et al., 2002).  The following concentrations and volumes of 
ZnSO4 were tested in the present study: 20, 50 and 100 µl of 0.5% ZnSO4, 20, 50 
and 100 µl of 5% ZnSO4 and 20 µl 10% ZnSO4 (Figure 4.10).  As can be seen in the 
representative images in Figure 4.10, 20 and 50 µl of 0.5% ZnSO4 caused no 
damage, whereas 100 µl only slightly damaged the OE.  20 µl of 5% ZnSO4 caused 
no damage, 50 µl damaged the top layers of cells in the OE and 100 µl of 5% 
ZnSO4 completely destroyed all of the cells within the OE.  20 µl of 10% ZnSO4 
destroyed most of the cells in the OE apart from the bottom layer of cells.  In 
subsequent experiments, the left nasal cavity of wild-type and ganglioside 
knockout mice was irrigated with 20 µl of 10% ZnSO4 as described in the methods 
section since mice recovered better after lower volumes of ZnSO4 were used and 
20 µl of 10% ZnSO4 sufficiently damaged the OE.  
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Figure 4.10. The effect of different ZnSO4 volumes and concentrations on OE width.   
Representative H & E images showing the effects of using 20, 50 or 100 µl of 0.5 % ZnSO4 (I to III, 
respectively), 20, 50 or 100 µl of 5% ZnSO4 (IV to VI, respectively) and 20 µl of 10% ZnSO4 (VII).  
Preliminary experiments were performed to determine the optimal ZnSO4 volume and 
concentration to use in subsequent experiments.  Various concentrations and volumes of ZnSO4 
were administered to the left nasal cavity of 6 week old wild type mice.  The following day, the 
mice were sacrificed, perfused with 4% paraformaldehyde and the OE dissected.  Sections of the 
OE were labelled with H & E to assess the extent of OE damage caused by different 
concentrations and volumes of ZnSO4.  The aim was to destroy all cells of the OE except the 
bottom layer of cells (the globose and horizontal basal cells).  20, 50 or 100 µl of 0.5% ZnSO4 or 
20 and 50 µl of 5% ZnSO4 were not sufficient to destroy all cells in the OE leaving only the bottom 
layer of cells, whereas 100 µl of 5% ZnSO4 destroyed all the cells, including the basal cell layer.  
20 µl of 10% ZnSO4 was sufficient to destroy all cells except for the basal cells (VII).  Scale bar = 
50 µm. 
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4.2.4 Gross morphological changes of the olfactory epithelium 
One day after irrigation with 10% ZnSO4, very few cells remained, much of the 
epithelium having dissociated from the underlying basement membrane (Figure 
4.11, I to IV).  The nasal lumen was filled with many lytic and necrotic cells.  
Seven days after irrigation (Figure 4.11, V to VIII) the epithelium began to 
increase in width, a process which continued for the proceeding 9 weeks.  
Although the epithelium began to regenerate as soon as 4 days after irrigation, 
the organised structure displayed in the control tissue did not start to reappear 
until 3 weeks after irrigation and sometimes did not reappear even 9 weeks 
following ZnSO4 treatment.  Moreover, 9 weeks following ZnSO4 treatment 
(Figure 4.11, IX to XI), the majority of OE had not regenerated to the original 
width in wild-type and ganglioside knockout mice.  This was the case in wild-
type and ganglioside knockout mice both at 6 weeks and 6 months of age. 
The width of the OE was measured at each time point from the basement 
membrane to the top of the epithelium in 6 week old (Figure 4.12) and 6 month 
old (Figure 4.13) wild-type and ganglioside knockout mice.  The average width of 
the control epithelium was around 45 µm in both wild-type and ganglioside 
knockout mice in both age groups (Figure 4.12 and 4.13).  The OE width 
decreased dramatically following ZnSO4 treatment, and was reduced to around 
10 µm after one day in wild-type and ganglioside knockout mice.  By day 4, the 
epithelium had begun to increase in width and continued to do so until the last 
time point examined (week 9).  However, 9 weeks following ZnSO4 treatment the 
width of the OE was only 50% of that of the untreated tissue in wild-type and 
ganglioside knockout tissue in both age groups.  As can be seen in Figure 4.12 
and 4.13 (B), the unilateral irrigation with ZnSO4 occasionally caused a bilateral 
lesion as has been described previously (Chuah et al., 1995).  This was probably 
due to leakage through the nasal septum.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.11. The gross morphological changes in the olfactory epithelium.  
The effects of nasal irrigation to the olfactory system were initially investigated by studying the changes to the olfactory epithelium in paraffin embedded tissue from 
wild-type (I, V and IX), Sia T -/- (II, VI and X), GalNAc T -/- (III, VII and XI) and double knockout (IV and VIII) tissue stained by H & E.  An example of untreated olfactory 
epithelium from a wild-type mouse is shown in XII for comparison.  After 1 day (I to IV), most of the cells of the epithelium had gone from the underlying basal lamina, 
leaving very few cells attached.  At this time the nasal cavity was seen to contain a lot of cellular debris.  By the 7th day (V to VIII), the epithelium already appeared to 
increase in width.  However, 9 weeks after treatment (IX to XI) the olfactory epithelium had not regained its organised appearance (compare with control sections in 
Figure 4.9).  Scale bar = 50 µm. 
WT week 9 Sia T -/- week 9 GalNAc T -/- week 9
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Figure 4.12. The change in epithelial width in 6 week old wild-type and ganglioside knockout 
mice. 
The width of the OE was measured from the basement membrane to the lumen and was found to 
have dramatically decreased following ZnSO4 treatment, from around 45 µm in untreated tissue 
to around 10 µm one day after ZnSO4 irrigation.  OE widths were measured from the treated (A) 
and untreated (B) side of the olfactory system.  However, the untreated side could not be used 
as an internal control since occasionally the untreated side also became damaged.  Each point 
represents the mean ± SEM (n=3). 
 
0.00
10.00
20.00
30.00
40.00
50.00
60.00
co
nt
ro
l
da
y 
1
da
y 
4
da
y 
7
w
ee
k 
3
w
ee
k 
9
co
nt
ro
l
da
y 
1
da
y 
4
da
y 
7
w
ee
k 
3
w
ee
k 
9
co
nt
ro
l
da
y 
1
da
y 
4
da
y 
7
w
ee
k 
3
w
ee
k 
9
co
nt
ro
l
da
y 
1
da
y 
4
da
y 
7
wild-type Sia T -/- GalNAc T -/- DKO
O
lf
a
c
to
ry
 e
p
it
h
li
u
m
 w
id
th
 (
µ
m
)
0.00
10.00
20.00
30.00
40.00
50.00
60.00
co
nt
ro
l
da
y 
1
da
y 
4
da
y 
7
w
ee
k 
3
w
ee
k 
9
co
nt
ro
l
da
y 
1
da
y 
4
da
y 
7
w
ee
k 
3
w
ee
k 
9
co
nt
ro
l
da
y 
1
da
y 
4
da
y 
7
w
ee
k 
3
w
ee
k 
9
co
nt
ro
l
da
y 
1
da
y 
4
da
y 
7
wild-type Sia T -/- GalNAc T -/- DKO
O
lf
a
c
to
ry
 e
p
it
h
e
li
u
m
 w
id
th
 (
µ
m
)
A
B
. TREATED SIDE
. UNTREATED SIDE
co
nt
ro
l
da
y 
1
da
y 
4
da
y 
7
w
ee
k 
3
w
ee
k 
9
co
nt
ro
l
da
y 
1
da
y 
4
da
y 
7
w
ee
k 
3
w
ee
k 
9
co
nt
ro
l
da
y 
1
da
y 
4
da
y 
7
w
ee
k 
3
w
ee
k 
9
co
nt
ro
l
da
y 
1
da
y 
4
da
y 
7
O
lf
a
c
to
ry
 e
p
it
h
li
u
m
 w
id
th
 (
µ
m
)
co
nt
ro
l
da
y 
1
da
y 
4
da
y 
7
w
ee
k 
3
w
ee
k 
9
co
nt
ro
l
da
y 
1
da
y 
4
da
y 
7
w
ee
k 
3
w
ee
k 
9
co
nt
ro
l
da
y 
1
da
y 
4
da
y 
7
w
ee
k 
3
w
ee
k 
9
co
nt
ro
l
da
y 
1
da
y 
4
da
y 
7
O
lf
a
c
to
ry
 e
p
it
h
e
li
u
m
 w
id
th
 (
µ
m
)
  165 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.13. The change in epithelial width in 6 month old wild-type and ganglioside 
knockout mice. 
The width of the OE was measured from the basement membrane to the lumen and was found to 
have dramatically decreased following ZnSO4 treatment, from around 45 µm in untreated tissue 
to around 10 µm one day after ZnSO4 irrigation.  OE widths were measured from the treated (A) 
and untreated (B) side of the olfactory system.  However, the untreated side could not be used 
as an internal control since occasionally the untreated side also became damaged.  Each point 
represents the mean ± SEM (n=3). 
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4.2.5 Proliferation within the olfactory epithelium 
It was shown in the previous chapter that in vitro, OECs isolated from Sia T -/- 
mice had a higher proliferation rate than OECs isolated from wild-type and 
GalNAc T -/- mice, when grown on collagen in the presence of growth factors.  
In this chapter, the aim was to examine if gangliosides play a role in the 
proliferation of the putative stem cells following destruction of the OE.  An 
antibody to proliferating cell nuclear antigen (PCNA) was used to label cells in 
the S phase of the cell cycle in the OE, in paraffin embedded tissue from 6 week 
old mice (Figure 4.14).  In control tissue, labelled cells were present as a single, 
discontinuous layer.  Due to their location and shape the majority of positive 
cells were presumed to be globose basal cells (GBCs).  One day following ZnSO4 
treatment, PCNA positive cells were visible as a single layer of cells, and by 7 
days after irrigation, many of the cells of the regenerating OE were labelled. 
The numbers of PCNA positive cells were quantified in tissue from 6 week old 
mice by counting the numbers of immunoreactive cells per mm of epithelium 
(Figure 5.15).  In control tissue, the average number of PCNA positive cells per 
mm of epithelium was 45 +/- 6 in all four genotypes at both age groups.  One 
day after ZnSO4 treatment, there was a decrease in the number of PCNA positive 
cells, followed by an increase 4 days after treatment.  After 9 weeks, the level 
of PCNA positive cells returned to control levels.   
Levels of PCNA positive cells in Sia T -/- and GalNAc T -/- mice followed the 
pattern seen in wild-type mice, however, DKO mice had a significantly higher 
number of PCNA positive cells seven days after ZnSO4 treatment (Figure 5.14 
panel D).   
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Figure 4.14.  PCNA labelling in the OE of wild-type and ganglioside knockout mice. 
In order to detect proliferating cells, sections of the olfactory mucosa were labelled with an 
antibody against PCNA.  Representative images from 6 week old wild-type (I-V), Sia T -/- (VI-X) 
and DKO (XI-XIII) mice are shown.  In untreated tissue of all the genotypes examined, PCNA-
positive cells were seen as a narrow band along the base of the epithelium.  Four days after 
ZnSO4 irrigation, many of the cells across the regenerating epithelium were immunoreactive for 
PCNA and by week 9, the PCNA immunoreactivity was again confined to the base of the 
epithelium.  The blue line shows the width of the olfactory epithelium. Scale bar = 20 µm 
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Figure 4.15.  Comparison of PCNA positive cells in the OE of wild-type and ganglioside knockout mice. 
To examine the role of gangliosides in the proliferation of basal cells of the olfactory epithelium following ZnSO4 treatment, sections of the olfactory 
mucosa were labelled with an antibody against PCNA that detects proliferating cells.  The number of cells expressing PCNA within the OE was 
quantified per mm.  Each point represents the mean ± SEM (n=3).  The number of proliferating cells in control, untreated olfactory epithelium was 
similar in all four genotypes examined.  Following nasal irrigation, there was a decrease, followed by an increase in the number of proliferating cells in 
wild-type, Sia T -/-, GalNAc T -/- and DKO mice.  By week 9, the number of PCNA positive cells was again decreased.  DKO tissue had a greater number 
of proliferating cells 7 days following ZnSO4 treatment compared to wild-type and the single knockouts (* p < 0.05). 
 
 
* 
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4.2.6 Degeneration and regeneration of olfactory axons 
To study the role of gangliosides in axonal regrowth from the PNS to the CNS the 
expression of SMI 31 was compared during degeneration and regeneration of the 
olfactory system (Figure 4.16 and 4.17).  SMI 31 binds to phosphorylated 
neurofilament, the major cytoskeletal component of axons.  The expression of 
phosphorylated neurofilament was examined both in the lamina propria where 
the axons first come out and in the olfactory nerve just before the axons reach 
the olfactory bulb.  The representative images are from wild-type tissue but a 
similar pattern was seen in all genotypes of 6 week old mice.  Subsequently, an 
antibody against olfactory marker protein (OMP) was obtained and was used to 
specifically label olfactory receptor neurons (Figures 4.18 and 4.19).  In control 
tissue, axons projected in an orderly manner in the olfactory nerve and were 
intensely stained with both SMI 31 and anti-OMP.  SMI 31 immunoreactivity was 
completely diminished as soon as one day after ZnSO4 treatment, whereas OMP 
immunoreactivity remained until at least the 4th day following ZnSO4 treatment, 
suggesting that axons of olfactory receptor neurons become de-phosphorylated 
prior to degenerating.  As shown in Figure 4.16 and 4.18, SMI 31 and OMP 
labelling began to reappear 3 weeks after ZnSO4 treatment and by week 9 the 
extent of labelling was similar to that in untreated mice.  However, this was not 
always the case and some sections remained SMI 31 or OMP negative even after 9 
weeks (not shown) suggesting that the extent of axonal regeneration was not 
uniform.  In contrast, in 6 month old wild-type, Sia T -/-, GalNAc T -/- mice only 
the control tissue labelled with SMI 31, whereas all of the time points following 
ZnSO4 treatment were negative.  Accordingly, anti-OMP immunoreactivity 
showed that in 6 month old mice olfactory receptor neurons had not regenerated 
even 9 weeks following ZnSO4 treatment.  This showed that the regeneration in 
the younger mice was a lot better than in the older mice.  The pattern in 
ganglioside knockout mice was the same as that observed in wild-type tissue in 
both age groups.  
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Figure 4.16.  SMI 31 labelling of 6 week old olfactory tissue. 
To examine the role of gangliosides in neurite extension of olfactory receptor neurons during 
regeneration of the olfactory system, tissue from 6 week old wild-type mice was labelled with 
SMI 31, an antibody that recognises phosphorylated neurofilament (I-XII).  In control tissue (I & 
VII), axons of the olfactory receptor neurons were strongly labelled with SMI 31, however 
following ZnSO4 treatment there was an immediate loss of SMI 31 immunoreactivity (II & VIII).  
This was accompanied by a loss of structural integrity of the projection from the olfactory 
epithelium (VIII).  SMI 31 staining began to reappear after 3 weeks, along with the return of 
structure of the nerve (V, XI).  Representative images are shown of olfactory nerve (A) and 
olfactory mucosa (B) from 6 week old wild-type mice, however a similar pattern was observed in 
6 week old Sia T -/- and GalNAc T -/- mice.  The blue lines delineate the OE, showing its width.  
Scale bar = 50 µm. 
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Figure 4.17. Quantitation of SMI 31 labelling during degeneration and regeneration of ORNs in the olfactory nerve in 6 week old mice.  
To examine the role of gangliosides in neurite extension during olfactory receptor neuron regeneration following ZnSO4 treatment, sections of the olfactory system 
were labelled with SMI 31, an antibody that recognises phosphorylated neurofilament.  The loss of axons was quantified by measuring optical density of the SMI 31 
staining in the olfactory nerve of wild-type, Sia T -/-, GalNAc T -/- and DKO mice.  Each point represents the mean ± SEM (n=3).  One day after ZnSO4 irrigation the 
intensity of staining was completely diminished.  The intensity of SMI 31 labelling began to increase after 7 days and continued to increase.  It can be seen that 3 and 9 
weeks after treatment the intensity of labelling had reached control levels in some sections, however as can be seen from the error bars the labelling was extremely 
variable.  A similar pattern was observed in all four genotypes tested. 
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Figure 4.18. The degeneration and regeneration of ORNs in 6 week old mice. 
To examine the role of gangliosides in neurite extension during the regeneration of the olfactory 
system after ZnSO4 treatment, sections were labelled with an anti-OMP antibody that specifically 
recognises olfactory receptor neurons.  The representative images show glomeruli (I, IV, VII, X & 
XIII), olfactory nerve (II, V, VIII, XI, XIV) and olfactory mucosa (III, VI, IX, XII & XV) from 6 week 
old wild-type mice, labelled with anti-OMP (green) and DAPI (blue) to show the cell nuclei.  In 
untreated tissue, ORNs were strongly labelled with anti-OMP (not shown) and this labelling 
remained until 4 days following ZnSO4 treatment (IV-VI).  7 days following ZnSO4 treatment, the 
OMP labelling had diminished (VII-IX).  9 weeks after ZnSO4 treatment, the OMP labelling 
reappeared in some sections (XIII-XV).  Scale bar = 50 µm. 
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4.2.7 Synapse formation  
To examine the role of gangliosides in synapse formation in the olfactory system, 
immunohistochemistry was performed using an antibody to synaptophysin, a 
synaptic vesicle membrane protein (Figure 4.20).  In control tissue, glomeruli 
could clearly be identified around the periphery of the olfactory bulbs and were 
intensely and uniformly labelled with synaptophysin.  One day after ZnSO4 
treatment, glomeruli were similar in appearance to untreated glomeruli, 
however, by the fourth day following treatment, they had lost much of the 
characteristic circular appearance and were no longer evenly labelled with 
synaptophysin.  This loss of synaptophysin labelling continued and even after 
nine weeks was not recovered suggesting that in the present study, the olfactory 
receptor neurons do not re-form synapses. 
The changes in the intensity of synaptophysin labelling were quantified by 
measuring optical density as described in the methods section (Figure 4.21).  
The optical density decreases immediately following ZnSO4 treatment and is 
never regained.  The pattern observed in 6 week old wild-type mice was also 
observed in ganglioside knockout mice in both age groups examined.  
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Figure 4.20. Synaptophysin labelling in the glomeruli of 6 week old mice. 
To examine the role of gangliosides in synapse formation during olfactory system regeneration, 
immunohistochemistry was carried out with an antibody against synaptophysin.  Representative 
images from wild-type (I-V) and Sia T -/- (VI-X) mice, 1 day (II & VII), 4 days(III & VIII), 3 weeks 
(IV & IX) and 9 weeks (V & X) after ZnSO4 treatment are shown. In control, untreated tissue (I & 
VI), the glomeruli of the olfactory bulb were seen as circular, densely-labelled structures.  Three 
weeks after ZnSO4 treatment (IV & IX) their distinctive round appearance was no longer evident 
and the synaptophysin labelling was less intense.  The synaptophysin labelling continued to 
decrease and was not regained 9 weeks after the initial damage (V & X).  Scale bar = 200 µm 
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Figure 4.21. The degeneration of synapses in 6 week old wild-type and ganglioside knockout mice. 
To examine the role of gangliosides in synapse formation during olfactory system regeneration following nasal irrigation with ZnSO4, olfactory bulb 
sections from 6 week old wild-type, Sia T -/-, GalNAc T -/- and DKO were labelled with an antibody to the synaptic vesicle membrane protein 
synaptophysin.  Optical density measurements were taken to quantify the loss of intensity of synaptophysin labelling in glomeruli of wild-type, Sia T -/-
, GalNAc T -/- and DKO mice.  Each point represents the mean ± SEM (n=3).  The loss in synaptophysin immunoreactivity was not evident until 7 days 
following ZnSO4 treatment and continued until the last time point examined (week 9).   
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4.2.8 The astrocytic response  
The astrocytic response in the olfactory bulb was detected using an antibody 
against glial fibrillary acidic protein (GFAP) and PCNA (Figure 4.22), in order to 
observe two features of astrocytosis: an increase in GFAP expression and 
proliferation. 
In the control tissue, typical, non-proliferating, GFAP-positive astrocytes were 
present in the glomerular layer.  Following ZnSO4 treatment, GFAP-labelling 
became more intense and the astrocytes began to express PCNA.  This continued 
up to week 3 after treatment.  After 9 weeks following treatment the GFAP 
expression was similar to that observed in control tissue and the astrocytes no 
longer labelled with PCNA.  The same pattern was observed in wild-type, Sia T -
/- and GalNAc T -/- tissue in both age groups.  Representative images for wild-
type and Sia T -/- tissue obtained from 6 week old mice are shown in Figure 
4.22. 
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Figure 4.22. The astrocytic response to nasal irrigation in wild-type and ganglioside knockout 
mice. The astrocytic response to damage caused by ZnSO4 was assessed with double 
immunohistochemistry using anti-GFAP (brown) and anti-PCNA (black).  Representative images 
show wild-type (I-V) and Sia T -/- (VI-X) tissue from 6 week old mice labelled with anti-GFAP and 
anti-PCNA 1 day (II and VII), 4 days (III and VIII), 3 weeks (IV and IX) and 9 weeks (V and X) 
following ZnSO4  treatment.  In control, untreated tissue (I and VI), GFAP positive astrocytes 
could be seen in the glomerular layer, although none double labelled with PCNA.  There was an 
increased expression of GFAP following ZnSO4 treatment and the GFAP-positive cells were double 
labelled with PCNA.  This astrocytosis persisted up to 3 weeks after ZnSO4 treatment.  After 9 
weeks the majority of astrocytes had stopped proliferating and the expression of GFAP was 
similar to that seen in the untreated tissue.  Scale bar = 20 µm. 
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4.3 Discussion 
4.3.1 Ganglioside expression of the olfactory system 
The initial aim of this study was to characterise the expression of major brain 
gangliosides GM1, GD1a, GD1b, GT1b and GQ1b in the olfactory system of 6-
week old mice.  This would ascertain whether there was justification to carry 
out further studies on the regeneration of the olfactory system in ganglioside 
knockout mice. 
Using immunofluorescent labelling with various anti-ganglioside antibodies, it 
was found that the olfactory system of wild-type mice expresses all of the 
gangliosides examined apart from GD1a.  This was surprising because GD1a is 
one of the major brain gangliosides.  GD1a is found on axons and is thought to 
act as a ligand for MAG (Collins et al., 1997).  In addition, the same antibody 
labelled axons in cultures of dissociated spinal cord (Figure 5.12).  It is thus very 
unlikely that GD1a is not present in the olfactory system.  Therefore, it is more 
likely that for some unknown reason the antibody used in the present study did 
not detect GD1a in the olfactory system.  Future studies should confirm the 
ganglioside content of the OB and the OM should by extracting gangliosides form 
the OB and the OM and analysing them by TLC and tandem mass spectrometry.  
The results of the present study also showed that the olfactory system of GalNAc 
T -/- mice lacked all a-series gangliosides, whereas the olfactory system of Sia T 
-/- mice lacked all b-series gangliosides but had higher levels of a-series 
gangliosides.  Both the lack and the excess of particular gangliosides may have 
an effect on the degeneration or the regeneration of the olfactory system.   
Future studies should examine in more detail the ganglioside expression of the 
various cell types within the olfactory system by double labelling with anti-
ganglioside antibodies and antibodies that recognise the specific cells types.  For 
instance, sections of the OB and OM could be double labelled with anti-
ganglioside antibodies and OMP which recognises ORNs or GBC-1 which 
recognises the globose basal cells. 
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4.3.2 Comparison of olfactory epithelial width 
The patterns of distribution of gangliosides during different stages of 
development, as well as their abundance in neural cells gave rise to the idea 
that gangliosides must play important roles in many biological processes in the 
nervous system.  Until the emergence of ganglioside knockout mice, most 
investigations into the biological role of gangliosides consisted of addition of 
gangliosides or inhibitors of their synthesis to cells in culture.  These studies 
suggested that gangliosides modulate many functions at the cellular level but 
could not address the physiological roles of gangliosides at the level of the whole 
organism.   
To investigate whether the lack or the overexpression of gangliosides had an 
effect on the anatomy of the olfactory system, the present study compared the 
olfactory epithelium widths of wildtype and ganglioside knockout mice. The 
width of the olfactory epithelium, which is composed of several cell layers 
whose structure is very organised, was measured as an indication of the 
development of the tissue.  The mean epithelial width in ganglioside knockout 
mice did not differ from that of wild-type mice which suggests that a change in 
the ganglioside expression does not affect the development of the OE.  This 
means that any changes in the epithelial width in the ganglioside knockout mice 
that may be observed in the regeneration study would be due to lack of 
regeneration. 
4.3.3 Preliminary studies of nasal ZnSO4 irrigation 
In order to study the role of gangliosides in the degeneration and regeneration of 
the olfactory system, an established method was used where the ORNs and other 
cells in the OE are destroyed by ZnSO4.  The biggest difficulty in this study was 
establishing the optimal volume and concentration of ZnSO4 to use in order to 
induce the right amount of OE damage.  It was decided to keep the volume low, 
since higher volumes were detrimental to the health of the mice, and 
preliminary studies indicated that 20 µl of ZnSO4 would be sufficient to induce 
destruction of the cells of the olfactory epithelium.  However, all the results of 
the present study suggest that this concentration was too high since in most 
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instances it also destroyed the basal cells which are needed in order for the 
olfactory epithelium to regenerate. 
Therefore, with hindsight, 20 µl of 10% ZnSO4 was too strong and destroyed too 
many basal cells which suggests that more concentrations should have been 
tested in the preliminary studies.  If I was to repeat this study I would try 
different volumes of 5% ZnSO4 to determine which damaged the OE enough to 
destroy all cells, leaving only the basal cells.  From the preliminary studies it 
can be seen that 50 µl of 5% ZnSO4 damaged the top layers of cells in the OE, 
whereas 100 µl of 5% ZnSO4 completely destroyed all of the cells within the OE.  
I would therefore irrigate the left nasal cavity of 6 month old wild-type mice 
with 60, 70 and 80 µl of 5% ZnSO4.  However, rather than adding it all at once, it 
would be better to add it in several stages because large volumes were 
detrimental to the health of the mice.  For instance, I would irrigate the nasal 
cavity with 2 x 10 µl of 5% ZnSO4 and an hour later, after the mouse has had time 
to recover, add another 2 x 10 µl, and an hour later another 2 x 10 µl of 5% 
ZnSO4.   
In addition, rather than examining the tissue one day after irrigation, 
preliminary studies should have also looked at a later time point to examine how 
much of the tissue had regenerated.  For instance, mice could have been 
sacrificed three weeks following ZnSO4 treatment to determine the extent of 
regeneration, by labelling the tissue with H & E to measure OE width, OMP, to 
observe the regeneration of ORNs and synaptophysin to examine if the synapses 
had re-formed.  Subsequent experiments should only be performed once it was 
demonstrated that a certain volume and concentration of ZnSO4 reproducibly 
caused enough damage to destroy all cells of the OE except the basal cells and 
that three weeks later all the cells of the OE had regenerated and that ORNs had 
reformed synapses with the second order neurons in the OB.  
With hind-sight the number of mice used in the present study was too large.  
Because many of the neurological defects seen in the single knockouts were age 
related, I would not study regeneration in the younger age group and would 
concentrate on the older age group.  This would mean leaving out the DKO mice 
but if a difference in the regeneration of the 6 month old single knockouts was 
seen, another study could compare the regeneration of, for example, 3 week old 
  182 
wild-type and DKO mice which would allow the examination of regeneration as 
far as 4 weeks following ZnSO4 treatment.  This is because, according to the 
Home Office licence, DKO mice cannot be kept after 7 weeks of age.   
However, concentrating on one age group would cut the numbers down 
considerably allowing an additional time point.  The time points used in the 
present study were 1, 4, 7, 21 and 63 days following ZnSO4 irrigation.  This 
meant that there was a big gap between 7 and 21 days during which the tissue 
was still in the process of regeneration.  Therefore, it would be beneficial to add 
a time point at 14 days after ZnSO4 treatment.  In addition, because of 
variability the number of mice per time point could be increased to six.  Finally, 
instead of embedding the tissue in paraffin, I would freeze the tissue instead 
because this would allow the use of more antibodies. 
4.3.4 The response of the olfactory epithelium to nasal ZnSO4 
irrigation 
To examine the role of gangliosides in the degeneration and regeneration of the 
olfactory system following ZnSO4 irrigation, I first compared the OE width, which 
is an indication of the degeneration and regeneration of the ORNs and other cells 
present in the olfactory epithelium.  One day after ZnSO4 treatment, the OE is 
reduced to one cell layer thick or in some places completely destroyed.  Over 
time the OE grows back, however after 9 weeks it does not reach control levels.  
In wild-type and ganglioside knockout mice, the olfactory epithelium reaches 
only 50% of the control value, suggesting incomplete regeneration.  This 
indicates that the concentration of ZnSO4 used was too strong, and that not 
enough basal cells survived the treatment to differentiate and repopulate all the 
cells of the OE. 
The respiratory epithelium is a ciliated, pseudo-stratified epithelium which 
functions to warm and humidify the incoming air.  It is located anterior to the 
olfactory epithelium in the nasal cavity.  There have been numerous reports in 
the literature that damage to the OE is, to a certain extent, irreversible, and 
results in the partial replacement of olfactory epithelium with respiratory 
epithelium (Schwob et al., 1995, Schwob et al., 1999).  Indeed, replacement of 
olfactory epithelium by respiratory epithelium is observed with naturally 
occurring rhinitis (Smith, 1938a), ZnSO4 irrigation (Harding et al., 1977, Smith, 
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1938b), and injection of 3-methyl indole either alone (Turk et al., 1987) or in 
combination with methyl bromide inhalation (Schwob et al., 1994b).  Schwob et 
al (Schwob et al., 1995) showed that where neurogenesis fails, the epithelium 
changes to respiratory in character, as defined by the presence of ciliated 
columnar cells and the absence of microvillar capped sustentacular cells.  From 
the results of the present study, it would appear that a significant fraction of 
olfactory epithelium became respiratory epithelium, which meant that it if 
gangliosides did play a role in the regeneration of the olfactory system it may 
not be detected.  The severity of initial injury correlates with the degree of 
replacement and it was evident from the H & E staining of the olfactory mucosa 
that in the present study many parts of the epithelium were destroyed down to 
the basal lamina, thus leading to the destruction of the entire population of 
putative stem cells.  
A closer inspection of at the graphs showing the OE measurements (Figures 4.12 
and 4.13) reveals that in some instances, the olfactory epithelium in the 
untreated side was also damaged and that there is variability between the 
extent of damage between time-points.  The observation that the amount of OE 
damage was not uniform, suggests that the amount of OE damage varied 
between treatment days because mice that were treated at the same time were 
generally used for the same time-point.  In other words, if I had treated five 
wild-type mice one day, all five would be sacrificed on, for example, the fourth 
day following irrigation.  However, it may have been better to sacrifice one 
mouse a day after the irrigation, one four days later, one seven days later and so 
on.  This may help reduce variability between time-points.  In addition, 
increasing the number of mice used per time point may compensate for some of 
the variability.  Finally, optimising the concentration of ZnSO4, so that it did not 
damage too many basal cells in the treated side of the OE, and did not damage 
the untreated side would allow an examination of the role of gangliosides in OE 
degeneration and regeneration and would allow the untreated side to be used as 
an internal control. 
 
4.3.5 Proliferation within the olfactory epithelium 
Numerous studies have suggested a role for gangliosides in the proliferation of 
various cell types (section 1.1.3.1 in the Introduction).  In addition, gangliosides 
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are thought to be involved in regeneration.  In the olfactory system, when the 
ORNs are destroyed, they grow back from the putative stem cells in the 
olfactory epithelium. Because the regeneration of the olfactory system depends 
on the proliferation and the differentiation of the putative stem cells, it was 
decided to examine if gangliosides play a role in the proliferation of the putative 
stem cells following destruction of the OE. 
An antibody to PCNA, a protein involved in DNA synthesis (Mathews et al., 1984), 
was used to label proliferating cells.  PCNA occurs in cells during the last 5% of 
the G1 phase and the first 35% of the S phase of the cell cycle (Paunesku et al., 
2001), and is widely used to label those cells undergoing proliferation (Hill-
Felberg et al., 1999).   
The present study showed that in the control, untreated tissue, the proliferation 
of cells in the basal layer of the OE was similar in wild-type and ganglioside 
knockout mice.  This suggests that gangliosides do not modulate the 
proliferation of the two classes of basal cell within the olfactory epithelium, the 
globose and horizontal basal cells, during development.   
Yet, seven days after the destruction of the olfactory epithelium by ZnSO4, 
levels of PCNA positive cells were significantly higher in DKO mice compared 
with wild-type and the single knockout mice.   Neurogenesis in the olfactory 
epithelium is under the regulation of a negative feedback, mature ORNs feeding-
back to inhibit the further differentiation of basal cells. Indeed, the  
proliferation of GBCs increases if the death of the ORNs is induced, whereas it 
decreases if ORNs are protected from damage (Farbman, 1990).  Therefore, the 
increased level of proliferation of basal cells in DKO mice suggests that the 
signalling between ORNs and basal cells, which regulates the proliferation rate 
of globose basal cells, is altered in the absence of complex gangliosides. 
However, the proliferation of cells in the basal layer in Sia T -/- and GalNAc T -
/- mice was similar to that in wild-type mice.  GalNAc T -/- mice lack all 
complex gangliosides and have higher levels of simple gangliosides GM3, GD3 and 
GT3, whereas DKO mice only have the simple ganglioside GM3.  Therefore, the 
lack of complex gangliosides in GalNAc T -/- mice has no effect on the 
proliferation of basal cell, possibly because increased levels of GD3 and GT3 can 
compensate for the lack of complex gangliosides. 
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Because of their location, proliferating cells were presumed to be basal cells.  In 
order to identify categorically the cells that were undergoing proliferation, 
future experiments could involve double-labelling studies.  
4.3.6 Olfactory receptor neuron regeneration 
To assess the role of gangliosides in axonal regrowth from the PNS to the CNS the 
expression of SMI 31, which binds to phosphorylated neurofilament, and OMP, 
which labels ORNs, was examined in wild-type and ganglioside knockout mice 
during degeneration and regeneration of the olfactory system.  It was found that 
in wild-type and ganglioside knockout mice, one day after ZnSO4 treatment, the 
axons of the ORNs were still present but had become de-phosphorylated, and 
after seven days had degenerated.  In 6 week old wild-type and ganglioside 
knockout mice some regeneration of the ORNs was evident 3 weeks after ZnSO4 
irrigation, however by 9 weeks most of the ORNs had not regenerated.  In the 6 
month old wild-type and ganglioside mice, no regeneration of the ORNs was 
observed following ZnSO4 irrigation.  
Despite a remarkable regenerative capacity, recovery of the mammalian 
olfactory epithelium can fail in severely injured areas, which subsequently 
reconstitute as aneuronal respiratory epithelium, which is a form of metaplasia 
(Jang et al., 2003).  Jang et al (2003) showed that in areas of olfactory 
epithelium in which GBC are preserved, they multiply and reconstitute the cells 
of the epithelium, however, in areas where the GBCs are also destroyed, the 
epithelium is repopulated, in part, by cells arising from Bowman’s glands.   
As a result of olfactory epithelium becoming replaced by aneuronal respiratory 
epithelium, the population of reinnervating fibres was less and consequently the 
olfactory bulb remained denervated even 9 weeks following ZnSO4 treatment, as 
shown by the OMP immunolabelling.  As was shown using SMI 31 phosphorylated 
neurofilament immunolabelling, some areas of the olfactory bulb are re-
innervated, however, in the majority of cases this was not the case.  It is also 
important to note that the damage to the olfactory epithelium was not uniform 
throughout the olfactory mucosa and that although some areas were rendered 
acellular by the treatment, there were areas that were spared damaged 
altogether.  Therefore, the neurofilament labelling observed following 
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treatment is either due to regenerated olfactory receptor neurons or the 
olfactory receptor neurons which were not damaged. 
Due to lack of regeneration, the role of gangliosides in neurite outgrowth during 
regeneration could not be examined in the present study.  However, being a 
constantly regenerative tissue, the olfactory system is a good system to study 
regeneration and studies in Sia T -/- mice have indicated that these mice have 
impaired PNS regeneration (Itoh et al., 2001).  In addition, gangliosides have 
been shown to be neurotrophic (Schengrund, 1990). Hence, future studies should 
asses the role of gangliosides in neurite outgrowth following damage of the 
olfactory epithelium using an improved, and more reproducible method of 
damaging the olfactory epithelium.  
4.3.7 Synapse formation  
Glomeruli of the olfactory bulb are dense collections of synapses.  In the present 
study, the role of gangliosides in synapse formation during regeneration of the 
olfactory system following ZnSO4 treatment was examined by labelling olfactory 
bulb tissue from wild-type and ganglioside knockout mice with an antibody to 
the synaptic vesicle membrane protein, synaptophysin, which has previously 
been used to identify synaptic degeneration (Meller et al, 1994).  It was found 
that synapses began to deteriorate four days after ZnSO4 treatment, and are not 
re-formed even as late as 9 weeks after the initial injury in wild-type and 
ganglioside knockout mice.   
The optical density of the synaptophysin immunohistochemistry, unlike that of 
the neurofilament, did not decrease to the same extent.  Whereas the loss of 
neurofilament staining was almost complete, the staining of synaptophysin 
decreased to around 50% of the control level.  This is because, firstly, the 
glomeruli not only contain ORN synapses, but also second order neuron and 
interneuron synapses and secondly, some ORNs may have survived the 
treatment. 
These results suggest that 9 weeks following ZnSO4 treatment, the ORNs do not 
regenerate sufficiently to re-form synapses with second order neurons in the 
olfactory bulb.  As a result, it is not possible to draw any conclusions on the role 
of gangliosides in synapse formation in the olfactory system. 
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4.3.8 The astrocytic response  
Reactive astrocytosis is one of the first consequences of injury to the CNS and is 
a process characterised by the proliferation and hypertrophy of astrocytes within 
the vicinity of damage.  Reactive astrocytes are thought to impede regeneration.  
The astrocytic response in the olfactory bulb was detected using an antibody 
against GFAP and PCNA, in order to observe two features of astrocytosis: an 
increase in GFAP expression and proliferation. 
In control tissue, non-proliferating, GFAP-positive astrocytes were present in the 
glomerular layer.  However, nasal irrigation with ZnSO4 lead to a rapid 
astrocytosis within the olfactory bulb, astrocytes both proliferating and 
becoming hypertrophic, as shown by double immunohistochemistry with GFAP 
and PCNA.  This was observed between and surrounding the glomeruli and in the 
outer region of the external plexiform layer beginning after 4 days and 
continuing 3 weeks after ZnSO4 treatment.  9 weeks following initial damage, 
the astrocytes were no longer proliferating and the levels of GFAP labelling were 
comparable to untreated tissue.  There was no difference in the astrocytic 
response to damage between wild-type and ganglioside knockout mice, which 
suggests that gangliosides are not involved in reactive astrocytosis. 
4.3.9 Conclusion and future studies 
Due to the destruction of the putative stem cells and subsequent failure of the 
epithelium to regenerate, it was not possible to properly examine the aims of 
the study, namely the role of gangliosides in the proliferation of putative stem 
cell, neuronal outgrowth, or synapse formation.  Although some differences 
were observed, due to the low n-number and high variability these differences 
were not significantly different.  Most of the results obtained from 6 week old 
mice suggest that at this age, the regeneration of ganglioside knockout mice is 
similar to that of wild-type but as the regeneration in all genotypes was 
incomplete it is difficult to draw any conclusions. 
However, if the experiment was repeated in older mice with a more suitable 
concentration of ZnSO4 and a higher number of mice per time-point, it may be 
possible to properly assess the role of gangliosides in all the processes involved 
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in the degeneration and regeneration of the olfactory system.  Moreover, if 
complete regeneration was achieved, it would be worthwhile to examine other 
aspects of the regenerative process such as the formation of immature ORNs, 
which are characterised by the expression of the phosphoprotein GAP43 
(Verhaagen et al., 1989), dendritic changes in the glomeruli, and the 
inflammatory cell response.  Finally, the response of the OECs, which are 
thought to facilitate regeneration in the olfactory system should be studied in 
wild-type and ganglioside knockout mice by examining the expression of in vivo 
OEC markers such as the calcium binding protein S100, which is primarily 
localised to the cytoplasm of glial cells (Fano et al., 1995), GFAP (Barber et al., 
1987), O4 and p75NTR (Au et al., 2003).  
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5 CHAPTER 5 
The effect of gangliosides on oligodendrocyte 
differentiation and axonal-glial interactions in vitro 
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5.1 Introduction 
Myelin facilitates saltatory conduction by restricting sodium currents to nodes of 
Ranvier and reducing the capacitance of the internodal axonal membrane 
thereby ensuring rapid and efficient action potential propagation.  The 
molecular architecture of axons and myelin sheaths are specialised for this 
function.  Myelinated axons are divided into four functional regions: nodes of 
Ranvier, paranodes, juxtaparanodes, and internodes (Poliak and Peles, 2003).  
Nodes of Ranvier contain clusters of voltage-gated sodium channels (Nav) in the 
axonal membrane that are important for the generation of action potentials 
(Rasband et al., 1999a, Rasband and Trimmer, 2001).  The paranodal axonal 
membrane contains cell adhesion molecules contactin-associated protein (Caspr) 
(Einheber et al., 1997, Peles et al., 1997) and contactin, while cell adhesion 
molecule neurofascin 155 (NF155) is present in the paranodal glial membrane.  
These cell adhesion molecules are important components of paranodal axo-glial 
junctions: NF155 interacts with a Caspr-contactin complex and thus links glial 
and axonal membranes at the paranodes (Charles et al., 2002).  Caspr and NF155 
are associated with lipid rafts.  Paranodal axo-glial junctions are important for 
ion channel clustering and rapid action potential propagation in myelinated 
nerve fibres.  Shaker-type voltage-gated potassium channels (Kv) are localised to 
juxtaparanodes.  In order for the saltatory conduction to occur, it is essential 
that proteins such as Caspr, NF155, Nav and Kv assemble in a correct fashion.  
Several studies have found that mice lacking complex gangliosides have 
myelination defects suggesting that they are important for the maintenance of 
myelin and the integrity of nerve fibres (Chiavegatto et al., 2000, Ma et al., 
2003, Sheikh et al., 1999b, Takamiya et al., 1996).  Gangliosides are also 
thought to be important in the maintenance of nodal architecture (Susuki et al., 
2007a) and GD1a and GT1b may be important in myelin stability due to their role 
as MAG ligands.  Since GalNAc T -/- mice lack GT1a and GT1b and Sia T -/- mice 
lack GT1b, it is possible that the absence of these MAG ligands may lead to a 
decrease in the stability of myelinated axons and the subsequent axonal 
degeneration.   
Oligodendrocytes are the myelinating glia of the CNS and have been shown to 
differentially express gangliosides.  Myelination is paramount for the proper 
  191 
conduction of neural impulses and failure of oligodendrocytes to re-myelinate is 
a problem in neurological diseases such as multiple sclerosis (MS).  Although 
oligodendrocyte progenitor cells (OPCs) are present within MS lesions they fail to 
myelinate the axons (Chang et al., 2000, Chang et al., 2002).  Maier et al (Maier 
et al., 2005) showed that raft association of NF155 was reduced in spinal cord 
experimental allergic encephalomyelitis rats and that fibronectin perturbed 
localisation and raft association of NF155 and inhibited the morphological 
differentiation of oligodendrocytes, suggesting that changes in the extracellular 
matrix can inhibit re-myelination.  Studying the myelination process may help 
explain the apparent inability of some oligodendrocytes within MS lesions to 
contribute to the repair process.  
To examine further the role of gangliosides in axonal integrity, myelination and 
interaction between glia and axons, myelinating cultures isolated from spinal 
cords of E13.5 wild-type and ganglioside knockout mice were utilised.  Initially, 
ganglioside expression of cell types present within spinal cord cultures was 
examined.  Next, the role of gangliosides in the differentiation of 
oligodendrocytes in the absence or presence of axons was investigated.  
Subsequently, the effect of gangliosides on axonal survival, myelination and the 
localisation of nodal proteins was studied. 
5.2 Results  
5.2.1 Differentiation of wild-type and Sia T -/- OPCs 
C-series gangliosides GT3 and O-acetyl GT3 are expressed in the early stage of 
oligodendrocyte differentiation.  As Sia T -/- mice lack these gangliosides the 
aim of the present study was to investigate if oligodendrocyte precursor cells 
(OPCs) isolated from 7-day old Sia T -/- mice differentiated into O4 expressing 
oligodendrocytes. GalNAc T -/- mice which lack all complex gangliosides but 
have an excess of simple gangliosides such as GT3 and O-acetyl GT3 were not 
included in this study because GalNAc T -/- litters are a combination of knockout 
and heterozygous pups, and therefore the optic nerve had to be cultured 
individually from each pup and then pooled only after the tissue had been 
genotyped.  However, due to the small volume of tissue obtained from optic 
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nerves, it is not feasible to culture them individually hence why this experiment 
was not performed using GalNAc T -/- mice.    
The antibody A2B5, which is expressed before O4 during oligodendrocyte 
differentiation, was used to detect c-series gangliosides GT3 and O-acetyl GT3.  
As shown in Figure 5.1 A, wild-type early OPC expressed A2B5 when maintained 
in DMEM-BS containing FGF and PDGF.  In contrast, Sia T -/- OPCs maintained 
under the same conditions did not express A2B5 as shown in Figure 5.1 B.  When 
the growth factors were removed, OPCs isolated from Sia T -/- mice, 
differentiated into multiprocessed O4-expressing oligodendrocytes as can be 
seen in Figure 5.1 B.  Subsequently, myelin membrane was evident (Figure 5.1 
B).  When maintained in medium containing serum they differentiate into type-2 
astrocytes (Figure 5.1 B).   
These findings suggest that, in the absence of axons, c-series gangliosides do not 
affect oligodendrocyte differentiation. 
5.2.2 Dissociated spinal cord culture: cell composition  
The next objective was therefore to investigate the effect of gangliosides on 
oligodendrocyte differentiation in the presence of axons and subsequently, glial-
axonal interaction.  For this purpose, dissociated spinal cord cultures from E13.5 
mice were utilised.  These cultures contain a mixture of cells including 
astrocytes, OPCs, neurons and microglia as can be seen in Figure 5.2.  Using this 
culture system, a series of events can be studied over time including neuronal 
survival, neurite extension and the ensheathment and myelination of axons by 
endogenous oligodendrocytes in the culture (Sorensen et al., 2008).   
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Figure 5.1. OPCs isolated from Sia T -/- mice did not express A2B5 but were able to 
differentiate into O4 expressing oligodendrocytes.   
(A) Early OPCs isolated from wild-type P7 mice expressed the marker, A2B5.  OPCs grown in 
DMEM-BS with no added growth factors differentiated into oligodendrocytes, whereas those 
grown in 10% FBS differentiated into type-2 astrocytes.  (B) Early OPCs isolated from P7 Sia T -/- 
mice, labelled with NG2 (I), were negative for A2B5, however, their differentiation into O4-
expressing oligodendrocytes (II-IV) or type-2 astrocytes (V) was unaffected.  Scale bars = 50 µm 
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Figure 5.2. Cell composition of dissociated spinal cord cultures at 7 DIV.   
Spinal cord cultures from wild-type E13.5 mice were labelled with various markers to elucidate 
their cellular composition.  Astrocytes (GFAP, red), neurons (SMI 31, red) and OPCs (NG2, green) 
were the main cells present in these cultures. There was also a small number of microglia (BS 
lectin, green).  Cell nuclei were labelled with DAPI (blue).  Scale bars = 50 µm. 
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5.2.3 Comparison of culture media 
Neurobasal B27 (NB) is a medium commonly used for the study of axonal glial 
interaction and myelination (Brewer et al., 1993); www.invitrogen.com).  
However, according to Thomson et al (2006), who compared NB with a serum-
free defined medium “differentiation medium”, myelination was better in 
cultures maintained in differentiation media.  These two media were therefore 
compared to optimise conditions for myelination in wild-type and Sia T -/- spinal 
cord cultures.   
To compare the antigenic differentiation of oligodendrocytes grown in either 
differentiation or NB media, the cultures were labelled with antibodies to 
antigens expressed at different stages of oligodendrocyte differentiation (NG2, 
O4 and MBP) at 21 and 28 DIV.  NG2 positive cells correspond to early OPCs; cells 
which label with both NG2 and O4 correspond to late OPCs; cells which are only 
O4 positive are intermediate between the late OPCs and pre-myelinating 
oligodendrocyte stage; O4- and MBP- positive cells are pre-myelinating 
oligodendrocytes and cells which are only MBP positive are myelinating 
oligodendrocytes (see Introduction Figure 1.5).  Figure 5.3 shows the proportion 
of cells immunoreactive for NG2, NG2/O4, O4, O4/MBP and MBP in wild-type and 
Sia T -/- cultures after 21 and 28 DIV.  No significant difference was found in the 
proportion of cells immunopositive for NG2, O4, and MBP alone or in 
combination between cultures grown in differentiation medium and cultures 
grown in NB medium.  Representative images of wild-type spinal cord cultures at 
28 DIV grown in differentiation medium and NB medium (Figure 5.4) showed that 
although there was no difference in the proportion of cells labelled with 
oligodendrocyte lineage markers, the cells differed morphologically.  O4-positive 
cells grown in differentiation medium had a dense network of secondary and 
tertiary processes.  In contrast, O4-positive cells grown in NB medium were less 
branched, containing mostly primary processes with few secondary processes.  
Those that were not in contact with axons seemed to produce myelin-like 
membrane.   
Next, the effect of the two different media, differentiation versus NB, on 
neuronal survival and axonal density were examined.  Axon density, expressed as 
the percentage of SMI 31-immunoreactivity per given area, was calculated for 
  196 
embryonic spinal cord cultures plated onto PLL at 21 and 28 DIV.  The 
percentage of axons that were myelinated was assessed using the antibody AA3, 
which binds to PLP/DM20 and recognises compact myelin.  There was no 
significant difference in axonal density or the myelination of these between 
cultures grown in differentiation medium or in NB medium as illustrated in 
Figure 5.4 (panel B).  Since the morphology of oligodendrocytes maintained in 
differentiation medium was more similar to that described in the literature 
(Trapp et al, 1997), subsequent cultures were grown in differentiation medium. 
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Figure 5.3. Antigenic profile of oligodendrocytes in differentiation and neurobasal media. 
Wild-type and Sia T -/- dissociated spinal cord cultures were grown in either differentiation or 
neurobasal media, and were stained with markers of the oligodendrocyte lineage at 21 (A) and 
28 DIV (B): NG2, O4 and MBP.  The graphs represent the percentage of total cells positive for 
NG2, NG2/O4, O4, O4/MBP and MBP in spinal cord cultures grown in either differentiation or 
neurobasal B27 medium.  There was no significant difference in the proportion of cells 
expressing antigens recognised by these antibodies alone or in combination between the two 
culture media.  Diff = differentiation medium, NB = neurobasal medium with B27 supplement.  
Each point represents the average ± SEM (n=3). 
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Figure 5.4. Wild-type spinal cord culture at 28 DIV in differentiation and neurobasal media. 
Representative image of wild-type spinal cord culture at 28 DIV grown in differentiation (A) and 
neurobasal (B) media and immunolabelled with NG2 (green, II), O4 (red, III) and MBP (blue, IV).  
The merged image is shown in I, while II to IV show the individual markers.  Examples of 
following can be seen in these images: NG2+ early OPCs (white arrow), NG2+/O4+ late OPCs 
(white arrowhead), O4+ oligodendrocytes (yellow arrow), and O4+/MBP+ pre-myelinating 
oligodendrocytes (yellow arrowhead).  Note that in cultures maintained in differentiation 
medium, NG2+ cells are branched with primary and secondary processes and O4+ cells have a 
dense network of primary, secondary and tertiary processes.  Also, the O4+/MBP+ staining 
resembles myelin formed following contact with axons and there is a break in the MBP staining 
resembling a node of Ranvier (pink arrow).  In cultures maintained in neurobasal medium, the 
processes of NG2+ and O4+ cells appear to be shorter compared with those seen in 
differentiation medium.  Also, some O4+/MBP+ labelling resembles myelin membranes formed by 
oligodendrocytes which have failed to contact an axon.  Scale bar = 50 µm.  
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Figure 5.5. Axonal density and PLP labelling in spinal cord cultures grown in either 
“differentiation” or “neurobasal” media.   
Spinal cord cultures isolated from wild-type and Sia T -/- mice and maintained in either 
differentiation or neurobasal media were labelled with an axonal marker, SMI 31, and PLP 
expression was revealed by staining for AA3.  Axonal survival was gauged by measuring axonal 
density (A) and was found to be similar in both media.  In addition, the percentage of axonal 
area covered by myelin (B) was not significantly different between cultures maintained in 
differentiation or neurobasal media.  Each point represents the average ± SEM (n=3). 
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5.2.4 Ganglioside expression of dissociated spinal cord 
cultures. 
Having established the optimal medium for myelination of axons in the 
dissociated spinal cord cultures, the ganglioside content of these cultures was 
examined.  Before studying the role of gangliosides in myelination and glial-
axonal interaction, it was important to demonstrate which gangliosides were 
expressed by cells present in the culture system.  Four ganglioside markers were 
chosen for this purpose: A2B5 and R24, which bind to simple gangliosides GT3, 
O-acetyl GT3 and GD3 and are differentially expressed during oligodendrocyte 
differentiation; CTx, which binds to the major brain ganglioside GM1; and 
MOG35, which is an antibody against ganglioside GD1a, the axonal ligand for 
MAG. 
All of the antigens labelled by the antibodies used in this study were found in 
wild-type dissociated spinal cord cultures (Figure 5.6).  A2B5, which binds to c-
series gangliosides GT3 and O-acetyl GT3, was found in GalNAc T -/- cultures, 
where the intensity was slightly higher compared to wild-type, but no positive 
immunoreactivity was found in Sia T -/- cultures which lack all c-series 
gangliosides (Figure 5.6).  To examine more specifically which cell types within 
the spinal cord cultures (astrocytes, oligodendrocytes or neurons) expressed 
antigens recognised by A2B5 at 21 DIV, the cultures were double labelled with 
A2B5 and one of the following antibodies: SMI 31, which is specific for 
phosphorylated epitopes on the heavy neurofilament peptide and to a lesser 
extent medium neurofilament peptide; TUJ1, which binds to the neuron specific 
Class III β-tubulin; NG2, which labels early OPCs; or GFAP, which binds to 
astrocytes (Figure 5.7).  A2B5 showed co-localisation with TUJ1 and SMI 31 as 
shown in Figure 5.7 suggesting that neurites express gangliosides.  A2B5 was also 
expressed by OPCs as shown by its co-expression with NG2 (Figure 5.7).  While 
the majority of GFAP positive cells were negative for A2B5 (type-1 astrocytes), 
some were co-labelled with A2B5, indicating the presence of type-2 astrocytes 
(Figure 5.7).  A similar pattern of co-localisation was found between A2B5 and 
SMI 31, TUJ1, NG2 and GFAP in cultures isolated from GalNAc T -/- mice. 
R24, which binds to gangliosides GD3, GT1a and GQ1b was expressed in wild-
type and GalNAc T -/- cultures, but not in Sia T -/- cultures (Figure 5.6).  Sia T -
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/- mice lack all b-series gangliosides including GD3 and GQ1b, while GalNAc T -/- 
mice lack all complex gangliosides including GT1a and GQ1b but have increased 
levels of GD3.  The R24 positive staining in GalNAc T -/- cultures is therefore due 
to R24 recognising the simple b-series ganglioside GD3 (Figure 5.6).  R24 
expression was stronger and more prevalent in GalNAc T -/- cultures than in 
wild-type.  To ascertain which cell type within the wild-type spinal cord cultures 
expressed R24 at 21 DIV, the cultures were double labelled with R24 and one of 
the following antibodies: NG2, O4, which labels oligodendrocytes, SMI 31 or 
GFAP (Figure 5.8).  As shown in Figure 5.8, R24 was co-expressed in NG2 positive 
cells indicating that OPCs express at least some of the gangliosides recognised by 
this antibody.  In addition, R24 was expressed in some, but not all, O4 positive 
oligodendrocytes: oligodendrocytes which were R24 negative were generally 
multi-processed and appeared to be in a later stage of the oligodendrocyte 
differentiation than R24 positive O4 cells (Figure 5.8).  While the majority of 
GFAP positive cells were negative for R24 (Figure 5.8), there were a few 
examples of R24 co-expression with GFAP, albeit rare.  Furthermore, the 
GFAP/R24 positive cells had a different morphology from other GFAP-positive 
cells as their GFAP staining was diffuse as opposed to fibrous as shown in Figure 
5.8.  R24 and SMI 31 did not co-localise, indicating that axons containing 
phosphorylated neurofilaments do not express the gangliosides recognised by 
this antibody (GD3, GT1a, GQ1b).  
To examine to which cell type the increased R24 expression seen in GalNAc T -/- 
cultures was localised, these were double labelled with R24 and one of the 
following antibodies: NG2, GFAP, or SMI 31 (Figure 5.8).  The increased R24 
immunolabelling in GalNAc T -/- cultures appeared to resemble axons, so it was 
surprising that the majority of SMI 31 positive axons were negative for R24 
(Figure 5.8).  However, when using the TUJ1 antibody, which labels both axons 
and dendrites, co-staining with R24 was evident as shown in Figure 5.8 (panel D).  
This suggests that GD3 was expressed in axons containing non-phosphorylated 
neurofilament and dendrites and to a lesser extent in axons containing 
phosphorylated neurofilament recognised by SMI 31.  As in the wild-type 
cultures, GalNAc T -/- cultures also showed that R24 was expressed by cells 
early in the oligodendrocyte lineage as shown in Figure 5.8 (Panel F).  Unlike in 
wild-type cultures, none of the astrocytes in GalNAc T -/- cultures were positive 
for R24 as shown in Figure 5.8 (panel J).   
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To examine whether myelinating oligodendrocytes expressed gangliosides 
recognised by A2B5 and R24, spinal cord cultures were co-labelled with AA3 
after 28 DIV (Figure 5.9).  It was found that myelinating oligodendrocytes as 
recognised by AA3, were negative for both A2B5 and R24 as shown in Figure 5.9. 
Immunoreactivity for CTx, which binds to GM1 was apparent in wild-type and Sia 
T -/- cultures but not GalNAc T -/- cultures as shown in Figure 5.6.  
Furthermore, in Sia T -/- cultures the intensity of the reactivity appeared to be 
slightly higher than in wild-type.  This may be due to an increase in the 
expression of a-series ganglioside GM1, in Sia T -/- mice.  As CTx specifically 
binds to a-series ganglioside GM1, it is not expressed in GalNAc T -/- cultures 
which lack all a-series gangliosides (Figure 5.6).  To determine which cell types 
within the spinal cord cultures expressed GM1 at 21 DIV, wild-type cultures were 
double labelled with CTx and one of the following markers: O4, GFAP or SMI 31 
(Figure 5.10).  GFAP positive astrocytes did not express GM1 as shown in Figure 
5.10.  After 21 DIV CTx was not expressed in O4 positive oligodendrocytes 
(Figure 5.10).  Contrastingly, after 28 DIV the O4 positive oligodendrocytes did 
co-express CTx (Figure 5.11), suggesting that GM1 expression is switched on in 
the more mature phenotype.  AA3 positive oligodendrocytes were also positive 
for CTx (Figure 5.11).  The majority of SMI 31 positive axons co-labelled with 
CTx after 21 DIV, however, at day 28, this was not always the case as shown in 
Figure 5.11.  Although in many instances CTx labelling was found throughout the 
myelinated axon, it was sometimes expressed near nodes of Ranvier in the 
paranodal region (Figure 5.11).  A similar pattern was seen in cultures isolated 
from Sia T -/- mice. 
MOG35, which is specific for a-series ganglioside GD1a, was expressed in wild-
type and Sia T -/- cultures but not in GalNAc T -/- cultures as these lack all a-
series gangliosides (Figure 5.6).  To elucidate which cell types express GD1a in 
the wild-type and Sia T -/- spinal cord cultures, these were double labelled with 
MOG 35 and one of the following antibodies: SMI 31, O4 or GFAP at 21 DIV 
(Figure 5.12).  GD1a was expressed on many, but not all, SMI 31 positive axons as 
shown in Figure 5.12 (panel A).  GFAP positive astrocytes were negative for 
MOG35 as shown in Figure 5.12 (panel C).  O4 positive oligodendrocytes did not 
express MOG 35 as shown in Figure 5.12 (panel B), however, AA3 positive 
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oligodendrocytes co-expressed MOG35 as illustrated in Figure 5.13.  In addition, 
an unidentified cell type expressed MOG35 as shown in Figure 5.12 (panel D).   
To summarise, various cell types (neurons, oligodendrocytes and astrocytes) 
within the spinal cord cultures expressed gangliosides investigated in this study, 
although some at different stages of development (see Table 5.1). 
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Figure 5.6. Ganglioside expression of dissociated spinal cord cultures from wild-type, Sia T -
/- and GalNAc T -/- mice. 
Dissociated spinal cord cultures from wild-type, GD3 S -/- and GalNAc T -/- mice were stained 
with CTx and antibodies A2B5, R24 and MOG35 at 21 DIV.  Wild-type and GalNAc T -/- cultures 
were positive for A2B5, which binds c-series gangliosides GT3 and O-acetyl GT3, whereas Sia T -
/- cultures lack all c-series gangliosides and therefore do not label with this antibody.  Wild-type 
and GalNAc T -/- cultures express R24, although the staining in GalNAc T -/- is stronger and more 
prevalent, suggesting an upregulation of b-series ganglioside GD3 which is labelled with R24.  Sia 
T -/- mice lack all b-series gangliosides and therefore do not label with R24.  Wild-type and Sia T 
-/- cultures label with CTx and MOG35 which label a-series gangliosides GM1 and GD1a, 
respectively.  GalNAc T -/- lack all a-series gangliosides and therefore do not label with these 
two markers.  Nuclei were labelled with DAPI (blue).  Scale bar = 50 µm.   
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Figure 5.7. A2B5 co-localised with SMI 31, TUJ1, GFAP and NG2 in wild-type cultures at 21 
DIV. 
Wild-type spinal cord cultures were double labelled with A2B5 and one of the following markers 
after 21 DIV: SMI 31 (A), TUJ1 (B), GFAP (C) and NG2 (D).  The co-localisation of A2B5 with SMI 31 
and TUJ1 in spinal cord cultures indicated that spinal cord neurons express gangliosides GT3 
and/or O-acetyl GT3, both of which are A2B5 antigens.  A2B5 staining co-localised with NG2 
which indicated that OPCs express GT3 and/or O-acetyl GT3.  The majority of GFAP positive 
astrocytes within spinal cord cultures were A2B5 negative (arrow), suggesting they are type-1 
astrocytes.  However, a subset of GFAP positive astrocytes was also labelled with A2B5 
suggesting they are type-2 astrocytes.  Nuclei were labelled with DAPI (blue).  Scale bar = 50 µm. 
NG2GFAP
A2B5 GFAP A2B5 NG2
A2B5 A2B5
SMI 31
A2B5 SMI 31
A2B5
A2B5 TUJ1
A2B5 TUJ1
B
D
A
C
  206 
 
R24 SMI 31
R24
A
SMI 31
R24 SMI 31
merged merged
B
R24 TUJ1C
merged R24 TUJ1 merged
R24 TUJ1D
w
ild
-
ty
pe
G
a
lN
Ac
 
T 
-
/-
w
ild
-
ty
pe
G
a
lN
Ac
 
T 
-
/-
w
ild
-
ty
pe
G
a
lN
Ac
 
T 
-
/-
w
ild
-
ty
pe
G
a
lN
Ac
 
T 
-
/-
  207 
 
R24
R24 NG2
R24 NG2
E R24 NG2
NG2
F
R24 O4
R24 O4
G R24 O4 R24 O4
R24
O4 O4
R24
H iiH i
w
ild
-
ty
pe
G
a
lN
Ac
 
T 
-
/-
w
ild
-
ty
pe
G
al
N
Ac
 
T 
-
/-
w
ild
-
ty
pe
G
a
lN
Ac
 
T 
-
/-
w
ild
-
ty
pe
G
al
N
Ac
 
T 
-
/-
  208 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.8.  R24 expression in wild-type and GalNAc T -/- cultures at 21 DIV. 
Wild-type (A, C, E, G and I) and GalNAc T -/- (B, D, F, H and J) spinal cord cultures were double 
labelled with R24 and one of the following markers after 21 DIV: SMI 31 (A and B), TUJ1 (C and 
D), NG2 (E and F), O4 (G and H) and GFAP (I and J).  Wild-type neurites were negative for both 
SMI 31 and TUJ1, whereas GalNAc T -/- neurites expressed the simple ganglioside GD3 as 
indicated by the co-localisation of R24 with SMI 31 (dashed box in B) and TUJ1.  However, not all 
SMI 31 positive axons expressed GD3 (white arrow in B).  The co-localisation of R24 with NG2 in 
these cultures indicated that OPCs express gangliosides recognised by this antibody.  O4 positive 
oligodendrocytes in the early stages of oligodendrocyte lineage expressed R24 (G and H i), while 
those with an extensive network of processes that appeared to be in the later stages of 
differentiation were R24 negative (pink arrow in G and H ii).  While a subset of GFAP-positive 
astrocytes within wild-type spinal cord cultures were R24 immunoreactive (*), the majority were 
R24 negative (yellow arrow). All of the GFAP positive astrocytes within GalNAc T -/- cultures 
were R24 negative, suggesting these are type-1 astrocytes.  Nuclei were labelled with DAPI 
(blue).  Scale bar = 50 µm. 
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Figure 5.9. A2B5 and R24 were not expressed by myelinating oligodendrocytes at 28 DIV. 
Wild-type spinal cord cultures were triple labelled with AA3, SMI 31 and either A2B5 (A) or R24 
(B) after 28 days in culture.  A2B5 and R24 did not co-localise with AA3 suggesting that 
myelinating oligodendrocytes did not express simple gangliosides GT3, O-acetyl GT3 or GD3.  
Scale bar = 50 µm. 
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Figure 5.10. CTx co-localises with SMI 31 in wild-type cultures at 21 DIV. 
Wild-type spinal cord cultures were double labelled with CTx, which specifically binds 
ganglioside GM1, and one of the following markers after 21 DIV: SMI 31 (A), O4 (B) and GFAP (C).  
The co-localisation of CTx with SMI 31 in these cultures indicated that phosphorylated 
neurofilament expresses GM1.  All of the GFAP positive astrocytes and O4 positive 
oligodendrocytes within these cultures were CTx negative at 21 DIV.  Nuclei were labelled with 
DAPI (blue).  Scale bar = 50 µm. 
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Figure 5.11. CTx co-localised with SMI 31, AA3 and O4 in wild-type cultures at 28 DIV. 
Wild-type spinal cord cultures were double labelled with CTx and the following markers after 28 
DIV: SMI 31 and AA3 (A and B) or O4 (C).  CTx expression changed between 21 and 28 DIV in that 
O4 positive oligodendrocytes which were in the late stage of differentiation became CTx positive 
whereas fewer SMI 31 positive axons showed CTx-immuoreactivity.  (*) shows an SMI 31 positive 
axon which was negative for CTx.  Also, at 28 DIV CTx was co-localised with AA3, which 
recognises myelin (box).  However, in some instances CTx labelling was not observed throughout 
the myelin, but rather in the paranodal region (arrow).  Nuclei were labelled with DAPI (blue).  
Scale bar = 10 µm.    
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Figure 5.12. MOG35 co-localised with SMI 31 in wild-type cultures at 21 DIV. 
Wild-type spinal cord cultures were double labelled with MOG35 and one of the following 
markers after 21 DIV: SMI 31 (A), O4 (B) or GFAP (C).  Oligodendrocytes and astrocytes did not 
express GD1a since O4 and GFAP did not co-localise with MOG 35.  Some SMI 31 positive axons 
expressed GD1a, whereas others did not (arrow).  There were MOG35 positive cells which did not 
label with SMI 31, O4 or GFAP (D).  Nuclei were labelled with DAPI (blue).  Scale bar = 50 µm.   
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Figure 5.13. MOG35 co-localised with AA3 in wild-type cultures at 28 DIV. 
Wild-type spinal cord cultures were triple labelled with AA3, SMI 31 and MOG35 after 28 days in 
culture.  MOG35 co-localised with AA3 suggesting that myelinating oligodendrocytes expressed 
simple gangliosides GD1a.  Scale bar = 10 µm. 
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Table 5.1. Table showing ganglioside expression in dissociated spinal cord cultures. 
Summary of ganglioside expression of cells in dissociated spinal cord cultures.  Wild-type neurons expressed gangliosides recognised by A2B5, CTx and MOG35, Sia T -/- 
neurons expressed gangliosides recognised by CTx and MOG35, and GalNAc T -/- neurons expressed gangliosides recognised by A2B5 and R24.  Only a small number of 
wild-type astrocytes expressed gangliosides recognised by A2B5 and R24 (*), Sia T -/- astrocytes were negative for all markers studied, while  a small number of GalNAc 
T -/- labelled with A2B5 (*).  Wild-type and GalNAc T -/- OPCs were positive for A2B5 and R24, whereas Sia T -/- OPCs were negative for all markers studied.  A subset 
of wild-type and Sia T -/- O4 positive oligodendrocytes which appeared to be in a late stage of oligodendrocyte differentiation and AA3 positive oligodendrocytes 
labelled with CTx (▫).  AA3 positive oligodendrocytes in wild-type and Sia T -/- cultures also labelled with MOG35 (•).  A subset of O4 positive oligodendrocytes which 
appeared to be in an early stage of oligodendrocyte differentiation were also positive for R24 in wild-type and GalNAc T -/- cultures(~).  
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5.2.5 Comparison of oligodendrocyte differentiation 
The remarkably distinctive ganglioside expression on differentiating 
oligodendrocytes suggests that they may play a functional role in 
oligodendrocyte differentiation.  To investigate this further, oligodendrocytes 
were labelled with markers found at different stages of oligodendrocyte 
differentiation, namely NG2, O4 and MBP. 
Spinal cord cultures from wild-type and ganglioside knockout mice were labelled 
with NG2, O4, and MBP as well as DAPI at 21 and 28 DIV.  Images were taken at 
x40 magnification and the number of immunopositive cells quantified from 
these.  Representative images for wild-type, Sia T -/- and GalNAc T -/- cultures 
at 21 DIV are shown in Figure 5.15, 5.16 and 5.17, respectively.  The 
representative images show that all three markers can be present in these 
cultures at the same time.   
The total number of DAPI positive nuclei was counted as well as the number of 
cells only labelled with NG2 (NG2+); cells which co-labelled with NG2 and O4 
(NG2+O4+); cells which only labelled with O4 (O4+); cells which co-labelled with 
O4 and MBP (O4+MBP+); and cells which were only labelled with MBP (MBP+).  The 
results are represented as the percentage of each cell type out of the total 
number of cells (Figure 5.14). 
It was found that spinal cord cultures from wild-type and Sia T -/- mice had a 
similar proportion of each cell type:  NG2+ early OPCs, NG2+O4+ late OPCs, O4+ 
oligodendrocytes, O4+MBP+ premyelinating oligodendrocytes and MBP+ 
myelinating oligodendrocytes.  In other words, the differentiation of 
oligodendrocytes from OPCs to myelinating oligodendrocytes was unaffected in 
mice lacking b- and c-series, but containing increased levels of a-series 
gangliosides.   
GalNAc T -/- cultures had a significantly lower proportion of NG2+ early OPCs 
compared with wild-type and Sia T -/- cultures (p=0.000), but had similar levels 
of NG2+O4+ late OPCs, O4+ oligodendrocytes, O4+MBP+ premyelinating 
oligodendrocytes and MBP+ myelinating oligodendrocytes.  Therefore, to 
summarise, the lack of complex, but increased simple gangliosides in GalNAc T -
/- cultures affects an early stage of differentiation in the oligodendrocytes 
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lineage, the differentiation of early OPCs into late OPCs, but has no affect on 
the later stages of oligodendrocytes differentiation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.14. Comparison of oligodendrocyte differentiation.  
Wild-type, Sia T -/- and GalNAc T -/- spinal cord were labelled with markers NG2, O4 and MBP at 
21 (A) and 28 DIV (B) to capture different stages of oligodendrocyte differentiation.  Cells which 
were only NG2 positive (NG2+) correspond to early OPCs; cells which were both NG2 and O4 
positive (NG2+O4+) are late OPCs; cells which were only O4 positive (O4+) are intermediate 
between the late OPC and the premyelinating oligodendrocyte stage; cells which were O4 and 
MBP positive (O4+MBP+) correspond to the premyelinating oligodendrocytes and cells which were 
only MBP positive (MBP+) are the myelinating oligodendrocytes.  The table shows that there was 
no significant difference in the proportion of cells double labelled with NG2 and O4; O4 alone; 
O4 and MBP; and MBP alone in ganglioside knockout mice compared with wild-type.  However, 
GalNAc T -/- mice had a significantly lower proportion of cells labelled with NG2 alone which 
indicated that they have a lower proportion of early OPCs when the spinal cord was cultured in 
vitro.  (*) p < 0.001. 
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Figure 5.15. Wild-type spinal cord culture at 21 DIV in differentiation medium. 
Representative image of wild-type spinal cord cultures at 21 DIV grown in differentiation media, 
immunolabelled with NG2 (green, III), O4 (red, IV) and MBP (blue, V).  The merged image is 
shown in I, while III to V show the individual markers.  Nuclei were labelled with DAPI (white, II).  
Examples of following can be seen in this image: NG2+ early OPCs (white arrow), NG2+/O4+ late 
OPCs (white arrowhead), O4+ oligodendrocytes (yellow arrow), O4+/MBP+ pre-myelinating 
oligodendrocytes (yellow arrowhead), and MBP+ myelinating oligodendrocytes (orange arrow).  
Note that NG2+/O4+ and O4+ cells were multi processed.  Scale bar = 50 µm.  
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Figure 5.16. Sia T -/- spinal cord culture at 21 DIV in differentiation medium. 
Representative image of Sia T -/- spinal cord culture at 21 DIV grown in differentiation medium, 
immunolabelled with NG2 (green, III), O4 (red, IV) and MBP (blue, V).  The merged image is 
shown in I, while III to V show the individual markers.  Nuclei were labelled with DAPI (white, II).    
Examples of following can be seen in this image: NG2+ early OPCs (white arrow), NG2+/O4+ late 
OPCs (white arrowhead), O4+ oligodendrocytes (yellow arrow), and MBP+ myelinating 
oligodendrocytes (orange arrow).  Note that the NG2+/O4+ and O4+ cells had many branched 
processes.  Scale bar = 50 µm.  
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Figure 5.17. GalNAc T -/- spinal cord culture at 21 DIV in differentiation medium. 
Representative image of GalNAc T -/- spinal cord culture at 21 DIV grown in differentiation 
medium, immunolabelled with NG2 (green, III), O4 (red, IV) and MBP (blue, V).  The merged 
image is shown in I, while III to V show the individual markers.  Nuclei were labelled with DAPI 
(white, II).  Examples of following can be seen in this image: NG2+/O4+ late OPCs (white 
arrowhead), O4+ oligodendrocytes (yellow arrow), and MBP+ myelinating oligodendrocytes 
(orange arrow).  Scale bar = 50 µm. 
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5.2.6 Relationship between oligodendrocytes and axons 
It has so far been shown that neurites and glia found in the spinal cord cultures 
differentially express gangliosides.  This, however, appeared to have no major 
effect on the differentiating properties of the oligodendrocytes.  To investigate 
whether the lack of gangliosides affects the relationship between glia and axons, 
the interaction between oligodendrocytes and axons in spinal cord cultures was 
studied by confocal microscopy after 7, 14, 21 and 28 days in culture.  Earlier 
stages of oligodendrocyte differentiation were visualised using the O4 antibody, 
and later using the AA3 antibody.  Axons were visualised using SMI 31 (Figures 
5.19 – 5.21).   
The interaction between oligodendrocytes and axons appeared to be similar 
when comparing wild-type and ganglioside knockout cultures (Figures 5.19 – 
5.21).  After 7 DIV the O4 positive oligodendrocytes had few processes.  After 14 
DIV, many of the oligodendrocytes were multiprocessed and some of their 
processes were contacting an axon.  After 21 DIV, many of the oligodendrocytes 
expressed AA3, and some myelin was seen wrapped around the axons.  The 
nodes of Ranvier were not evident at this stage; however, after 28 DIV the nodes 
of Ranvier were more abundant.  
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Figure 5.18. Relationship between oligodendrocytes and axons in wild-type cultures. 
Wild-type spinal cord cultures were co-labelled with O4 (green) and SMI 31 (red) after 7 and 14 
DIV as well as AA3 (green) and SMI 31 (red) after 21 and 28 days in culture to observe the 
relationship between oligodendrocytes and axons.  At 7 DIV, oligodendrocytes had very few 
processes and were located near axons.  By 14 DIV oligodendrocytes had developed extensive 
networks of processes and began to contact and ensheath the axons (arrows).  At 21 and 28 DIV 
it could be seen that oligodendrocytes were in close contact with the axons and were forming 
myelin.  In addition, at 28 DIV, the myelin sheaths appeared to be interrupted by nodes of 
Ranvier.  Scale bars = 50µm. 
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Figure 5.19. Relationship between oligodendrocytes and axons in Sia T -/- cultures. 
Sia T -/- spinal cord cultures were co-labelled with O4 (green) and SMI 31 (red) after 7 and 14 
DIV as well as AA3 (green) and SMI 31 (red) after 21 and 28 days in culture to observe the 
relationship between oligodendrocytes and axons.  Sia T -/- oligodendrocytes differentiated and 
began to myelinate axons in a similar manner to that described for wild-type cultures (Figure 
5.18).  Scale bars = 50µm. 
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Figure 5.20. Relationship between oligodendrocytes and axons in GalNAc T -/- cultures. 
GalNAc T -/- spinal cord cultures were co-labelled with O4 (green) and SMI 31 (red) after 7 and 
14 DIV as well as AA3 (green) and SMI 31 (red) after 21 and 28 days in culture to observe the 
relationship between oligodendrocytes and axons.  GalNAc T -/- oligodendrocytes differentiated 
and began to myelinate axons in a similar manner to that described for wild-type cultures 
(Figure 5.18).  Scale bars = 50µm. 
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5.2.7 Comparison of axonal density and PLP staining 
The studies using confocal microscopy showed no obvious difference in the 
interplay between axons and oligodendrocytes as a result of altering the 
ganglioside expression.  The next aim was therefore to investigate the 
myelinating properties of wild-type, Sia T -/- and GalNAc T -/- oligodendrocytes.  
For this purpose spinal cord cultures were double-labelled with an axonal marker 
SMI 31 and the AA3 antibody that recognises PLP at 21 and 28 days in culture 
(Figure 5.21).  Axonal density was quantified using Image J by determining the 
area of SMI 31 immunoreactivity as a percentage of the total area of the image.  
The percentage of axons expressing PLP was calculated by measuring the 
immunoreactivity associated with AA3, dividing it by the area obtained for 
axonal density and multiplying it by a 100.  The percentage of axons within a 
given area and the percentage of these expressing PLP is shown in Figure 5.21.   
After 21 days in culture axonal density was significantly higher in Sia T -/- 
cultures compared to GalNAc T -/- and wild type cultures (p < 0.05), however, 
by 28 DIV axonal density was similar in all three genotypes.  Thus, although the 
increase in a-series and the lack of b- and c-series gangliosides in axons of Sia T -
/- mice initially lead to increased axonal density, this increase was not 
sustained.  Furthermore, in agreement with the observation that 
oligodendrocyte differentiation was unaffected in Sia T -/- cultures, PLP 
labelling was also unaffected in Sia T -/- cultures, again suggesting that 
increased a-series and lack of b- and c-series gangliosides does not affect 
oligodendrocyte differentiation and axonal myelination.  
The lack of complex gangliosides in GalNAc T -/- mice did not have an effect on 
axonal development either.  However, the percentage of axons expressing PLP 
after 21 DIV was significantly lower in GalNAc T -/- (p < 0.05).  However, after 
28 DIV the difference was no longer statistically significant.  This suggests that 
the lack of complex gangliosides and the concomitant increase in simple 
gangliosides, leads to delayed expression of PLP but levels are restored to those 
similar to wild-type by 28 DIV.  
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Figure 5.21.  Axonal density and PLP labelling in wild-type, Sia T -/- and GalNAc T -/- spinal 
cord cultures. 
Axonal density (A) and PLP labelling (B) of wild-type, Sia T -/- and GalNAc T -/- spinal cord 
cultures maintained in differentiation medium at 21 and 28 days in culture.  Spinal cord cultures 
from wild-type and ganglioside knockout mice were labelled with SMI 31 to detect axons and AA3 
to detect PLP expression at 21 and 28 DIV.  The percentage axons within a given area and the 
percentage area of axons labelled with AA3 was measured as described in the Methods section.  
At 21 DIV, Sia T -/- cultures showed increased axonal density compared with wild-type and 
GalNAc T -/- cultures (blue *; p = 0.029), however, by 28 DIV the axonal density was similar in all 
cultures.  At 21 DIV, PLP labelling was significantly lower in GalNAc T -/- cultures (green *; p = 
0.045), however, at 28 DIV the percentage of myelinated axons was similar in all three 
genotypes.  
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5.2.8 Localisation of proteins at the node of Ranvier 
As shown in Figures 5.19 to 5.21, after 28 DIV the myelin internodes were 
interrupted by what appeared to be node of Ranvier.  To examine whether 
gangliosides play a role in node of Ranvier formation the localisation of NF155 
and Caspr at the paranodes, Nav at the nodes of Ranvier and Kv at the 
juxtaparanodes was investigated.  Wild-type, Sia T -/- and GalNAc T -/- cultures 
were triple labelled with AA3 to detect myelin, Nav antibody and one of the 
following antibodies: Kv1.2, Caspr or NF155.  Cultures were also labelled with an 
antibody against Kv1.1, however, none of the cultures were positive for this 
antibody. 
As shown in Figure 5.22, Nav were distributed continuously throughout the 
axonal membrane in unmyelinated axons, however, in myelinated axons 
containing nodes of Ranvier, the Nav immunoreactivity was confined to the node.  
As shown in Figure 5.22 (panel C) GalNAc T -/- cultures sometimes had sodium 
channels distributed throughout the axonal membrane as well as concentrated at 
the nodes of Ranvier.  This did not occur in wild-type and Sia T -/- cultures. 
The distribution of Caspr and NF155 immunoreactivity was found to be confined 
to the paranodal region, on either side of the sodium channel.  This pattern was 
similar in all three genotypes as shown in Figures 5.24 and 5.25, respectively.   
In wild-type and Sia T -/- myelinated fibres, Kv1.2 immunolabelling was located 
at the paranodal and juxtaparanodal regions as shown in Figure 5.25 (panels A 
and B, respectively).  Although, in some wild-type myelinated fibres Kv1.2 were 
beginning to confine to only the juxtaparanodal regions as demonstrated in 
Figure 5.26.   
In contrast to wild-type and Sia T -/- cultures, the Kv1.2 immunolabelling in 
GalNAc T -/- cultures after 28 DIV was either spread throughout the myelinated 
axon as shown in Figure 5.25 (panel C), was co-localised with Nav at the node of 
Ranvier or was only observed on one side of the node of Ranvier in the paranodal 
and juxtaparanodal regions as shown in Figure 5.29 (panel D).  However, as can 
be seen in Figure 5.27, at 30 and 32 DIV in GalNAc T -/- cultures Kv labelling is 
also localised in the paranodal and juxtaparanodal regions. 
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In summary, in wild-type and Sia T -/- mice Caspr, neurofascin 155, Kv1.2, and 
Nav were localised as would be expected based on in vivo observations.  
However, in GalNAc T -/- myelinated axons Kv1.2 immunoreactivity was not 
confined to the paranodal and juxtaparanodal regions until 30 to 32 DIV.  
Instead, it was spread throughout the axonal membrane and was only beginning 
to localise at the juxtaparanode at 28 DIV.  These results suggest that the 
assembly of nodal proteins is retarded in the absence of complex gangliosides.   
5.2.9 Comparison of astrocyte morphology 
Several studies have shown that the addition of exogenous gangliosides can alter 
the morphology of astrocytes (Hefti et al, 1985; Skaper et al, 1986; Facci et al, 
1987).  To determine whether the morphology of astrocytes was different in 
ganglioside knockout mice compared with wild-type, astrocytes were labelled 
with GFAP and their morphology studied using confocal microscopy.  As shown in 
figure 5.28, the morphology of astrocytes was similar in all genotypes.  It has 
also been shown that processes of perinodal astrocytes are in close association 
with the node of Ranvier.  To determine if perinodal astrocytes were present in 
spinal cord cultures, these were triple labelled with AA3 to visualise myelin, SMI 
31 to visualise axons and GFAP to visualise astrocytes (Figure 5.29).  Although 
astrocytes were present near nodes of Ranvier, it was not possible to determine 
by confocal microscopy whether their processes were associated with nodes of 
Ranvier (see Figure 5.29). 
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Figure 5.22. Sodium channel clustering at nodes of Ranvier at 28 DIV. 
Wild-type (panel A), Sia T -/- (panel B) and GalNAc T -/- (panel C) spinal cord cultures were 
labelled with AA3 (red), which recognises compact myelin, and an antibody against voltage 
dependent sodium channels (Nav; green).  In unmyelinated fibres Nav staining was observed 
throughout the axonal membrane (white arrowheads).  In myelinated fibres in wild-type and Sia 
T -/- cultures, Nav clustering is displayed at nodes of Ranvier (white arrows).  Although GalNAc T 
-/- cultures displayed Nav clustering at node of Ranvier (Figures 5.25 and 5.26), it was also 
observed that some myelinated fibres in GalNAc T -/- cultures showed Nav immunoreactivity 
throughout the axonal membrane (pink arrowheads) as well as at the node of Ranvier.  However, 
the occurrence of the latter was not quantified.  Scale bar = 20 µm. 
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Figure 5.23. The paranodal localisation of Caspr 
Wild-type (panel A), Sia T -/- (panel B) and GalNAc T -/- (panel C) spinal cord cultures were 
labelled with AA3 (red), which recognises compact myelin, Nav (blue) to show the node of 
Ranvier and Caspr (green) at 28 DIV.  It was observed that Caspr was localised at the paranodes 
of myelinated fibres in all three genotypes (white arrows).  Scale bar = 20 µm. 
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Figure 5.24. The paranodal localisation of neurofascin 155 
Wild-type (panel A), Sia T -/- (panel B) and GalNAc T -/- (panel C) spinal cord cultures were 
labelled with AA3 (red), which recognises compact myelin, Nav (blue) to show the node of 
Ranvier and neurofascin 155 (green) at 28 DIV.  It was observed that neurofascin was localised at 
the paranodes of myelinated fibres in all three genotypes (white arrows).  Scale bar = 20 µm. 
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Figure 5.25. The paranodal and juxtaparanodal localisation of Kv1.2 
Wild-type (panel A), Sia T -/- (panel B) and GalNAc T -/- (panel C and D) spinal cord cultures 
were labelled with AA3 (red), which recognises compact myelin, Nav (blue) to show the node of 
Ranvier and Kv1.2 (green) at 28 DIV.  In wild-type and Sia T -/- cultures, Kv1.2 was seen in the 
paranodal and juxtaparanodal area, however, in GalNAc T -/- cultures, the localisation of Kv1.2 
was disturbed.  Instead of being only localised to the paranodes and juxtaparanodes, Kv were 
also spread throughout the axonal membrane (C) and node of Ranvier (D).  Scale bar = 20 µm. 
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Figure 5.26. Juxtaparanodal localisation of Kv1.2 in wild-type cultures at 28 DIV. 
Wild-type spinal cord cultures were labelled with AA3 (red), which recognises compact myelin, 
Nav (blue) to show the node of Ranvier and Kv1.2 (green) at 28 DIV.  As shown in Figure 5.25, at 
28 DIV, Kv was localised at paranodes and juxtaparanodes in the majority of wild-type 
myelinated fibres, however, occasionally Kv labelling was starting to localise to only the 
juxtaparanode.  Scale = 20 µm. 
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Figure 5.27. The localisation of Kv1.2 in GalNAc T -/- cultures at 30 and 32 DIV. 
GalNAc T -/- spinal cord cultures were labelled with AA3 (red), which recognises compact 
myelin, Nav (blue) to show the node of Ranvier and Kv1.2 (green) at 30 DIV (panel A) and AA3 
(red), SMI 31 (blue) to show the axons and Kv1.2 at 32 DIV (panel B).  As shown in Figure 5.25, at 
28 DIV in GalNAc T -/- cultures, Kv were spread throughout the axonal membrane, however, by 
30 to 32 DIV Kv labelling was localised to the paranode and juxtaparanode.  In other words, at 30 
to 32  DIV, the Kv labelling in GalNAc T -/- cultures resembled that of wild-type and Sia T -/- 
cultures at 28 DIV.  Scale bar = 20 µm. 
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Figure 5.28. Morphology of astrocytes. 
Spinal cord cultures obtained from wild-type (I), Sia T-/- (II) and GalNAc T -/- (III) mice were 
labelled with the typical astrocyte marker GFAP and DAPI to show cell nuclei (in III) to 
investigate if the morphology of astrocytes differed between wild-type and ganglioside knockout 
mice.  It was found that there was no difference in astrocyte morphology between wild-type and 
ganglioside knockout mice.  Scale bar = 50 µm. 
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Figure 5.29. Representative images of astrocytes located near node of Ranvier in wild-type 
spinal cord cultures. 
To investigate whether astrocyte processes were associated with node of Ranvier of Ranvier in 
spinal cord cultures, wild-type cultures were labelled with GFAP to visualise astrocytes, AA3 to 
visualise compact myelin and SMI 31 to visualise axons.  Although the astrocytes processes were 
found near nodes of Ranvier it was not possible to determine whether they were in contact.  
Scale bar = 20 µm. 
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5.3 Discussion 
5.3.1 Ganglioside expression of dissociated spinal cord 
cultures. 
The The main aim of this study was to characterise the ganglioside expression of 
the main cell types present within dissociated spinal cord cultures, namely 
astrocytes, neurons, and oligodendrocytes.  This would then allow us to 
ascertain if there was differential expression between the various cell types and 
also whether there was justification to carry out further studies on the various 
cell types from the ganglioside transgenic mice.   
Initially, the optimal culture conditions for these cultures were investigated.  
Two media were tested which had subtle differences in their composition, to 
ensure I had optimal conditions for myelination.  Thomson et al (2006) found 
that myelin formation was better in differentiation medium and was not 
promoted by Neurobasal medium with B27 supplement.  Although the present 
study did not find any difference in axonal growth or myelination between 
cultures maintained in the two media, it was decided to perform subsequent 
experiments using cultures maintained in differentiation medium.  The cultures 
were initially established in serum-rich plating medium, and were subsequently 
fed using serum-free differentiation medium such that the concentration of 
serum declined with each feeding so that, by 10–12 days in vitro, it was less than 
1% (Thomson et al., 2006). 
5.3.1.1 Ganglioside expression of OPCs and oligodendrocytes 
During nervous system development OPCs progress through a series of 
morphologically and immunohistochemically distinct differentiation steps, 
starting as proliferating and migrating progenitor cells and leading to mature 
myelinating oligodendrocytes.  Out of the four markers tested, OPCs, as labelled 
by the antibody NG2, were positive for A2B5 and R24 but negative for CTx and 
MOG35.  As OPCs matured into oligodendrocytes, their ganglioside expression 
changed.  Mature myelinating oligodendrocytes no longer labelled with A2B5 and 
R24 and instead labelled with CTx and MOG35.  This is in agreement with 
previous studies looking at ganglioside expression of oligodendrocytes, which 
  241 
also found that their ganglioside expression differs during different stages of 
development.   
Farrer and Quarles (1999) showed that OPCs in culture express ganglioside GT3, 
O-acetyl GT3 and 9-O-acetyl GD3, all of which are down-regulated as OPCs 
differentiate into oligodendrocytes but continue to be expressed when they 
differentiate into type-2 astrocytes.  This is in agreement with the present 
study, where it was found that A2B5, which binds to GT3 and O-acetyl GT3 
(Fenderson et al., 1987, Dubois et al., 1990) co-labelled with the OPC marker 
NG2 and astrocyte marker GFAP, but not myelinating oligodendrocyte marker 
AA3.  Yim et al  (1994, , 1995) showed that GD3 and GM3 are major gangliosides 
in OPCs, with GM3 synthesis increasing dramatically as OPCs differentiate to 
mature oligodendrocytes, whereas the level of GD3 remained relatively constant 
as the cells differentiated to mature oligodendrocytes.  The present study did 
not investigate the expression of the simple ganglioside GM3.  In agreement with 
Yim et al, the present study demonstrated that GD3 was expressed in both NG2 
positive OPCs as well as O4 positive oligodendrocytes. 
Yu and Yen (1975) showed that GM1 is the major ganglioside in mouse myelin 
and that it increases with age.  This was confirmed by Cochran et al (1982) who 
also showed that mouse myelin contained 59.6% GM1, 4.7% GM4, 4.2% GD3, 4.8% 
GD2, 8% GD1b, 4.2% GT1b, 2.6% GQ1b, 0.3% GM3, 3.6% GM2, 8% GD1a and 4.8% 
GT1a.  This is partly in agreement with the present study where it was found 
that myelinating oligodendrocytes contained GM1 and GD1a, however in contrast 
to the study by Cochran et al (1982), the present study did not observe co-
localisation of AA3 with R24, which binds to GD3.   
Ganglioside expression of oligodendrocytes suggests that simple gangliosides, 
GT3 and GD3 that are recognised by A2B5 and R24, respectively, and are found 
on OPCs, are more likely to be involved in modulating functions such as 
proliferation and migration.  Whereas complex gangliosides, GM1 and GD1a that 
are recognised by CTx and MOG35, respectively, and are found on mature 
oligodendrocytes, are more likely to be involved in modulating functions such as 
myelination and node of Ranvier formation.  
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5.3.1.2 Ganglioside expression of astrocytes 
Type-2 astrocytes are positive for A2B5 antibody labelling (Farrer and Quarles, 
1999), whereas type-1 astrocytes are negative (Raff et al., 1983a, Murakami et 
al., 1999).  Type-2 astrocytes also express GD3 (Murakami et al., 1999).  The 
present study demonstrated that the majority of astrocytes within spinal cord 
cultures are A2B5 negative although some A2B5 positive astrocytes were also 
present.  In addition, very few spinal cord astrocytes labelled with R24, which 
binds to GD3.  This indicates that the majority of astrocytes in spinal cord 
cultures are type-1 astrocytes.  The present study also found that astrocytes in 
spinal cord  cultures did not express GM1 or GD1a, which is in agreement with 
previous studies that have shown that rodent astrocytes do not contain GM1 on 
their cell surface (Asou and Brunngraber, 1983, Yamamoto et al., 2007, Asou et 
al., 1989a, Asou et al., 1989b, Sbaschnig-Agler et al., 1988).  In contrast, it was 
demonstrated that adult human brain tissue expressed GM1 and GD1b on all 
astrocytes (Marconi et al., 2005) and a study in mouse foetal astrocytes found 
GM1 expression to be regulated by the cell cycle, with maximal expression 
during G0/G1 phase (Xie et al., 2004, Ledeen and Wu, 2006).  Kawai et al 
(1999b, 1999a) reported that normal astrocytes in adult human tissue lack GD3 
expression, but instead GD3 is expressed in the cytoplasm of reactive and 
neoplastic astrocytes.  It is possible that the astrocytes which labelled with R24 
in the present study are reactive astrocytes.  In contrast to the present study, it 
was found that in young and adult mouse brain, both normal and reactive 
astrocytes express GD3 (Cammer and Zhang, 1996), which may indicated that 
astrocytes have a different ganglioside expression in vivo and in vitro.  Moreover, 
in contrast to the present study GD3 was found to be expressed in cultured rat 
astrocytes (Kawashima et al., 1996), which might be due to a species difference.   
To confirm the ganglioside expression of astrocytes, primary astrocyte cultures 
could be obtained (differentiated from neurospheres isolated from the corpus 
striatum), gangliosides extracted and the ganglioside content examined by thin 
layer chromatography and tandem mass spectrometry.  
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5.3.1.3 Ganglioside expression of spinal cord neurons 
The present study found that neurons present in dissociated spinal cord cultures 
isolated from wild-type mice labelled with A2B5, which binds to gangliosides 
GT3, O-acetyl GT3 (Dubois et al., 1990, Fenderson et al., 1987) and GQ1c (Kasai 
and Yu, 1983), CTx, which binds to GM1 and MOG35, which binds to GD1a.  A2B5 
was originally thought to bind only to neurons in chick CNS and PNS tissues 
(Eisenbarth et al., 1979), and was found to bind to the majority of neurons in 
cultures of a variety of vertebrate CNS tissues (Berg and Schachner, 1982, 
Schnitzer and Schachner, 1982), which is in agreement with the present study.  
In agreement with the present study, numerous studies have shown that neurons 
express GM1 on their cell surface both in situ and in vitro (Asou et al., 1983, 
Okada et al., 1982).  Vyas et al (2002) showed that GD1a is expressed on the cell 
surface of nerves, which is in accordance with the present study.  Furthermore, 
gangliosides GD1a and GT1b, which are present on the surface of axons, act as 
functional ligands for MAG and play a role in MAG-mediated inhibition of neurite 
outgrowth (Vyas et al., 2002).  However, in contrast to other studies (Molander 
et al., 1997, Sheikh et al., 1999a, Susuki et al., 2007b), the present study did 
not observe the localisation of GM1 at paranodes.  These contrasting results may 
reflect differences in antibodies used or experimental methods.  In previous 
studies the animals were perfused with paraformaldehyde prior to dissection 
(Molander et al., 1997, Sheikh et al., 1999a, Susuki et al., 2007b) and the tissue 
permeabilised with Triton X (Molander et al., 1997, Susuki et al., 2007b), 
whereas in the present study, the ganglioside labelling was performed on 
unfixed cultures without the use of detergents, which could account for the 
different results.  Indeed, it has been found that the fixation method can greatly 
influence the apparent localisation of gangliosides (Schwarz and Futerman, 
1997).  Autoantibodies to GM1 and GD1a attack the nodal region and cause 
AMAN, which is usually restricted to peripheral motor nerve fibres (Hughes and 
Cornblath, 2005).  The present study did not observe the presence of GD1a at 
paranodes of cultured spinal cord neurons, so it is possible that GD1a is only 
present near nodes of Ranvier in peripheral nerves. 
The present study revealed that axons in wild-type spinal cord cultures were R24 
negative whereas GalNAc T -/- axons were R24 positive suggesting that in wild-
type axons GD3 is converted into more complex gangliosides. 
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Because ganglioside knockout mice have altered paranodal junctions, broadened 
Na+ channel clusters, and mislocalisation of juxtaparanodal K+ channels at the 
paranodes (Susuki et al., 2007a), it is important to examine the ganglioside 
expression of axons and oligodendrocytes at and around the nodes of Ranvier in 
more detail.  Different staining protocols should be tested to examine the 
ganglioside expression of myelinated axons in spinal cord cultures at 28 and 32 
DIV at which point many of the myelinated axons contain nodes of Ranvier.  
5.3.1.4 Summary of ganglioside expression  
The initial aim of this study was to investigate the role of gangliosides in the 
final step of oligodendrocyte differentiation, the myelination of axons.  As 
demonstrated by immunocytochemistry in this study and by others, ganglioside 
composition undergoes significant changes during oligodendrocyte development.  
This could potentially have an impact on the myelination of axons by 
oligodendrocytes.  It has also been shown that axons express gangliosides on 
their cell surface, and these gangliosides may also play a role in the myelination 
process.  Finally, although astrocytes are not directly involved in the myelination 
process, it has been shown that astrocytes promote myelination by mature 
oligodendrocytes in an activity dependent manner (Ishibashi et al., 2006) and 
the close association of perinodal astrocyte processes with nodes of Ranvier 
suggests that they may play a functional role.  Astrocytes also express numerous 
gangliosides (described in section 1.2.1.2), which could affect their function.  
5.3.2 Differentiation of oligodendrocytes 
The present study found that the antigenic differentiation of oligodendrocytes 
was similar in all three genotypes with one major exception being that GalNAc T 
-/- mice had lower numbers of the more immature NG2+O4- OPCs.   
The differentiation of Sia T -/- OPCs into oligodendrocytes was unaffected in 
optic nerve and spinal cord cultures despite the lack of many of the gangliosides 
normally present in OPCs.  This would suggest that b-series ganglioside GD3 
which is present in OPCs and oligodendrocytes in wild-type cultures but absent 
in Sia T -/- cultures and c-series gangliosides GT3 and O-acetyl GT3, which are 
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present in wild-type OPCs but absent in Sia T -/- OPCs, do not play a role in the 
differentiation in the early or late stages of the oligodendrocyte lineage.   
Reduced numbers of NG2+O4- early OPCs in GalNAc T -/- could be due to several 
factors.  The increased amount of simple gangliosides GM3, GD3 and GT3 in 
GalNAc T -/- cultures may drive the differentiation into NG2+O4+ 
oligodendrocytes.  It can be seen in figure 5.14 that GalNAc T -/- cultures do 
have higher levels of NG2+O4+ cells compared with wild-type and Sia T -/- 
cultures (although this increase is not statistically different), which would 
support this argument.  Indeed Yu et al (Yu et al., 1994) have shown that 
increased level of GM3 enhances the differentiation of OPCs towards 
premyelinating oligodendrocytes.   
Alternatively, it may be that the increased amount of simple gangliosides leads 
to a reduction in the proliferation or survival of OPCs.  The spinal cord cultures 
were maintained in the presence of insulin, which is a survival factor for 
oligodendrocytes (Barres et al., 1992), after which the insulin is withdrawn.  It 
may be possible that GalNAc T -/- early OPCs are less resistant to the withdrawal 
of insulin.  Due to time constraints it was not possible to perform proliferation or 
apoptosis assays to examine whether the lack of NG2+ OPCs in GalNAc T -/- 
cultures was due to reduced proliferation or increased cell death.  However, it 
was observed that GalNAc T -/- cultures at 7 DIV did not appear to have lower 
levels of NG2+ OPCs compared with wild-type which would suggest that reduced 
early OPC numbers in GalNAc T -/- mice at 21 and 28 DIV may be due to either 
reduced proliferation or increased apoptosis.   
GalNAc T -/- knockouts have decreased myelination in the optic nerve and 
demyelination in the sciatic nerve (Sheikh et al., 1999a).  It has been shown that 
adult brains also contain a pool of OPCs which could be used to produce 
myelinating oligodendrocytes.  Future studies could examine whether GalNAc T -
/- mice contain lower number of “adult OPCs” in vivo.  If this is the case, 
inadequate remyelination in GalNAc T -/- mice may be the result of a reduced 
number of OPCs.  It is possible that the lack of OPCs means that when myelin 
deteriorates, there are not enough OPCs present to differentiate and form 
myelinating oligodendrocytes in order to replace the damaged myelin. 
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The present study has demonstrated a reduction in OPCs in GalNAc T -/- cultures 
which have increased levels of GD3.  This may reflect the pathology of MS as it 
has been reported that plaques have high levels of GD3 (Yu et al., 1974).  Thus 
the increased GD3 in MS plaques may cause decreased proliferation or increased 
apoptosis of OPCs which may contribute to the failure of OPCs to remyelinate 
the demyelinated axons. 
To try and interpret the reason for lower numbers of the NG2+/O4- OPCs future 
studies could examine the differentiation of oligodendrocytes in GalNAc T -/- 
mice in more detail in the presence and in the absence of axons.  In this study, I 
compared the differentiation of wild-type, GalNAc T -/- and Sia T -/- 
oligodendrocytes in the presence of axons, at 21 and 28 DIV.  It would be 
beneficial to repeat this experiment at earlier time-points (for example, after 1, 
7 and 14 DIV) to assess if the numbers of NG2+O4- early OPCs in GalNAc T -/- 
mice are lower initially or if this develops over time.    
In this project I studied the differentiation of wild-type and Sia T-/- optic nerve 
oligodendrocytes in the absence of axons.  The low number of oligodendrocytes 
obtained from the optic nerve limited the number and the type of experiments 
that could be carried out and meant that I could only examine wild-type and Sia 
T -/- oligodendrocytes.  In order to examine the role of gangliosides in 
oligodendrocyte biology in more detail a method of generating large numbers of 
mouse oligodendrocytes is needed. This could be achieved by culturing OPCs 
isolated from neonatal mouse spinal cord using a method previously described 
(Thomson et al., 1999).  This method could be used to obtain not only wild-type 
and Sia T -/- cultures, but also GalNAc T -/- and DKO cultures because each 
spinal cord could be cultured separately and the genotype examined by labelling 
with CTx.  This would allow a more detailed examination of the role of 
gangliosides in oligodendrocyte differentiation in the absence of axons, by 
comparing antigen expression, morphology and by measuring process extension 
as previously described (Sorensen et al., 2008).  This would show whether 
GalNAc T -/- cultures also had lower numbers of NG2+O4- early OPCs in the 
absence of axons. 
Having shown that b- and c-series gangliosides do not play a role in the 
differentiation of oligodendrocytes, the next step would be to examine whether 
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gangliosides expressed in migratory and proliferative OPCs modulate these 
processes.  Using OPCs isolated from neonatal spinal cord, proliferation and 
differentiation of oligodendrocytes obtained from wild-type and ganglioside 
knockout mice could be compared using flow cytometry as described previously 
(Lu et al., 2008).  Alternatively, oligodendrocyte proliferation could be 
examined by Ki67 or BrdU immunolabelling. 
OPC migration is controlled by a combination of short-range attractants and 
repellents, such as tenascin, ephrin and anosmin-1 as well as long-range 
chemoattractants and chemorepellents, such as chemokines, growth factors and 
semaphorins. The role of each of these factors can differ depending on the 
location and during the course of development, probably due to changes in the 
receptor repertoire of OPCs and to environmental co-factors.  Numerous in vitro 
studies have suggested that gangliosides play a modulatory role in cell migration 
and adhesion, however, the fact that ganglioside knockout mice develop 
normally suggests that compensatory mechanisms and/or molecular or functional 
substitutions must exist.  It is likely that gangliosides do not directly influence 
OPC migration but rather that they modulate the effects of other molecules.  
Indeed, it has been shown that an interaction of tenascin-R with cell surface 
disialogangliosides mediates a selective inhibition of integrin-dependent cell 
adhesion to fibronectin in vitro (Probstmeier et al., 1999).  Since GD3-positive 
OPCs are highly motile, it would be interesting to examine the migration of OPCs 
obtained from ganglioside knockout mice, especially from the double knockout 
mice.  Since gangliosides are thought to modulate the function of most growth 
factors, it would be interesting to examine the migration of OPCs in response to 
PDGF and FGF, both of which are chemoattractant for OPCs. To examine the 
interaction between gangliosides, integrins and tenascin-R, OPC adhesion and 
migration would have to be examined on different substrates such as PLL, 
laminin, fibronectin and vitronectin, in the presence and absence of tenascin.  
Moreover, if gangliosides do play a role in OPC migration, future studies should 
investigate whether gangliosides interact with any of the other molecules 
involved in OPC migration, such as NG2, netrin or PSA-NCAM.  
Due to time constrains, I was not able to repeat any of the experiments using 
cultures obtained from double knockout mice as these animals are poor breeders 
and produce low numbers of homozygous pups.  The simpler gangliosides are, to 
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some extent, able to compensate for the lack of complex gangliosides, which 
makes it more difficult to interpret results obtained from single knockouts 
because it is hard to dissect out whether a particular result is due to the lack of 
particular gangliosides or the excess of others.  Therefore, experiments in 
double knockout mice which only express GM3, should shed more light on the 
role of ganglioside in oligodendrocyte proliferation, migration and 
differentiation in the absence or presence of axons.  
5.3.3 Relationship of oligodendrocytes with axons 
The mixed spinal cord cultures used in these experiments seem to follow in vivo 
development, allowing the in vitro study of several stages of neural development 
(Hardy and Friedrich, 1996, Sherman and Brophy, 2005, Trapp et al., 1997).  The 
early phase of development is characterised by neuronal survival and 
axon/neurite extension and OPCs proliferation.  This is followed by OPC 
differentiation from a premyelinating cell with many, highly branched processes 
into a myelinating cell with fewer processes and the ensheathment/myelination 
of axons and their formation of nodes of Ranvier (Sorensen et al., 2008). 
The present study showed that the relationship between oligodendrocytes and 
axons prior to the formation of node of Ranvier was similar in wild-type and 
ganglioside knockout mice.  This suggests that the early interaction of 
oligodendrocytes with axons is not modulated by gangliosides.  However, this 
experiment needs to be repeated in the double knockout mice because it is 
possible that, in the single knockouts, the simpler gangliosides are able to 
compensate for the lack of complex gangliosides.   
5.3.4 Comparison of axonal density and myelination 
The effect of knocking out gangliosides on neuronal survival and the density of 
axons was examined using embryonic spinal cord cultures plated on PLL.  Axonal 
density (% SMI 31-immunoreactivity/given area) was found to be significantly 
higher in Sia T -/- cultures at 21 DIV but is similar in all genotypes at 28 DIV.  
The transient increase in neurite extension in Sia T -/- cultures may be due to 
the lack of b- or c- series gangliosides or the increased levels of a-series 
gangliosides.  To determine which, axonal density measurements need to be 
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carried out in double knockout mice:  if the axonal density is increased in double 
knockout mice then it would suggest that it is the lack of b-series gangliosides, 
rather than the increase in a-series gangliosides that is responsible for the 
transient increase in axonal density.  
It has been shown that MAG inhibits neurite outgrowth by binding to GT1a and 
GT1b (McKerracher et al., 1994, Mukhopadhyay et al., 1994).  It is possible that 
increased a-series gangliosides on Sia T -/- neurons initially lead to increased 
neurite outgrowth and survival, but once oligodendrocytes begin to express MAG, 
it inhibits further neurite outgrowth.  Future studies should examine the MAG 
expression in wild-type and ganglioside knockout cultures at several time-points 
(for example 7, 14, 21, and 28 DIV) and measure the axonal density at the same 
time-points to examine if there is a correlation between MAG expression and the 
reduction of axonal density in Sia T -/- cultures. 
Sia T -/- cultures lack the ganglioside O-acetyl GD3 which is associated with 
elongation of neurites.  It has been shown that neurite outgrowth in neurons of 
embryonic rat dorsal root ganglia explants grown on laminin is halted in the 
presence of Jones monoclonal antibody which binds to 9-O-acetyl GD3 (Mendez-
Otero and Friedman, 1996).  This would suggest that Sia T -/- which lack O-
acetyl GD3 would have decreased neurite outgrowth.  However, Yang et al (Yang 
et al., 2007) found that Jones antibody had the same effect on wild-type and Sia 
T -/- neurons which lack O-acetyl GD3, suggesting that its effects on neurite 
outgrowth are not mediated by O-acetyl GD3 binding, which explains why we 
have not seen a reduced neurite outgrowth in Sia T -/- cultures in the present 
study.     
PLP labelling was found to be lower in GalNAc T –/- mice at 21 DIV, however, by 
28 DIV, it was similar in all genotypes.  This finding suggests that complex 
gangliosides may play a role in the initiation of myelination.  GalNAc T -/- mice 
lack all complex gangliosides but have excess of simple gangliosides such as 
GM3.  It was shown that excess GM3 drives the differentiation of 
oligodendrocytes toward the premyelinating stage (Yim et al., 1994, Yim et al., 
1995).  As seen from the ganglioside expression of oligodendrocytes, simpler 
gangliosides are present in the early stages of oligodendrocytes differentiation 
and are replaced by complex gangliosides such as GM1 and GD1a in the later 
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stages of differentiation.  The results of the present study suggest that without 
these complex gangliosides, the differentiation of premyelinating 
oligodendrocytes into myelinating oligodendrocytes is slower. 
To test whether the decreased PLP labelling in GalNAc T -/- mice is due to 
increased levels of simple gangliosides or the lack of complex gangliosides, this 
experiment needs to be repeated in double knockout mice.  If the level of PLP 
labelling is also decreased in double knockout mice it would suggest that the 
decreased levels of PLP labelling are more likely to be due to the decreased 
levels of a-series gangliosides, although the possibility that it’s due to increased 
levels of GM3 could not be excluded.   
There could be several reasons for the decreased myelination in GalNAc T -/- 
cultures at 21 DIV.  Axonal density is similar in wild-type and GalNAc T -/- 
cultures at 21 DIV which suggests that the reason for reduced myelination in 
GalNAc T -/- cultures at 21 DIV may be a reduction in oligodendrocyte process 
extension or in oligodendrocyte numbers, rather than a lack of axons.  The 
reduced myelination in GalNAc T -/- mice may also be due to an inhibitory 
contact-mediated mechanism between axons and oligodendrocytes.  
Alternatively, GalNAc T -/- oligodendrocytes could be more responsive to a 
secreted inhibitory factor that prevents myelination, or there may be a delay in 
GalNac T -/- axons secreting a premyelinating factor.  Future studies should 
elucidate the mechanism in more detail. 
In the present study, I used PLP labelling as an indicator of the extent of 
myelination.  However, this gives no indication of whether the myelin is 
compacted and well formed at the ultrastructural level.   To examine 
myelination in more detail, future experiments should use electron microscopy 
to compare the quality of myelin produced in wild-type cultures with that of 
ganglioside knockout cultures.  This would allow the measurement of myelin 
thickness and would show up any myelination defects. 
Studies have shown that synapse formation and the development of electrical 
activity promotes myelination.  Future studies could compare the effect of 
electrical activity on myelination in wild-type and ganglioside knockout mice by 
adding tetrodotoxin, which blocks action potentials or α-scorpion toxin, which 
increases axonal firing (Demerens et al., 1996). 
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As shown in the present study, neuronal survival and myelination were good in 
both wild-type and ganglioside knockout cultures maintained in differentiation 
medium on non-specific substrate PLL.  It is interesting to note that in rat 
cultures neuron survival was poor past one to two weeks and that myelinated 
axons were observed rarely in rat embryonic spinal cord cultures grown on PLL 
under the same conditions (Sorensen et al., 2008), which highlights the different 
growth requirements for mouse and rat cells. 
5.3.5 Localisation of proteins at the node of Ranvier 
The mature molecular organisation of the membrane of myelinated axons 
includes clusters of Nav1.6 at nodes, Caspr and NF155 forming paranodal 
junctions and aggregations of Kv1.2 in juxtaparanodal regions.   
The present study showed that Caspr and NF155 localisation was unaffected in 
both Sia T -/- and GalNAc T -/- mice.  In addition, the distribution of Nav at 
developing nodes of Ranvier formed in Sia T -/- dissociated spinal cord cultures 
by differentiating oligodendrocytes was found to be similar to that observed at 
wild-type nodes.  Kv localisation in Sia T -/- spinal cord cultures was also similar 
to that observed in wild-type cultures.  These findings suggest that GM1 or 
GD1a, which are found on Sia T -/- axons, may play important stabilising roles at 
paranodal junctions in spinal cord neurons. 
As at wild-type nodes (Bhat, 2003, Girault and Peles, 2002, Poliak and Peles, 
2003, Salzer, 2002), the populations of channels in Sia T -/- cultures were 
sharply delimited, with Nav clustered at the nodal axolemma and Kv channels at 
the paranodal and juxtaparanodal region.  In wild-type and Sia T -/- cultures, no 
Nav were detected beneath the myelin sheath in the internodes, in accordance 
with the observation that Nav are present only in low density beneath the myelin 
sheath in normal axons (Waxman and Ritchie, 1993).   
However, in GalNAc T -/- cultures, Nav were often observed throughout the 
myelinated axon, resembling the Nav labelling in unmyelinated axons.  
Furthermore, the localisation of Kv to paranodal and juxtaparanodal regions was 
delayed in GalNAc T -/- cultures compared with wild-type.  Rather at 28 DIV, 
when Kv were localised to the paranodal and juxtaparanodal regions in wild-type 
cultures, in GalNAc T -/- cultures, the Kv were observed throughout the 
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membrane or were clustered at the node of Ranvier.  These abnormalities in 
distribution are absent in nodes of Ranvier formed in Sia T -/- and wild-type 
cultures. 
Kv are generally not observed in the nodal axolemma (Mi et al., 1995, Wang et 
al., 1993).  Instead, they are aggregated within juxtaparanodal domains, and 
their segregation to this region is dependent on intact paranodal axo-glial 
junctions (Rasband, 2004, Rasband et al., 1999b).  In the absence of intact 
paranodal junctions, Kv1 channels can encroach into paranodal and even nodal 
domains, leading to abnormalities in conduction parameters (Bhat et al., 2001, 
Boyle et al., 2001, Coetzee et al., 1996, Dupree et al., 1998).  Since Kv are 
localised in paranodal and juxtaparanodal regions in wild-type and Sia T -/- 
cultures, it would suggest that the paranodal axo-glial junctions are not properly 
formed, despite Caspr and NF155 being present at their correct locations at the 
paranodes.  Kv localisation in wild-type and Sia T -/- mice showed a similar 
pattern as previously reported (Poliak et al., 2001, Susuki et al., 2007a, Vabnick 
et al., 1999).   
The present in vitro study is partly in agreement with the in vivo observations in 
ganglioside knockout mice (Susuki et al., 2007a).  Susuki et al (2007) observed 
broadened Na+ channel clusters and found that the localisation of Kv to 
juxtaparanodes was slower in GalNAc T -/- mice during development.  The same 
study found that immunostaining of Caspr and NF155 was reduced in both 
peripheral and central nervous nerves, which became more prominent with age 
(Susuki et al., 2007a).  This is in contrast to the present study where no 
difference was found in the immunolabelling of Caspr and NF155 between wild-
type and ganglioside knockout mice.  Susuki et al observed myelination and 
nodal defects in Sia T -/- mice, however these defects were less frequent in Sia 
T -/- mice compared with GalNAc T -/- mice (Susuki et al., 2007a).  In contrast, 
the present study found no difference between wild-type and Sia T -/- in terms 
of myelination and the formation of nodes of Ranvier.   
However, Susuki et al (2007a) found that paranodal junctions and ion channel 
clusters were disrupted in ventral rather than in dorsal roots from GalNAc-T -/- 
mice, suggesting that the composition or contribution of gangliosides at 
paranodal structures may differ between peripheral motor and sensory nerve 
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fibers.  The neurons in the dissociated spinal cord cultures examined in the 
present study are most likely to be motor neurons.  Therefore, it is possible that 
no abnormalities are observed in Sia T -/- cultures for this reason.  Our findings 
do not exclude the possibility that defects may be present in Sia T -/- sensory 
neurons.  
Studies in sciatic nerve (Boiko et al., 2001) and optic nerve (Boiko et al., 2001, 
Jenkins and Bennett, 2002, Kaplan et al., 2001, Rios et al., 2003) have 
demonstrated that Nav1.2 is distributed along premyelinated axons and is 
transiently present at immature nodes in these tracts.  Nav1.2 is subsequently 
replaced by Nav1.6, which was shown to be the predominant isoform at mature 
nodes of Ranvier in both the PNS and CNS (Caldwell et al., 2000).  The Nav 
antibody used in the present study recognises all known vertebrate sodium 
channels, so it was not possible to distinguish which subtype of sodium channel 
was present in the spinal cord cultures.  Future studies could include an 
examination of the subtype of sodium channel present at the nodes of Ranvier in 
wild-type and ganglioside knockout mice.   
It has been shown that the axonal membrane also undergoes a sequential 
transformation during development.  In the PNS, cell adhesion molecules such as 
neurofascin 155 are the first molecules to appear at prospective nodes, followed 
by ankyrin G isoforms and Nav (Lambert et al., 1997).  Finally clusters of Kv1.1 
and Kv1.2 channels appear after clusters of Nav channels and ankyrin G are well 
established (Vabnick and Shrager, 1998, Vabnick et al., 1999).  The Kv channels 
gradually become sequestered in the juxtaparanodal region, where they are 
thought to be electrically isolated from the nodes.  The fact that myelinating 
cultures from GalNAc T -/- mice show normal distribution of Caspr and NF155 
and sometimes Nav but not Kv at 28 DIV suggests that the assembly of the 
molecular components in and around the node of Ranvier is slower in these mice 
compared with wild-type.  This raises the question whether the retarded 
temporal expression in GalNAcT -/- cultures is specific to Nav and Kv or is it the 
case that that the assembly of all the proteins is slower in GalNAc T -/- mice.  In 
other words, it is possible that the expression of Caspr and neurofascin 155 is 
also slowed in GalNAc T -/- but the time points that were chosen in the present 
study were too late to observe this.  This question could be answered by 
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examining the expression of neurofascin 155 and Caspr at time points between 
21 and 28 DIV. 
Since abnormalities in the assembly of nodal proteins were less frequent in Sia T 
-/- mice lacking GD1b and GT1b and since the major gangliosides in Sia T -/- 
mice are GM1 and GD1a (Okada et al., 2002), it suggests that GM1 or GD1a play 
a role in the formation of node of Ranvier.  However, changes due to other 
minor gangliosides or excess of a-series gangliosides such as GM1 and GD1a 
cannot be excluded.  
The findings of the present study show that gangliosides do play a role in the 
assembly of node of Ranvier.  However, from previous studies in adult 
ganglioside knockout mice, it would appear that gangliosides are more important 
in the maintenance than the development of myelinated axons.  Finally, it is 
possible that the concurrent increase in simple gangliosides that goes hand-in-
hand with knocking out complex gangliosides has a compensatory role during 
development, and minimises the detrimental effects of knocking out complex 
gangliosides.  Due to time restrictions it was not possible to carry out studies on 
double knockout mice in the present study.  However, it would be interesting to 
repeat these experiments using double knockout mice which lack all gangliosides 
apart from the simplest ganglioside GM3.  It is possible that much more severe 
effects would be observed. 
5.3.6 Conclusion 
In the present study, dissociated spinal cord cultures have been validated as a 
good model for studying oligodendrocytes differentiation, neurite outgrowth and 
myelination since temporal changes in these cultures can mirror developmental 
events in vivo.   
Cells of the oligodendrocyte lineage in dissociated spinal cord cultures express 
simple b- and c-series gangliosides GD3 and GT3 in the early stages of 
differentiation and with time the ganglioside expression profile changes to 
express a-series gangliosides GM1 and GD1a.  The majority of astrocytes were 
negative for all four markers tested in this study, however, a subset of 
astrocytes labelled with A2B5 and R24, revealing the presence of type-2 
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astrocytes in these cultures.  Axons of spinal cord neurons expressed gangliosides 
recognised by A2B5, as well as GM1 and GD1a.   
The major finding of the present study are that GalNAc T -/- cultures lacking all 
complex gangliosides contain significantly lower number of early OPCs, have 
decreased myelination initially and that Nav and Kv channel assembly to the node 
of Ranvier and juxtaparanode, respectively, is slower compared to wild-type and 
Sia T -/- mice.  In contrast, no abnormalities were observed in Sia T -/- cultures 
which lack all b-series gangliosides, with the exception of initially higher axonal 
density compared with wild-type and GalNAc T -/- cultures.   
Previous studies have shown that astrocytes express gangliosides and that they 
can promote myelination of CNS axons (Blakemore and Crang, 1989; Blakemore 
et al., 2003, Franklin et al., 1991, Ishibashi et al., 2006, Sorensen et al., 2008). 
Therefore, future studies should examine in more detail the role of astrocytes in 
myelination in wild-type and ganglioside knockout mice. 
It has been shown that gangliosides modulate cellular events by interacting with 
integrins or growth factor receptors.  These cultures could be used to examine 
the interaction of gangliosides with growth factors by comparing the effects of 
the addition of growth factors.  To investigate whether the effects of knocking 
out gangliosides observed in the present study involve integrin signalling, future 
studies could include a more detailed investigation into the effect of other 
substrates, such as laminin, extracellular matrix or fibronectin and the addition 
of antibodies to specific integrins.  Gangliosides have been shown to be localised 
in lipid rafts, which are thought to be sites of cell signalling.  It is possible that 
the myelination defects observed in ganglioside knockout mice are due to the 
altered ganglioside composition of the lipid raft which may affect cell signalling.  
Therefore, future studies should examine lipid raft association of molecules 
involved in myelination in wild-type and ganglioside knockout. 
Future studies should investigate signalling and should be aimed at examining 
whether gangliosides are a trophic axonal signal that signals oligodendrocytes to 
differentiate or are the gangliosides present on oligodendrocyte used in cell-to-
cell interaction in the cross-talk between oligodendrocytes and axons. These 
questions could be addressed by setting up co-cultures of neurons from wild-type 
mice (without other cells) and glia (oligodendrocytes and astrocytes) from 
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knockout mice and vice versa similar to co-cultures described previously (Chan 
et al, 2004, Lubetzki et al., 1993, Mi et al., 2005, Wang et al., 2007).   
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6 CHAPTER 6 
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Ganglioside enrichment in neural cells (neurons and glia) has led to 
investigations into their role in nervous system function.  As a result, 
gangliosides have been implicated in the neurobiology of diseases, and in the 
regulation of many cellular and molecular properties.  However, most studies 
have focused on the role of gangliosides in neuronal function.  The aim of my 
thesis was to investigate ganglioside function in glial cell biology by using wild-
type and ganglioside knockout mice.  I initially studied detailed cellular 
properties of olfactory ensheathing cells (OECs) and Schwann cells followed by 
the role of gangliosides in the regeneration of the olfactory system and in 
oligodendrocyte differentiation and myelination using an embryonic spinal cord 
culture system. 
Central nervous system (CNS) pathologies are often very debilitating due to the 
inability of the CNS to undergo repair following damage.  Examples of such 
pathologies include chronic neurodegenerative diseases such as Parkinson’s 
disease and Alzheimer’s disease, and disorders characterised by cell death or 
loss of key neural pathways such as spinal cord injury and ischemic stroke.  
Although neuronal degeneration and death are the ultimate consequences of 
these pathological processes, alterations in the function of surrounding glial cells 
are key features in the progression of many of these diseases. 
Numerous potential therapies are being investigated at present to promote 
repair of the damaged CNS, ranging from use of cellular transplantation to 
mediate repair and remyelination, to growth factor delivery to improve survival 
rates of neurons and promote axonal outgrowth, and use antibodies or 
pharmacological agents against inhibitory factors.  The findings that neuronal 
accumulation of gangliosides in lysosomal storage diseases profoundly influenced 
the development and differentiation of neurons (Purpura and Suzuki, 1976) and 
that the addition of exogenous gangliosides could promote the regrowth of 
damaged neurons (Ceccarelli et al., 1976) prompted studies to examine the 
potential use of exogenous gangliosides as therapeutic agents for neurological 
diseases. 
Subsequent studies have demonstrated that gangliosides can affect multiple 
neuronal populations including dopaminergic, cholinergic, glutamatergic, 
serotonergic and noradrenergic neurons (Hadjiconstantinou and Neff, 1998).  
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Several preclinical studies have reported acute neuroprotective and longer-term 
neuroregenerative effects of GM1 in experimental models of ischemia and injury 
(Agnati et al., 1983, Bose et al., 1986, Ceccarelli et al., 1976, Di Gregorio et al., 
1984, Fass and Ramirez, 1984, Gorio, 1988, , 1986, Gorio et al., 1980, Gorio et 
al., 1984a, Gorio et al., 1984b, Itoh et al., 1999, Itoh et al., 2001, Karpiak, 
1984, Karpiak et al., 1987, Kojima et al., 1984, Lainetti et al., 1998, Ledeen, 
1984, Pope-Coleman et al., 2000, Ramirez et al., 1987a, Ramirez et al., 1987b, 
Roisen et al., 1981, Rybak et al., 1983, Sabel et al., 1987, Sabel et al., 1984a, 
Sabel et al., 1984b, Sabel and Stein, 1986, Skaper and Leon, 1992, Toffano et 
al., 1984a, Toffano et al., 1983, Walker, 1991, Wang et al., 1995).  For instance, 
administration of GM1 in experimental models of Parkinson’s disease in rodents 
and primates, stimulated the regeneration of dopaminergic neurons in the 
substantia nigra and ameliorated the abnormal motor responses (Fadda et al., 
1993, Hadjiconstantinou and Neff, 1988, Pope-Coleman et al., 2000, Raiteri et 
al., 1985, Schneider et al., 1992, Toffano et al., 1983, Toffano et al., 1984b).  
These pre-clinical findings led to a small clinical trial of GM1 in patients with 
Parkinson’s disease.  These patients responded to the treatment with an overall 
improvement of motor function, including decreased rigidity and bradykinesia 
(Schneider, 1998, Schneider et al., 1998) which demonstrates the usefulness of 
GM1 as a treatment for Parkinson’s disease.  
A small clinical trial designed to investigate the efficacy of GM1 in patients with 
cervical and thoracic spinal cord injury suggested that GM1 had the ability to 
enhance recovery of lower extremities after 1 year (Geisler et al., 1991).  This 
led to a larger scale trial to further investigate the efficacy of low and high dose 
GM1 following standard treatment with methylprednisolone (Geisler et al., 
2001).  However, despite GM1 demonstrating improved rates of recovery, along 
with improved bladder/bowel function, sacral sensation, and anal contraction 
over the first 3 months post-injury the prospectively planned analysis at 6 
months was negative (Geisler et al., 2001). 
However, Sia T -/- mice, which lack b-series gangliosides, but have increased 
levels of a-series gangliosides such as GM1, have reduced regeneration of 
axotomised hypoglossal nerves compared with wild-type.  Since numerous 
studies have demonstrated the neuroprotective role of GM1 it is surprising that 
mice which have increased levels of GM1 have decreased regeneration.  In order 
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to understand better the role of gangliosides in regeneration, I compared 
regeneration of the olfactory system in wild-type and gangliosides knockout 
mice. 
The olfactory system was chosen for this study since it has a great capacity for 
repair.  Olfactory receptor neurons (ORNs) are constitutively replaced 
throughout life.  Because they are in direct contact with the outside 
environment, they are susceptible to damage from airborne toxins and 
pathogens (Farbman and Buchholz, 1992) and as a result require continual 
neurogenesis.  This regenerative capacity has often been utilised in studies of 
regeneration following experimental damage.  Many different experimental 
methods have been used to induce damage in the olfactory system, each with 
advantages and disadvantages.  The transection of the olfactory nerve leads to 
the retrograde degeneration of mature ORNs, however this method compromises 
the natural structure of the system and does not damage any of the other cells 
in the olfactory epithelium including immature ORNs which have not yet 
extended an axon.  The removal of olfactory bulbs also causes the degeneration 
of ORNs, however the cells are unable to fully mature without a target.  In 
contrast, irrigation of the nasal cavity with zinc sulphate (ZnSO4) results in the 
rapid degeneration of all cell types of the olfactory epithelium (OE) and is more 
akin to naturally occurring sequence of events.  Williams et al (Williams et al., 
2004) showed that ZnSO4 irrigation is a reliable method of inducing ORN 
degeneration and regeneration in the rat.  However, other studies have found 
that this method is partially irreversible (Burd, 1993, Ducray et al., 2002, 
Harding et al., 1978).  In this study, I have observed similar results in that the 
OE regenerated to about 50% of the control value.  It may be that ZnSO4 
irrigation is more reliable in rats than in mice.   
I have shown that complex gangliosides are present in the normal adult olfactory 
system.  However, I did not observe reduced regeneration in ganglioside 
knockout cells compared with wild-type.  This may be due to the simpler 
gangliosides being able to compensate for the lack of complex gangliosides.  
Alternatively, it may be the case that excess of the simpler gangliosides has a 
neuroprotective role.  On the other hand, it may be possible that the method we 
used was too harsh in that it did not lead to complete regeneration and as a 
result, any subtle changes in the regeneration capacity in ganglioside knockout 
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mice may be missed.  A milder method of causing damage to the OE might lead 
to better regeneration of the mouse olfactory system and may be better for 
studying the effect of gangliosides on the degeneration and regeneration of the 
olfactory system.  
As mentioned above, one of the strategies for repair is cell transplantation.  A 
range of cells have been studied for cellular transplantation including 
oligodendrocyte precursor cells (OPCs), neural stem cells, Schwann cells and 
OECs.  It is becoming clear that no single strategy will be sufficient to repair 
spinal cord injury and many studies have a multi-strategy approach such as cell 
transplantation combined with the addition of growth factors or agents which 
reduce inhibitory signals.  Therefore, a potential treatment for CNS repair could 
be the addition of gangliosides such as GM1, as well as transplantation of cells 
such as OECs or Schwann cells.  In that case, it would be important to 
understand the effect gangliosides have on the transplanted cells. 
For this reason, I compared the cellular properties of OECs and Schwann cells 
isolated from wild-type and ganglioside knockout mice.  I have shown that the 
majority of OECs and Schwann cells express a-series gangliosides GM1 and GD1a.  
Subtle effects were seen in cells obtained from ganglioside knockout mice.  For 
example, OECs isolated from Sia T-/- mice grown on collagen in the presence of 
growth factors had faster proliferation compared to OECs isolated from wild-
type and GalNAc T-/- mice.  This suggests that the increase in GM1 and GD1a 
due to the lack of Sia T -/- may be mediating this effect.  Furthermore, since 
the effect on proliferation was only seen on collagen IV in the presence of 
growth factors and not on PLL or laminin, it suggests that there is an interaction 
between these gangliosides and integrins.  However, it is difficult to identify the 
mechanism by which this occurs since there are no known specific collagen IV-
binding integrins which do not also interact with laminin.  Cell adhesion to 
collagen IV is mediated by integrins α1β1 and α2β1, however these integrins also 
bind to laminin (Ruoslahti, 1991).  It would, thus, be interesting to examine the 
signalling involved in mediating the increased proliferation in OECs isolated from 
Sia T -/- mice. 
My experiments also revealed differences in the properties of OECs and Schwann 
cells isolated from Sia T -/- mice.  For instance, Sia T-/- derived OECs had a 
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greater proliferation rate than Sia T-/- derived Schwann cells.  However, this 
may be difficult to analyse since OECs and Schwann cells were grown in their 
optimal growth media, which are different.  OEC medium (OMM+5%FBS) contains 
additional factors to Schwann cell medium (10%HF) including astrocyte 
conditioned medium (ACM) and FGF2 and less foetal bovine serum.  ACM 
contains numerous growth factors including FGF2 (Araujo and Cotman, 1992), 
PDGF (Richardson et al., 1988), TGFβ (Saad et al., 1991), CNTF (Stockli et al., 
1989), NGF (Furukawa et al., 1986, Houlgatte et al., 1989) and NT-3 (Rudge et 
al., 1992).  So the differential growth of the two glial cells may reflect these 
growth factor differences.  If this is the case, it might be that an interaction 
between gangliosides, integrins and growth factors is responsible for the 
increase in the proliferation of Sia T -/- OECs.  It has been shown in 
oligodendrocytes that interaction between gangliosides, integrins and growth 
factors can affect the response of cells: laminin-2 induces the co-localisation of 
integrin α6β1 and the PDGFαR within the same raft domain and enhances PI3K 
signalling in response to PDGF (Baron et al., 2003).  Also, the fact that Sia T -/- 
OECs do not show an increase in proliferation when grown in the medium 
without growth factors, also suggests an interaction between gangliosides and 
growth factors. 
On the other hand the difference observed in the response of OECs and Schwann 
cells to the depletion of b-series gangliosides and increase in a-series 
gangliosides may be due to OECs and Schwann cells expressing different 
integrins.  Final differentiation of Schwann cells and myelination requires the 
synthesis and assembly of ECM molecules, such as laminins and type IV collagen, 
to form a basal lamina (Bunge, 1993, Bunge et al., 1986, Eldridge et al., 1989, 
Eldridge et al., 1987, Fernandez-Valle et al., 1993).  Non-myelinating Schwann 
cells express α1β1 (a collagen and laminin receptor) and α6β1 (a unique laminin 
receptor).  Not a lot is known about the integrin expression of OECs.  However, 
they do express the β1 subunit (Au and Roskams, 2003, Pastrana et al., 2006) 
and the α6 subunit co-localises with p75NTR in the outer nerve layer suggesting 
that OECs express α6.  The α6 subunit is thought to be involved in neuronal 
migration, neurite outgrowth, and axon guidance during olfactory development 
(Whitley et al., 2005).  Since no reports have been published on the integrin 
expression of OECs, it would be interesting to characterise the integrin 
expression of OECs to examine if the different effects of gangliosides on the 
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proliferation and migration of OECs and Schwann cells are due to the interaction 
of gangliosides with different integrins. 
A common feature seen in chronic neurodegenerative diseases is apoptosis, a 
form of programmed cell death believed to be caused by secondary injury 
processes (Bossy-Wetzel et al., 2004).  Ganglioside GD3 mediates apoptosis in 
some cell types, including oligodendrocytes.  It would have been interesting to 
compare the survival of OECs and Schwann cells derived from wild-type, Sia T -/-
(which lack GD3) and GalNAc T -/- (which have increased levels of GD3) mice to 
determine if GD3 plays a role in their survival.  However, due to time constraints 
this was not possible. 
Multiple sclerosis (MS) is a chronic inflammatory disease of the CNS white 
matter, thought to result from an autoimmune attack against autoantigens 
within the myelin sheath.  It is the most common disabling neurological 
condition affecting young adults, with 85,000 sufferers in the United Kingdom.  
Disease onset usually occurs in young adults and is more common in women.  The 
prevalence of MS varies from country to country and is much more prevalent in 
northern Europe, continental North America and Ausralasia than in countries 
near the equator (Rosati, 2001). Climate, diet, geomagnetism, toxins, sunlight 
exposure, genetic factors, and infectious diseases have all been discussed as 
possible reasons for these regional differences. Environmental factors during 
childhood may play an important role in the development of MS later in life 
(Marrie, 2004). Pathological characteristics of MS include the loss of 
oligodendrocytes, demyelination and neurodegeneration (Kalman et al., 2007).  
Although initially spontaneous remyelination occurs in many MS lesions, the 
repair process eventually fails (Chari, 2007).  Understanding oligodendrocyte 
differentiation and the myelination process may help to develop strategies to 
promote myelin repair.   
Recent findings suggest that gangliosides play a role in myelination and assembly 
and maintenance of nodes of Ranvier (Susuki et al., 2007a).  To examine the role 
of gangliosides in oligodendrocyte differentiation, myelination and the formation 
of node of Ranvier, I used embryonic spinal cord cultures obtained from wild-
type, Sia T -/-and GalNAc T -/- mice.  The spinal cord cultures revealed several 
changes in ganglioside knockout mice compared with wild-type.  There was a big 
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difference in the number of NG2 positive cells between wild-type and GalNAc T -
/- cultures which suggests that the GalNAc T -/- cultures have less progenitor 
cells.  If this is also true in vivo, it would mean that adult GalNAc T -/- mice 
would have reduced numbers of adult progenitors which would affect 
remyelination.  It has been shown that adult GalNAc T -/- mice have myelination 
defects (Chiavegatto et al., 2000, Ma et al., 2003, Sheikh et al., 1999b, 
Takamiya et al., 1996).  The reason for the reduced number of progenitors in 
GalNAc T -/- mice could be that the lack of complex gangliosides or the rise in 
simple gangliosides GD3 and GT3, which are predominantly expressed in OPCs, 
somehow speeds up the differentiation of OPCs into more mature 
oligodendrocytes or results in decreased proliferation or survival of OPCs. 
Another difference observed in GalNAc T -/- mice was in the reduced 
localisation of sodium channels to the node of Ranvier.  This is in agreement 
with studies performed by Susuki et al (Susuki et al., 2007a), which show that 
lack of complex gangliosides affects nodal stability.  No difference was observed 
between wild-type and Sia T -/- cultures suggesting that b-series gangliosides 
are not vital for oligodendrocyte differentiation, myelination or the formation of 
node of Ranvier.  This study also demonstrates that dissociated spinal cord 
culture is a useful model for studying myelination in vitro.   
Although studies in ganglioside knockout mice may not lead directly to 
treatment of diseases such as MS, it is nevertheless important to examine their 
contribution to the maintenance of the nervous system.  The determination of 
normal functions of gangliosides should eventually enable an understanding of 
how they participate in pathological states such as neurodegenerative disorders.  
The more we understand about the nervous system function the easier it will be 
to come up with repair strategies when things go wrong.   
In conclusion, the comparison of glial cells isolated from wild-type and knockout 
mice lacking complex gangliosides suggest that gangliosides are not essential in 
glial cell development and differentiation; however, they do seem to be 
important in the maintenance of the nervous system.  Indeed, babies born with a 
defect in the ganglioside biosynthesis pathway develop epileptic seizures within 
the first year of life associated with developmental stagnation and blindness 
(Simpson et al., 2004), supporting the idea that gangliosides play an important 
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role in nervous system maintenance and stability.  Finally, future studies in mice 
lacking all ganglio-series gangliosides (Yamashita et al., 2005) should contribute 
much more to the understanding the physiological role of gangliosides in the 
nervous system. 
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1.1 Equipment 
Axioplan 2 fluorescent microscope Zeiss, Herts, UK 
Axioskop fluorescent microscope  Zeiss, Herts, UK 
Axiovert S100 time-lapse microscope Zeiss, Herts, UK 
Axioplan 200 time-lapse microscope Zeiss, Herts, UK 
Camera controller (time-lapse)  Hamamatsu Photonics Ltd, Middlesex, UK 
Clifton unstirred water bath  Bennett Scientific, Devon, UK 
FACSVantage SE sorter   Becton Dickinson, Oxford, UK 
Halogen hot plate/stirrer   Bibby Sterilin, Stone, UK 
Leica TCS SP2 confocal microscope Leica Microsystems (UK) Ltd, Bucks, UK 
Microcentaur desk top centrifuge  MSE Ltd, Kent, UK 
Olympus CK2 phase microscope   Olympus, London, UK 
Olympus Fluoview FV1000 confocal Olympus, London, UK 
Sigma 4K15 centrifuge (T/C)  Sigma, Osterode am Harz, Germany 
Syngene Bioimaging System  Syngene, Cambridge, UK 
Tissue Culture Hoods    Medical Air Technology, Oldham, UK 
Vortex Genie     Scientific Industries Inc, New York, USA 
 
 
1.2 General Plasticware 
Bijous – 5 ml     Bibby-Sterilin, Stone, UK    
Cell strainer – 70 µl    Becton Dickinson, Oxford, UK 
Coverslips     BDH, Pool, UK 
Eppendorfs – 0.5 ml, 1.5 ml  Eppendorf, Cambridge, UK 
Falcon tube – 15 ml, 50 ml   Becton Dickinson, Oxford, UK 
Filters with receiver – 250 ml  Nalge Nunc Int, Rochester, NY, USA 
Flasks – T25, T75    Bibby-Sterilin, Stone, UK  
Haemocytometer    Weber Scintific Int. Ltd., Middlesex, UK 
ImmEdge Pen    Vector Laboratories, Burlingame, USA  
Microscope slides    BDH, Poole, UK 
Needles – 21G, 23G    Becton Dickinson, Oxford, UK 
Pastettes     Elkay Lab products, Basingstoke, UK 
Petri dishes     Bibby-Sterilin, Stone, UK 
Gilson Diamond pipette tips  Gilson, France 
Plates – 24-well, 6-well   Bibby-Sterilin, Stone, UK  
Polystyrene round bottom tubes – 5 ml Becton Dickinson, Oxford, UK 
Scalpels     Swann-Morton Ltd, Sheffield, UK 
Slide Storage File    Ted Pella, California, USA 
Syringes – 5 ml, 20 ml   Becton Dickinson, Oxford, UK 
Syringe Filters – 0.2 µm, 0.4 µm  PALL Live Sciences, NY, USA 
Universals – 30 ml    Bibby-Sterilin, Stone, UK 
 
 
1.3 Chemicals and reagents 
Absolute Alcohol    James Burrough Ltd., Essex, UK 
Acetic Acid     Fisher Scientific, Leicestershire, UK 
Agarose, Electrophoresis Grade  Invitrogen, Inchinnan, UK 
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AmpliTaq Gold DNA polymerase   Applied Biosystems, California, USA 
Apo-transferrin (human)   Sigma Aldrich, Dorset, UK 
Avidin/HRP     DakoCytomation, Cambridgeshire, UK   
Bouins Fixative    Bios Europe, Lancashire, UK 
Bovine Serum Albumin   Sigma Aldrich, Dorset, UK 
B27 supplement    Invitrogen, Inchinnan, UK 
BSA      Sigma Aldrich, Dorset, UK 
BSA path-o-cyte    Sigma Aldrich, Dorset, UK 
Cholera Toxin B subunit FITC labelled Sigma Aldrich, Dorset, UK 
Collagen Type IV (human placenta) Sigma Aldrich, Dorset, UK 
Collagenase Type I    MP Biomedicals, Ohio, USA 
DAB peroxidase substrate kit  Vector Laboratories, Burlingame, USA 
DMEM – 1885     Invitrogen, Paisley, UK 
Deoxyribonuclease     Sigma Aldrich, Dorset, UK 
dNTPs (A, C, G and T)   PerkinElmer, Bucks, UK 
DNA ladder 100bp      
Donkey Serum    Abcam, Cambridge, UK 
EGF      Peprotech, London, UK 
Eosin      Surgipath, Cambridge, UK 
FBS      Autogen Bioclear, Caine, UK 
FGF      Peprotech, London, UK 
Forskolin     Sigma Aldrich, Dorset, UK 
Gelatin (porcine skin)   Sigma Aldrich, Dorset, UK 
Gentamycin     Sigma Aldrich, Dorset, UK 
Glucose      Sigma Aldrich, Dorset, UK 
Glutamax     Invitrogen, Paisley, UK 
L-glutamine     Sigma Aldrich, Dorset, UK 
Glycerol     Fisher Scientific, Leicestershire, UK 
Halothane     Rhodia Organique Fine Ltd, Bristol, UK 
HBSS      Invitrogen, Inchinnan, UK 
Harris’ Haematoxylin   Surgipath, Cambridge, UK 
Heparin     Leo Laboratories, Dublin, Ireland 
Heregulin     R&D systems, Abingdon, UK 
Histoclear     Fisher Scientific, Leicestershire, UK 
Histomount     Hughes & Hughes Ltd, Somerset UK 
Hydrochloric acid    Fisher Scientific, Leicestershire, UK 
Hydrocortisone    Sigma Aldrich, Dorset, UK 
Hydrogen peroxide    Fisher Scientific, Leicestershire, UK 
Insulin (bovine pancreas)   Sigma Aldrich, Dorset, UK 
Isopropanol     Fisher Scientific, Leicestershire, UK 
L-15       Invitrogen, Paisley, UK 
Laminin (human placenta)   Sigma Aldrich, Dorset, UK 
Methanol     Fisher Scientific, Leicestershire, UK 
MgCl2      Bioline, London, UK 
NaOH      Fisher Scientific, Leicestershire, UK 
Neurobasal media w/o L-glutamine Invitrogen, Paisley, UK 
Normal Rabbit Serum   DakoCytomation, Cambridgeshire, UK 
Normal Goat Serum    Vector Laboratories, Burlingame, USA 
O.C.T. compound    VWR International Ltd, Poole, UK 
Orange G     Merck, Darmstadt, Germany 
PCR buffer 10x    Applied Biosystems, California, USA 
PCR primers     gift from Prof. Willison’s lab 
Paraformaldehyde    Sigma Aldrich, Dorset, UK 
PBS tablets     Oxoid Ltd, Hampshire, UK 
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PDGF      Peprotech, London, UK 
Penicillin/Streptomycin   Invitrogen, Paisley, UK 
PLL      Sigma Aldrich, Dorset, UK 
Progesterone     Sigma Aldrich, Dorset, UK 
Proteinase K     Sigma Aldrich, Dorset, UK  
Puregene Mouse Tail Kit   Gentra Systems, Minnesota, USA 
Putrescine     Sigma Aldrich, Dorset, UK 
Scott’s Tap Water Substitute  Surgipath, Cambridge, UK 
Selenium     MP Biomedicals, Ohio, USA 
Sodium chloride    Fisher Scientific, Leicestershire, UK  
Soyabean trypsin inhibitor   Sigma Aldrich, Dorset, UK 
Sucrose     Fisher Scientific, Leicestershire, UK 
Thyroxine     Sigma Aldrich, Dorset, UK 
Transferrin     Sigma Aldrich, Dorset, UK 
Tri-iodo-thyronine    Sigma Aldrich, Dorset, UK 
Triton X-100     Sigma Aldrich, Dorset, UK 
Trypsin     Invitrogen, Paisley, UK 
Vectabond     Vector Laboratories, Burlingame, USA 
Vectashield with DAPI   Vector Laboratories, Burlingame, USA 
Vector SG peroxidase substrate kit Vector Laboratories, Burlingame, USA  
Zinc Sulphate    VWR International Ltd, Poole, UK 
 
 
1.4 PCR reagents 
1.4.1 Agarose gel 
2 g agarose  
100 ml 1% TBS 
Microwave for 1.25 minutes 
Add 3.5 µl ethidium bromide 
 
 
1.4.2 Loading buffer 
2 ml of 2x TBE 
2 ml glycerol 
2 µl Orange G 
 
 
1.4.3 Master Mix 
For 1 sample: 
13.35 µl distilled water 
2.5 µl 10x PCR buffer 
0.5 µl of each 100 mM dNTP: A, C, G, T 
0.3 µl of each primer: PAGN3, PES4-bL, ALK5-3L 
2 µl of 25 mM MgCl2 
0.25 µl AmpliTaq Gold DNA polymerase  
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1.4.4 PCR primers 
1. PAGN3 (Neor sense)  
5’–GCC TGC TTG CCG AAT ATC ATG GTG GAA AAT-3’ 
2. PES4-bL (anti-sense) 
5’-GAA GAA TTC AAG ACT GTC TGT GAA ATT CTG-3’ 
3. AK5-3L (sense) 
 5’-TCC CCC GTG AGA GTC ACT CCT GTT ACT TCC-3’ 
 
 
1.5 Tissue culture reagents 
1.5.1 10% FBS with heregulin and forskolin (10%HF) 
10% FBS 
2µM forskolin 
20ng/ml beta-1 heregulin 
 
 
1.5.2 Bottenstein-Sato’s serum free media (DMEM-BS) 
25 µg/ml Gentamycin 
5 ng/ml Insulin 
50 ng/ml Transferrin 
0.011% SATO mix (see below) 
100 mM Glutamine  
in DMEM (1885) 
 
 
1.5.3 Collagenase 
1.33% Collagenase (6.6 mg/ml) 
in L15 
 
 
1.5.4 Differentiation Medium 
47.9 ml DMEM (1885) 
50 µl Biotin (10 ng/ml) 
250 µl N1 medium (see below) 
250 µl hydrocortisone (10 mM) 
583 µl 30% glucose  
1 ml Insulin (0.5 mg/ml) 
 
After 12 DIV Insulin is withdrawn from this media 
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1.5.5 Dubco’s Modified Eagle Medium with 10% FBS (10% FBS) 
10% FBS 
25 µg/ml Gentamycin 
100 mM Glutamine  
in DMEM (1885) 
 
 
1.5.6 Dubco’s Modified Eagle Medium with 1% FBS (1% FBS) 
1% FBS 
25 µg/ml Gentamycin 
100 mM Glutamine  
in DMEM (1885) 
 
 
1.5.7 OEC mitogen media with FBS (OMM+5%FBS) 
75% SATO 
5% FBS 
500 ng/ml FGF2 
50 ng/ml Heregulin 
5x10-7M Forskolin 
20% ACM (astrocyte conditioned medium) 
 
 
1.5.8 N1 medium 
1 mg/ml Apo-transferrin  
3.422 mg/ml Putrescine 
1.258 µg/ml Progesterone 
1.038 µg/ml Selenium 
 
 
1.5.9 Neurobasal/B27 
24.25 ml Neurobasal media without L-glutamine  
0.5 ml B27 supplement  
250 µl glutamax 
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1.5.10 Plating medium (PM) 
25% HBSS without Ca, Mg 
25% horse serum 
400 µl L-glutamine 
in DMEM (1885) 
 
 
1.5.11 SATO mix 
0.01288% BSA path-o-cyte 4 
72.5 µg/ml Putrescine 
180.2 µg/ml Thyroxine 
151.8 µg/ml Tri-iodo-thyronine 
28.1 µg/ml Progesterone 
17.4 µg/ml Selenium 
 
 
1.5.12 Soyabean trypsin inhibitor-DNAse (SD) 
0.52 mg/ml Soyabean trypsin inhibitor 
0.04 mg/ml bovine pancreas deoxyribonucelase (DNAse) 
3.0 mg/ml bovine serum albumin, fraction A 
in L15 
 
 
1.6 Immunocytochemistry reagents 
1.6.1 Acid Alcohol 
70 % ethanol 
1% concentrated hydrochloric acid 
 
 
1.6.2 Citric Acid Buffer, pH 6.0 
10 mM Citric acid 
 
 
1.6.3 4% paraformaldehyde 
40 g paraformaldehyde 
1 l PBS 
Solution heated to around 53 ºC 
Sodium hydroxide added until solution became clear 
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1.7 Macro: “percentage of BrdU positive nuclei”  
Dapi="blue"; 
BrDU="green"; 
None="red";     //Sets which colour channel holds which stain 
thresh = 40     //Value to set threshold at 
 
iTitle=getTitle; 
imageDirectory = getDirectory("image");  //get the directory where the open image is saved 
print (imageDirectory);      //record directory path to be analysed 
 
fList=getFileList(imageDirectory);  //save a list of all files in directory 
 
selectWindow(iTitle); 
run("Close");     //close the open image 
 
for (i=0; i<fList.length; i++){   //main loop - for each image in directory 
 
 if (endsWith(fList[i],"tif")) {   //check file to open is a *.tiff" image 
 
 open(imageDirectory + fList[i]);  //open the file 
run("RGB Color");    //make sure image is a 24-bit RGB file 
 
iTitle = getTitle;     //get the image's name 
iTitleDapi = iTitle + " (" + Dapi + ")"; 
iTitleBrDU = iTitle + " (" + BrDU + ")"; 
iTitleNone = iTitle + " (" + None + ")";  //work out names of colour channels 
 
run("RGB Split");    //split image into colour channels 
selectWindow(iTitleNone); 
run("Close");     //close the 3rd channel with nothing on it 
 
selectWindow(iTitleDapi);   //select the DAPI channel 
rename("dapi");     //rename it to "dapi" 
run("Subtract Background...", "rolling=50"); //subtract the background 
 
setThreshold(thresh, 255);   //set the threshold using value at the top 
run("Threshold", "thresholded remaining black"); //threshold it  
run("Watershed");    //separate nuclei that are close together 
run("Analyze Particles...", "minimum=15 maximum=500 bins=20 show=Nothing display clear"); 
DapiCount=nResults;    //analyse particles and count the number of nuclei 
run("Invert");     //invert, to allow image to be AND-ed with BrdU 
 
selectWindow(iTitleBrDU);   //Select BrdU channel 
rename("brdu");     //Rename it to “BrdU” 
run("Subtract Background...", "rolling=50"); //Subtract the background 
setThreshold(thresh, 255);   //Set the threshold 
run("Threshold", "thresholded remaining black"); //threshold it 
run("Invert");     //Invert to AND with DAPI 
run("Image Calculator...", "image1=[brdu] operation=AND image2=[dapi]"); 
//AND image with DAPI 
run("Threshold", "thresholded remaining black"); //Make sure the image is still thresholded 
run("Analyze Particles...", "minimum=15 maximum=500 bins=20 show=Nothing display clear"); 
BrDUCount=nResults;    //analyse particles and count the number of nuclei 
 
selectWindow("brdu");    //Close BrdU window 
run("Close"); 
selectWindow("dapi");    //Close DAPI window 
run("Close"); 
 
print (iTitle + "," + DapiCount + "," + BrDUCount + "," + (BrDUCount / DapiCount * 100));}} 
  //record the number of DAPI nuclei, BrdU nuclei and calculate BrdU/DAPI*100 
  //loop back and open the next image, or end the macro if all images are done 
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1.8 Macro: “quantitation of PLP labelling” 
thresh_red = 80; 
thresh_green = 67; 
thresh_blue = 128;     //Values to set thresholds at 
 
iTitle=getTitle; 
imageDirectory = getDirectory("image"); 
print (imageDirectory); 
print ("Image name,Red Black,Red White,Green Black,Green White,Blue Black,Blue White") 
//get the name of the open image, and the folder it came from 
fList=getFileList(imageDirectory);   //build a list of all images in the folder  
selectWindow(iTitle); 
run("Close");     //close window 
 
for (i=0; i<fList.length; i++){   //start the loop to open files 
if (endsWith(fList[i],"tif")) {   //check that file is a valid image 
open(imageDirectory + fList[i]);   //if it is valid, open it 
  
iTitle=getTitle; 
iTitleRed=iTitle + " (red)"; 
iTitleGreen=iTitle + " (green)"; 
iTitleBlue=iTitle + " (blue)";    //build names of color component images 
  
run("RGB Split");    //split image into colour components 
 
string="image1=["+iTitleGreen + "] operation=AND image2=[" + iTitleBlue+"] create"; 
run("Image Calculator...", string); 
iTitleAND = getTitle; 
setThreshold(thresh_blue, 255); 
run("Threshold", "thresholded remaining black"); 
run("Invert");     //get red and blue areas and threshold 
getStatistics(area, mean, min, max, std, histogram); 
n_blue_black=histogram[0]; 
n_blue_white=histogram[255];    //measure areas 
selectWindow(iTitleAND); 
run("Close"); 
selectWindow(iTitleBlue); 
run("Close");     //close windows 
 
selectWindow(iTitleRed); 
setThreshold(thresh_red, 255); 
run("Threshold", "thresholded remaining black"); 
run("Invert");     //get red threshold 
getStatistics(area, mean, min, max, std, histogram); 
n_red_black=histogram[0]; 
n_red_white=histogram[255];   //measure areas 
selectWindow(iTitleRed); 
run("Close");     //close window 
 
selectWindow(iTitleGreen); 
setThreshold(thresh_green, 255); 
run("Threshold", "thresholded remaining black"); 
run("Invert");     //get green threshold 
getStatistics(area, mean, min, max, std, histogram); 
n_green_black=histogram[0]; 
n_green_white=histogram[255];   //measure areas 
selectWindow(iTitleGreen); 
run("Close");     //close window 
  
print 
(iTitle+","+n_red_black+","+n_red_white+","+n_green_black+","+n_green_white+","+n_blue_black+
","+n_blue_white);}}     //display results 
